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Abstract 
Hypophonia, or reduced speech intensity, is frequently observed in individuals with 
Parkinson’s disease (PD). This speech deficit can impact speech intelligibility and 
communicative participation. However, there is little empirical evidence exploring the 
day-to-day variability of speech and communicative participation in individuals with PD. 
The purpose of this study is to investigate the temporal variability of acoustic and 
perceptual speech measures and psychosocial measures in individuals with hypophonia 
and PD. Additionally, this study seeks to examine the relationships among measures of 
speech intensity, speech intelligibility, self- and proxy-rated communicative participation, 
demographic factors, and non-speech factors. Twenty-three participants with PD, 23 
primary communication partners, and 30 control participants attended three experimental 
visits. At each visit, participants completed questionnaires related to speech loudness and 
communicative participation. Participants with PD and control participants also 
performed speech intensity and speech intelligibility tasks. Variability in habitual speech 
intensity and Lombard response slope was found for participants with PD. Differences 
were found in maximum speech intensity, magnitude production, speech intelligibility, 
and self-perceived typical speech loudness for participants with PD and control 
participants. The results revealed similar self- and proxy-ratings of speech loudness in 
participants with PD. A significant difference was found between participants with PD 
and control participants across self-rated communicative participation measures. Greater 
variability was observed for the Communicative Participation Item Bank (CPIB), six 
questions of the Communicative Effectiveness Survey (CES), and two subsections of the 
Voice Activity and Participation Profile (VAPP) in participants with PD. Self- and proxy-
rated communicative participation was comparable. Significant relationships were 
identified between maximum speech intensity and magnitude production, between speech 
intelligibility measures, between the CPIB and two VAPP subsections, between VAPP 
subsections, between proxy-ratings of typical speech loudness and six VAPP subsections, 
the CPIB and select CES questions, and VAPP subsections in participants with PD. A 
retest analysis involving reliability and repeatability estimates for all dependent measures 
was also reported. These findings contribute to the understanding of hypophonia in PD 
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and may provide context in the interpretation of treatment outcomes in this clinical 
population.  
Keywords 
Parkinson’s disease, hypophonia, speech intensity, speech intelligibility, communicative 
participation, retest reliability, repeatability, speech language pathology. 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
iv 
Summary for Lay Audience 
Hypophonia, or reduced speech loudness, is frequently observed in individuals with 
Parkinson’s disease (PD). This speech difficulty can impact an individual’s speech 
intelligibility (how understandable they are) and their communicative participation 
(engaging in situations where information is shared). However, there is little empirical 
evidence exploring the day-to-day variability of various speech and communication 
measures in individuals with PD. The purpose of this study is to investigate the 
variability of such measures in individuals with hypophonia and PD. Additionally, this 
study seeks to examine the relationships among measures of speech loudness, speech 
intelligibility, communicative participation, and other demographic and non-speech 
factors. Twenty-three participants with PD, 23 communication partners of participants 
with PD, and 30 control participants attended three experimental visits. At each visit, 
participants completed questionnaires related to speech loudness and communicative 
participation. Participants with PD and control participants also performed speech 
intensity and speech intelligibility tasks. Significant variability was found in various 
speech tasks in participants with PD, including habitual speech loudness and Lombard 
response function (how one’s speech loudness changes in the presence of background 
noise). Differences were found between participants with PD and control participants for 
various speech loudness, speech intelligibility, and communicative participation 
measures. Similar perceptions of speech loudness and communicative participation were 
found in participants with PD and their communication partners. Significant relationships 
were identified between select speech loudness, speech intelligibility, and communicative 
participation measures. These findings contribute to the understanding of hypophonia in 
PD and may facilitate the interpretation of treatment outcomes in this clinical population.   
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
v 
Acknowledgements 
 
I would like to extend my appreciation and gratitude to my supervisors, Dr. Scott Adams 
and Dr. Allyson Page, for their support and guidance throughout my degree and the 
completion of this project. Their assistance and contributions have been invaluable 
throughout every step of the way. I would also like to thank my advisory committee, Dr. 
Mandar Jog and Dr. Julie Theurer, for their guidance and expertise. Many thanks to my 
thesis examination committee, Dr. Julie Theurer, Dr. Jeff Holmes, Dr. Mary Jenkins, and 
Dr. Mark Hakel, for taking the time to read my thesis and ensuring a high caliber final 
product. 
 
These last six years would not have been possible without my parents, Diane Pardillo and 
John Mancinelli. Thank you for your unwavering encouragement and faith in me. Your 
unconditional love and support have allowed me to persevere and achieve my academic 
goals and realize that I am capable of accomplishing anything I chose to strive towards. I 
would also like to thank my brother and extended family for your love and 
encouragement throughout this journey. 
 
Thank you to my dearest friends and lab mates, Anita Abeyesekera, Thea Knowles, and 
Daryn Cushnie-Sparrow, and my treasured friends Caitlin Coughler, Anjana Balakrishna, 
and Meg Haggitt. Thank you for your friendship, support, and motivation. Thank you for 
helping me gain perspective, setting and accomplishing goals, and ensuring that I have 
balance in my life. I could not have asked for stronger and more supportive friends. 
 
Finally, I would like to express my deepest appreciation and thanks to all of the 
participants who generously donated their time to take part in this study. This project 
would not have been possible without them. 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
vi 
Table of Contents 
ABSTRACT ....................................................................................................................... II 
SUMMARY FOR LAY AUDIENCE ............................................................................... IV 
ACKNOWLEDGEMENTS ............................................................................................... V 
LIST OF TABLES ....................................................................................................... XVII 
LIST OF FIGURES ...................................................................................................... XXV 
LIST OF APPENDICES ............................................................................................. XXXI 
LIST OF ACRONYMS .............................................................................................. XXXII 
Chapter 1 ............................................................................................................................. 1 
1 Introduction ................................................................................................................. 1 
1.1 Hypophonia and Parkinson’s Disease ..................................................................... 1 
1.2 Regulation of Speech Intensity in Hypophonia and Parkinson’s Disease ............... 3 
1.2.1 Speech intensity in hypophonia and Parkinson’s disease .................................... 5 
1.2.2 The effect of background noise on speech intensity in hypophonia and 
Parkinson’s disease .......................................................................................................... 7 
1.3 Loudness Perception in Hypophonia and Parkinson’s Disease ............................. 10 
1.4 Speech Intelligibility in Hypophonia and Parkinson’s Disease ............................ 12 
1.4.1 The effect of background noise on speech intelligibility in hypophonia and 
Parkinson’s disease ........................................................................................................ 13 
1.5 Communicative Participation in Hypophonia and Parkinson’s Disease ............... 15 
1.5.1 Communicative Participation Item Bank .......................................................... 17 
1.5.2 Voice Activity and Participation Profile ........................................................... 17 
1.5.3 Communicative Effectiveness Survey ............................................................... 18 
1.6 Demographic and Non-Speech Factors in Hypophonia and Parkinson’s Disease 20 
1.7 Rationale for the Current Study ............................................................................. 22 
1.8  Purpose .................................................................................................................. 24 
CHAPTER 2 ...................................................................................................................... 27 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
vii 
2 METHODS ................................................................................................................ 27 
2.1 Participants ............................................................................................................ 27 
2.1.1  Participants with Parkinson’s disease ............................................................... 27 
2.1.2 Control participants ........................................................................................... 28 
2.1.3 Primary communication partners of participants with Parkinson’s disease ...... 28 
2.1.4 Listener participants .......................................................................................... 29 
2.2 Materials ................................................................................................................ 29 
2.2.1 Apparatus ........................................................................................................... 29 
2.2.2 Noise source ...................................................................................................... 30 
2.2.3 Audio recordings ............................................................................................... 30 
2.2.4  Speech intensity measures ............................................................................. 30 
2.2.5 Speech intelligibility measures .......................................................................... 31 
2.2.5.1 Sentence Intelligibility Test ....................................................................... 31 
2.2.5.2 Conversational intelligibility ..................................................................... 31 
2.2.6 Questionnaires ................................................................................................... 31 
2.2.6.1 Intake questions ......................................................................................... 31 
2.2.6.2 Montreal Cognitive Assessment ................................................................ 35 
2.2.6.3 Geriatric Depression Scale ........................................................................ 36 
2.2.6.4 Medication Effectiveness Scale ................................................................. 36 
2.2.6.4 Typical Loudness Scale ............................................................................. 36 
2.2.6.5 Communicative Effectiveness Survey ....................................................... 36 
2.2.6.6 Voice Activity and Participation Profile ................................................... 37 
2.2.6.7 Communication Participation Item Bank .................................................. 37 
2.2.6.8 Level of Speech Usage Scale .................................................................... 38 
2.3 Procedures ............................................................................................................. 38 
2.3.1 Visit 1 ................................................................................................................ 38 
2.3.2 Visit 2 ................................................................................................................ 43 
2.3.3 Visit 3 ................................................................................................................ 44 
2.3.4 Listener perceptual evaluation ........................................................................... 45 
2.3.4.1 Sentence Intelligibility Test ....................................................................... 45 
2.3.4.2 Conversational intelligibility ..................................................................... 46 
2.4 Data Analysis ......................................................................................................... 46 
2.4.1 Statistical analysis for objective 1: Speech intensity ......................................... 47 
2.4.2 Statistical analysis for objective 2: Typical speech loudness ............................ 49 
2.4.3 Statistical analysis for objective 3: Speech  intelligibility ................................. 50 
2.4.4 Statistical analysis for objective 4: Self-rated communicative participation .... 51 
2.4.5 Statistical analysis for objective 5: Self- and proxy-rated communicative 
participation ................................................................................................................... 52 
2.4.6 Statistical analysis for objective 7: Inter-relationships among variables in 
participants with Parkinson’s disease ............................................................................ 53 
2.4.7 Statistical analysis for objective 8: Inter-relationships among proxy-measures in 
participants with Parkinson’s disease ............................................................................ 53 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
viii 
2.4.8 Statistical analysis for objective 9: Inter-relationships among variables in 
control participants ........................................................................................................ 54 
CHAPTER 3 ...................................................................................................................... 55 
3 Results ....................................................................................................................... 55 
3.1 Statistical Power .................................................................................................... 55 
3.2 Reliability .............................................................................................................. 56 
3.3 Statistical Analysis for Objective 1: Speech Intensity .......................................... 58 
3.3.1 Habitual speech intensity ................................................................................... 58 
3.3.1.1 Retest analyses ........................................................................................... 61 
3.3.1.1.1 Retest analysis of habitual speech intensity for participants with 
Parkinson’s disease ................................................................................................ 62 
3.3.1.1.2 Retest analysis of habitual speech intensity for control participants .... 63 
3.3.2 Maximum speech intensity ................................................................................ 64 
3.3.2.1 Retest analyses ........................................................................................... 66 
3.3.2.1.1 Retest analysis of maximum speech intensity for participants with 
Parkinson’s disease ................................................................................................ 67 
3.3.2.1.2 Retest analysis of maximum speech intensity for control participants 68 
3.3.3 Lombard response function ............................................................................... 69 
3.3.3.1 Retest analyses ........................................................................................... 70 
3.3.3.1.1 Retest analysis of Lombard response function for participants with 
Parkinson’s disease ................................................................................................ 71 
3.3.3.1.2 Retest analysis of Lombard response function for control participants 72 
3.3.4 Magnitude production ....................................................................................... 72 
3.3.4.1 Retest analyses ........................................................................................... 74 
3.3.4.1.1 Retest analysis of magnitude production for participants with 
Parkinson’s disease ................................................................................................ 75 
3.3.4.1.2 Retest analysis of magnitude production for control participants ........ 76 
3.4 Statistical Analysis for Objective 2: Typical Speech Loudness ............................ 77 
3.4.1 Retest analyses ................................................................................................... 79 
3.4.1.1 Retest analysis of self-rated typical speech loudness for participants with 
Parkinson’s disease .................................................................................................... 80 
3.4.1.2 Retest analysis of self-rated typical speech loudness for control 
participants ................................................................................................................ 81 
3.4.1.3 Retest analysis of proxy-rated typical speech loudness by primary 
communication partners ............................................................................................ 82 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
ix 
3.5 Statistical Analysis for Objective 3: Speech Intelligibility ................................... 83 
3.5.1 SIT transcription scores ..................................................................................... 83 
3.5.1.1 Retest analyses ........................................................................................... 85 
3.5.1.1.1 Retest analysis of SIT transcription scores of participants with 
Parkinson’s disease ................................................................................................ 86 
3.5.1.1.2 Retest analysis of SIT transcription scores for control participants ..... 87 
3.5.2 SIT VAS scores ................................................................................................. 88 
3.5.2.1 Retest analyses ........................................................................................... 89 
3.5.2.1.1 Retest analysis of SIT VAS scores for participants with Parkinson’s 
disease….. .............................................................................................................. 90 
3.5.2.1.2 Retest analysis of SIT VAS scores for control participants ................. 91 
3.5.3 Conversational intelligibility VAS scores ......................................................... 92 
3.5.3.1 Retest analyses ........................................................................................... 93 
3.5.3.1.1 Retest analysis of VAS conversational intelligibility scores for 
participants with Parkinson’s disease .................................................................... 94 
3.5.3.1.2 Retest analysis of VAS conversational intelligibility scores for control 
participants ............................................................................................................ 95 
3.6 Statistical Analysis for Objective 4: Self-Rated Communicative Participation .... 96 
3.6.1 CES question scores .......................................................................................... 96 
3.6.1.1 Retest analyses ......................................................................................... 109 
3.6.1.1.1 Retest analysis of CES question 1 (Having a conversation with a family 
member or friends at home) scores for participants with Parkinson’s disease .... 110 
3.6.1.1.2 Retest analysis of CES question 1 (Having a conversation with a family 
member or friends at home) scores for control participants ................................ 111 
3.6.1.1.3 Retest analysis of CES question 2 (Participating in conversation with 
strangers in a quiet place) scores for participants with Parkinson’s disease ...... 112 
3.6.1.1.4 Retest analysis of CES question 2 (Participating in conversation with 
strangers in a quiet place) scores for control participants .................................. 114 
3.6.1.1.5 Retest analysis of CES question 3 (Conversing with a familiar person 
over the telephone) scores for participants with Parkinson’s disease ................. 114 
3.6.1.1.6 Retest analysis of CES question 3 (Conversing with a familiar person 
over the telephone) scores for control participants .............................................. 116 
3.6.1.1.7 Retest analysis of CES question 4 (Conversing with a stranger over the 
telephone) scores for participants with Parkinson’s disease ............................... 117 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
x 
3.6.1.1.8 Retest analysis of CES question 4 (Conversing with a stranger over the 
telephone) scores for control participants ............................................................ 118 
3.6.1.1.9 Retest analysis of CES question 5 (Being part of a conversation in a 
noisy environment (social gathering)) scores for participants with Parkinson’s 
disease….. ............................................................................................................ 119 
3.6.1.1.10 Retest analysis of CES question 5 (Being part of a conversation in a 
noisy environment (social gathering)) scores for control participants ................ 120 
3.6.1.1.11 Retest analysis of CES question 6 (Speaking to a friend when you are 
emotionally upset or you are angry) scores for participants with Parkinson’s 
disease….. ............................................................................................................ 121 
3.6.1.1.12 Retest analysis of CES question 6 (Speaking to a friend when you are 
emotionally upset or you are angry) scores for control participants ................... 123 
3.6.1.1.13 Retest analysis of CES question 7 (Having a conversation while 
travelling in a car) scores for participants with Parkinson’s disease .................. 123 
3.6.1.1.14 Retest analysis of CES question 7 (Having a conversation while 
traveling in a car) scores for control participants ............................................... 125 
3.6.1.1.15 Retest analysis of CES question 8 (Having a conversation with 
someone at a distance (across a room)) scores for participants with Parkinson’s 
disease….. ............................................................................................................ 126 
3.6.1.1.16 Retest analysis of CES question 8 (Having a conversation with 
someone at a distance (across a room)) scores for control participants ............. 127 
3.6.2 VAPP subsection scores ..................................................................... 128 
3.6.2.1 Retest analyses ......................................................................................... 140 
3.6.2.1.1 Retest analysis of VAPP self-perceived voice problem scores for 
participants with Parkinson’s disease .................................................................. 141 
3.6.2.1.2 Retest analysis of VAPP self-perceived voice problem scores for 
control participants .............................................................................................. 142 
3.6.2.1.3 Retest analysis of VAPP daily communication scores for participants 
with Parkinson’s disease ...................................................................................... 143 
3.6.2.1.4 Retest analysis of VAPP daily communication scores for control 
participants .......................................................................................................... 145 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xi 
3.6.2.1.5 Retest analysis of VAPP social communication scores for participants 
with Parkinson’s disease ...................................................................................... 146 
3.6.2.1.6 Retest analysis of VAPP social communication scores for control 
participants .......................................................................................................... 147 
3.6.2.1.7 Retest analysis of VAPP emotion scores for participants with 
Parkinson’s disease .............................................................................................. 148 
3.6.2.1.8 Retest analysis of VAPP emotion scores for control participants ...... 150 
3.6.2.1.9 Retest analysis of VAPP activity limitation scores for participants with 
Parkinson’s disease .............................................................................................. 150 
3.6.2.1.10 Retest analysis of VAPP activity limitation scores for control 
participants .......................................................................................................... 152 
3.6.2.1.11 Retest analysis of VAPP participation restriction scores for 
participants with Parkinson’s disease .................................................................. 153 
3.6.2.1.12 Retest analysis of VAPP participation restriction scores for control 
participants .......................................................................................................... 154 
3.6.2.1.13 Retest analysis of VAPP total scores for participants with Parkinson’s 
disease….. ............................................................................................................ 155 
3.6.2.1.14 Retest analysis of VAPP total scores for control participants ............ 157 
3.6.3 CPIB scores ..................................................................................................... 157 
3.6.3.1 Retest analyses ......................................................................................... 160 
3.6.3.1.1 Retest analysis of CPIB scores for participants with Parkinson’s 
disease….. ............................................................................................................ 160 
3.6.3.1.2 Retest analysis of CPIB scores for control participants ..................... 162 
3.6.4 LSUS scores .................................................................................................... 162 
3.6.4.1 Retest analyses ......................................................................................... 165 
3.6.4.1.1 Retest analysis of LSUS scores for participants with Parkinson’s 
disease….. ............................................................................................................ 165 
3.6.4.1.2 Retest analysis of LSUS scores for control participants .................... 167 
3.7 Statistical Analysis for Objective 5: Self- and Proxy-Rated Communicative 
Participation ..................................................................................................................... 167 
3.7.1 CES question scores ........................................................................................ 168 
3.7.1.1 Retest analyses ......................................................................................... 179 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xii 
3.7.1.1.1 Retest analysis of CES question 1 (Having a conversation with a family 
member or friends at home) scores for participants with Parkinson’s disease .... 180 
3.7.1.1.2 Retest analysis of CES question 1 (Having a conversation with a family 
member or friends at home) scores for primary communication partners .......... 180 
3.7.1.1.3 Retest analysis of CES question 2 (Participating in conversation with 
strangers in a quiet place) scores for participants with Parkinson’s disease ...... 181 
3.7.1.1.4 Retest analysis of CES question 2 (Participating in conversation with 
strangers in a quiet place) scores for primary communication partners ............. 181 
3.7.1.1.5 Retest analysis of CES question 3 (Conversing with a familiar person 
over the telephone) scores for participants with Parkinson’s disease ................. 182 
3.7.1.1.6 Retest analysis of CES question 3 (Conversing with a familiar person 
over the telephone) scores for primary communication partners ........................ 182 
3.7.1.1.7 Retest analysis of CES question 4 (Conversing with a stranger over the 
telephone) scores for participants with Parkinson’s disease ............................... 183 
3.7.1.1.8 Retest analysis of CES question 4 (Conversing with a stranger over the 
telephone) scores for primary communication partners ...................................... 183 
3.7.1.1.9 Retest analysis of CES question 5 (Being part of a conversation in a 
noisy environment (social gathering)) scores for participants with Parkinson’s 
disease….. ............................................................................................................ 184 
3.7.1.1.10 Retest analysis of CES question 5 scores (Being part of a conversation 
in a noisy environment (social gathering)) for primary communication 
partners….. .......................................................................................................... 184 
3.7.1.1.11 Retest analysis of CES question 6 (Speaking to a friend when you are 
emotionally upset or you are angry) scores for participants with Parkinson’s 
disease….. ............................................................................................................ 185 
3.7.1.1.12 Retest analysis of CES question 6 (Speaking to a friend when you are 
emotionally upset or you are angry) scores for primary communication 
partners…. ........................................................................................................... 185 
3.7.1.1.13 Retest analysis of CES question 7 (Having a conversation while 
traveling in a car) scores for participants with Parkinson’s disease ................... 186 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xiii 
3.7.1.1.14 Retest analysis of CES question 7 (Having a conversation while 
traveling in a care) scores for primary communication partners ........................ 186 
3.7.1.1.15 Retest analysis of CES question 8 (Having a conversation with 
someone at a distance (across a room)) scores for participants with Parkinson’s 
disease….. ............................................................................................................ 187 
3.7.1.1.16 Retest analysis of CES question 8 (Having a conversation with 
someone at a distance (across a room)) scores for primary communication 
partners….. .......................................................................................................... 187 
3.7.2 VAPP subsection scores .................................................................................. 188 
3.7.2.1 Retest analyses ......................................................................................... 197 
3.7.2.1.1 Retest analysis of VAPP self-perceived voice problem scores for 
participants with Parkinson’s disease .................................................................. 198 
3.7.2.1.2 Retest analysis of VAPP self-perceived voice problem scores for 
primary communication partners ......................................................................... 198 
3.7.2.1.3 Retest analysis of VAPP daily communication scores for participants 
with Parkinson’s disease ...................................................................................... 199 
3.7.2.1.4 Retest analysis of VAPP daily communication scores for primary 
communication partners ...................................................................................... 199 
3.7.2.1.5 Retest analysis of VAPP social communication scores for participants 
with Parkinson’s disease ...................................................................................... 200 
3.7.2.1.6 Retest analysis of VAPP social communication scores for primary 
communication partners ...................................................................................... 200 
3.7.2.1.7 Retest analysis of VAPP emotion scores for participants with 
Parkinson’s disease .............................................................................................. 201 
3.7.2.1.8 Retest analysis of VAPP emotion scores for primary communication 
partners 201 
3.7.2.1.9 Retest analysis of VAPP activity limitation scores for participants with 
Parkinson’s disease .............................................................................................. 202 
3.7.2.1.10 Retest analysis of VAPP activity limitation scores for primary 
communication partners ...................................................................................... 202 
3.7.2.1.11 Retest analysis of VAPP participation restriction scores for 
participants with Parkinson’s disease .................................................................. 203 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xiv 
3.7.2.1.12 Retest analysis of VAPP participation restriction scores for primary 
communication partners ...................................................................................... 203 
3.7.2.1.13 Retest analysis of VAPP total scores for participants with Parkinson’s 
disease 204 
3.7.2.1.14 Retest analysis of VAPP total scores for primary communication 
partners 204 
3.7.3 CPIB scores ..................................................................................................... 205 
3.7.3.1 Retest analyses ......................................................................................... 206 
3.7.3.1.1 Retest analysis of CPIB scores for participants with Parkinson’s disease
 206 
3.7.3.1.2 Retest analysis of CPIB scores for primary communication partners 207 
3.7.4 LSUS scores .................................................................................................... 207 
3.7.4.1.1 Retest analysis of LSUS scores for participants with Parkinson’s 
disease 209 
3.7.4.1.2 Retest analysis of LSUS scores for primary communication partners209 
3.8 Statistical Analysis for Objective 7: Inter-Relationships Among Variables in 
Participants with Parkinson’s Disease ............................................................................ 210 
3.8.1 Speech intensity measures ............................................................................... 217 
3.8.2 Speech intelligibility measures ........................................................................ 217 
3.8.3 Communicative participation measures .......................................................... 217 
3.8.4 Demographic and non-speech factors ............................................................. 218 
3.9 Statistical Analysis for Objective 8: Inter-Relationships Among Self- and Proxy-
Measures in participants with Parkinson’s Disease ........................................................ 219 
3.9.1 Speech intensity measures ............................................................................... 227 
3.9.2 Speech intelligibility measures ........................................................................ 227 
3.9.3 Communicative participation measures .......................................................... 228 
3.9.4 Demographic and non-speech factors ............................................................. 229 
3.10 Statistical Analysis for Objective 9: Inter-Relationships Among Variables in 
Control Participants ......................................................................................................... 230 
3.10.1 Speech intensity measures ........................................................................... 238 
3.10.2 Speech intelligibility measures .................................................................... 238 
3.10.3 Communicative participation measures ...................................................... 238 
3.10.4 Demographic and non-speech factors ......................................................... 239 
CHAPTER 4 .................................................................................................................... 241 
4 Discussion ................................................................................................................ 241 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xv 
4.1 Objective 1: Speech Intensity .............................................................................. 244 
4.1.1 Habitual speech intensity ................................................................................. 244 
4.1.2 Maximum speech intensity .............................................................................. 248 
4.1.3 Lombard response function ............................................................................. 250 
4.1.4 Magnitude production ..................................................................................... 252 
4.2 Objective 2: Typical Speech Loudness ............................................................... 254 
4.3 Objective 3: Speech Intelligibility ....................................................................... 257 
4.3.1 SIT transcription scores ................................................................................... 257 
4.3.2 SIT VAS scores ............................................................................................... 260 
4.3.3 VAS conversational intelligibility scores ........................................................ 262 
4.4 Objective 4: Self-Rated Communicative Participation ....................................... 266 
4.4.1 Communicative Effectiveness Survey ............................................................. 266 
4.4.2 Voice Activity and Participation Profile ......................................................... 269 
4.4.3 Communicative Participation Item Bank ........................................................ 271 
4.4.4 Level of Speech Usage Scale .......................................................................... 272 
4.5 Objective 5: Self- and Proxy-Rated Communicative Participation ..................... 274 
4.5.1 Communicative Effectiveness Survey ............................................................. 274 
4.5.2 Voice Activity and Participation Profile ......................................................... 276 
4.5.3 Communicative Participation Item Bank ........................................................ 278 
4.5.4 Level of Speech Usage Scale .......................................................................... 279 
4.6 Objective 7: Inter-Relationships Among Variables in Participants with 
Parkinson’s Disease ......................................................................................................... 280 
4.6.1 Speech intensity measures ............................................................................... 280 
4.6.2 Speech intelligibility measures ........................................................................ 283 
4.6.3 Communicative participation .......................................................................... 283 
4.6.4 Demographic and non-speech factors ............................................................. 286 
4.7 Objective 8: Inter-Relationships Among Proxy-Measures in Participants with 
Parkinson’s Disease ......................................................................................................... 288 
4.7.1 Proxy-rated speech loudness measures ........................................................... 288 
4.7.2 Speech intelligibility measures ........................................................................ 289 
4.7.3 Proxy-rated communicative participation ....................................................... 289 
4.7.4 Demographic and non-speech factors ............................................................. 291 
4.8 Objective 9: Inter-Relationships Among Variables in Control Participants ....... 292 
4.8.1 Speech intensity measures ............................................................................... 292 
4.8.2 Speech intelligibility measures ........................................................................ 292 
4.8.3 Communicative participation .......................................................................... 292 
4.8.4 Demographic and non-speech factors ............................................................. 294 
4.9 Study Limitations ................................................................................................ 294 
4.10 Future Directions ................................................................................................. 296 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xvi 
4.11 Clinical Implications ........................................................................................... 297 
4.12 Summary and Conclusion .................................................................................... 298 
REFERENCES ................................................................................................................ 304 
APPENDICES ................................................................................................................. 319 
CURRICULUM VITAE ................................................................................................. 352 
 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xvii 
List of Tables 
Table 1: Description of Demographic and Non-Speech Factors for Participants with 
Parkinson’s Disease ........................................................................................................... 33 
Table 2: Description of Demographic and Non-Speech Factors for Control Participants 34 
Table 3: Description of Demographic and Non-Speech Factors for Primary 
Communication Partners of Participants with Parkinson's Disease .................................. 35 
Table 4: Description of Diadochokinetic Rates (syllables/second) for Participants with 
Parkinson's Disease Across All Three Visits .................................................................... 40 
Table 5: Description of Voice Quality for Participants with Parkinson's Disease Across 
All Three Visits ................................................................................................................. 41 
Table 6: Description of Diadochokinetic Rates (syllables/second) for Control Participants 
Across all Three Visits ...................................................................................................... 42 
Table 7: Description of Voice Quality for Control Participants Across All Three Visits . 43 
Table 8: Inter-Rater Reliability for Listeners Across Measures of Speech Intelligibility . 57 
Table 9: Intra-Rater Reliability for Listeners Across Measures of Speech Intelligibility . 57 
Table 10: Descriptive Statistics of Speech Intensity Measures for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ........................... 60 
Table 11: Retest Analyses of Habitual Speech Intensity for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 ............................................... 62 
Table 12: Retest Analyses of Maximum Speech Intensity for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ........................... 67 
Table 13: Retest Analyses of Lombard Response Function for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ........................... 71 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xviii 
Table 14: Retest Analyses of Magnitude Production for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 ............................................... 75 
Table 15: Descriptive Statistics of Self- and Proxy-Rated Typical Speech Loudness for 
Participants with Parkinson's Disease, Primary Communication Partners of Participants 
with Parkinson's Disease, and Control Participants Across Visits 1, 2, and 3 .................. 78 
Table 16: Retest Analyses of Self- and Proxy-Rated Typical Speech Loudness for 
Participants with Parkinson's Disease, Primary Communication Partners of Participants 
with Parkinson's Disease, and Control Participants Across Visits 1, 2, and 3 .................. 80 
Table 17: Descriptive Statistics of Speech Intelligibility Measures for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ........................... 84 
Table 18: Retest Analyses of Sentence Intelligibility Transcription Scores for Participants 
with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ................... 86 
Table 19: Retest Analyses of Speech Intelligibility Test Visual Analogue Scale Scores for 
Participants with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 90 
Table 20: Retest Analyses of Conversational Intelligibility Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ........................... 94 
Table 21: Descriptive Statistics of Self- and Proxy-Rated Individual Questions of the 
Communication Effectiveness Survey for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 ................................................................................ 98 
Table 22: Multivariate Testing Analysis of Self-Rated Individual Questions of the 
Communicative Effectiveness Survey for Participants with Parkinson's Disease and 
Control Participants Across Visits 1, 2, and 3 ................................................................... 99 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xix 
Table 23: Univariate Testing Analysis of the Variability of Self-Rated Individual 
Questions of the Communicative Effectiveness Survey for Participants with Parkinson’s 
Disease and Control Participants Across Visits 1, 2, and 3 ............................................. 109 
Table 24: Retest Analyses of Communicative Effectiveness Survey Question 1 (Having a 
Conversation with a Family Member or Friends at Home) for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, and Control Participants Across Visits 1, 2, and 3 ............................................ 110 
Table 25: Retest Analyses of Communicative Effectiveness Survey Question 2 
(Participating in Conversation with Strangers in a Quiet Place) for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, and Control Participants Across Visits 1, 2, and 3 ............................................ 113 
Table 26: Retest Analyses of Communicative Effectiveness Survey Question 3 
(Conversing with a Familiar Person over the Telephone) for Participants with Parkinson's 
Disease, Primary Communication Partners of Participants with Parkinson’s Disease, and 
Control Participants Across Visits 1, 2, and 3 ................................................................. 115 
Table 27: Retest Analyses of Communicative Effectiveness Survey Question 4 
(Conversing with a Stranger over the Telephone) for Participants with Parkinson's 
Disease, Primary Communication Partners of Participants with Parkinson’s Disease, and 
Control Participants Across Visits 1, 2, and 3 ................................................................. 117 
Table 28: Retest Analyses of Communicative Effectiveness Survey Question 5 (Being 
Part of a Conversation in a Noisy Environment (Social Gathering)) for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, and Control Participants Across Visits 1, 2, and 3 ............................................ 119 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xx 
Table 29: Retest Analyses of Communicative Effectiveness Survey Question 6 (Speaking 
to a Friend When You are Emotionally Upset or You are Angry) for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, Control Participants Across Visits 1, 2, and 3 .................................................. 122 
Table 30: Retest Analyses of Communicative Effectiveness Survey Question 7 (Having a 
Conversation While Traveling in a Car) for Participants with Parkinson's Disease, 
Primary Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 .............................................................................. 124 
Table 31: Retest Analyses of Communicative Effectiveness Survey Question 8 (Having a 
Conversation with Someone at a Distance (Across a Room)) for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, and Control Participants Across Visits 1, 2, and 3 ............................................ 126 
Table 32: Descriptive Statistics of Self- and Proxy-Rated Individual Subsections of the 
Voice Activity and Participation Profile for Participants with Parkinson's Disease, 
Primary Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 .............................................................................. 130 
Table 33: Multivariate Testing Analysis of Self-Rated Individual Subsections of the 
Voice Activity and Participation Profile for Participants with Parkinson's Disease and 
Control Participants for Visits 1, 2, and 3 ....................................................................... 131 
Table 34: Univariate Testing Analysis of Self-Rated Individual Subsections of the Voice 
Activity and Participation Profile for Participants with Parkinson's Disease and Control 
Participants for Visits 1, 2, and 3 .................................................................................... 140 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxi 
Table 35: Retest Analyses of Voice Activity and Participation Profile Self-Perceived 
Voice Problem Subsection Scores for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 .............................................................................. 141 
Table 36: Retest Analyses of Voice Activity and Participation Profile Daily 
Communication Subsection Scores for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control Partners 
Across Visits 1, 2, and 3 .................................................................................................. 144 
Table 37: Retest Analyses of Voice Activity and Participation Profile Social 
Communication Subsection Scores for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 .............................................................................. 146 
Table 38: Retest Analyses of Voice Activity and Participation Profile Emotion 
Subsection Scores for Participants with Parkinson's Disease, Primary Communication 
Partners of Participants with Parkinson’s Disease, and Control Participants Across Visits 
1, 2, and 3 ........................................................................................................................ 149 
Table 39: Retest Analyses of Voice Activity and Participation Profile Activity Limitation 
Subsection Scores for Participants with Parkinson's Disease, Primary Communication 
Partners of Participants with Parkinson’s Disease, and Control Participants Across Visits 
1, 2, and 3 ........................................................................................................................ 151 
Table 40: Retest Analyses of Voice Activity and Participation Profile Participation 
Restriction Subsection Scores for Participants with Parkinson's Disease, Primary 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxii 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 .............................................................................. 153 
Table 41: Retest Analyses of Voice Activity and Participation Profile Total Subsection 
Scores for Participants with Parkinson's Disease, Primary Communication Partners of 
Participants with Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3
 ......................................................................................................................................... 156 
Table 42: Descriptive Statistics of Self- and Proxy-Rated Communicative Participation 
Item Bank for Participants with Parkinson's Disease, Primary Communication Partners of 
Participants with Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3
 ......................................................................................................................................... 159 
Table 43: Retest Analyses of Communicative Participation Item Bank Scores for 
Participants with Parkinson's Disease, Primary Communication Partners of Participants 
with Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3 ................ 161 
Table 44: Descriptive Statistics of Self- and Proxy-Rated Level of Speech Usage Scale 
for Participants with Parkinson's Disease, Primary Communication Partners of 
Participants with Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3
 ......................................................................................................................................... 164 
Table 45: Retest Analyses of Level of Speech Usage Scale for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, and Control Participants Across Visits 1, 2, and 3 ............................................ 166 
Table 46: Multivariate Testing Analysis of the Variability of Self-Rated Individual 
Questions of the Communicative Effectiveness Survey for Participants with Parkinson's 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxiii 
Disease and Primary Communication Partners of Participants with Parkinson’s Disease 
Across Visits 1, 2, and 3 .................................................................................................. 169 
Table 47: Univariate Testing Analysis of the Variability of Self-Rated Individual 
Questions of the Communicative Effectiveness Survey for Participants with Parkinson's 
Disease and Primary Communication Partners of Participants with Parkinson’s Disease 
Across Visits 1, 2, and 3 .................................................................................................. 171 
Table 48: Multivariate Testing Analysis of the Variability of Self-Rated Individual 
Subsections of the Voice Activity and Participation Profile for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 ................................................................. 189 
Table 49: Univariate Testing Analysis of the Variability of Self-Rated Individual 
Subsections of the Voice Activity and Participation Profile for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 ................................................................. 190 
Table 50: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Communicative Participation Measures, Demographic Factors, and Non-Speech Factors 
for Participants with Parkinson's Disease for Visit 1 ...................................................... 211 
Table 51: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Communicative Participation Measures, Demographic Factors, and Non-Speech Factors 
for Participants with Parkinson's Disease for Visit 2 ...................................................... 213 
Table 52: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Communicative Participation Measures, Demographic Factors, and Non-Speech Factors 
for Participants with Parkinson's Disease for Visit 3 ...................................................... 215 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxiv 
Table 53: Descriptive Statistics of Demographic and Non-Speech Factors for Participants 
with Parkinson's Disease and Control Participants ......................................................... 219 
Table 54: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Proxy-Rated Communicative Participation Measures, Demographic Factors, and Non-
Speech Factors for Participants with Parkinson's Disease for Visit 1 ............................. 221 
Table 55: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Proxy-Rated Communicative Participation Measures, Demographic Factors, and Non-
Speech Factors for Participants with Parkinson's Disease for Visit 2 ............................. 223 
Table 56: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Proxy-Rated Communicative Participation Measures, Demographic Factors, and Non-
Speech Factors for Participants with Parkinson's Disease for Visit 3 ............................. 225 
Table 57: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Communicative Participation Measures, Demographic Factors, and Non-Speech Factors 
for Control Participants for Visit 1 .................................................................................. 232 
Table 58: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Communicative Participation Measures, Demographic Factors, and Non-Speech Factors 
for Control Participants for Visit 2 .................................................................................. 234 
Table 59: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, 
Communicative Participation Measures, Demographic Factors, and Non-Speech Factors 
for Control Participants for Visit 3 .................................................................................. 236 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxv 
List of Figures 
Figure 1: Means of Habitual Speech Intensity for Participants with Parkinson's Disease 
and Control Participants Across Visits 1, 2, and 3 ............................................................ 61 
Figure 2: Means of Maximum Speech Intensity for Participants with Parkinson's Disease 
and Control Participants Across Visits 1, 2, and 3 ............................................................ 66 
Figure 3: Means of Lombard Response Function for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 ............................................... 70 
Figure 4: Means of Magnitude Production for Participants with Parkinson's Disease and 
Control Participants Across Visits 1, 2, and 3 ................................................................... 74 
Figure 5: Means of Typical Speech Loudness Perceptions by Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with Parkinson's 
Disease, and Control Participants Across Visits 1, 2, and 3 .............................................. 79 
Figure 6: Means of Speech Intelligibility Test Transcription Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ........................... 85 
Figure 7: Means of Speech Intelligibility Test Visual Analogues Scale Scores for 
Participants with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 89 
Figure 8: Means of Conversational Intelligibility Scores for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 ............................................... 93 
Figure 9: Means of Communicative Effectiveness Survey Question 1 (Having a 
Conversation with a Family Member or Friends at Home) Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ......................... 101 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxvi 
Figure 10: Means of Communicative Effectiveness Survey Question 2 (Participating in 
Conversation with Strangers in a Quiet Place) Scores for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 ............................................. 102 
Figure 11: Means of Communicative Effectiveness Survey Question 3 (Conversing with 
a Familiar Person over the Telephone) Scores for Participants with Parkinson's Disease 
and Control Participants Across Visits 1, 2, and 3 .......................................................... 103 
Figure 12: Means of Communicative Effectiveness Survey Question 4 (Conversing with 
a Stranger over the Telephone) Scores for Participants with Parkinson's Disease and 
Control Participants Across Visits 1, 2, and 3 ................................................................. 104 
Figure 13: Means of Communicative Effectiveness Survey Question 5 (Being Part of a 
Conversation in a Noisy Environment (Social Gathering)) Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ......................... 105 
Figure 14: Means of Communicative Effectiveness Survey Question 6 (Speaking to a 
Friend When You are Emotionally Upset or You are Angry) Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ......................... 106 
Figure 15: Means of Communicative Effectiveness Survey Question 7 (Having a 
Conversation While Traveling in a Car) Scores for Participants with Parkinson's Disease 
and Control Participants Across Visits 1, 2, and 3 .......................................................... 107 
Figure 16: Means of Communicative Effectiveness Survey Question 8 (Having a 
Conversation with Someone at a Distance (Across a Room)) Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ......................... 108 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxvii 
Figure 17: Means of Voice Activity and Participation Profile Self-Perceived Voice 
Problem Subsection Scores for Participants with Parkinson's Disease and Control 
Participants Across Visits 1, 2, and 3 .............................................................................. 133 
Figure 18: Means of Voice Activity and Participation Profile Daily Communication 
Subsection Scores for Participants with Parkinson's Disease and Control Participants 
Across Visits 1, 2, and 3 .................................................................................................. 134 
Figure 19: Means of Voice Activity and Participation Profile Social Communication 
Subsection Scores for Participants with Parkinson's Disease and Control Participants 
Across Visits 1, 2, and 3 .................................................................................................. 135 
Figure 20: Means of Voice Activity and Participation Profile Emotion Subsection Scores 
for Participants with Parkinson's Disease and Control Participants Across Visits 1, 2, and 
3 ....................................................................................................................................... 136 
Figure 21: Means of Voice Activity and Participation Profile Activity Limitation 
Subsection Scores for Participants with Parkinson's Disease and Control Participants 
Across Visits 1, 2, and 3 .................................................................................................. 137 
Figure 22: Means of Voice Activity and Participation Profile Participation Restriction 
Subsection Scores for Participants with Parkinson's Disease and Control Participants 
Across Visits 1, 2, and 3 .................................................................................................. 138 
Figure 23: Means of Voice Activity and Participation Profile Total Subsection Scores for 
Participants with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3
 ......................................................................................................................................... 139 
Figure 24: Means of Communicative Participation Item Bank Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ......................... 160 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxviii 
Figure 25: Means of Level of Speech Usage Scale Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 ......................... 165 
Figure 26: Means of Communicative Effectiveness Survey Question 1 (Having a 
Conversation with a Family Member or Friends at Home) scores for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 ................................................................. 172 
Figure 27: Means of Communicative Effectiveness Survey Question 2 (Participating in 
Conversation with Strangers in a Quiet Place) Scores for Participants with Parkinson's 
Disease and Primary Communication Partners of Participants with Parkinson’s Disease 
Across Visits 1, 2, and 3 .................................................................................................. 173 
Figure 28: Means of Communicative Effectiveness Survey Question 3 (Conversing with 
a Familiar Person over the Telephone) Scores for Participants with Parkinson's Disease 
and Primary Communication Partners of Participants with Parkinson’s Disease Across 
Visits 1, 2, and 3 .............................................................................................................. 174 
Figure 29: Means of Communicative Effectiveness Survey Question 4 (Conversing with 
a Stranger over the Telephone) Scores for Participants with Parkinson's Disease and 
Primary Communication Partners of Participants with Parkinson’s Disease Across Visits 
1, 2, and 3 ........................................................................................................................ 175 
Figure 30: Means of Communicative Effectiveness Survey Question 5 (Being Part of a 
Conversation in a Noisy Environment (Social Gathering)) Scores for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 ................................................................. 176 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxix 
Figure 31: Means of Communicative Effectiveness Survey Question 6 (Speaking to a 
Friend When You are Emotionally Upset or You are Angry) Scores for Participant with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 ................................................................. 177 
Figure 32: Means of Communicative Effectiveness Survey Question 7 (Having a 
Conversation While Traveling in a Car) Scores for Participants with Parkinson's Disease 
and Primary Communication Partners of Participants with Parkinson’s Disease Across 
Visits 1, 2, 3 ..................................................................................................................... 178 
Figure 33: Means of Communicative Effectiveness Survey Question 8 (Having a 
Conversation with Someone at a Distance (Across a Room)) Scores for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 ................................................................. 179 
Figure 34: Means of Voice Activity and Participation Profile Self-Perceived Voice 
Problem Subsection Scores for Participants with Parkinson's Disease and Primary 
Communication Partners of Participants with Parkinson’s Disease Across Visits 1, 2, and 
3 ....................................................................................................................................... 191 
Figure 35: Means of Voice Activity and Participation Profile Daily Communication 
Subsection Scores for Participants with Parkinson's Disease and Primary Communication 
Partners of Participants with Parkinson’s Disease Across Visits 1, 2, and 3 .................. 192 
Figure 36: Means of Voice Activity and Participation Profile Social Communication 
Subsection Scores for Participants with Parkinson's Disease and Primary Communication 
Partners of Participants with Parkinson’s Disease Across Visits 1, 2, and 3 .................. 193 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxx 
Figure 37: Means of Voice Activity and Participation Profile Emotion Subsection Scores 
for Participants with Parkinson's Disease and Primary Communication Partners of 
Participants with Parkinson’s Disease Across Visits 1, 2, and 3 ..................................... 194 
Figure 38: Means of Voice Activity and Participation Profile Activity Limitation 
Subsection Scores for Participants with Parkinson's Disease and Primary Communication 
Partners of Participants with Parkinson’s Disease Across Visits 1, 2, and 3 .................. 195 
Figure 39: Means of Voice Activity and Participation Profile Participation Restriction 
Subsection Scores for Participants with Parkinson's Disease and Primary Communication 
Partners of Participants with Parkinson’s Disease Across Visits 1, 2, and 3 .................. 196 
Figure 40: Means of Voice Activity and Participation Profile Total Subsection Scores for 
Participants with Parkinson's Disease and Primary Communication Partners of 
Participants with Parkinson’s Disease Across Visits 1, 2, and 3 ..................................... 197 
Figure 41: Means of Communicative Participation Item Bank Scores for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 ................................................................. 206 
Figure 42: Means of Level of Speech Usage Scale Scores for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 ................................................................. 208 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxxi 
List of Appendices 
Appendix A: Geriatric Depression Scale - 15-Item Short Form ..................................... 319 
Appendix B: Medication Effectiveness Scale ................................................................. 320 
Appendix C: Typical Speech Loudness .......................................................................... 321 
Appendix D: Communication Effectiveness Survey ....................................................... 322 
Appendix E: Voice Activity and Participation Profile .................................................... 323 
Appendix F: Communication Participation Item Bank ................................................... 326 
Appendix G: Level of Speech Usage Scale ..................................................................... 327 
Appendix H: Letter of Information for Participants with Parkinson's Disease ............... 328 
Appendix I: Consent Form for Participants with Parkinson's Disease ............................ 333 
Appendix J: Letter of Information for Control Participants ............................................ 334 
Appendix K: Consent Form for Control Participants ...................................................... 339 
Appendix L: Letter of Information for Primary Communication Partners of Participants 
with Parkinson's Disease ................................................................................................. 340 
Appendix M: Consent Form for Primary Communication Partners of Participants with 
Parkinson's Disease ......................................................................................................... 345 
Appendix N: Letter of Information for Listeners ............................................................ 346 
Appendix O: Consent Form for Listeners ....................................................................... 350 
Appendix P: Visual Analogue Scale for Ratings of Speech Intelligibility ..................... 351 
 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxxii 
List of Acronyms 
PD  Parkinson’s disease 
IWPD  Individuals with Parkinson’s disease 
dB  Decibels 
SPL  Sound pressure level 
LSVT  Lee Silverman Voice Treatment 
SIT  Sentence Intelligibility Test 
WHO  World Health Organization 
ICF  International Classification of Functioning, Disability, and Health 
PRO  Patient-reported outcome measures 
CPIB  Communicative Participation Item Bank 
VAPP   Voice Activity and Participation Profile 
CES   Communicative Effectiveness Survey 
UPDRS Unified Parkinson’s Disease Rating Scale 
LSUS  Level of Speech Usage Scale 
HL   Hearing level 
Hz  Hertz 
MOCA Montreal Cognitive Assessment 
GDS-15 Geriatric Depression Scale – short form 
MES  Medication Effectiveness Scale 
m  Meters 
cm  Centimeters 
kHz  Kilohertz 
TLS   Typical Loudness Scale 
VAS  Visual analogue scale 
CETI-M Communicative Effectiveness Index – Modified 
CETI  Communicative Effectiveness Index 
ANOVA Analysis of variance 
SEM  Standard error of measurement 
CR  Repeatability coefficient 
CR%  Percent coefficient of repeatability 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
 
xxxiii 
ICC  Interclass correlations 
SRD%  Smallest real difference percentage 
MANOVA Multivariate analysis of variance 
MDD  Minimum detectable difference 
VHI  Voice Handicap Index 
PROMIS Patient Reported Outcomes Measurement Information System 
PDQ-8  Parkinson’s Disease Questionnaire - 8 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
1 
Chapter 1 
1 Introduction 
 
Parkinson’s disease (PD) is a progressive neurodegenerative disease that typically affects 
individuals between the ages of 60 and 70 years (Adams & Jog, 2009). The hallmark 
motor features of PD: tremor, bradykinesia, rigidity, and postural instability, typically 
appear once 50 – 60% and 80% of dopamine has been depleted in the substantia nigra, 
and striatum, respectively (Duffy, 2013; Sapir, 2014; Schneider & Obeso, 2014; 
Wirdefeldt, Adami, Cole, Trichopoulos, & Mandel, 2011). The degeneration of 
dopaminergic pathways can also result in speech difficulties (Duffy, 2013; Sapir, 2014).  
 
Over the course of the disease, approximately 70 – 90% of individuals with PD (IWPD) 
will develop a variety of speech impairments, collectively referred to as hypokinetic 
dysarthria (Sapir, 2014). Darley, Aronson, and Brown (1969a; 1969b) coined the term 
hypokinetic dysarthria in order to describe the most common characteristics of 
Parkinsonian speech. The distinctive features of hypokinetic dysarthria include 
monopitch, reduced stress, monoloudness, reduced loudness, imprecise consonants, 
inappropriate silences, short rushes of speech, harsh voice, breathiness, low pitch, and 
variable rates of speech (Darley et al., 1969a; 1969b; Duffy, 2013). While it is unlikely 
for any one IWPD to express all of the above described speech features, there is a variety 
in symptom manifestation, suggesting heterogeneity in the dysarthric profiles of IWPD 
(Duffy, 2013).  
1.1 Hypophonia and Parkinson’s Disease 
 
Hypophonia, or reduced speech intensity, is a commonly treated and highly debilitating 
speech feature of Parkinsonian speech, affecting an estimated 50% of IWPD (Adams, 
Dykstra, Abrams, Winnell, Jenkins, & Jog, 2006a; Adams, Dykstra, Jenkins, & Jog, 
2008; Adams, Haralabous, Dykstra, Abrams, & Jog, 2005; Adams, Moon, Dykstra, 
Abrams, Jenkins, & Jog, 2006b; Dykstra, Adams, & Jog, 2012a). Additionally, 
hypophonia frequently emerges as an initial speech symptom in the early stages of PD 
(Dykstra et al., 2012a; Dykstra, Adams, & Jog, 2015). While hypokinetic dysarthria 
affects the vast majority of IWPD over the course of the disease, 30% of hypokinetic 
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speakers consider hypophonia, along with other aspects of their speech impairments, to 
be among the most devastating of their PD-related symptoms (Berke, Gerratt, Kreiman, 
& Jackson, 1999). Challenges frequently experienced by individuals with hypophonia 
include difficulty being heard in social settings, and numerous requests from 
communication partners to speak louder and to repeat themselves (Adams et al., 2006a; 
Adams et al., 2006b; Dykstra et al., 2012a).   
 
Hypophonia can also have a negative impact on the acoustics of an individual’s speech 
production (Kwan & Whitehill, 2011; Tjaden, Richards, Kuo, Wilding, & Sussman, 
2013). Judgements pertaining to the severity of an individual’s hypophonia may be made 
via acoustic measures, including but not limited to habitual speech intensity, intensity 
decay, and intensity variability (Adams, Winnell, & Jog, 2010; Ho, Iansek, & Bradshaw, 
2001; McCaig, Adams, Dykstra, & Jog, 2016; Rosen, Kent, Delaney, & Duffy, 2006; 
Rosen, Kent, & Duffy, 2005;). 
 
The habitual speech intensity of individuals with hypophonia and PD is typically reduced 
by 2 – 5 decibels (dB) sound pressure level (SPL) compared to healthy speakers (Adams 
et al., 2010). This difference can be quite dramatic, as a reduction of 4 dB SPL in speech 
intensity is equivalent to a 40% decrease in the perceived loudness level (McCaig et al., 
2016). Intensity decay is defined as the declination of an individual’s speech intensity 
(Ho et al., 2001; Rosen et al., 2005). Intensity decay can be calculated by examining the 
average and peak intensity of a syllable or prolonged vowel, as well by examining the 
intensity contour of a sentence or conversation (Rosen et al., 2005). Furthermore, the rate 
and amount of intensity declination can be observed (Ho et al., 2001; Rosen, et al., 2005). 
To some extent, intensity decay naturally occurs in speech tasks, such as at the end of 
declarative sentences (Rosen et al., 2005). However, individuals with hypophonia and PD 
have demonstrated a larger declination in intensity than control participants in vowel 
prolongation and syllable repetition, but not in conversational tasks, and with inconsistent 
results for sentence reading tasks (Ho et al., 2001; Rosen et al., 2005). It has been 
suggested that neurological differences are present in speech and non-speech motor tasks 
(Kent, 2004). These differences may include the complex and unique musculature 
associated with the speech system, the functional differences of the craniofacial, lingual, 
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and laryngeal muscles as compared to skeletal muscles, and the effects of medical 
intervention. The task-specific intensity decay reported by Rosen and colleagues (2005) 
may suggest that declination is the result of the interference between sub-processes 
required for the tasks described by Kent (2004), in addition to task demands or goals.  
Intensity variability is the standard deviation observed in the intensity contour of an 
utterance (Rosen et al., 2006). While intensity variability is typically observed during 
conversational speech, the proportion of variability appears to differ in IWPD and healthy 
speakers (Rosen et al., 2006). Rosen and colleagues (2006) found that overall intensity 
variability was reduced in IWPD compared to control participants during sentence and 
conversational tasks, at levels of 5.4 dB SPL and 6.5 dB SPL, respectively. Additionally, 
the speech intensity range of individuals with hypophonia may also be reduced (Adams & 
Dykstra, 2009; Darley et al., 1969a; 1969b; Darley, Aronson, & Brown,1975). Decreased 
intensity variability in conjunction with reduced speech intensity range may contribute to 
the perception of monoloudness in the speech of IWPD (Adams & Dykstra, 2009; Darley 
et al., 1969a; 1969b; 1975). While there are numerous methods to assess an individual’s 
speech intensity, the mechanisms that regulate speech intensity in IWPD are poorly 
understood.  
1.2 Regulation of Speech Intensity in Hypophonia and 
Parkinson’s Disease 
 
The progressive nature of PD often results in a variety of physiological and anatomical 
changes, which may manifest as various motor and non-motor symptoms observed in PD 
(Duffy, 2013). Hypophonia may be a manifestation of complex interactions among the 
neurodegenerative physiological and anatomical changes associated with PD. It is 
believed that the neurological system, and consequently neurological impairments, has a 
significant impact on the regulation of speech intensity in individuals with hypophonia 
and PD (Arnold, Gehrig, Gispert, Seifried, & Kell, 2014; Braak, Ghebremedhin, Rüb, 
Bratzke, & Del Tredici, 2004; Clark, Adams, Dykstra, Moodie, & Jog, 2014; Conte, 
Khan, Defazio, Rothwell, & Berardelli, 2013; Ho, Iansek, & Bradshaw, 1999b; Kempler 
& Van Lancker, 2002). Many functional and structural changes in PD are believed to be 
governed by dysfunctional basal ganglia, and these functional and structural changes are 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
4 
hypothesized to be the underlying cause of speech impairments such as hypophonia in 
IWPD (Ho et al., 1999b). 
 
The basal ganglia are dopamine-modulated subcortical structures that are impacted in PD 
(Sapir, 2014). The dopamine depletion observed in PD affects all of the structures 
comprising the basal ganglia, particularly the globus pallidus, subthalamic nucleus, 
substantia nigra, and striatum; the latter of which is composed of the caudate nucleus and 
putamen (Sapir, 2014). While it has been demonstrated that a reduction of dopamine 
within these structures results in the classic motor symptoms associated with PD, it has 
been suggested that basal ganglia pathology and direct cortico-striatal pathways 
connecting the ipsilateral caudate nucleus to the dorsolateral prefrontal cortex can be 
attributed to the development of hypokinetic dysarthria symptoms associated with PD, 
including hypophonia, (Arnold et al., 2014; Sapir, 2014). However, several studies 
suggest that the presentation of hypokinetic dysarthria may also be related to pathologies 
in non-dopaminergic structures and pathways at earlier stages of PD development (Braak 
et al., 2004; Sapir, 2014). Several of these key neural structures, such as the striatum, are 
involved in motor and sensory activities, as well as sensorimotor integration (Conte et al., 
2013; Kempler & Van Lancker, 2002). These functions include the regulation of muscle 
tone, coordinating and stabilizing the body during voluntary movements, scaling the 
force, amplitude, and duration of movements, adapting movements to suit the 
environment, as well as play a role in learning, planning, and initiating movements 
(Duffy, 2013). Therefore, it has been hypothesized that the presentation of hypophonia 
may be causally related to a sensorimotor integration deficit in IWPD (Clark et al., 2014; 
Ho, Bradshaw, & Iansek, 2000).  
 
Sensorimotor integration typically uses the available sensory information in order to 
monitor, plan, and execute movement, and is typically impaired in IWPD (Clark et al., 
2014; Ho et al., 2000). Thus, individuals with hypophonia and PD may demonstrate 
evidence of sensory and somatosensory deficits in addition to sensorimotor integration 
deficits, as evidenced by reduced speech intensity and impaired loudness perception 
(Clark et al., 2014; Conte et al., 2013; Ho et al., 2000). 
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1.2.1 Speech intensity in hypophonia and Parkinson’s 
disease 
 
As discussed previously, differences in the habitual speech intensity of individuals with 
hypophonia compared to healthy speakers can be quite dramatic (Adams et al., 2010; 
McCaig et al., 2016). In addition, hypophonia may be assessed via several acoustic 
measures, including habitual speech intensity, intensity decay, and intensity variability 
(Adams et al., 2010; Ho et al., 2001; McCaig et al., 2016; Rosen et al., 2006; Rosen et al., 
2005). However, anecdotal evidence suggests that IWPD and hypophonia may 
experience a range in their day-to-day speech intensity. Little is known about the natural 
variability of individuals’ speech in everyday situations. While many studies have 
examined the day-to-day speech behaviours of teachers (Astolfi et al., 2012; Astolfi, 
Puglisi, Pavese, & Carullo, 2014; Bottalico, & Astolfi, 2012; Franca, 2013; Schmidt, 
Andrews, & McCutcheon, 1998), few studies have examined speech patterns and 
behaviours in individuals with speech and voice disorders (Fox & Ramig, 1997; Ramig, 
Sapir, Fox, & Countryman, 2001; Sapir, Spielman, Ramig, Story, & Fox, 2007; 
Schalling, Gustafsson, Ternström, Bulukin Wilén, & Södersten, 2013).  A study by 
Schalling and colleagues (2013) tracked daily voice use over three weeks in six IWPD 
and hypophonia. Participants wore a VoxLog which recorded their speech intensity and 
the general noise level.  A range of 11 dB was observed over the course of three weeks, 
which may demonstrate a potential for a substantial degree of day-to-day variation and 
individual differences in a population of IWPD and hypophonia. 
 
The previously described study by Schalling and colleagues (2013) appears to be the only 
published study to have examined the long-term daily speech behaviours of individuals 
with hypophonia and PD. However, several other studies have explored the variations of 
speech intensity and self-perceptions of communication in IWPD and hypophonia (Fox & 
Ramig, 1997; Ramig et al., 2001; Sapir et al., 2007). Ramig and colleagues (2001) 
explored the effect of Lee Silverman Voice Treatment (LSVT) on speech intensity in 
IWPD and hypokinetic dysarthria. Fourteen IWPD receiving LSVT, 14 IWPD not 
receiving treatment, and 14 control participants were recorded while performing four 
speech tasks on seven different occasions: three times within two weeks prior to onset 
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group, twice immediately following the completion of LSVT, and twice six months 
following the completion of LSVT. The results demonstrated that the speech intensity of 
participants not receiving treatment remained relatively consistent across all speech tasks 
at each of the three time points, with mean intensity ranging from 69.3 – 71.9 dB, across 
all time points and speech tasks.  
 
Similarly, Sapir and colleagues (2007) sought to explore the impact of LSVT on the 
articulation and intensity of vowels in IWPD and dysarthria. Fourteen IWPD who 
received LSVT, 15 IWPD who did not receive speech treatment, and 14 control 
participants were audio recorded while reading three different phrases during each visit in 
order to obtain speech intensity levels for each of the vowels /i/, /u/, and /a/. Speech 
recordings were collected for all participants on three different days prior to LSVT onset, 
as well as on two different days following the completion of LSVT. The average speech 
intensity for these vowels of the IWPD who received treatment ranged from 72.6 – 73.6 
dB, in the pre- and post-LSVT conditions. Non-significant differences were also observed 
between pre- and post-LSVT values for the IWPD who did not receive treatment.  
 
Fox and Ramig (1997) examined the speech intensity of 15 male and 15 female IWPD 
and dysarthria, and seven male and seven female control participants. Participants 
attended three visits during a four-day period, wherein they completed four speech tasks 
at every visit. The results demonstrated that the speech intensity differences among all 
four groups were statistically different from one another. It was also reported that the 
speech intensity of IWPD was 2 – 4 dB lower than that of control participants. 
Additionally, the IWPD demonstrated a smaller variability of speech intensity compared 
to control participants, as demonstrated by their smaller standard deviations.   
 
It is important to note that the above-mentioned studies reported the range and standard 
deviations of speech intensity measures for their participants. (Fox & Ramig, 1997; Sapir 
et al., 2007; Schalling et al. 2013). However, measurements such as interclass 
correlations (ICC) and coefficients of repeatability (CR) would provide greater 
information. ICC are used to assess the correlation between multiple sets of 
measurements and incorporates the consistency of within-subject measures and the 
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average change of a group mean over time (Vaz, Falkmer, Passmore, Parsons, & 
Andreou, 2013). The CR, also referred to as the Smallest Real Difference and the 
Minimal Detectable Difference (Beckerman et al., 2001; Furlan & Sterr, 2018; Steffen & 
Seney, 2008), is the value below which the absolute differences between two 
measurements would lie with 0.95 probability (Vaz, et al., 2013).  In other words, 
difference values above the CR would reflect 95% probability of a true level of change as 
opposed to a difference that may simply be due to measurement error. It is also suggested 
that CR reflects the minimal detectable true level of change of an outcome measure. 
Examining the retest reliability and repeatability of speech intensity in IWPD and 
hypophonia via ICC and CR may provide valuable insight into the variability of the 
measure. 
1.2.2 The effect of background noise on speech intensity 
in hypophonia and Parkinson’s disease 
 
The Lombard effect is described as an involuntary and reflexive increase in speech 
intensity in the presence of background noise (Brumm & Zollinger, 2011; Garnier & 
Henrich, 2014). This reflex serves to monitor and adjust one’s speech intensity as needed 
in order to ensure appropriate speech intensity levels with communication partners in the 
presence of background noise (Brumm & Zollinger, 2011; Dykstra et al., 2012a). The 
Lombard effect is present in individuals with hypophonia and PD, as well as healthy 
individuals without neurological disease (Adams & Lang, 1992; Adams et al., 2005; 
Stathopoulos et al., 2014).  
 
Adams and Lang (1992) explored the effect of 90 dB SPL of white background noise on 
the speech intensity of 10 IWPD during a reading task. All participants demonstrated a 
Lombard response, with observed increases in speech intensity levels ranging from 2.1 – 
7.5 dB SPL. The high degree of variability of the speech intensity increase in IWPD may 
suggest individual differences with regard to a Lombard response (Adams & Lang, 
1992). These authors suggest that there may be individual differences in the levels of 
background noise needed for IWPD to achieve similar increases in speech intensity.  
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A similar study by Stathopoulos and colleagues (2014) examined responses to the 
Lombard effect in 33 IWPD during a speech task. The intensity level of the background 
noise presented to participants increased until participants’ speech intensities were an 
average of 3 dB SPL higher than their habitual speech intensity. The manipulation 
resulted in 79% of participants with PD speaking with increased speech intensity in the 
presence of background noise. The authors did not report any data regarding the intensity 
level of background noise presented. However, it is possible that the manipulation of the 
level of background noise by Stathopoulos and colleagues (2014) for each participant to 
achieve a similar increase in speech intensity is related to the individual variability in the 
Lombard response previously discussed by Adams and Lang (1992).  
 
While several studies have examined the Lombard effect in individuals with hypophonia 
and PD (Adams et al., 2006a; Adams et al. 2005; Adams & Lang, 1992; Dykstra et al., 
2012a; Ho, Bradshaw, Iansek, & Alfredson, 1999a; Stathopoulos et al., 2014), few 
studies have attempted to delineate potential relationships among speech intensity and 
different intensity levels (i.e., ranging from 50-90 dB) and types (i.e., pink, instrumental 
music, and multi-talker) of background noise presented (Adams et al. 2006a; Adams et 
al., 2005; Adams & Lang, 1992). Adams and colleagues (2005) investigated whether 
such a relationship between speech intensity and type of background noise existed by 
having 10 individuals with hypophonia and PD and 10 control participants repeat 
sentences in five multi-talker background noise conditions. These researchers found that 
a Lombard response was elicited in both experimental groups, however IWPD 
consistently produced speech intensity levels that were 2 – 3 dB SPL lower than control 
participants across all background noise conditions. In 2006a, Adams and colleagues 
sought to investigate the effect of different types of background noise on speech intensity. 
In their study, 23 IWPD and hypophonia and 15 control participants conversed for two 
minutes in the presence of three types of background noise (i.e., multi-talker noise, 
instrumental music, and pink noise), each presented at five different intensity levels. Both 
groups of participants demonstrated the Lombard sign, however the speech intensity 
levels of IWPD was on average 3 – 5 dB SPL lower than that of their healthy 
counterparts. Significant differences between types of background noise were only 
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observed with pink noise and multi-talker noise when presented at specific intensity 
levels. The speech intensity of IWPD was 0.66 dB SPL higher in the presence of 70 dB 
SPL of multi-talker noise, as compared to 70 dB SPL of pink noise. The speech intensity 
of control participants was 0.69 dB SPL higher in the presence of 70 dB SPL of multi-
talker noise, compared to 70 dB SPL of pink noise. The speech intensity of control 
participants was also 0.74 dB SPL higher in the presence of 55 dB SPL of multi-talker 
noise, compared to 55 dB SPL of pink noise. These results support the findings of Adams 
and colleagues (2005) and suggest that the relationship between speech intensity and 
background noise for individuals with hypophonia and PD is similar, but attenuated, in 
comparison to the response of control participants. Additionally, the results of Adams and 
Lang (1992) may suggest that multi-talker background noise, compared to pink noise or 
instrumental music, may be more beneficial in eliciting a Lombard response in IWPD and 
healthy individuals without neurological impairment.  
 
Dykstra and colleagues (2012a) investigated maximum intensity, habitual intensity, and 
the effect of various intensity levels of background noise (ranging from 50 – 70 dB SPL) 
on the conversational speech intensity of 30 individuals with hypophonia and 15 control 
participants. Participants with PD demonstrated reduced maximum intensity of 
approximately 10 dB SPL compared to control participants. Participants with PD 
demonstrated reduced habitual intensity of approximately 5 dB compared to control 
participants. Both groups of participants demonstrated a Lombard response during the 
conversational speech task. However, the conversational speech intensity levels of IWPD 
were reduced by approximately 5 dB across noise conditions. The conversational 
intensity response pattern in IWPD was parallel, but attenuated, compared to the response 
pattern of control participants. The findings from this study further support the previously 
identified parallel but attenuated Lombard effect (Adams et al., 2006a; Adams et al., 
2005) in individuals with hypophonia and PD compared to control participants. 
 
In sum, the literature demonstrates that while individual responses to the Lombard effect 
may vary, the presence of background noise naturally facilitates the ability of individuals 
with hypophonia and PD to increase their speech intensity. Furthermore, the performance 
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of IWPD parallels that of control participants regardless of the type of noise used to elicit 
the Lombard effect.  
 
Additionally, noise may play multiple roles in communication in individuals with 
hypophonia and PD. In addition to increasing speech intensity, background noise may 
also influence listener perceptions of hypophonia severity, and potentially introduce 
communication challenges, such as reducing the speech intelligibility (Adams et al., 
2008; Dykstra, Adams, & Jog, 2012b) and communicative participation (Baylor, Burns, 
Eadie, Britton, & Yorkston, 2011) of individuals with hypophonia. 
1.3 Loudness Perception in Hypophonia and Parkinson’s 
Disease 
 
Individuals with hypophonia and PD may be unaware of their reduced speech loudness 
level (Adams & Dykstra, 2009; Clark et al., 2014; Fox & Ramig, 1997; Ho et al., 2000; 
Huber, Stathopoulos, Ramig, & Lancaster, 2003). Individuals with hypophonia are 
frequently requested by communication partners to speak louder and to repeat themselves 
(Dykstra et al., 2012a). A number of studies have explored loudness perception in this 
population (Clark et al., 2014; Fox & Ramig, 1997; Ho et al., 2000). 
 
Ho and colleagues (2000) examined the ability of 15 individuals with hypophonia and PD 
and 15 control participants to perceive the loudness level of their own speech production. 
Participants were audio-recorded using their soft, normal, and loud voice while 
completing a reading task, and while engaged in conversation. Participants then adjusted 
a volume control knob to indicate the loudness level at which they had just spoken. These 
volume adjustments were completed twice: immediately following each speech 
production, and after replaying the recorded sample. The authors found that IWPD 
significantly over-estimated their spoken loudness levels during both reading and 
conversational tasks compared to control participants. These observed discrepancies 
between perceived and produced speech intensity levels may suggest impaired 
sensorimotor integration deficits in individuals with hypophonia and PD (Ho et al., 2000). 
 
A recent study by Clark and colleagues (2014) sought to compare loudness perception in 
17 individuals with hypophonia and PD and 25 control participants. Participants 
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completed a magnitude estimation task, an imitation task, and a magnitude production 
task, all involving a five-word target sentence. During the magnitude estimation task, 
participants rated the loudness of the target sentence when presented at 60, 65, 70, 75, 
and 80 dB SPL. Prior to beginning the task, a 70 dB SPL presentation of the target 
sentence was assigned a value of 100. During the imitation task, participants repeated the 
target sentence at the same speech intensity at which it was presented (60, 65, 70, 75, and 
80 dB SPL). During the magnitude production task, participants initially read the target 
sentence at their habitual speaking volume, and this intensity level was designated a value 
of 100. Participants were then instructed to reproduce the target sentence in varying 
magnitudes (25, 50, 100, 200, and 400) compared to their initial performance.  
 
Results from the magnitude estimation task indicated that IWPD rated stimuli presented 
at higher intensity levels (75 and 80 dB SPL) lower than did control participants, and 
rated stimuli presented at lower intensity levels (60 and 65 dB SPL) higher than did 
control participants. These findings suggest that IWPD have a flatter psychophysical 
loudness function and a more restricted range of intensity perception than control 
participants (Clark et al., 2014). Results from the imitation task demonstrated that all 
participants exhibited an increase in speech intensity as the intensity of the presented 
sentence increased, however IWPD spoke at consistently lower speech intensities than 
did their healthy counterparts. These findings suggest that IWPD exhibit shallower slopes 
in their imitation speech intensity function compared to control participants. Results from 
the magnitude production task revealed that IWPD made smaller adjustments to their 
intensity levels compared to control participants across all magnitude production 
conditions. These results suggest that the slope of the magnitude production function is 
less steep in IWPD compared to control participants.  
 
The abnormal loudness perception results of Clark and colleagues (2014) and Ho and 
colleagues (2000) suggest that IWPD may have a deficit in their perception of loudness 
levels. Anecdotal reports that individuals with hypophonia perceive themselves as 
speaking too loudly when increasing their speech intensity to typical conversational 
intensity levels (Kwan & Whitehill, 2011) lend further support to the finding of Clark and 
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colleagues (2014) and Ho and colleagues (2000). It is possible that this loudness 
perception deficit may then influence their ability to produce speech at greater intensities. 
1.4 Speech Intelligibility in Hypophonia and Parkinson’s 
Disease 
 
Hypophonia may influence multiple facets of one’s ability to communicate in everyday 
life. An individual’s ability to effectively and intelligibly take part in speech and 
communicative interactions is an essential part of one’s communicative activities (De 
Bodt, Hernández-Díaz Huici, & Van De Heyning, 2002). A high level of speech 
intelligibility is critical for effective and efficient oral communication (Kent, Weismer, & 
Kent, 1989; Miller, 2013). It is important to assess the speech intelligibility of IWPD and 
hypophonia because speech intelligibility is often reduced in individuals with hypokinetic 
dysarthria secondary to PD (Adams et al., 2008). 
 
Speech intelligibility is typically established by calculating the proportion of words 
correctly understood by a listener (Duffy, 2013; Kent et al., 1989). Furthermore, speech 
intelligibility is considered the “gold standard” for evaluating an individual’s level of 
functional communication (Sussman & Tjaden, 2012). Reduced speech intelligibility is 
frequently characteristic of the speech of IWPD and hypokinetic dysarthria (Adams et al., 
2008). The speech intelligibility of individuals with hypokinetic dysarthria and PD is 
typically evaluated at the single word or sentence level, with few studies examining 
conversational speech intelligibility (Andreetta, Adams, Dykstra, & Jog, 2016; Dykstra et 
al., 2012b; Tjaden & Wilding, 2011; Walsh & Smith, 2012). Some studies have 
suggested that the speech intelligibility of IWPD differs across speech tasks. For 
example, speech intelligibility is more likely to be reduced in tasks consisting of longer 
sentences or in spontaneous conversation than compared to single word utterances 
(Kempler & Van Lanker, 2002; Tjaden & Wilding, 2011; Walsh & Smith, 2012). 
 
Sentence intelligibility is frequently used to obtain measures of overall speech 
intelligibility, (Miller, 2013). Once such test that is commonly used is the Sentence 
Intelligibility Test (SIT; Yorkston, Beukelman, & Tice, 2011). The SIT is obtained via 
computer software that randomly generates 11 sentences of increasing word count that 
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range from 5 to 15 words in length. Measures of speech intelligibility are then obtained 
via orthographic transcription. Psychometric evaluations by Yorkston, Beukelman and 
Tice (1996) demonstrated that the SIT is a reliable and valid measure for assessing the 
speech intelligibility of individuals with dysarthria. A study by Cannito and colleagues 
(2012) used the SIT to examine sentence intelligibility in eight individuals with 
hypophonia before and after a loudness-training program. Participants were audio-
recorded during three pre-treatment sessions and three post-treatment, wherein 
participants completed the SIT during each session. The recorded stimuli were played 
back to listeners at an adjusted volume of 55 dB SPL in the presence of white noise. 
Listeners rated sentence intelligibility via orthographic transcription. The average 
sentence intelligibility of participants increased from 81.11% pre-treatment, to 85.82% 
post-treatment. These results suggest that sentence intelligibility may increase following a 
loudness training treatment designed to increase the speech intensity of individuals with 
hypophonia and PD. However, no published studies have systematically explored any 
naturally occurring day-to-day variability of speech intelligibility in IWPD and 
hypophonia. Further investigation of the reliability and repeatability of measures of 
speech intelligibility using ICC and CR may lend further support to the strength of such 
treatment outcomes. 
 
Additionally, the standard clinical method of assessing speech intelligibility may not fully 
capture the effects of reduced speech intensity on intelligibility in individuals with 
hypophonia (Adams et al., 2008; Dykstra et al., 2012b; Sussman & Tjaden, 2012). 
Therefore, obtaining conversational estimates of intelligibility and assessing intelligibility 
in noise may be beneficial in the management of individuals with hypophonia and PD. 
Few studies have explored the effect of hypophonia on conversational speech 
intelligibility (Adams et al., 2008; Andreetta et al., 2016; Dykstra et al., 2012b). These 
studies have included the effect of background noise in their study of conversational 
speech intelligibility in individuals with hypophonia and PD. 
1.4.1 The effect of background noise on speech 
intelligibility in hypophonia and Parkinson’s disease 
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Factors, such as background noise, may facilitate or limit speech intelligibility in 
individuals with hypophonia (Adams et al., 2008; Dykstra et al., 2012b). Adams and 
colleagues (2008) examined speech-to-noise levels and the speech intelligibility of 
individuals with hypophonia and PD in the presence of varying intensity levels of 
background noise. The speech intelligibility of 25 participants with hypophonia and 15 
age-matched control participants was assessed during a conversational speech task in 
various background noise conditions, including no added background noise, 60, 65, and 
70 dB SPL. Sentence intelligibility was also measured using the SIT in a quiet 
environment. The conversational intelligibility scores of IWPD were approximately 20 – 
30% lower than those of control participants across all noise conditions, with the 
intelligibility scores of IWPD ranging from approximately 45 – 82% as the level of 
background noise increased. Additionally, the authors reported high levels of speech 
intelligibility for IWPD in sentences, with average SIT scores of 92%. Conversational 
speech intelligibility scores in noise conditions, however, were on average 5 – 10% lower 
than conversational intelligibility scores assessed in a quiet environment. These results 
suggest reduced conversational speech intelligibility is further exacerbated in increased 
levels of background noise in individuals with hypophonia. This reduction in 
conversational intelligibility appears to occur despite the relatively high levels of 
intelligibility of individuals with hypophonia when evaluated via the SIT.  
 
Dykstra and colleagues (2012b) also sought to assess conversational speech intelligibility 
in background noise in individuals with hypophonia and PD. Two listeners rated the 
conversational speech intelligibility of 30 participants with hypophonia and 15 control 
participants. All participants completed conversation tasks in different background noise 
conditions, including: no added background noise, 60, 65, and 70 dB SPL. The authors 
found the conversational intelligibility of IWPD to be lower than that of control 
participants in the no added background noise condition, however; these results were not 
significant. The results of this study indicated that the conversational intelligibility of 
control participants decreased modestly as the intensity of background noise increased, 
with intelligibility values of 95.40%, 94.13%, and 85.03% in 60 dB SPL, 65 dB SPL, and 
70 dB SPL, respectively. In contrast, the conversational intelligibility of IWPD decreased 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
15 
differentially in comparison to that of control participants across all noise conditions, 
with intelligibility values of 77.47%, 68.98%, and 57.57% in 60 dB SPL, 65 dB SPL, and 
70 dB SPL respectively. These results suggest that engaging in conversation in the 
presence of background noise has adverse effects on the speech intelligibility of 
individuals with hypophonia. 
 
Based on the work of Adams and colleagues (2008) and Dykstra and colleagues (2012b), 
the conversational speech intelligibility of IWPD becomes increasingly reduced with 
increasing background noise. It has been established in the literature that speech 
intelligibility in this population deteriorates during the performance of more complex 
speech tasks (Kempler & Van Lancker, 2002; Tjaden & Wilding, 2011). Therefore, the 
findings of Adams and colleagues (2008) and Dykstra and colleagues (2012b) reveal that 
conversational speech intelligibility appears to capture a more ecologically valid measure 
of speech intelligibility than measures typically used in a clinical context with IWPD. 
Assessing speech intelligibility and evaluating the effectiveness of speech treatments in 
these ecologically valid contexts in addition to measures of sentence intelligibility can 
provide valuable information regarding the impact of hypophonia on communicative 
functioning.   
1.5 Communicative Participation in Hypophonia and 
Parkinson’s Disease 
 
An individual’s speech intelligibility may influence many factors related to one’s 
participation in various social and communicative contexts. The construct of 
‘participation’ is defined by the World Health Organization’s (WHO) International 
Classification of Functioning, Disability, and Health (ICF) as “involvement in a life 
situation” (WHO, 2001). Participation is comprised of many components, including 
communication (WHO, 2001). Communication is a ubiquitous component of 
participation and daily life for all individuals, regardless of the presence of disease, 
disability, or communication disorder (Eadie et al., 2006). 
 
Communicative participation is defined as “taking part in life situations where 
knowledge, information, ideas or feelings are exchanged. This may take the form of 
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speaking, listening, reading, writing, or nonverbal means of communication” (p. 309; 
Eadie et al., 2006). Communicative participation examines the communicative roles and 
actions in which individuals are engaged, as well as the frequency, quality, level of 
satisfaction, and effectiveness of their communicative endeavors (Baylor, Yorkston, 
Eadie, Miller, & Amtmann, 2009). It may also be used to assess the functional outcomes 
of impaired activities, such as speech intelligibility (Baylor et al., 2009). These measures 
may be used to provide a broader and more holistic perspective of an individual’s 
experience with a disease or impairment.  
 
IWPD and hypophonia may experience numerous changes in communicative functioning, 
including reduced communicative participation, reduced confidence in their speaking 
abilities, and feelings of embarrassment at the reactions of others (Fox & Ramig, 1997; 
Miller, Noble, Jones, & Burn, 2006). IWPD and their families perceive hypokinetic 
dysarthria as a highly disabling aspect of PD (Fox & Ramig, 1997; Ramig, Fox, & Sapir, 
2008). Speech impairments, such as hypophonia, may be detrimental to the lifestyles and 
vocational abilities of IWPD (Jiang et al., 1999). The psychosocial impact of dysarthria 
may directly influence an individual’s participation (Walshe & Miller, 2010). These 
individuals may be more likely to describe their communicative abilities as being 
impaired. They may also have increased concerns related to the effects of changes in 
speech production on their ability to communicate effectively (Kwan & Whitehill, 2011). 
Furthermore, IWPD believe that the impact of hypokinetic dysarthria on their 
communication abilities directly influences their social involvement (Miller et al., 2006). 
Thus, examining communicative participation in individuals with hypophonia and PD is a 
vital component of clinical assessment, as well as crucial for developing our 
understanding of the impact of hypophonia. 
 
Patient-reported outcome measures (PROs) are particularly useful with regard to 
assessing an individual’s communicative participation. PROs enable an individual with a 
communication disorder to report the subjective experiences and perspectives of their 
communicative interactions (Baylor et al., 2013). Three PROs that can be used to 
evaluate the communicative participation of individuals with motor speech disorders are 
the Communicative Participation Item Bank (CPIB; Baylor et al., 2013), the Voice 
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Activity and Participation Profile (VAPP; Ma & Yiu, 2001), and the Communicative 
Effectiveness Survey (CES; Donovan, Velozo, & Rosenbek, 2007). To date, few studies 
have explored communicative participation in IWPD using the CPIB (Baylor et al., 2014; 
McAuliffe, Baylor, & Yorkston, 2016) and VAPP (Simberg, Rae, Kallvik, Salo, & 
Martikainen, 2012). However, several studies have explored communicative effectiveness 
in IWPD and hypophonia (Donovan et al., 2007; Donovan, Kendall, Young, & Rosenbek, 
2008; Dykstra et al., 2015). Furthermore, the retest reliability and repeatability of very 
few PROs exploring communicative participation have been explored in IWPD and 
hypophonia. A closer examination of these questionnaires may provide valuable insight 
into the validity of their repeated use over time in IWPD and hypophonia. 
1.5.1 Communicative Participation Item Bank 
 
The CPIB is used to evaluate the effect of an individual’s speech and communication 
difficulties on their communicative participation. Seven hundred and one individuals with 
multiple sclerosis, PD, amyotrophic lateral sclerosis, or head and neck cancer completed 
the original 94-item CPIB in order to calibrate individual items using item response 
theory (Baylor et al., 2013). These analyses resulted in a 10-item questionnaire 
commonly referred to as the short form of the CPIB. Baylor and colleagues (2014) then 
explored the cross-cultural applicability of the CPIB. Two hundred eighteen IWPD in the 
United States and 210 IWPD in New Zealand completed the CPIB. Differential item 
analysis revealed no significant differences between the two groups, suggesting that the 
items and scoring of the CPIB is appropriate for IWPD in the United States and in New 
Zealand. While McAuliffe and colleagues (2016) later explored the variables associated 
with communicative participation in IWPD, no published studies have used the CPIB to 
explore communicative participation in individuals with PD and hypophonia as their 
primary dysarthric feature. 
1.5.2 Voice Activity and Participation Profile 
 
The VAPP was designed to assess the impact of an individual’s self-perception of voice 
problems, activity limitations, and participation restrictions in individuals with voice 
disorders (Ma & Yiu, 2001). While originally validated on individuals with dysphonia 
and normal speakers, it has since been administered to IWPD with speech and voice 
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difficulties (Simberg et al., 2012). Simberg and colleagues (2012) sought to evaluate the 
impact of a 15-day treatment on the speech and voice in 6 IWPD. Prior to beginning the 
course of treatment, IWPD completed the VAPP in order to obtain self-ratings of voice 
function. Six months and one year following the treatment onset, individual self-ratings 
of voice function were evaluated using the VAPP. The authors found that participants’ 
self-ratings of their overall VAPP scores decreased from 83 pre-treatment to 63 six 
months post-treatment. The post treatment self-ratings remained stable one year post-
treatment, with overall VAPP self-ratings of 65. However, these changes were not 
significant, possibly due to increased standard deviation.  
 
Simberg and colleagues (2012) also obtained proxy ratings of voice function for the 
IWPD. The spouses of the IWPD participating in the study evaluated their partner’s voice 
impairments via the VAPP. Spouses completed the VAPP prior to their partner beginning 
the 15-day rehabilitation course, as well as six months and one year following the course 
onset. The authors reported that spousal ratings of their partner’s voice functioning were 
less severe compared to the self-ratings of IWPD. Overall proxy-rated VAPP scores 
decreased from 77 pre-treatment to 44 six months post-treatment. However, overall 
proxy-rated VAPP scores increased to 56 one year post-treatment. Changes in proxy 
ratings of voice function over time were not significant. Yet, all spouses reported positive 
changes in the speech and voice of their partner with PD during post-treatment 
interviews. The authors concluded that PROs and proxy ratings provide valuable insight 
to the functional perspective of individuals with communication disorders. 
1.5.3 Communicative Effectiveness Survey 
 
Communicative participation is comprised of multiple components, including 
communicative effectiveness (Donovan et al., 2008). Communicative effectiveness can 
be defined as an individual’s ability to successfully communicate in multiple settings in 
order to fulfill their various life and social roles (Donovan et al., 2008; Dykstra et al., 
2015).  In 2007, Donovan and colleagues developed the CES in order to evaluate an 
individual’s perception of communicative effectiveness during various communicative 
interactions and contexts (Donovan et al., 2007; Donovan et al., 2008). The CES was 
originally validated for use in IWPD (Donovan et al., 2008). 
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Donovan and colleagues (2008) examined the communicative effectiveness of individuals 
with hypokinetic dysarthria and PD using the CES. Twenty-five IWPD and hypokinetic 
dysarthria, 25 participants without PD or dysarthria, and 25 primary communication 
partners of the IWPD used the CES to self-rate communicative effectiveness, or the 
communicative effectiveness of their partner with PD. Donovan and colleagues (2008) 
found that IWPD and dysarthria had lower CES scores than individuals without PD. 
Additionally, participants with dysarthria self-rated their own communicative 
effectiveness significantly higher than did their primary communicative partners. The 
authors suggest that the observed discrepancy in CES ratings between participants with 
PD and their primary communication partners may be related to reduced perceptual 
awareness on the part of IWPD with respect to their speech and communication 
difficulties. While this study was the first to explore communicative effectiveness in 
participants with hypokinetic dysarthria, the findings of this study may not be predictive 
of communicative effectiveness in individuals with hypophonia as their primary 
dysarthric feature. 
 
In a recent study, Dykstra and colleagues (2015) sought to explore the relationship 
between speech intensity and self-rated communicative effectiveness in IWPD and 
hypophonia. Conversational intensity measures were obtained from 30 IWPD and 
hypophonia and 15 control participants. All participants also completed the CES to obtain 
a measure of self-rated communicative effectiveness. The authors found that the habitual 
conversational speech intensity of IWPD was approximately 5 dB lower than that of 
control participants.  
 
Additionally, Dykstra and colleagues (2015) found that IWPD and hypophonia 
experienced reduced levels of self-perceived communicative effectiveness compared to 
control participants. IWPD self-reported reduced communicative effectiveness in 
communicative contexts and situations related to conversing over distances and 
conversing in background noise. These results suggest there may be a hierarchy of 
communicative situations that individuals with hypophonia find the most challenging.  
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Dykstra and colleagues (2015) also evaluated proxy ratings of communicative 
effectiveness made by the primary communication partners of participants with 
hypophonia and PD. Ratings of communicative effectiveness were similar between 
IWPD and their primary communication partners. These findings are in contrast to those 
of Donovan and colleagues (2008) who found that IWPD self-rated communicative 
effectiveness higher than did their primary communication partners. The difference in the 
findings of Donovan and colleagues (2008) and Dykstra and colleagues (2015) may be 
due to factors such as severity, or salient dysarthric features. For example, Donovan and 
colleagues (2008) examined individuals with a diagnosis of hypokinetic dysarthria. These 
participants likely presented with a range of dysarthric features associated with 
hypokinetic dysarthria (i.e., articulatory imprecision, prosodic abnormalities, impairments 
in speech rate; Donovan et al., 2008), whereas Dykstra and colleagues (2015) evaluated 
participants with hypophonia as their primary dysarthric feature. 
 
Finally, Dykstra and colleagues (2015) identified a non-significant relationship between 
speech intensity measures and participants’ self-ratings of communicative effectiveness. 
These results suggest that communicative participation may be a distinct construct that 
differs from perceptual or acoustic outcome measures, such as measures of speech 
intelligibility or speech intensity. While Dykstra and colleagues (2015) explored the 
relationship between speech intensity and communicative effectiveness in IWPD, other 
studies have explored relationships among other demographic and non-speech factors in 
PD. 
1.6 Demographic and Non-Speech Factors in Hypophonia 
and Parkinson’s Disease 
 
McAuliffe and colleagues (2016) identified variables associated with communicative 
participation in IWPD. Three hundred seventy-eight IWPD in the United States and New 
Zealand completed the CPIB. Participants also provided information for possible 
predictors of communicative participation. These possible predictors included self-rated 
communication disorder severity, individual speech usage, hearing, cognition, physical 
activity, fatigue, pain, swallowing difficulties, and emotional problems.  Backward 
stepwise linear regression was used to assess the relationship between communicative 
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participation and possible predictive factors. The authors found communicative 
participation to be significantly related to perceptions of speech severity, with mild 
speech difficulty perceptions associated with greater communicative participation. 
Increased level of speech usage was also associated with increased communicative 
participation. Increased levels of fatigue, cognitive issues, emotional difficulties, and 
swallowing problems were all negatively associated with communicative participation. 
Perceptions of emotional difficulties were obtained via one general question regarding the 
impact of “emotional problems such as feeling anxious, depressed or irritable” 
(McAuliffe et al., 2016, p.11). While no published studies have explored the relationship 
between communicative participation and depression in IWPD and hypophonia, Yorkston 
and colleagues (2008) explored the relationships between participation and personal 
factors, including mobility, depression, general health, fatigue, and pain, in individuals 
with multiple sclerosis. Additionally, older individuals reported an overall greater level of 
communicative participation. Gender effects were observed, with men demonstrating 
increased communicative participation as compared to women.  
 
Other studies have reported mixed results regarding gender effects in IWPD (Fox & 
Ramig, 1997; Sapir et al., 2007). While exploring the impact of LSVT on vowel intensity, 
Sapir and colleagues (2007) found significant gender differences in the intensity 
measures of the vowels /i/, /a/, and /u/, across all treatment conditions. However, while 
examining the impact of LSVT, Fox and Ramig (1997) did not find gender differences in 
IWPD in the speech intensity across four speech tasks, or in self-ratings of nine 
perceptual variables. 
 
While investigating the construct validity of the CES for IWPD and dysarthria, Donovan 
and colleagues (2008) found that 47% of the variability in CES scores was accounted by 
for the Hoehn and Yahr staging in IWPD. However, compared to the Unified Parkinson’s 
Disease Rating Scale (UPDRS), the Hoehn and Yarh staging scales do not provide 
measures of motor ability. In a longitudinal study, Skodda, Flasskamp, and Schlegel 
(2011) explored the stability of motor speech performance in order to find possible 
markers of disease progression in IWPD. Fifty-eight IWPD and 35 control participants 
were tested and retested a minimum of twelve months later. During each visit, 
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participants performed a syllable repetition task, and their motor abilities were assessed 
via the UPDRS. The authors did not find a correlation between variability of syllable 
repetition and general motor impairment. The authors concluded that the underlying 
mechanism contributing to instability of speech measures might be independent from 
dopaminergic deficits. However, this study only examined the stability of syllable 
repetition over time. Additional studies are required to explore the stability of speech 
intensity and speech intelligibility over time, and to examine the relationship between 
speech intensity, speech intelligibility, communicative participation, and motor symptoms 
associated with PD in IWPD and hypophonia.  
1.7 Rationale for the Current Study 
 
It appears that few published studies have investigated the variability of habitual speech 
intensity, speech intelligibility, and communicative participation in individuals with 
hypophonia and PD. Fox and Ramig (1997) and Schalling and colleagues (2013) appear 
to be the only published studies to have directly explored the day-to-day variability of 
speech intensity in individuals with hypophonia and PD. Both of these studies reported 
individual variability within participants, as demonstrated by large standard deviations. 
Additionally, the variability (or stability) of an individual’s response to background noise 
has received minimal attention. In addition to increasing speech intensity, background 
noise may also influence listener perceptions of hypophonia severity, and potentially 
introduce communication challenges, such as reducing the speech intelligibility (Adams 
et al., 2008; Dykstra et al., 2012b) and communicative participation (Baylor et al., 2011) 
in individuals with hypophonia. Fox and Ramig (1997) appear to be the only published 
study to explore the day-to-day variability in self-perceived ratings of speech 
intelligibility and communicative participation in IWPD. However, no published studies 
have examined the variability of speech intelligibility and communicative participation 
with PRO measures in this population. 
 
While the temporal variability of self-perception of loudness, speech intelligibility, and 
communicative participation have not been directly evaluated, Fox and Ramig (1997) 
explored perceptual self-ratings speech and voice characteristics of the IWPD during 
three visits within a four-day period. These characteristics included loudness, being 
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understood by others, and the ability to participate in conversations. Large standard 
deviations were associated with these ratings. Perceived loudness ratings ranged from 
51.62 – 57.80, with standard deviation values ranging from 12.89 – 16.78 over the three 
days. Perceived intelligibility ratings ranged from 54.71 – 56.96, with standard deviation 
values ranging from 13.99 – 18.21 over the three days. Perceived communicative 
participation ratings ranged from 57.64 – 61.50, with standard deviation values ranging 
from 18.65 – 20.21 over the three days.  It may be possible that the large standard 
deviations suggest variability in individual and day-to-day responses of IWPD.  While 
Fox and Ramig (1997) explored individuals’ overall self-perception of loudness, speech 
intelligibility, and participation, the temporal or day-to-day variability of the speech 
intelligibility and communicative participation in IWPD and hypophonia has not been 
systematically examined.  
 
Multi-baseline studies are needed to explore the temporal variation and fluctuations of 
speech intensity, speech intelligibility, and communicative participation in individuals 
with hypophonia and PD. Such studies are needed in order to develop a deeper 
understanding of the stability of these measures in IWPD and hypophonia. Further 
understanding the fluctuations of these measures in individuals with hypophonia may 
assist in the development of clinical tools that can be reliably used to ascertain the 
severity and impact of hypophonia. 
 
Several published studies have attempted to delineate potential relationships among 
acoustic and psychosocial measures, and demographic (i.e., age, gender, level of 
education, disease duration) and non-speech (i.e., disease severity, depression, cognition, 
motor symptoms associated with PD) factors in IWPD (Donovan et al., 2008; Fox & 
Ramig, 1997; McAuliffe et al., 2016; Sapir et al., 2007; Skodda et al., 2011). However, 
many of these studies explored these relationships in IWPD who did not demonstrate 
hypophonia as their primary dysarthric feature. Exploring whether these relationships 
exist in a population of IWPD and hypophonia will provide a broader and more holistic 
understanding of hypophonia. Additionally, it has been proposed that all facets of living 
with a disease or disability must be examined in order to develop a complete 
understanding of the particular disease or disability (Morse & Johnson, 1991). Since 
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hypophonia has the potential to affect all facets of an IWPD’s life, it is important to 
explore the impact of and relationship among as many facets of an individual’s life as 
possible. Examining hypophonia from such a perspective may allow us to better 
understand the mechanisms for speech intensity regulation and the impact of hypophonia 
on an individual’s functional communicative abilities. Exploring relationships among 
acoustic measures, self-rated communicative participation, demographic, and non-speech 
factors in IWPD and hypophonia may help to guide the clinical management of speech 
and communication difficulties as the disease progresses.  
1.8  Purpose 
 
The purpose of this study is to systematically examine the temporal and day-to-day 
variability of acoustic and perceptual speech measures and psychosocial measures in 
individuals with hypophonia and PD. An additional purpose of this study is to examine 
the relationships among speech intensity measures, speech intelligibility measures, self- 
and proxy ratings of communicative participation, demographic factors, and non-speech 
factors. Speech intensity measures will include habitual speech intensity, magnitude 
production intensity, Lombard response intensity, and self- and proxy perceptions of 
typical loudness. Speech intelligibility measures will include habitual sentence 
intelligibility, and conversational speech intelligibility. Communicative participation 
measures will include self- and proxy-rated CES scores, self- and proxy-rated CPIB 
sores, self- and proxy-rated VAPP scores, and self- and proxy-rated Level of Speech 
Usage Scale (LSUS) scores. Demographic factors will include age, gender, and disease 
duration. Non-speech factors will include depression, disease severity, cognition, and 
motor symptoms associated with PD, as measures by the UPDRS. Exploring the 
variability within these variables, as well as defining relationships among these variables 
will provide a deeper clinical understanding that is crucial for the assessment and 
management of individuals with hypophonia and PD.  
 
Nine objectives will be examined in this study. These objectives are: 
 
1. To examine the temporal variability of speech intensity measures in participants with 
PD and control participants over three time points. 
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2. To evaluate the temporal variability of perceived typical speech loudness in 
participants with PD, their primary communication partners, and control participants 
over three time points. 
 
3. To evaluate the temporal variability of speech intelligibility measures in participants 
with PD and control participants over three time points. 
 
4. To evaluate the temporal variability of self-rated communicative participation in 
participants with PD and control participants over three time points. 
 
5. To evaluate the temporal variability of self- and proxy-rated communicative 
participation in participants with PD and their primary communication partners. 
 
6. To examine the retest reliability and repeatability of measures of speech intensity, 
speech intelligibility, and communicative participation in participants with PD, their 
primary communication partners, and control participants. This objective has been 
addressed and embedded within Objectives 1-5.  
 
7. To evaluate relationships among speech intensity measures, speech intelligibility 
measures, self-rated communicative participation, demographic factors, and non-
speech factors for participants with PD. 
 
8. To evaluate relationships among speech intensity measures, speech intelligibility 
measures, proxy-rated communicative participation, demographic factors, and non-
speech factors for participants with PD.  
 
9. To evaluate relationships among speech intensity measures, speech intelligibility 
measures, self-rated communicative participation measures, demographic factors, 
non-speech factors for control participants. 
 
Six hypotheses are predicted for this study. It is hypothesized that: 
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1. IWPD will demonstrate greater temporal variability of speech intensity measures, 
speech intelligibility measures, and self-rated communicative participation measures 
compared to control participants. 
 
2. IWPD will demonstrate reduced speech intensity measures, speech intelligibility 
measures, and self-rated communicative participation measures compared to control 
participants. 
 
3. The self-rated typical speech loudness and self-rated communicative participation 
will be reduced compared to proxy-rated typical speech loudness and self-rated 
communicative participation for participants with PD. 
 
4. Measures of speech intensity, speech intelligibility, and communicative participation 
will demonstrate good retest reliability and acceptable repeatability for participants 
with PD, their primary communication partners, and control participants. 
 
5. Measures of self- and proxy-rated communicative participation will all be correlated 
with one another for participants with PD and control participants. 
 
6. Increased disease duration, increased depression, increased UPDRS scores, 
decreased perceived mediation effectiveness, and reduced cognition will be 
correlated with measures of speech intensity, speech intelligibility, and self- and 
proxy-rated communicative participation in participants with PD.  
 
This study was approved by the Health Sciences/Lawson Research Ethics Board at 
Western University, London, Ontario, Canada. 
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Chapter 2 
2 Methods 
2.1 Participants 
2.1.1 Participants with Parkinson’s disease 
 
Thirty individuals with idiopathic PD aged 58 – 82 years, M = 70.2 years (SD = 5.46), 
male = 21, female = 9 were recruited to participate in this study. IWPD were referred for 
this study as they presented with hypokinetic dysarthria, and hypophonia as their primary 
distinctive speech feature as confirmed by a neurologist. However, seven IWPD were 
excluded from the present study as they did not meet our inclusion criteria of presenting 
with hypophonia. Thus, a total of 23 individuals with idiopathic PD aged 58 – 82 years, 
M = 69.48, (SD = 5.57), male = 16, female = 7 were included in the analysis of the 
present study. 
 
Inclusion criteria for participants with PD included: having a diagnosis of idiopathic PD 
for a minimum of 3 years, being between 55 – 85 years of age, having a diagnosis of 
hypophonia, and speaking English as their first language. Exclusion criteria for 
participants with PD included:  an inability to read and/or write English, a positive history 
of speech, language, or neurological impairments, except those related to PD, an inability 
to pass a 40 dB hearing level (HL) hearing screening at 500, 1000, and 2000 Hertz (Hz) 
in at least one ear, except in those individuals whose hearing was aided via hearing aids, 
receiving deep brain stimulation surgery as treatment for PD, currently receiving speech-
language therapy, receiving a score below 21 on the Montreal Cognitive Assessment 
(MOCA; Nasreddine, et al., 2005), at the time of their last visit to their neurologist.  
 
All participants with PD completed a cognitive screening using the MOCA (Nasreddine, 
et al., 2005), a depression screening using the Geriatric Depression Scale - short form 
(GDS-15; Sheikh & Yesavage, 1986), a Medication Effectiveness Scale (MES) and a 
motor assessment using the motor examination section (part 3) of the UPDRS (Goetz, et 
al., 2007). IWPD were stable on their anti-parkinsonian medication and were tested in an 
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“on” state. All participants attended three experimental sessions, with the exception of 
one participant who was unable to attend visit 3 due to scheduling difficulties. Participant 
visits took place at 9 am or 1 pm, and testing time remained consistent for each 
participant throughout the study. IWPD were recruited through the Movement Disorders 
Clinic at University Hospital in London, Ontario. 
2.1.2 Control participants 
 
Thirty healthy control participants aged 55 – 82 years, M = 69.58 years, (SD = 7.66), 
male = 9, female = 21 also took part in this study. Inclusion criteria for control 
participants included: not having a diagnosis of PD, being between 55 – 85 years of age, 
and speaking English as their first language. Exclusion criteria for control participants 
included: an inability to read and/or write English, a positive history of speech, language 
or neurological impairments, an inability to pass a 40 dB HL hearing screening at 500, 
1000, and 2000 Hz in at least one ear, except in those individuals whose hearing was 
aided via hearing aids, and receiving a score below 26 on the MOCA. 
 
Control participants completed a cognitive screening using the MOCA (Nasreddine, et 
al., 2005) and a depression screening using the GDS-15 (Sheikh & Yesavage, 1986). 
Control participants were also required to attend all three experimental sessions. Control 
participants were primarily recruited via convenience sampling through the Canadian 
Centre for Activity and Aging.  
 2.1.3 Primary communication partners of participants with 
Parkinson’s disease 
 
Twenty-three primary communication partners of participants with PD aged 48 – 81 
years, M = 68.13 years (SD = 7.18), male = 5, female = 18 were included in this study. A 
primary communication partner is defined as an individual having daily or frequent 
contact with the participant with PD. Primary communication partners included spouses, 
siblings, friends, and/or caregivers of participants with PD. Inclusion criteria for primary 
communication partners included: being 18 years of age or older, speaking English as 
their first language, and having daily or frequent contact with the participant with PD. 
Exclusion criteria for primary communication partners included: an inability to write 
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and/or read English, an inability to pass a 40 dB HL hearing screening at 500, 1000, and 
2000 Hz in at least one ear, except in those individuals whose hearing was aided via 
hearing aids, and not having daily or frequent communication with the participant with 
PD. Primary communication partners were also required to attend all three experimental 
sessions with their communication partner with PD.  
2.1.4 Listener participants 
 
Three female experienced listeners aged 22 – 28 years, M = 25 years (SD = 3.00) took 
part in this study. Inclusion criteria for listeners included: being 18 years of age or older 
and speaking English as their first language. Exclusion criteria for listeners included: an 
inability to read and/or write English, a positive history of speech, language, hearing, or 
neurological impairments, and an inability to pass a 25 dB HL bilateral hearing screening 
at 500, 1000, 2000, and 4000 Hz.  
2.2 Materials 
2.2.1 Apparatus 
 
Participants with PD and control participants were seated in a quiet laboratory 
environment in Elborn College at Western University for all three experimental sessions. 
Participants were seated 1.5 metres (m) away from the experimenter throughout each 
session. Participants’ speech was audio recorded throughout each session via a headset 
microphone (AKG C520) and a second microphone mounted 1 m off the ground on a 
desk and tripod, at a distance of 2 m from participants. The headset microphone was 
located six centimetres (cm) from each participants’ mouth. The microphone placement 
was verified prior to calibration, speech intensity tasks, and speech intelligibility tasks. 
The headset microphone was calibrated using a sound level meter placed 15 cm from 
participants’ mouths. During calibration, participants produced a steady and prolonged 
‘ah’. The intensity of a steady segment was noted in dBA SPL, as indicated on the sound 
level meter. Background noise was presented to participants over a loudspeaker (M 
Audio AV40) located 2 m away from participants. Speech samples were presented to 
listeners over loudspeakers (M Audio AV40), located 60 cm away from participants 
during separate sessions. 
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2.2.2 Noise source 
 
A recording of multi-talker noise (Audiotech – 4 talker noise) was presented to 
participants during a background noise speech task. The multi-talker noise was presented 
at four different intensity increments ranging from 60 to 75 dB SPL. The presentation 
order of background noise intensity level was randomized across all participants and 
sessions. The presentation order was determined using www.randomizer.org.   
2.2.3 Audio recordings 
 
The speech of participants with PD and control participants was recorded using Praat 
(Boersma & Weenink, 2018), with a recording sampling rate of 22.05 kilohertz (kHz). 
The audio recordings were stored in an uncompressed (.wav) file format. The software 
Praat (Beorsma & Weenink, 2018) was used to analyze the recorded audio files and 
generate audio clips later used to assess speech intelligibility. 
2.2.4  Speech intensity measures 
 
The sentence “she saw Patty buy two poppies” was used during habitual speech intensity, 
maximum speech intensity, Lombard response function, and magnitude production tasks. 
Praat (Boersma & Weenink, 2018) was used to determine the speech intensity produced 
by participants during each of these tasks. The first and last syllables of the sentence “she 
saw Patty buy two poppies” were excluded from speech intensity calculations. During the 
Lombard response function task, participants produced the target sentence using their 
habitual speech intensity in 60, 65, 70, and 75 dB SPL of multi-talker background noise. 
The Lombard response function was then determined by calculating the slope of speech 
intensity when participants repeated the target sentence in 60, 65, 70, and 75 dB SPL of 
multi-talker background noise. Participants also repeated the target sentence at their 
habitual speech intensity, two times louder than their habitual speech intensity, four times 
louder than their habitual speech intensity, and their maximal speech intensity. The 
magnitude production function was determined by calculating the slope of speech 
intensity when participants repeated the target sentence at their habitual speech intensity, 
two time louder than their habitual speech intensity, and four times louder than their 
habitual speech intensity. 
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2.2.5 Speech intelligibility measures 
2.2.5.1 Sentence Intelligibility Test 
 
The SIT (Yorkston et al., 2011) was used to obtain speech intelligibility measures. The 
SIT consists of 11 randomly generated sentences of increasing word count. The length of 
these sentences ranges from 5 to 15 words. Each participant read a unique list of 11 
randomly generated sentences, presented on an 8 ½ by 11inch piece of white paper in 18 
point Times New Roman font. However, only those SIT sentences comprising of 13, 14, 
and 15 words were evaluated by listeners.  
2.2.5.2 Conversational intelligibility 
 
Conversational intelligibility samples were obtained by asking participants to discuss a 
familiar topic for two minutes. Participants were prompted with the following discussion 
points: 
 
1. Tell me about the jobs you’ve had. 
 
2. Tell me about the hobbies you enjoy. 
 
3. Tell me about your favourite vacation. 
 
Secondary questions were asked for each topic if prompting for additional conversation 
was needed.  
 
Conversation samples were then pared down to include recorded conversational 
utterances, with excerpts ranging in length from 15 – 20 seconds. These conversational 
excerpts were then presented to listeners in order to obtain ratings of conversational 
intelligibility. 
2.2.6 Questionnaires 
2.2.6.1 Intake questions 
 
Participants completed intake questions in order to collect demographic information. The 
demographic information obtained for IWPD included partial date of birth, gender, 
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occupation, time since onset of PD, time since PD symptom onset, general health, and 
history of speech therapy. See Table 1 for a complete description of participants with PD. 
The demographic information obtained for control participants included partial date of 
birth, gender, occupation, general health, and history of speech therapy. See Table 2 for a 
description of control participants. The demographic information obtained for primary 
communication partners of participants with PD included partial date of birth, gender, 
and relationship to their communication partner with PD. See Table 3 for a description of 
primary communication partners. 
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Table 1: Description of Demographic and Non-Speech Factors for Participants with 
Parkinson’s Disease 
Participant 
ID 
Age 
(years) 
Gender Disease 
duration 
(years 
GDS-15 
score 
MES 
score 
MOCA 
score 
UPDRS 
score 
1 72 Male 10 3 6 22 24 
2 75 Male 5 1 3 20 N/A* 
3 72 Female 9 2 7 29 27 
4 62 Male 10 2 6 25 18 
5 74 Male 3 2 3 28 51 
6 58 Female 9 15 4 23 40 
7 66 Female 8 0 5 29 37 
8 70 Male 5 3 2 24 31 
9 67 Female 11 2 5 27 56 
10 73 Male 10 4 5 22 66 
11 72 Male 9 3 6 21 34 
12 63 Male 15 3 5 20 36 
13 67 Female 6 2 5 28 33 
14 66 Male 10 3 4 25 40 
15 75 Male 22 4 5 16** 56 
16 66 Male 29 0 5 25 42 
17 69 Male 5 0 2 28 35 
18 71 Male 7 3 5 24 43 
19 64 Female 15 1 5 28 24 
20 69 Male 13 1 4 27 22 
21 79 Male 6 0 4 26 30 
22 66 Male 13 3 4 23 43 
23 82 Female 14 0 6 28 40 
Note. This table describes the demographic and non-speech factors of participants with 
PD. *Participant 2 was not able to attend visit 3 due to scheduling conflicts. As a result, 
the UPDRS was not completed for this participant. **Participant 15 did not wish to 
complete the delayed recall and fluency sections of the MOCA. As a result, his MOCA 
score was calculated out of a total of 24 points instead of 30 points. GDS-15 scores 
between 0 – 4 fall within the normal range, scores between 5 – 8 are indicative of mild 
depression, scores between 9 – 11 are indicative of moderate depression, scores between 
12 – 15 are indicative of severe depression (Sheikh & Yesavage, 1986). The UPDRS 
reflects the severity of PD motor symptoms with a total possible score of 108. 
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Table 2: Description of Demographic and Non-Speech Factors for Control 
Participants 
Participant ID Age (years) Gender GDS-15 score MOCA score 
1 55 Female 3 30 
2 66 Female 0 30 
3 55 Female 0 26 
4 65 Male 0 29 
5 69 Female 4 28 
6 74 Female 0 26 
7 79 Male 1 27 
8 68 Female 0 27 
9 68 Female 1 30 
10 66 Female 0 28 
11 72 Male 1 29 
12 74 Female 0 30 
13 75 Male 1 26 
14 71 Female 0 29 
15 63 Female 0 30 
16 58 Female 0 26 
17 78 Male 0 26 
18 77 Female 1 28 
19 72 Female 0 29 
20 82 Female 2 29 
21 72 Female 0 27 
22 60 Female 1 29 
23 62 Female 2 28 
24 81 Male 0 26 
25 66 Female 0 28 
26 61 Female 0 29 
27 63 Male 0 26 
28 70 Male 1 27 
29 79 Female 0 30 
30 80 Male 0 30 
Note. This table describes the demographic and non-speech factors of control 
participants. GDS-15 scores between 0 – 4 fall within the normal range, scores between 5 
– 8 are indicative of mild depression, scores between 9 – 11 are indicative of moderate 
depression, scores between 12 – 15 are indicative of severe depression (Sheikh & 
Yesavage, 1986). 
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Table 3: Description of Demographic and Non-Speech Factors for Primary 
Communication Partners of Participants with Parkinson's Disease 
Participant ID Age (years) Gender Relationship to participant with PD 
1 66 Female Spouse 
2 71 Female Sibling 
3 62 Male Spouse 
4 62 Female Spouse 
5 75 Female Spouse 
6 48 Male Friend 
7 67 Male Spouse 
8 69 Female Spouse 
9 63 Male Sibling 
10 71 Female Spouse 
11 67 Female Spouse 
12 61 Female Spouse 
13 73 Male Spouse 
14 70 Female Spouse 
15 72 Female Spouse 
16 64 Female Spouse 
17 65 Female Spouse 
18 71 Female Spouse 
19 67 Female Friend 
20 81 Female Spouse 
21 81 Female Spouse 
22 64 Female Spouse 
23 77 Female Friend 
Note. This table describes the age, gender, and relationship of primary communication 
partners to the participants with PD. 
 
2.2.6.2 Montreal Cognitive Assessment 
 
The MOCA is a 10-minute screening tool used to detect cognitive impairment 
(Dalrymple-Alford, et al., 2010; Nasreddine et al., 2005). The MOCA assesses 
individuals on eight cognitive domains, including visuospatial/executive, naming, 
memory, attention, language, abstraction, delayed recall, and orientation. Additionally, 
several alternate forms of the MOCA have been developed and found to be valid for 
serial assessments of cognitive impairment in order to avoid practice effects (Costa et al., 
2012). The MOCA appears to be a valid and reliable tool for detecting cognitive 
impairment in IWPD (Dalrymple-Alford, et al., 2010; Gill, Freshman, Blender, & 
Ravina, 2008; Hoops et al., 2009;). 
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2.2.6.3 Geriatric Depression Scale 
 
The GDS-15 is a 15-item self-report measure used to assess an individual’s non-somatic 
symptoms of depression, such as the psychological features and the social repercussions 
associated with depression (Sheikh & Yesavage, 1986).  Each item is evaluated via a 
‘yes’ or ‘no’ response (Sheikh & Yesavage, 1986). The GDS-15 has been found to be a 
valid and reliable tool to screen for depression in IWPD (Schrag et al., 2007; Weintraub, 
Oehlberg, Katz, & Stern, 2006; Weintraub, Saboe, & Stern, 2007a; Weintraub, Xie, 
Karlawish, & Siderowf, 2007b). See Appendix A to view the GDS-15. 
2.2.6.4 Medication Effectiveness Scale 
 
Participants with PD evaluated their medication effectiveness on the MES. Participants 
indicated on a 7-point scale the effectiveness of their medication at managing their 
symptoms of PD. The anchor of “not at all effective” was associated with a score of 1. 
The anchor of “very effective” was associated with a score of 7. See Appendix B to view 
the Medication Effectiveness Scale. 
2.2.6.4 Typical Loudness Scale 
 
Participants evaluated typical loudness on a Typical Loudness Scale (TLS) using visual 
analogue scale (VAS) estimation. A VAS measuring 10 cm was presented to participants 
with the anchors “very quiet” and “normal loudness”. See Appendix C to view the 
Typical Loudness Scale. Participants rated typical loudness by indicating their rating with 
an X or a dash on the VAS.  
2.2.6.5 Communicative Effectiveness Survey 
 
The CES is an eight-item questionnaire using a four-point equal appearing interval scale 
(Donovan et al., 2007). The CES assesses an individual’s perception of their own 
communicative effectiveness in different communicative interactions and contexts 
(Donovan et al., 2007; Donovan et al., 2008).  The CES was adapted from the 
Communicative Effectiveness Index - Modified (CETI-M; Ball, Beukelman, & Pattee, 
2004). The CETI-M was modified from the Communicative Effectiveness Index (CETI), 
which was originally designed to assess changes in an individual’s communicative 
effectiveness over time (Lomas et al., 1989). The CETI was designed as a proxy measure 
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to assess changes in the communicative effectiveness of individuals with aphasia (Lomas 
et al., 1989). The CETI was found to have acceptable test-retest reliability (Lomas et al., 
1989). Since the CES was adapted from a modified CETI, it is also used to assess 
changes in an individual’s communicative effectiveness over time (Donovan et al., 2007; 
Donovan et al., 2008). Thus, repeated administration of the CES to participants in this 
study is considered to be an appropriate procedure. While the CETI was originally 
validated for use in adults with aphasia (Lomas et al., 1989), the CES was originally 
validated for use in IWPD (Donovan et al., 2007). See Appendix D to view the CES. 
2.2.6.6 Voice Activity and Participation Profile 
 
The VAPP is a 28-item, self-report questionnaire (Ma & Yiu, 2001). The VAPP evaluates 
an individual’s perception of their voice problem, their activity limitations, and 
restrictions to their participation, in accordance with the definitions put forth by the WHO 
(1997; Ma & Yiu, 2001). The VAPP is used to explore the effects of an individual’s 
voice impairment on their job, daily communication, social communication, and 
emotions, as well as self-perceptions of their voice problem. Originally validated in 
individuals with dysphonia, the VAPP has since been validated for use with a variety of 
individuals with speech and voice concerns (Bassi et al., 2011; Dragone, 2011; Duarte De 
Almeida, Santos, Bassi, Teixeira, & Côrtes Gama, 2013; Dykstra, Adams, & Jog, 2007; 
Kleemola, Helminen, Rorarius, Sihvo, & Isotalo, 2011b; Martinello, Lauris, & 
Brasolotto, 2011; Piwowarczyk, Oliveira, Loureno, & Behlau, 2012; Simberg et al., 
2012), as well as cross-culturally (Behlau, Oliveira, dos Santos, & Ricarte, 2009; Fava, 
Paolillo, Oliveira, & Behlau, 2014; Kleemola, Helminen, Rorarius, Isotalo, & Sihvo, 
2011a; Ricarte, Oliveira, & Behlau, 2013; Sukanen et al., 2007;). Additionally, the 
original VAPP and its cross-cultural adaptations demonstrate good test-retest reliability 
(Kleemola, et al., 2011a; Ma & Yiu, 2001; Ricarte et al., 2013; Sukanen, et al., 2007;). 
See Appendix E to view the VAPP.  
2.2.6.7 Communication Participation Item Bank 
 
The CPIB short form is a 10-item questionnaire using a four-point equal appearing 
interval scale and is used to assess the impact of an individual’s speech and 
communication difficulties on their communicative participation (Baylor et al., 2013; 
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Baylor et al., 2009). The CPIB was developed according to the principles of Item 
Response Theory and validated for use across individuals with a wide variety of 
communication disorders (Baylor et al., 2013; Baylor et al., 2009). The CPIB has also 
been validated cross-culturally in IWPD (Baylor et al., 2014). However, no published 
study has assessed the test-retest reliability of the CPIB. See Appendix F to view the 
CPIB. 
2.2.6.8 Level of Speech Usage Scale 
 
The LSUS is a self-report categorical scale designed for use with adults with any number 
of communication disorders (Baylor, Yorkston, Eadie, Miller, & Amtmann, 2008). While 
completing this questionnaire, participants were instructed to select the everyday degree 
of speech usage from five different categories: undemanding, intermittent, routine, 
extensive, and extraordinary (Baylor et al., 2008). However, no published study has 
assessed the test-retest reliability of the LSUS. See Appendix G to view the LSUS. 
2.3 Procedures 
 
All participants attended a total of three experimental visits, with each visit ranging from 
45 – 90 minutes in duration. Visit 1 denoted the start of the study, visit 2 took place two 
to five day following visit 1, and visit 3 took place four weeks following visit 2.  
2.3.1 Visit 1 
 
All participants read a detailed letter of information and provided their written consent 
prior to beginning the study. The Letter of Information provided to participants with PD 
is found in Appendix H. The Consent Form signed by participants with PD is provided in 
Appendix I. The Letter of Information provided to control participants is found in 
Appendix J. The Consent Form signed by control participants is provided in Appendix K. 
The Letter of Information provided to primary communication partners is found in 
Appendix L. The Consent Form signed by primary communication partners is provided in 
Appendix M. A hearing screening was conducted on all participants. Participants with PD 
and control participants completed the GDS-15 and the MOCA. All participants then 
completed five questionnaires (TLS, VAPP, CPIB, LSUS, and CES).  Proxy-measures 
for the participants with PD for each questionnaire were collected from their primary 
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communication partners. The presentation order of the scales was randomized across 
participants and visits. The presentation order was determined using 
www.randomizer.org.   
 
Participants with PD and control participants then completed various speech tasks. 
Participants completed maximum sustained vowel phonation and diadochokinetic tasks. 
Praat was used to generate voice reports indicating jitter, shimmer, and signal-to-noise 
ratio for the maximum sustained vowel phonation task. The rate of syllable production 
(syllables per second) for /pÙ/, /tÙ/, and /kÙ/ was manually counted using Praat. Table 4 
provides diadochokinetic task rates for participants with PD and Table 5 provides 
description of voice report summaries for participants with PD. Table 6 provides 
diadochokinetic task rates for control participants and Table 7 provides a description of 
voice report summaries for control participants. Various speech intensity measures were 
then collected. The sentence “she saw Patty buy two poppies” was used during habitual 
and maximum speech intensity tasks. Participants also produced this sentence using their 
habitual speech intensity in 60, 65, 70, and 75 dB SPL of multi-talker background noise. 
Participants also completed a magnitude production task, wherein they repeated the 
sentence at their habitual speech intensity, two times louder than their habitual speech 
intensity, four times louder than their habitual speech intensity, and their maximal speech 
intensity. Participants then completed the SIT and engaged in two minutes of 
conversation with the experimenter. 
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Table 4: Description of Diadochokinetic Rates (syllables/second) for Participants 
with Parkinson's Disease Across All Three Visits 
Participant 
ID 
Visit 1 Visit 2 Visit 3 
/pÙ/ /tÙ/ /kÙ/ /pÙ/ /tÙ/ /kÙ/ /pÙ/ /tÙ/ /kÙ/ 
1 5.64 5.79 5.20 6.14 6.43 5.62 5.80 5.81 5.36 
2 5.01 4.09 4.64 5.02 4.89 5.30 N/A* N/A* N/A* 
3 6.74 5.50 5.47 6.39 5.67 5.71 6.51 5.97 5.88 
4 6.34 5.95 4.96 5.49 5.31 4.64 6.47 5.69 4.98 
5 7.27 7.67 5.99 7.05 6.00 6.75 7.18 7.28 6.00 
6 5.70 5.98 5.61 5.96 5.70 5.26 6.03 5.79 5.16 
7 5.82 4.67 4.39 4.74 4.62 4.29 5.65 5.07 4.45 
8 6.44 5.49 3.95 6.00 5.86 5.52 6.29 5.07 5.09 
9 5.77 5.51 5.18 5.59 5.32 4.91 5.59 5.38 4.97 
10 5.50 5.03 4.86 5.96 4.81 4.84 5.92 5.06 5.09 
11 5.67 5.30 5.26 4.99 5.43 5.48 5.93 5.26 5.27 
12 6.23 6.07 5.65 6.31 5.78 5.44 6.69 6.45 5.95 
13 6.39 5.94 5.73 6.49 5.92 5.62 6.34 6.02 5.67 
14 5.19 5.67 5.38 5.75 5.55 5.40 5.59 5.10 5.15 
15 5.18 4.27 4.47 5.35 4.95 4.61 5.36 4.77 4.73 
16 6.88 5.78 3.20 7.00 5.49 4.08 6.42 5.72 4.88 
17 6.61 4.64 3.39 5.87 3.51 3.40 6.16 3.81 3.45 
18 6.87 7.14 7.68 6.43 7.05 6.89 6.65 6.31 6.17 
19 6.35 6.18 5.41 6.24 5.84 5.02 6.09 6.10 5.06 
20 4.75 4.94 4.11 4.25 4.95 3.93 4.08 3.94 3.56 
21 5.58 5.24 4.86 5.40 5.19 5.01 5.55 5.17 5.05 
22 6.81 7.02 6.73 6.26 6.19 6.13 6.54 6.46 5.76 
23 6.39 5.00 4.19 6.42 4.98 4.46 7.03 4.47 4.81 
Note. This table describes the diadochokinetic rate (syllables/second) data collected from 
participants with PD across all 3 visits. *Participant 2 was not able to attend visit 3 due to 
scheduling conflicts. 
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Table 5: Description of Voice Quality for Participants with Parkinson's Disease 
Across All Three Visits 
Participant 
ID 
Visit 1 Visit 2 Visit 3 
Jitter Shimmer Signal-
to-noise 
Jitter Shimmer Signal-
to-noise 
Jitter Shimmer Signal-
to-noise 
1 0.55 1.72 22.91 0.39 1.53 24.21 0.43 2.21 22.99 
2 0.77 3.72 18.58 0.60 2.55 21.57 N/A* N/A* N/A* 
3 0.14 1.36 30.60 0.23 1.62 28.04 0.15 1.37 29.84 
4 0.46 2.22 22.46 0.55 3.69 20.74 0.42 2.53 22.48 
5 0.37 1.95 26.03 0.41 2.20 22.30 0.55 2.29 23.54 
6 0.79 4.01 21.85 0.55 3.18 21.41 0.71 4.81 19.66 
7 0.48 3.70 26.13 0.61 4.81 23.42 0.38 3.19 26.52 
8 0.98 4.77 17.32 1.20 6.87 16.53 0.91 6.28 17.56 
9 0.32 1.52 25.46 0.29 1.96 25.46 0.27 1.21 28.39 
10 0.75 4.98 20.18 1.17 3.80 20.61 0.92 4.81 18.70 
11 1.07 8.32 14.55 1.00 9.73 14.63 1.05 8.49 13.23 
12 0.64 3.06 22.54 1.26 4.20 18.80 0.47 2.19 25.20 
13 0.53 2.77 21.10 0.27 0.94 24.78 0.37 2.22 21.66 
14 0.75 7.83 19.80 0.50 3.81 21.42 0.59 3.37 20.22 
15 2.06 5.70 18.21 2.71 6.96 17.09 0.87 2.93 20.80 
16 0.89 3.17 21.93 0.55 3.33 21.18 1.03 2.94 17.28 
17 0.34 2.45 23.65 0.23 1.03 27.07 0.49 3.28 21.94 
18 0.56 4.02 23.33 0.35 2.43 27.71 0.37 1.86 27.80 
19 0.20 1.23 33.48 0.19 1.18 32.80 0.22 1.23 32.67 
20 0.42 1.47 28.59 0.24 1.08 31.96 0.38 2.01 29.24 
21 0.54 5.55 19.42 0.54 3.63 20.60 0.39 2.54 23.30 
22 0.49 3.17 24.15 1.00 4.52 19.88 0.85 5.21 20.05 
23 3.91 8.76 8.38 1.67 5.90 14.46 0.64 4.64 21.76 
Note. This table describes the voice quality data collected from participants with PD 
across all 3 visits. *Participant 2 was not able to attend visit 3 due to scheduling conflicts. 
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Table 6: Description of Diadochokinetic Rates (syllables/second) for Control 
Participants Across all Three Visits 
Participants 
ID 
Visit 1 Visit 2 Visit 3 
/pÙ/ /tÙ/ /kÙ/ /pÙ/ /tÙ/ /kÙ/ /pÙ/ /tÙ/ /kÙ/ 
1 6.87 6.22 5.98 7.20 6.75 6.41 6.76 6.41 6.03 
2 5.56 5.09 4.81 5.49 4.88 4.73 5.68 4.80 4.59 
3 7.43 7.49 6.79 7.24 7.31 6.64 7.36 7.21 6.56 
4 5.78 5.28 4.59 6.01 5.47 5.17 5.97 5.70 5.27 
5 6.01 6.20 6.54 7.10 6.54 6.68 6.56 6.36 6.25 
6 5.98 5.79 5.70 6.00 5.65 5.71 6.00 5.93 5.69 
7 5.81 5.30 4.76 5.74 5.55 4.99 5.61 5.36 4.84 
8 7.56 6.37 6.38 7.33 6.28 6.17 7.48 6.13 6.27 
9 5.55 5.38 5.28 6.00 5.78 5.53 5.90 5.56 5.58 
10 6.60 6.53 5.82 6.63 6.52 5.93 6.52 6.35 5.93 
11 5.76 5.31 4.68 5.13 4.80 4.41 5.35 4.80 4.42 
12 7.23 7.51 6.53 7.22 7.31 6.08 7.33 7.59 6.34 
13 5.77 5.16 4.96 5.88 5.33 5.11 6.04 5.34 5.11 
14 6.05 6.81 6.17 6.00 6.67 6.16 6.37 6.90 6.31 
15 6.32 5.74 5.27 6.34 5.88 5.56 6.16 5.54 5.23 
16 6.63 6.25 6.06 6.76 6.77 6.35 6.57 6.24 5.95 
17 6.13 5.77 4.71 6.26 5.48 4.86 6.02 5.66 4.90 
18 6.47 6.02 5.21 6.52 6.00 5.20 6.39 6.18 5.11 
19 6.53 5.87 5.52 6.18 5.68 5.54 6.42 5.97 5.72 
20 6.44 5.56 5.16 6.53 5.36 5.02 6.36 5.29 5.21 
21 5.99 6.59 5.49 6.67 6.74 5.20 6.75 6.82 5.43 
22 6.75 7.05 6.22 6.17 6.53 6.30 6.34 6.80 6.58 
23 6.58 5.95 5.58 6.38 5.75 5.44 6.67 6.01 5.69 
24 5.79 5.28 4.63 5.86 5.28 5.09 5.79 5.24 4.72 
25 5.17 4.82 4.58 6.51 5.72 4.77 5.32 5.64 5.00 
26 7.00 6.68 6.13 6.82 6.49 5.95 6.68 6.27 7.84 
27 6.64 6.50 5.78 6.69 6.16 5.64 6.81 6.49 5.78 
28 5.80 5.56 5.20 5.68 5.35 5.19 5.81 5.33 4.94 
29 6.51 5.96 5.53 6.61 6.09 5.65 6.25 5.55 5.44 
30 6.39 6.02 5.78 6.61 6.30 5.91 6.16 5.98 5.63 
Note. This table describes the diadochokinetic rate (syllables/second) data collected from 
control participants across all 3 visits. 
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Table 7: Description of Voice Quality for Control Participants Across All Three 
Visits 
Participant 
ID 
Visit 1 Visit 2 Visit 3 
Jitter Shimmer Signal-
to-noise 
Jitter Shimmer Signal-
to-noise 
Jitter Shimmer Signal-
to-noise 
1 0.46 3.13 27.30 0.41 3.28 27.33 0.31 1.81 30.12 
2 0.29 1.68 29.41 0.34 1.55 26.45 0.29 1.55 28.78 
3 0.22 1.50 28.88 0.17 1.22 31.28 0.21 1.58 28.79 
4 1.96 5.15 19.14 1.70 5.13 20.15 0.78 6.08 20.79 
5 0.19 1.06 30.64 0.33 1.87 26.33 0.35 3.13 25.24 
6 1.80 3.21 24.64 1.66 2.69 21.17 1.08 2.68 20.24 
7 0.40 1.18 24.16 0.35 1.90 25.71 0.25 0.78 27.78 
8 0.25 1.74 32.61 0.24 2.21 31.19 0.18 1.43 35.16 
9 0.44 2.33 26.28 0.61 2.13 26.41 0.35 1.50 28.11 
10 0.38 2.04 25.91 0.35 2.31 24.43 0.44 2.20 24.13 
11 0.25 1.23 28.04 0.23 1.23 27.61 0.29 1.28 28.12 
12 0.45 2.43 23.99 0.41 1.97 24.76 0.28 2.10 26.55 
13 0.43 2.10 26.75 0.34 1.65 28.72 0.41 2.61 25.72 
14 0.33 1.54 24.87 0.39 2.03 23.45 0.38 2.29 22.15 
15 0.25 1.17 26.49 0.17 0.92 30.44 0.21 1.09 26.66 
16 0.36 2.38 25.31 0.32 1.42 27.60 0.37 1.99 26.82 
17 0.40 3.05 20.82 0.52 3.29 19.62 0.39 3.17 20.77 
18 0.54 3.72 22.46 0.49 3.00 22.66 0.45 4.74 23.03 
19 0.29 2.42 25.74 0.40 1.89 25.83 0.23 1.57 26.10 
20 0.42 2.10 26.75 0.48 2.36 24.63 0.28 1.66 28.16 
21 0.48 2.49 22.55 0.34 1.87 24.35 0.50 2.38 22.44 
22 0.34 2.57 25.14 0.49 2.01 24.58 0.53 1.48 24.64 
23 0.41 1.77 26.05 0.33 1.62 26.58 0.24 1.51 27.99 
24 1.67 3.82 16.45 2.03 3.97 16.47 1.06 2.93 19.28 
25 0.15 1.03 30.88 0.14 2.12 30.91 0.27 4.57 24.34 
26 0.16 1.05 31.75 0.26 1.19 27.69 0.25 1.47 28.77 
27 1.57 3.39 21.42 0.58 2.14 24.51 0.44 1.97 22.85 
28 0.43 1.81 24.36 0.56 2.14 22.20 0.80 2.53 22.82 
29 1.56 3.54 21.72 2.09 4.92 22.47 0.60 3.52 24.95 
30 0.51 1.57 23.61 0.45 1.99 22.47 0.85 1.97 23.94 
Note. This table describes the voice quality data collected from control participants across 
all 3 visits. 
 
2.3.2 Visit 2 
 
The motor symptoms associated with PD were assessed in participants with PD via the 
UPDRS. Participants with PD also indicated their self-perceived level of medication 
effectiveness via the MES. All participants complete five questionnaires (TLS, VAPP, 
CPIB, LSUS, and CES).  Proxy measures for the participants with PD for each 
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questionnaire were collected from their primary communication partners. The 
presentation order of the scales was randomized across participants and visits. The 
presentation order was determined using www.randomizer.org.   
 
Participants with PD and control participants then completed various speech tasks. 
Participants completed maximum sustained vowel phonation and diadochokinetic tasks. 
Table 4 provides diadochokinetic task rates for participants with PD and Table 5 provides 
description of voice report summaries for participants with PD. Table 6 provides 
diadochokinetic task rates for control participants and Table 7 provides a description of 
voice report summaries for control participants. Various speech intensity measures were 
then collected.  The sentence “she saw Patty buy two poppies” was used during a 
magnitude production task, where participants repeated the sentence at their habitual 
speech intensity, two times louder than their habitual speech intensity, four times louder 
than their habitual speech intensity, and their maximal speech intensity. The magnitude 
production function was determined by calculating the slope of speech intensity when 
participants repeated the target sentence at their habitual speech intensity, two time louder 
than their habitual speech intensity, and four times louder than their habitual speech 
intensity. Participants also produced this sentence using their habitual speech intensity in 
60, 65, 70, and 75 dB SPL of multi-talker background noise. The Lombard response 
function was then determined by calculating the slope of speech intensity when 
participants repeated the target sentence in 60, 65, 70, and 75 dB SPL of multi-talker 
background noise. Participants then completed the SIT and engaged in two minutes of 
conversation with the experimenter.  
2.3.3 Visit 3 
 
All participants completed five questionnaires (TLS, VAPP, CPIB, LSUS, and CES).  
Proxy measures for the participants with PD for each questionnaire were collected from 
their primary communication partners. The presentation order of the scales was 
randomized across participants and visits. The presentation order was determined using 
www.randomizer.org.   
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Participants with PD and control participants then completed various speech tasks. 
Participants completed maximum sustained vowel phonation and diadochokinetic tasks. 
Table 4 provides diadochokinetic task rates for participants with PD and Table 5 provides 
description of voice report summaries for participants with PD. Table 6 provides 
diadochokinetic task rates for control participants and Table 7 provides a description of 
voice report summaries for control participants. Various speech intensity measures were 
then collected.  The sentence “she saw Patty buy two poppies” was used during a 
magnitude production task, where participants repeated the sentence at their habitual 
speech intensity, two times louder than their habitual speech intensity, four times louder 
than their habitual speech intensity, and their maximal speech intensity. The magnitude 
production function was determined by calculating the slope of speech intensity when 
participants repeated the target sentence at their habitual speech intensity, two time louder 
than their habitual speech intensity, and four times louder than their habitual speech 
intensity. Participants also produced this sentence using their habitual speech intensity in 
60, 65, 70, and 75 dB SPL of multi-talker background noise. The Lombard response 
function was then determined by calculating the slope of speech intensity when 
participants repeated the target sentence in 60, 65, 70, and 75 dB SPL of multi-talker 
background noise. Finally, participants completed the SIT and engaged in two minutes of 
conversation with the experimenter.  
2.3.4 Listener perceptual evaluation 
 
All listeners read a detailed letter of information and provided their written consent prior 
to beginning the study. The Letter of Information presented to listeners is found in 
Appendix N. The Consent Form signed by listeners is provided in Appendix O. Listeners 
took part in three sessions, each lasting two to three hours in duration. All listening 
sessions took place in a quiet laboratory environment. Auditory stimuli were presented to 
listeners via free-field presentations with M-Audio speakers (AV 40) placed 60 cm away 
from listeners. During these sessions, listeners evaluated the sentence and conversational 
speech intelligibility of IWPD and control participants. Listeners were blinded to group 
and visit throughout their evaluation of speech intelligibility. 
2.3.4.1 Sentence Intelligibility Test 
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Only 13-, 14-, and 15-word sentences of the SIT were presented to and orthographically 
transcribed by listeners using a custom Praat script on a 2016 13-inch MacBook Pro 
laptop. Each sentence was presented to listeners twice. Sentence intelligibility was 
determined by calculating the percentage of words correctly transcribed.  
 
Following the presentation and transcription of each set of 13-, 14-, and 15-word 
sentences of the SIT, listeners provided an overall rating of speech intelligibility for the 
speaker. Speech intelligibility measures for the presented SIT sentences were obtained 
using VAS estimation. A VAS with the anchors “0% intelligible” and “100% intelligible” 
was presented to listeners using a custom Praat script on a 2016 13-inch MacBook Pro 
laptop following each set of 13-, 14-, and 15-word sentences of the SIT. Listeners rated 
speech intelligibility by indicating their rating with their cursor on the VAS. See 
Appendix P for an example of the VAS used for sentence intelligibility. Speech 
intelligibility was then automatically translated to a percentage for each rating. Stimuli 
presentation was randomized for across participants and visits using a custom Praat 
script. 
2.3.4.2 Conversational intelligibility 
 
Conversational intelligibility was evaluated using VAS estimation.  From the two 
minutes of conversation recorded, each participant’s recorded utterances were edited into 
a single spontaneous conversational excerpt ranging in length from 15 – 20 seconds in 
durations. Each conversational speech intelligibility sample was presented once to 
listeners prior to evaluating speaker intelligibility. A VAS with the anchors “0% 
intelligible” and “100% intelligible” was presented to listeners on a 2016 13-inch 
MacBook Pro laptop following each conversational speech intelligibility sample. 
Listeners rated speech intelligibility by indicating their rating with their cursor on the 
VAS. See Appendix P for an example of the VAS used for conversational speech 
intelligibility. Speech intelligibility was converted to a percentage for each rating. Stimuli 
presentation was randomized for across participants and visits using a custom Praat 
script. 
2.4 Data Analysis 
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Eight objectives were established in this study. The first objective addressed the 
variability of speech intensity measures of the participants with PD and control 
participants. The second objective focused on the perceptions of typical speech loudness 
between the participants with PD, their primary communication partner, and control 
participants.  The third objective addressed the variability of sentence and conversational 
speech intelligibility of the participants with PD and control participants. The fourth and 
fifth objectives evaluated the variability of self-rated communicative participation of the 
participants with PD and control participants, and the participants with PD and their 
primary communication partner respectively. 
 
The next three objectives focused on relationships across speech intensity, speech 
intelligibility, communicative participation, demographic factors, and non-speech factors. 
The first of these objectives focused on the relationships among these variables for the 
participants with PD. The second of these objectives focused on the relationships among 
proxy-rated variables for participants with PD. The third of these objectives focused on 
the relationships between these variables for control participants. The statistical 
procedures are outlined below. 
2.4.1 Statistical analysis for objective 1: Speech intensity 
 
This analysis examined the temporal variability of speech intensity measures of 
participants with PD and control participants while repeating the phrase “She saw Pattie 
buy two poppies”. The measures of speech intensity under examination in this objective 
were habitual speech intensity, maximal speech intensity, Lombard response, and 
magnitude productions. For each of the four dependent measures related to speech 
intensity, a separate two-factor repeated measures analysis of variance (ANOVA) were 
performed to evaluate differences in speech intensity between participants with PD and 
control participants over time. The following factors were used in this analysis: one 
between-group independent factor with two levels [PD, control], one within-group 
independent factor with three levels [visit 1, visit 2, visit 3]. 
 
A secondary retest analysis exploring the retest reliability and repeatability of each 
dependent measure of speech intensity was performed for both participants with PD and 
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control participants. This retest analysis of the intensity measures used 1) correlations 
between visits 1-2, 1-3 and 2-3, 2) SEM across visits 1-2, 1-3, and 2-3, 3) mean 
difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) pairwise CR involving visits 1-2, 
1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 2-3.  
 
ICC were used to assess the correlation between multiple sets of measurements and 
incorporates the consistency of within-subject measures and the average change of a 
group mean over time (Vaz et al., 2013). The mean difference is a measure of the 
difference between the mean values of two groups of a single measurement. The mean 
difference was calculated by subtracting mean values of one visit from the mean values 
of another visit. The mean difference was evaluated statistically using a paired t-test. The 
SEM is an estimate of how much variation (error) there would be across repeated 
measures of a single participant’s values or scores. The SEM is the within-subject 
standard deviation of a measurement and is a measure of the degree to which scores are 
spread around a true score. The SEM reflects the precision of a measure. Thus, a lower 
SEM reflects a more precise measure. The SEM was calculated by multiplying the pooled 
standard deviation, obtained for the pair of retest visits, by the square root of one minus 
the ICC. The CR was calculated by multiplying the SEM by 2.77. CR is calculated in the 
same units as the dependent measure under study, as a result, it is a useful parameter for 
estimating the probable limits of measurement error when interpreting the effects of 
clinical treatments (Vaz, et al., 2013). The CR is the value below which the absolute 
differences between two measurements would lie with 0.95 probability (Vaz, et al., 
2013).  In other words, difference values above the CR would reflect 95% probability of a 
true level of change as opposed to a difference that may simply be due to measurement 
error. It is also suggested that CR reflects the minimal detectable true level of change of 
an outcome measure. The CR% is also referred to as the smallest real difference 
percentage (SRD%). The CR% was calculated by dividing the CR by the mean of the 
dependent variable and multiplying the resulting value by 100. Previous studies have 
proposed that CR% values less than or equal to 10% are indicative of good repeatability 
(Lu, Chen, Huan, & Hsieh, 2007; Smidt, et al., 2002). The current study also proposes 
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CR% values between 11 – 20 % to be indicative of marginal repeatability, and CR% 
values greater than 20% to be indicative of unacceptable repeatability. 
 
These analyses were used to address objective 1 and the associated research question: Do 
speech intensity measures differ between and within participants with PD and control 
participants over time? In addition, these analyses were used to address objective 6 and 
the associated research question: Do speech intensity measures demonstrate good retest 
reliability and acceptable repeatability for participants with PD and control 
participants? 
2.4.2 Statistical analysis for objective 2: Typical speech 
loudness 
 
This analysis on evaluating whether perceptions of typical speech loudness differ 
between participants with PD, their primary communication partner, and control 
participants using their responses on the Typical Loudness Scale. A multi-factor repeated 
measures ANOVA was performed to evaluate differences in perceptions of typical speech 
loudness among participants with PD, their primary communication partners (PCP) and 
control participants over time. The following factors were used in this analysis: one 
between-group independent factor with three levels [PD, communication partners, 
control], one within-group independent factor with three levels [visit 1, visit 2, visit 3], 
one dependent factor [perceptions of typical loudness].  
 
A secondary retest analysis exploring the retest reliability and repeatability of perceived 
typical speech loudness was performed for participants with PD, their primary 
communication partners, and control participants. This retest analysis of perceived 
loudness measures used 1) correlations between visits 1-2, 1-3 and 2-3, 2) SEM across 
visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) 
pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 
2-3. 
 
These analyses were used to address objective 2 and the associated research question: Do 
participants with PD perceive their typical speech loudness differently from their primary 
communicative partners and control participants over time? In addition, these analyses 
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were used to address objective 6 and the associated research question: Do ratings of 
perceived typical speech loudness demonstrate good retest reliability and acceptable 
repeatability for participants with PD, their primary communication partners, and 
control participants? 
2.4.3 Statistical analysis for objective 3: Speech 
 intelligibility 
 
This analysis explored the temporal variability of measures of speech intelligibility of 
participants with PD and control participants. The measures of speech intelligibility under 
examination in this objective was sentence intelligibility as measured via SIT 
transcription and VAS scores, and conversational speech intelligibility. For each of the 
three dependent measures related to speech intelligibility, a separate two-factor repeated-
measures ANOVA was performed to compare the speech intelligibility of participants 
with PD and control participants over time. The following factors were used in this 
analysis: one between-group independent factor with two levels [PD, control], one 
within-group independent factors with 3 levels [visit 1, visit 2, visit 3].  
 
A secondary retest analysis exploring the retest reliability and repeatability of each 
dependent measure of speech intelligibility was performed for both participants with PD 
and control participants. This retest analysis of speech intelligibility measures used 1) 
correlations between visits 1-2, 1-3 and 2-3, 2) SEM across visits 1-2, 1-3, and 2-3, 3) 
mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) pairwise CR involving visits 
1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 2-3. 
 
These analyses were used to address objective 3 and the associated research question: Do 
speech intelligibility measures differ between and within participants with PD and 
control participants over time? In addition, these analyses were used to address objective 
6 and the associated research question: Do speech intelligibility measures demonstrate 
good retest reliability and acceptable repeatability for participants with PD and control 
participants? 
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2.4.4 Statistical analysis for objective 4: Self-rated 
communicative participation 
 
This analysis explored the temporal variability of self-rated communicative participation 
of the participants with PD and control participants over time. The measures of 
communicative participation under examination in this objective was the individual CES 
question scores, the individual VAPP subsection scores, the standardized CPIB scores, 
and the LSUS scores. Note that the section exploring the effects of voice impairment on 
an individual’s job on the VAPP was excluded from calculations as the majority of 
participants were retired at the time of this study and were unable to complete this section 
of the questionnaire. For the individual CES question scores and the individual VAPP 
subsection scores, a separate repeated measure multivariate analysis of variance 
(MANOVA) was performed to analyze communicative participation between participants 
with PD and control participants. For CPIB and LSUS scores, a separate two-factor 
repeated measures ANOVA was performed to analyze communicative participation 
between participants with PD and control participants. The following factors were used in 
each of these analyses was: one between-group independent factor with two levels [PD, 
control], one within-group independent variable with three levels [visit 1, visit 2, visit 3.  
 
A secondary retest analysis exploring the retest reliability and repeatability of each 
dependent measure of communicative participation was performed for both participants 
with PD and control participants. This retest analysis of communicative participation 
measures used 1) correlations between visits 1-2, 1-3 and 2-3, 2) SEM across visits 1-2, 
1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) pairwise CR 
involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 2-3. 
 
These analyses were used to address objective 4 and the associated research question: Do 
self-ratings of communicative participation differ between and within participants with 
PD and control participants over time? In addition, these analyses were used to address 
objective 6 and the associated research question: Do self-ratings of communicative 
participation demonstrate good retest reliability and acceptable repeatability for 
participants with PD and control participants? 
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2.4.5 Statistical analysis for objective 5: Self- and proxy-
rated communicative participation 
 
This analysis explored differences in ratings of communicative participation between 
participants with PD and their primary communication partner. Self- and proxy-measures 
of communicative participation under examination in this objective was the individual 
CES question scores, the individual VAPP subsection scores, the standardized CPIB 
scores, and the LSUS scores. Note that the section exploring the effects of voice 
impairment on an individual’s job on the VAPP was excluded from calculations as the 
majority of participants were retired at the time of this study and were unable to complete 
this section of the questionnaire. For the individual CES question scores and the 
individual VAPP subsection scores, a separate repeated measures MANOVA was 
performed to analyze communicative participation between participants with PD and 
their primary communication partners. For CPIB and LSUS scores, a separate two-factor 
repeated measures ANOVA was performed to analyze communicative participation 
between participants with PD and their primary communication partners. The following 
factors were used in these analyses: one between-group independent factor with two 
levels [PD, communication partners], one within-group independent variable with three 
levels [visit 1, visit 2, visit 3].  
 
A secondary retest analysis exploring the retest reliability and repeatability of each 
dependent measure of communicative participation was performed for both participants 
with PD and their primary communication partners. This retest analysis of 
communicative participation measures used 1) correlations between visits 1-2, 1-3 and 2-
3, 2) SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 
1-3, and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving 
visits 1-2, 1-3, and 2-3. 
 
These analyses were used to address objective 5 and the associated research question: Do 
ratings of communicative participation differ between and within participants with PD 
and their primary communication partners over time? In addition, these analyses were 
used to address objective 6 and the associated research question #6: Do ratings of 
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communicative participation demonstrate good retest reliability and acceptable 
repeatability for participants with PD and their primary communication partners? 
2.4.6 Statistical analysis for objective 7: Inter-relationships 
among variables in participants with Parkinson’s 
disease 
 
This exploratory analysis evaluated inter-relationships among in speech intensity 
measures, speech intelligibility measures, self-rated communicative participation 
measures, demographic factors, and non-speech factors for participants with PD across 
each of the three experimental visits. A matrix of inter-correlations was obtained via three 
series of Pearson correlation procedures (p<.05) applied to all possible pairwise 
combination of the experimental variables, demographic factors, and non-speech factors 
among participants with PD. The criteria for interpreting the strength of the correlations 
was as follows: 0 – 0.25 = little to no correlation; 0.25 – 0.50 = a fair correlation; 0.50 – 
0.75 = a good to moderate correlation; 0.75 and above = a good to excellent correlation 
(Portney & Watkins, 2000). The resulting correlation matrix was used to examine 
potential relationships among the various experimental variables for each of the three 
visits.  
 
These analyses were used to address objective 7 and the associated research question: Are 
measures of speech intensity, speech intelligibility, communicative participation, 
demographic factors, and non-speech factors related to one another in participants with 
PD? 
2.4.7 Statistical analysis for objective 8: Inter-relationships 
among proxy-measures in participants with 
Parkinson’s disease 
 
This exploratory analysis evaluated inter-relationships among in speech intensity 
measures, speech intelligibility measures, proxy-rated communicative participation 
measures, demographic factors, and non-speech factors for participants with PD across 
each of the three experimental visits. A matrix of inter-correlations was obtained via a 
series of Pearson correlation procedures (p<.05) applied to all possible pairwise 
combination of the experimental variables, demographic factors, and non-speech factors 
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among participants with PD. The criteria for interpreting the strength of the correlations 
was as follows: 0 – 0.25 = little to no correlation; 0.25 – 0.50 = a fair correlation; 0.50 – 
0.75 = a good to moderate correlation; 0.75 and above = a good to excellent correlation 
(Portney & Watkins, 2000). The resulting correlation matrix was used to examine 
potential relationships among the various experimental variables for each of the three 
visits.  
 
These analyses were used to address objective 8 and the associated research question: Are 
measures of speech intensity, speech intelligibility, proxy ratings of communicative 
participation, demographic factors, and non-speech factors related to one another in 
participants with PD? 
2.4.8 Statistical analysis for objective 9: Inter-
relationships among variables in control participants 
 
This exploratory analysis evaluated inter-relationships among in speech intensity 
measures, speech intelligibility measures, self-rated communicative participation 
measures, demographic factors, and non-speech factors for control participants across 
each of the three experimental visits. A matrix of inter-correlations was obtained via a 
series of Pearson correlation procedures (p<.05) applied to all possible pairwise 
combination of the experimental variables, demographic factors, and non-speech factors 
among participants with PD and control participants. The criteria for interpreting the 
strength of the correlations was as follows: 0 – 0.25 = little to no correlation; 0.25 – 0.50 
= a fair correlation; 0.50 – 0.75 = a good to moderate correlation; 0.75 and above = a 
good to excellent correlation (Portney & Watkins, 2000). The resulting correlation matrix 
was used to examine potential relationships among the various experimental variables.  
 
These analyses were used to address objective 9 and the associated research question: Are 
measures of speech intensity, speech intelligibility, communicative participation, 
demographic factors, and non-speech factors related to one another in control 
participants? 
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Chapter 3 
3 Results  
 
This study examined the temporal variability of acoustic and perceptual speech measures, 
and psychosocial measures in individuals with hypophonia and PD. Additionally, this 
study explored the relationships among speech intensity measures, speech intelligibility 
measures, self- and proxy-rated communicative participation measures, demographic 
factors, and non-speech factors. In order to provide a comprehensive representation of the 
different variables of interest and their relationship to one another, each of the nine 
objectives in this study were analyzed separately, with the exception of objective 6 which 
is embedded within objectives 1-5. The results for objectives 1 through 5 consist of 
analyses that will evaluate variability over time. Objective 6 describes the retest analyses 
of each variable and, therefore, objective 6 is embedded with the first 5 objectives. The 
results for objectives 7 through 9 consist of analyses that will evaluate relationships 
existing among variables. 
 
3.1 Statistical Power 
 
Statistical power reflects the prospect of identifying differences resulting from a 
treatment and probability of the successful replication of a study (Keppel, 1991). 
Statistical power is established based on the interaction and relationship between sample 
size, variance within data, effect size, and statistical significance (Portney & Watkins, 
2000). G*Power v3.1 (Faul, Erdfelder, Lang, & Buchner, 2007) was used to perform a 
post-hoc power analysis. The power calculations were based on the findings of previous 
studies exploring speech intensity (Adams et al., 2006b; Dykstra et al., 2012a) and 
communicative participation (Dykstra et al., 2015). The Adams and colleagues (2006b) 
study was used to estimate differences between mean habitual conversational speech 
intensity for participants with PD and control participants to be approximately 4 dB with 
a standard deviation of approximately 3 dB. The resulting effect size was 1.66. A post-
hoc power analysis using a sample size of 53 (PD = 23; controls = 30), an effect size of 
1.33, and an alpha level of .05. This post-hoc analysis provided a power estimate of .99. 
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The Dykstra and colleagues (2012a) study was used to estimate differences between 
mean habitual conversational speech intensity for participants with PD and control 
participants to be approximately 5 dB with a standard deviation of approximately 2.99 
dB. The resulting effect size was 1.66. A post-hoc power analysis using a sample size of 
53 (PD = 23; controls = 30), an effect size of 1.66, and an alpha level of .05. This post-
hoc analysis provided a power estimate of .99. The work of Dykstra and colleagues 
(2012a) was used to estimate differences between maximum speech intensity for 
participants with PD and control participants to be approximately 10.50 dB with a 
standard deviation of approximately 4.25 dB. The resulting effect size was 2.47. A post-
hoc power analysis using a sample size of 53 (PD = 23; controls = 30), an effect size of 
2.47, and an alpha level of .05. This post-hoc analysis provided a power estimate of 1.00. 
The Dykstra and colleagues (2012a) study was also used to estimate differences between 
speech intensity during 65 dB of background noise for participants with PD and control 
participants to be approximately 5.60 dB with a standard deviation of approximately 2.89 
dB. The resulting effect size was 1.93. A post-hoc power analysis using a sample size of 
53 (PD = 23; controls = 30), an effect size of 1.93, and an alpha level of .05. This post-
hoc analysis provided a power estimate of .99. A study by Dykstra and colleagues (2015) 
study was used to estimate differences between ratings of perceived communication 
effectiveness for participants with PD and control participants to be approximately 2.0 
with a standard deviation of approximately 1.07. The resulting effect size was 1.86. A 
post-hoc power analysis using a sample size of 53 (PD = 23; controls = 30), an effect size 
of 1.66, and an alpha level of .05. This post-hoc analysis provided a power estimate of 
.99. Based on these five estimates of power, it appears that the current study demonstrates 
of power estimate of .99. These results suggest that statistical power is satisfactory for the 
present study. 
3.2 Reliability 
 
Inter-rater reliability was calculated for all three measures of speech intelligibility (SIT 
transcription scores, SIT VAS scores, and conversational intelligibility VAS scores).  The 
ICC values related to the measures of speech intelligibility was found to be the following: 
SIT transcription scores of ICC = .85, p < .001 for visit 1, ICC = .80, p < .001 for visit 2, 
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and ICC = .74, p < .001 for visit 3; SIT VAS scores of ICC = .84, p < .001 for visit 1, 
ICC = .82, p < .001 for visit 2, and ICC = .84, p < .001 for visit 3; and conversational 
intelligibility VAS scores of ICC = .72, p < .001 for visit 1, ICC = .63, p < .001 for visit 
2, and ICC = .78, p < .001 for visit 3. See Table 8 for a complete description of inter-rater 
reliability. These results suggest good reliability between listeners for all three measures 
of speech intelligibility. 
 
Table 8: Inter-Rater Reliability for Listeners Across Measures of Speech 
Intelligibility 
 SIT transcription scores SIT VAS scores Conversational 
intelligibility VAS scores 
ICC[95% CI] p value ICC[95% CI] p value ICC[95% CI] p value 
Visit 1 . 85[.76-.91] <.001 .84[.69-.91] <.001 .72[.52-.84] <.001 
Visit 2 .80[.69-.88] <.001 .82[.71-.89] <.001 .63[.38-.78] <.001 
Visit 3 .74[.59-.85] <.001 .84[.69-.91] <.001 .78[.53-.89] <.001 
Note. This table illustrates the interclass correlations, 95% confidence intervals, and 
statistical significance as a measure of inter-rater reliability for listener ratings for the 
different speech intelligibility measures. 
 
Scores generated by each listener for each of the three speech intelligibility tasks were 
measured against each other in order to ascertain each listener’s intra-rater reliability. In 
order to determine intra-rater reliability, each listener re-measured 10% of the 
intelligibility data. The Cronbach’s alphas related to the measures of speech intelligibility 
ranged from .58 - .98 for listener 1, .56 - .97 for listener 2, and .19 - .95 for listener 3. See 
Table 9 for a complete description of intra-rater reliability. These results suggest 
moderate to excellent reliability for listeners on eight of nine measures of speech 
intelligibility. 
 
Table 9: Intra-Rater Reliability for Listeners Across Measures of Speech 
Intelligibility 
 SIT transcription scores 
Cronbach’s alpha 
SIT VAS scores 
Cronbach’s alpha 
Conversational 
intelligibility VAS scores 
Cronbach’s alpha 
Listener 1 .98 .95 .58 
Listener 2 .56 .91 .97 
Listener 3 .19 .78 .95 
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Note. This table illustrates Cronbach’s alpha as a measure of intra-rater reliability for 
each listener ratings for the different speech intelligibility measures. 
 
3.3 Statistical Analysis for Objective 1: Speech Intensity 
 
In order to answer the question ‘Do speech intensity measures differ over time between 
and within participants with PD and control participants?’, a separate two-factor 
repeated measures ANOVA was performed on each of the four dependent speech 
intensity measures (i.e., habitual speech intensity, maximum speech intensity, Lombard 
response function, magnitude production). Each of the two-factor repeated measures 
ANOVAs involved a “Group” factor with two separate levels (participants with PD and 
control participants) and a “Visit” factor with three levels (visit 1, visit 2, and visit 3). 
Whenever the ANOVA resulted in a significant main effect for the factor “Visit”, a post-
hoc analysis was performed using pairwise comparisons. 
3.3.1 Habitual speech intensity 
 
Measures of habitual speech intensity were obtained from audio recordings of 
participants with PD and control participants reading the sentence “She saw Patty buy 
two poppies” using their habitual speaking loudness. Descriptive statistics for habitual 
speech intensity are shown in Table 10. The results of the two-way repeated measures 
ANOVA for the dependent measure of habitual speech intensity showed that there was no 
significant main effect of “Group” F(1,49) =1.60, p = .211 with participants with PD 
having a similar marginal mean (M = 67.71, SD = 3.61) to that of control participants (M 
= 69.01, SD = 3.61). In contrast, there was a significant main effect of “Visit” on habitual 
speech intensity F(2,98) = 5.54, p = .005. A closer look at the factor “Visit”, using 
pairwise post-hoc analyses indicated that the marginal mean habitual speech intensity at 
visit 1 (M = 67.35, SD = 4.28) was significantly lower than the mean habitual speech 
intensity at visit 2 (M = 69.24, SD = 4.57) and visit 3 (M = 68.50, SD = 4.21). It is 
important to note that this main effect of “Visit” needs to be qualified because of the 
finding of a significant “Group” by “Visit” interaction F(2,98) = 3.50, p = .034 for 
habitual speech intensity. This significant interaction is illustrated in Figure 1. It appears 
that at visit 1 the group difference between the PD and control participants’ habitual 
speech intensity is greater than the group differences that were found at visit 2 and visit 3. 
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Results of a post-hoc analyses involving comparisons of these group differences at each 
visit provided additional information about this significant “Group” by “Visit” 
interaction. For the post-hoc comparison related to visit 1, the participants with PD had a 
mean habitual speech intensity (M = 66.09, SD = 4.79) that was significantly lower (-3.06 
dB SPL) than the mean habitual speech intensity of control participants (M = 69.15, SD = 
4.12), t(2,51) = -2.50, p = .016.  In contrast, the post-hoc comparisons related to group 
differences were not significant at visit 2 t(2,50) = -0.27, p = .786 or visit 3 t(2,50) = -
0.69, p = .494. Thus, it appears that although the habitual speech intensity of the IWPD 
was significantly lower than that of the controls at visit 1, it increased to a level that was 
not significantly different from the controls at visit 2 and visit 3.   
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Table 10: Descriptive Statistics of Speech Intensity Measures for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 Habitual speech 
intensity 
mean(SD) 
Maximum 
speech intensity 
mean(SD) 
Lombard response 
function  
mean(SD) 
Magnitude 
production 
mean(SD) 
Participants with PD 
Visit 1 66.09(4.79) 77.55(6.61) 0.34(0.17) 2.34(1.50) 
Visit 2 69.09(4.39) 79.32(6.50) 0.31(0.12) 2.01(1.06) 
Visit 3 68.27(4.02) 78.68(6.11) 0.28(0.14) 2.02(0.97) 
Control participants 
Visit 1 69.15(4.12) 83.75(6.36) 0.32(0.13) 3.13(1.31) 
Visit 2 69.43(4.57) 82.40(5.75) 0.26(0.16) 2.60(1.09) 
Visit 3 69.13(4.70) 83.35(7.08) 0.25(0.17) 2.81(1.16) 
   Marginal means 
Participants with PD 67.71(3.61) 78.20(5.68) 0.31(0.14) 2.09(1.08) 
Control participants 69.01(3.61) 82.88(5.65) 0.27(0.11) 2.86(1.08) 
Visit 1 67.35(4.28) 80.22(6.76) 0.32(0.14) 2.75(1.43) 
Visit 2 69.24(4.57) 80.63(6.45) 0.29(0.14) 2.24(1.00) 
Visit 3 68.50(4.21) 80.77(6.99) 0.26(0.14) 2.42(1.14) 
Note. This table illustrates the means and standard deviations for the different speech 
intensity measures for participants with PD and control participants across visits. 
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Figure 1: Means of Habitual Speech Intensity for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 1. This figure demonstrates the changes in habitual speech intensity scores for 
participants with PD and control participants across visits. Error bars represent standard 
deviations. 
 
3.3.1.1 Retest analyses 
 
Following the primary variability analysis described above, secondary retest analyses 
related to the evaluation of the retest reliability and repeatability of habitual speech 
intensity were performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) 
SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, 
and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-
2, 1-3, and 2-3. The purpose of these analyses was to 1) Evaluate the strength of the retest 
reliability values using the previously recommended correlation of ICC > .75. This ICC 
value was used as a point of reference since an ICC of .75 or higher is indicative of good 
to excellent reliability (Koo & Li, 2016). 2) Provide an estimate of the smallest value that 
would be considered to represent the measurement error. 3) Indicate the difference 
between the mean values of two groups of a single measurement. 4) Provide an estimate 
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of a significant change between two or more time points of a measure. The CR is also 
referred to as the Smallest Real Difference (SRD; Beckerman, Roebroeck, Lankhorst, 
Becher, Bezemer, & Verbeek, 2001) and the Minimal Detectable Difference (MDD; 
Furlan & Sterr, 2018; Steffen & Seney, 2008). 5) Evaluating the percentage of variation 
present in a measure. Based on previous studies, CR% values less than or equal to 10% 
are used to indicate good repeatability in the present study (Lu et al., 2007; Smidt, et al., 
2002). The current study also uses CR% values between 11 – 20 % to indicate marginal 
repeatability, and CR% values greater than 20% to indicate unacceptable repeatability. 
The retest analysis, involving the ICC, mean difference t-test, SEM, CR and CR%, were 
performed on the participants with PD and control participants. Results for the retest 
analysis of habitual speech intensity are summarized in Table 11.  
Table 11: Retest Analyses of Habitual Speech Intensity for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .64[.10-.85] -3.00 4.30 -3.35 .003 4.59 2.76 7.64 11.55 
Visits 1 – 3 .64[.15-.85] -2.45 4.22 -2.73 .013 4.42 2.65 7.35 10.64 
Visits 2 – 3 .79[.50-.91] 0.78 3.55 1.03 .313 4.21 1.93 5.34 7.83 
Control participants 
Visits 1 – 2 .77[.52-.89] -0.56 3.67 -0.83 .416 4.35 2.09 5.78 8.36 
Visits 1 – 3 .73[.43-.87] 0.02 4.12 0.03 .978 4.42 2.30 6.36 9.16 
Visits 2 – 3 .66[.28-.84] 0.70 4.45 0.85 .402 4.64 2.70 7.49 10.83 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of habitual speech intensity for participants with PD and control 
participants. 
 
3.3.1.1.1 Retest analysis of habitual speech intensity for 
participants with Parkinson’s disease 
 
The ICC values related to the repeated measurement of habitual speech intensity across 
the three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = .64, p 
= .002, visit 1 versus visit 3 ICC = .64, p = .004, and visit 2 versus visit 3 ICC = .79, p < 
.001. These results suggest that habitual speech intensity as measured in the present study 
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did not demonstrate good retest reliability in IWPD because the ICC values across two of 
three comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for habitual speech intensity was -3.00 
dB SPL (SD = 4.30) and this difference was significant t(22) = -3.35, p = .003. The mean 
difference between visit 1 and visit 3 for habitual speech intensity was -2.45 dB SPL (SD 
= 4.22) and this difference was significant t(21) = -2.73, p = .013. The mean difference 
between visit 2 and visit 3 for habitual speech intensity was 0.78 dB SPL (SD = 3.55) and 
this difference was not significant t(21) = 1.034, p = .313. These mean differences in 
retest values ranged from -6.57 – 9.36 dB SPL. Additionally, the following CR values 
and CR percentages were obtained for the following visit comparisons: for visit 1 vs visit 
2 CR = 7.64 and CR% = 11.55%, for visit 1 vs visit 3 CR = 7.35 and CR% = 10.64%, and 
for visit 2 vs visit 3, CR = 5.34 and CR% = 7.83%. Based on the CR, an observed change 
in the habitual speech intensity of at least 5.34– 7.64 dB SPL would suggest an 
acceptable amount of measurement error ranging from 7.83 – 11.55% variation in the 
habitual speech intensity of IWPD. These results suggest that the measure of habitual 
speech intensity demonstrates fairly good repeatability for IWPD. 
3.3.1.1.2 Retest analysis of habitual speech intensity for 
control participants 
 
The ICC values related to the repeated measurement of habitual speech intensity across 
the three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = .77, p 
< .001, visit 1 versus visit 3 ICC = .73, p < .001, and visit 2 versus visit 3 ICC = .66, p = 
.003. These results suggest that habitual speech intensity as measured in the present study 
did not demonstrate good retest reliability in healthy speakers because the ICC values 
across two of three comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for habitual speech intensity was -0.56 
dB SPL (SD = 3.67) and this difference was not significant t(28) = -0.83, p = .416. The 
mean differences in retest values ranged from -6.80 – 6.95 dB SPL. The mean difference 
between visit 1 and visit 3 for habitual speech intensity was 0.02 dB SPL (SD = 4.12) and 
this difference was not significant t(29) = 0.03, p = .978. The mean differences in retest 
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values ranged from -6.08 – 10.05 dB SPL. The mean difference between visit 2 and visit 
3 for habitual speech intensity was 0.70 dB SPL (SD = 4.45) and this difference was not 
significant t(28) = 0.85, p = .402. The mean differences in retest values ranged from -6.79 
– 14.91 dB SPL. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 5.78 and CR% = 8.36%, for visit 1 vs visit 
3, CR = 6.36 and CR% = 9.16%, and for visit 2 vs visit 3, CR = 7.49 and CR% = 10.83%. 
Based on the CR, an observed change in the habitual speech intensity of at least 5.78 – 
7.49 dB SPL would suggest an acceptable amount of measurement error ranging from 
8.36 – 10.83% variation in the habitual speech intensity of control participants. These 
results suggest that the measure of habitual speech intensity demonstrates good 
repeatability for control participants. 
3.3.2 Maximum speech intensity 
 
Measures of maximum speech intensity were obtained from audio recordings of 
participants with PD and control participants reading the sentence “She saw Patty buy 
two poppies” using as loud a voice as possible. Descriptive statistics for maximum 
speech intensity are shown in Table 10. The results of the two-way repeated measures 
ANOVA for the dependent measure of maximum speech intensity showed that there was 
significant main effect of “Group” F(1,49) = 8.49, p = .005 with the participants with PD 
having a statistically significantly lower marginal mean (M = 78.20, SD = 5.68) to that of 
the control participants (M = 82.88, SD = 5.65). In contrast, there was no significant main 
effect of “Visit” on maximum speech intensity F(2,98) = 0.42, p = .661. A closer look at 
the factor “Visit”, using pairwise post-hoc analyses indicated that the marginal mean of 
maximum speech intensity at visit 1 (M = 80.23, SD = 6.76) was similar to the marginal 
mean of maximum speech intensity at visit 2 (M = 80.63, SD = 6.45) and visit 3 (M = 
80.77, SD = 6.99) It is important to note that this main effect of “Visit” needs to be 
qualified because of the finding of a “Group” by “Visit” interaction that trended towards 
significance F(2,98) = 2.76, p = .069 for maximum speech intensity. This significant 
interaction is illustrated in Figure 2. It appears that at visit 1 the group difference between 
the PD and control participants’ maximum speech intensity is greater than the group 
differences that were found at visit 2 and visit 3. Results of a post-hoc analyses involving 
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comparisons of these group differences at each visit provided additional information 
about this significant “Group” by “Visit” interaction. For the post-hoc comparison related 
to visit 1, the participants with PD had a mean maximum speech intensity (M = 77.07, SD 
= 6.34) that was significantly lower (-6.31 dB) than the mean maximum speech intensity 
of control participants (M = 83.38, SD = 6.13), t(2,51) = -3.46, p=.001.  For the post-hoc 
comparison related to visit 3, the participants with PD had a mean maximum speech 
intensity (M = 78.68, SD = 6.11) that was significantly lower (-4.67 dB) than the mean 
maximum speech intensity of control participants (M = 83.35, SD = 7.08), t(2,50) = -2.48, 
p = .016. In contrast, the post-hoc comparisons related to group differences was not 
significant at visit 3 t(2,50) = -1.81, p = .077. Thus, it appears that although the maximum 
speech intensity of the participants with PD was significantly lower than that of control 
participants at visit 1 and visit 3, it increased to a level that was not significantly different 
from control participants at visit 2. 
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Figure 2: Means of Maximum Speech Intensity for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 2. This figure demonstrates the changes in maximum speech intensity scores for 
participants with PD and control participants across visits. Error bars represent standard 
deviations. 
 
3.3.2.1 Retest analyses 
 
An analysis of the retest reliability and repeatability of maximum speech intensity were 
performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) SEM across visits 
1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) 
pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 
2-3. Separate retest analyses were performed on the participants with PD and control 
participants. Results for retest analyses of maximum speech intensity are summarized in 
Table 12. 
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Table 12: Retest Analyses of Maximum Speech Intensity for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .86[.67-.94] -1.77 4.39 -1.94 .066 6.56 2.45 6.79 8.76 
Visits 1 – 3 .80[.53-.92] -1.61 4.96 -1.54 .142 6.36 2.85 7.88 9.94 
Visits 2 – 3 .93[.81-.97] 0.17 3.37 0.24 .812 6.31 1.67 4.62 5.88 
Control participants 
Visits 1 – 2 .87[.74-.94] 0.99 3.93 1.35 .187 6.06 2.19 6.06 7.23 
Visits 1 – 3 .89[.76-.95] 0.41 4.33 0.51 .609 6.73 2.23 6.18 7.50 
Visits 2 – 3 .82[.62-.92] -0.46 4.88 -0.51 .612 6.45 2.74 7.58 9.09 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of maximum speech intensity for participants with PD and control 
participants. 
 
3.3.2.1.1 Retest analysis of maximum speech intensity for 
participants with Parkinson’s disease 
 
The ICC values related to the repeated measurement of maximum speech intensity across 
the three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = .86, p 
< .001, visit 1 versus visit 3 ICC = .80, p < .001, and visit 2 versus visit 3 ICC = .93, p < 
.001. These results suggest that maximum speech intensity as measured in the present 
study demonstrated good retest reliability in IWPD because all of the ICC values across 
all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for maximum speech intensity was -1.77 
dB SPL (SD = 4.39) and this difference approached significance t(22) = -1.94, p = .066. 
The mean differences in retest values ranged from -11.17 – 5.21 dB SPL. The mean 
difference between visit 1 and visit 3 for maximum speech intensity was -1.61 dB SPL 
(SD = 4.96) and this difference was not significant t(21) = -1.53, p = .142. The mean 
differences in retest values ranged from -12.12 – 6.34 dB SPL. The mean difference 
between visit 2 and visit 3 for maximum speech intensity was 0.17 dB SPL (SD = 3.37) 
and this difference was not significant t(21) = 0.24, p = .812. The mean differences in 
retest values ranged from -6.34 – 6.94 dB SPL. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 6.79 and 
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CR% = 8.76%, for visit 1 vs visit 3, CR = 7.88 and CR% = 9.94%, and for visit 2 vs visit 
3, CR = 4.62 and CR% = 5.88%. Based on the CR, an observed change in the maximum 
speech intensity of at least 4.62 – 7.88 dB SPL would suggest an acceptable amount of 
measurement error ranging from 5.88 – 9.94% variation in the maximum speech intensity 
of IWPD. These results suggest that the measure of maximum speech intensity 
demonstrates good repeatability for IWPD. 
3.3.2.1.2 Retest analysis of maximum speech intensity for 
control participants  
 
The ICC values related to the repeated measurement of maximum speech intensity across 
the three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = .87, p 
< .001, visit 1 versus visit 3 ICC = .89, p < .001, and visit 2 versus visit 3 ICC = .82, p < 
.001. These results suggest that maximum speech intensity as measured in the present 
study demonstrated good retest reliability in healthy speakers because all of the ICC 
values across all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for maximum speech intensity was 0.99 
dB SPL (SD = 3.93) and this difference was not significant t(28) = 1.35, p = .187. The 
mean differences in retest values ranged from -6.35 – 8.96 dB SPL. The mean difference 
between visit 1 and visit 3 for maximum speech intensity was 0.41 dB SPL (SD = 4.33) 
and this difference was not significant t(29) = 0.52, p = .609. The mean differences in 
retest values ranged from -10.74 – 10.84 dB SPL. The mean difference between visit 2 
and visit 3 for maximum speech intensity was -0.46 dB SPL (SD = 4.88) and this 
difference was not significant t(28) = -0.51, p = .612. The mean differences in retest 
values ranged from -14.13 – 11.78 dB SPL. Additionally, the following CR values were 
obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 6.06 and CR% = 
7.23%, for visit 1 vs visit 3, CR = 6.18 and CR% = 7.50%, and for visit 2 vs visit 3, CR = 
7.58 and CR% = 9.09%. Based on the CR, an observed change in the maximum speech 
intensity of at least 6.06 – 7.58 dB would suggest an acceptable amount of measurement 
error ranging from 7.23 – 9.09% variation in the maximum speech intensity of control 
participants. These results suggest that the measure of maximum speech intensity 
demonstrates good repeatability for IWPD. 
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3.3.3 Lombard response function 
 
Lombard response function was determined from audio recordings of participants with 
PD and control participants reading the sentence “She saw Patty buy two poppies” in 60, 
65, 70, and 75 dB SPL of multi-talker background noise. The Lombard response function 
was calculated by determining the slope of speech intensity across each of these four 
background noise conditions. Descriptive statistics for Lombard response function can be 
found in Table 10. The results of the two-way repeated measures ANOVA for the 
dependent measure of Lombard response function showed that there was no significant 
main effect of “Group” F(1,49) = 1.13, p = .292 with participants with PD having a 
similar marginal mean (M = 0.31, SD = 0.14) to that of the control participants (M = 0.27, 
SD = 0.11). In contrast, there was a significant main effect of “Visit” of the Lombard 
response function F(2,98) = 3.95, p = .022. A closer look at the factor “Visit”, using 
pairwise post-hoc analyses indicated that the marginal mean Lombard response function 
at visit 1 (M = 0.32, SD = 0.14) was significantly greater than the marginal mean of the 
Lombard response function at visit 2 (M = 0.29, SD = 0.14) and visit 3 (M = 0.26, SD = 
0.14). Additionally, no significant “Group” by “Visit” interaction was found F(2,98) = 
0.40, p = .674 for Lombard response function. This non-significant interaction is 
illustrated in Figure 3. Thus, it appears that although the Lombard response function of 
the IWPD was not significantly different from control participants, the Lombard response 
function at visit 1 was significantly different compared to the Lombard response function 
at visit 2 and visit 3. 
 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
70 
Figure 3: Means of Lombard Response Function for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 3. This figure demonstrates the changes in Lombard response function scores for 
participants with PD and control participants across visits. Error bars represent standard 
deviations. 
 
3.3.3.1 Retest analyses 
 
Following the primary variability analysis described above, secondary retest analyses 
related to the evaluation of the retest reliability and repeatability of Lombard response 
function were performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) 
SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, 
and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-
2, 1-3, and 2-3. Separate retest analyses were performed on the participants with PD and 
control participants. Results for retest analyses of Lombard response function are 
summarized in Table 13. 
  
Participants with PD 
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Table 13: Retest Analyses of Lombard Response Function for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .15[-1.02-.64] 0.035 0.20 0.83 .415 0.15 0.14 0.38 110.52 
Visits 1 – 3 .49[-.20-.79] 0.046 0.18 1.19 .246 0.16 0.11 0.31 99.37 
Visits 2 – 3 .72[.32-.88] 0.027 0.12 1.02 .318 0.13 0.07 0.19 68.25 
Control participants 
Visits 1 – 2 .73[.43-.88] 0.053 0.13 2.21 .036 0.15 0.08 0.21 65.57 
Visits 1 – 3 .66[.30-.84] 0.066 0.15 2.44 .021 0.15 0.09 0.24 94.01 
Visits 2 – 3 .77[.52-.89] 0.021 0.14 0.81 .422 0.17 0.08 0.22 87.72 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of Lombard response function for participants with PD and control 
participants. 
 
3.3.3.1.1 Retest analysis of Lombard response function for 
participants with Parkinson’s disease 
 
The ICC values related to the repeated measurement of Lombard response function 
across the three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = 
.15, p = .351, visit 1 versus visit 3 ICC = .49, p = .063, and visit 2 versus visit 3 ICC = 
.72, p = .003. These results suggest that Lombard response function as measured in the 
present study did not demonstrate good retest reliability in IWPD because all of the ICC 
values across all comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for Lombard response function was 0.04 
(SD = 0.20) and this difference was not significant t(22) = 0.83, p = .415 . The mean 
differences in retest values ranged from -0.33 – 0.40. The mean difference between visit 1 
and visit 3 for Lombard response function was 0.05 (SD = 0.18) and this difference was 
not significant t(21) = 1.19, p = .246. The mean differences in retest values ranged from -
0.35 – 0.35. The mean difference between visit 2 and visit 3 for Lombard response 
function was 0.03 (SD = 0.12) and this difference was not significant t(21) = 1.02, p = 
.318. The mean differences in retest values ranged from -0.26 – 0.31. Additionally, the 
following CR values were obtained for the following visit comparisons: for visit 1 vs visit 
2, CR = 0.38 and CR% = 110.52%, for visit 1 vs visit 3, CR = 0.31 and CR% = 99.37%, 
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and for visit 2 vs visit 3, CR = 0.19 and CR% = 68.25%. Based on the CR, an observed 
change in the Lombard response function of at least 0.19 – 0.38 would suggest a large 
amount of measurement error ranging from 68.25 – 110.52% variation in the Lombard 
response function of IWPD. These results suggest that the measure of Lombard response 
function demonstrates unacceptable repeatability for IWPD. 
3.3.3.1.2 Retest analysis of Lombard response function for 
control participants 
 
The ICC values related to the repeated measurement of Lombard response function 
across the three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = 
.73, p < .001, visit 1 versus visit 3 ICC = .66, p = .001, and visit 2 versus visit 3 ICC = 
.77, p < .001. These results suggest that Lombard response function as measured in the 
present study did not demonstrate good retest reliability in healthy speakers because the 
ICC values across two of three comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for Lombard response function was 0.05 
(SD = 0.13) and this difference was significant t(28) = 2.20 p = .036. The mean difference 
between visit 1 and visit 3 for Lombard response function was 0.07 (SD = 0.15) and this 
difference was significant t(29) = 2.44, p = .021. The mean difference between visit 2 and 
visit 3 for Lombard response function was 0.02 (SD = 0.14) and this difference was not 
significant t(28) = 0.81, p = .422. The mean differences in retest values ranged from -0.18 
– 0.34. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2, CR = 0.21 and CR% = 65.57%, for visit 1 vs visit 3, 
CR = 0.24 and CR% = 94.01%, and for visit 2 vs visit 3, CR = 0.22 and CR% = 87.72%. 
Based on the CR, an observed change in the Lombard response function of at least 0.21 – 
0.24 would suggest a large amount of measurement error ranging from 65.57 – 94.01% 
variation in the Lombard response function of control participants. These results suggest 
that the measure of Lombard response function demonstrates unacceptable repeatability 
for control participants. 
3.3.4 Magnitude production 
 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
73 
Measures of magnitude production were obtained from audio recordings of participants 
with PD and control participants reading the sentence “She saw Patty buy two poppies” 
using their typical speech loudness, speaking two times louder than normal, and speaking 
four times louder than normal. Descriptive statistics for magnitude production can be 
found in Table 10. The results of the two-way repeated measures ANOVA for the 
dependent measure of magnitude production revealed a significant main effect of 
“Group” F(1,49) = 6.47, p = .014, with participants with PD having a significantly lower 
(-0.77) marginal mean (M = 2.09, SD = 1.08) compared to that of the control participants 
(M = 2.86, SD = 1.08). A significant main effect of “Visit” was also found, F(2,98) = 
8.95, p < .001. A closer look at the factor “Visit”, using pairwise post-hoc analyses, 
indicated that the marginal mean of magnitude production at visit 1 (M = 2.75, SD = 
1.43) was significantly greater (+0.51) than the marginal mean of magnitude production 
at visit 2 (M = 2.24, SD = 1.00) and (+0.33) visit 3 (M = 2.42, SD = 1.14). For the post-
hoc comparison related to visit 1, the participants with PD had a mean magnitude 
production (M = 2.35, SD = 1.53) that was significantly lower (-0.81) than the mean 
magnitude production of control participants (M = 3.16, SD = 1.32), t(2,51) = -2.02, p = 
.048.  For the post-hoc comparison related to visit 2, the participants with PD had a mean 
magnitude production (M = 2.01, SD = 1.06) that was lower (-0.59) than the mean 
magnitude production of control participants (M = 2.60, SD = 1.09). This comparison 
trended towards significance, t(2,51) = -1.95, p = .056.  For the post-hoc comparison 
related to visit 3, the participants with PD had a mean magnitude production (M = 2.02, 
SD = 0.97)  that was significantly lower (-0.79) than the mean magnitude production of 
control participants (M = 2.81, SD = 1.16), t(2,50) = -2.58, p = .013. Additionally, no 
significant “Group” by “Visit” interaction was found F(2,98) = 0.08, p = .928 for 
magnitude production. This non-significant interaction is illustrated in Figure 4. It seems 
that the magnitude production of participants with PD was significantly lower, or the 
difference approached significance, than that of control participants across all visits. 
Furthermore, it appears that the group difference between the magnitude production for 
participants with PD and control participants is fairly consistent across all three visits.  
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Figure 4: Means of Magnitude Production for Participants with Parkinson's Disease 
and Control Participants Across Visits 1, 2, and 3 
 
Figure 4. This figure demonstrates the changes in magnitude production scores for 
participants with PD and control participants across visits. Error bars represent standard 
deviations. 
 
3.3.4.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of magnitude production were performed 
via 1) ICC between visits 1-2, 1-3 and 2-3, 2) pairwise t-tests between visits 1-2, 1-3 and 
2-3, 3) calculation of the SEM and 4) determination of the CR related to visits 1-2, 1-3, 
and 2-3. Separate retest analyses were performed on the participants with PD and control 
participants. Results for retest analyses of magnitude production are summarized in Table 
14. 
  
Participants with PD 
Control participants 
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Table 14: Retest Analyses of Magnitude Production for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .77[.46-.90] 0.33 1.11 1.44 .16 1.30 0.62 1.73 73.73 
Visits 1 – 3 .81[.55-.92] 0.33 1.01 1.52 .14 1.26 0.55 1.53 75.88 
Visits 2 – 3 .91[.78-.96] -0.14 0.54 -1.23 .23 1.02 0.30 0.84 41.80 
Control participants 
Visits 1 – 2 .75[.41-.89] 0.56 1.00 3.01 .01 1.21 0.60 1.67 53.32 
Visits 1 – 3 .85[.68-.93] 0.31 0.87 2.00 .06 1.24 0.48 1.33 51.05 
Visits 2 – 3 .86[.70-.93] -0.21 0.78 -1.48 .15 1.13 0.42 1.17 41.51 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of magnitude production for participants with PD and control 
participants. 
 
3.3.4.1.1 Retest analysis of magnitude production for 
participants with Parkinson’s disease 
 
The ICC values related to the repeated measurement of magnitude production across the 
three pairwise visits was found to be the following:  visit 1 versus visit 2 ICC = .77, p < 
.001, visit 1 versus visit 3 ICC = .81, p < .001, and visit 2 versus visit 3 ICC = .91, p < 
.001. These results suggest that magnitude production as measured in the present study 
demonstrated good retest reliability in IWPD because all of the ICC values across all 
comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for magnitude production was 0.33 (SD = 
1.11) and this difference was not significant t(22) = 1.44, p = .164. The mean differences 
in retest values ranged from -2.62 – 2.69. The mean difference between visit 1 and visit 3 
for magnitude production was 0.33 (SD = 1.01) and this difference was not significant 
t(21) = 1.52, p = .143. The mean differences in retest values ranged from -1.37 – 2.49. 
The mean difference between visit 2 and visit 3 for magnitude production was -0.14 (SD 
= 0.54) and this difference was not significant t(21) = -1.23, p = .232. The mean 
differences in retest values ranged from -1.02 – 0.93. Additionally, the following CR 
values were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.73 
and CR% = 73.73%, for visit 1 vs visit 2, CR = 1.53 and CR% = 75.88%, and for visit 2 
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vs visit 3, CR = 0.84 and CR% = 41.80%. Based on the CR, an observed change in the 
magnitude production of at least 0.84 – 1.73 would suggest a fairly large amount of 
measurement error ranging from 41.80 – 73.73% variation in the magnitude production 
of IWPD. These results suggest that the measure of magnitude production demonstrates 
unacceptable repeatability for IWPD. 
3.3.4.1.2 Retest analysis of magnitude production for control 
participants 
 
The ICC values related to the repeated measurement of magnitude production across the 
three pairwise visits were found to be the following: visit 1 versus visit 2 ICC = .75, p < 
.001, visit 1 versus visit 3 ICC = .85, p < .001, and visit 2 versus visit 3 ICC = .86, p < 
.001. These results suggest that magnitude production as measured in the present study 
demonstrated good retest reliability in healthy speakers because all of the ICC values 
across all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for magnitude production was 0.56 (SD = 
1.00) and this difference was significant t(28) = 3.01, p = .006. The mean difference 
between visit 1 and visit 3 for magnitude production was 0.32 (SD = 0.87) and this 
difference trended towards significance t(29) = 2.00, p = .055. The mean differences in 
retest values ranged from -1.65 – 1.94. The mean difference between visit 2 and visit 3 
for magnitude production was -0.21 (SD = 0.78) and this difference was not significant 
t(28) = -1.48, p = 0.15. The mean differences in retest values ranged from -1.79 – 1.49. 
Additionally, the following CR values were obtained for the following visit comparisons: 
for visit 1 vs visit 2, CR = 1.67 and CR% = 53.32%, for visit 1 vs visit 3, CR = 1.33 and 
CR% = 51.05%, and for visit 2 vs visit 3, CR = 1.17 and CR% = 41.51%. Based on the 
CR, an observed change in the magnitude production of at least 1.17 – 1.67 would 
suggest a fairly large amount of measurement error ranging from 41.51 – 53.32% 
variation in the magnitude production of control participants. These results suggest that 
the measure of magnitude production demonstrates unacceptable repeatability for control 
participants. 
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3.4 Statistical Analysis for Objective 2: Typical Speech 
Loudness 
 
In order to answer the question ‘Do participants with PD perceive their typical speech 
loudness differently over time from their primary communicative partners and as 
compared to control participants?’, a multi-factor repeated measures ANOVA was 
performed to evaluate: 1) differences in perception of typical speech loudness over time 
among participants with PD, 2) how primary communication partners rate the loudness of 
his/her partner with PD, and 3) how control participants rate their typical speech 
loudness. The multi-factor repeated measures ANOVA involved a “Group” factor with 
three separate levels [PD, control, communication partners] and a “Visit” factor with 
three levels [visit 1, visit 2, and visit 3]. Whenever the ANOVA resulted in a significant 
main effect, a post-hoc analysis was performed using pairwise comparisons. 
 
Measures of perceived typical speech loudness were obtained from the Typical Speech 
Loudness scale, wherein participant’s VAS responses were measured and assigned a 
percentage value. Descriptive statistics for perceptions of typical speech loudness scores 
can be found in Table 15. The results of the multi-factor repeated measures ANOVA for 
the perceived typical speech loudness revealed a significant main effect of “Group” 
F(2,71) = 29.73, p < .001 with control participants having a greater (+31.90 %) marginal 
mean (M = 83.22, SD = 17.69) compared to participants with PD (M = 51.32, SD = 
17.68) and a greater (+32.66%) marginal mean compared to the primary communication 
partners of participants with PD (M = 50.56, SD = 17.68). In contrast, there was no 
significant main effect of “Visit” on perceived typical speech loudness F(2,142) = 2.48, p 
= .088 with a marginal mean at visit 1 (M = 58.31, SD = 21.68) that was similar to visit 2 
(M = 64.08, SD = 21.51) and visit 3 (M = 62.71, SD = 23.91). Additionally, there was no 
significant “Group” by “Visit” interaction F(4,142) = 0.52, p = .723 for perception of 
typical speech loudness. This interaction is illustrated in Figure 5.  
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Table 15: Descriptive Statistics of Self- and Proxy-Rated Typical Speech Loudness 
for Participants with Parkinson's Disease, Primary Communication Partners of 
Participants with Parkinson's Disease, and Control Participants Across Visits 1, 2, 
and 3 
 Typical speech loudness 
mean(SD) 
Participants with PD 
Visit 1 51.96(23.78) 
Visit 2 52.35(25.43) 
Visit 3 51.95(26.05) 
Control participants 
Visit 1 78.60(19.04) 
Visit 2 86.07(15.02) 
Visit 3 85.00(18.84) 
Primary communication partners 
Visit 1 46.22(21.84) 
Visit 2 56.39(24.36) 
Visit 3 51.18(26.93) 
Marginal means 
Participants with PD 51.32(17.68) 
Control participants 83.22(17.69) 
Primary communication partners 50.56(17.68) 
Visit 1 58.31(21.68) 
Visit 2 64.08(21.51) 
Visit 3 62.71(23.91) 
Note. This table illustrates the means and standard deviations for perceptions of typical 
speech loudness for participants with PD, their primary communication partners, and 
control participants across visits. 
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Figure 5: Means of Typical Speech Loudness Perceptions by Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with 
Parkinson's Disease, and Control Participants Across Visits 1, 2, and 3 
 
Figure 5. This figure demonstrates the changes in typical speech loudness perception 
scores for participants with PD, their primary communication partners, and control 
participants across visits. Error bars represent standard deviations. 
 
3.4.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of typical speech loudness ratings. These 
analyses were performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) 
SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, 
and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-
2, 1-3, and 2-3. Separate retest analyses were performed on the participants with PD, 
control participants, and primary communication partners of participants with PD. 
Results for retest analyses of typical speech loudness are summarized in Table 16. 
  
Participants with PD 
Control participants 
Primary communication 
partners 
(%
) 
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Table 16: Retest Analyses of Self- and Proxy-Rated Typical Speech Loudness for 
Participants with Parkinson's Disease, Primary Communication Partners of 
Participants with Parkinson's Disease, and Control Participants Across Visits 1, 2, 
and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .59[.01-.83] -0.39 26.74 -0.07 .945 24.62 15.76 43.67 84.04 
Visits 1 – 3 .50[-.24-.80] -1.14 28.94 -0.18 .856 24.94 17.64 48.85 93.32 
Visits 2 – 3 .85[.63-.94] -0.77 18.96 -0.19 .850 25.74 9.97 27.62 53.16 
Control participants 
Visits 1 – 2 .53[.06-.77] 7.47 18.95 -2.16 .039 17.15 11.76 32.56 41.43 
Visits 1 – 3 .25[-.52-.64] -6.40 24.72 -1.42 .167 18.94 16.40 45.44 52.79 
Visits 2 – 3 .30[-.51-.67 1.07 21.95 0.267 .792 17.04 14.25 39.48 46.45 
Primary communication partners 
Visits 1 – 2 .70[.30-.87] -10.17 21.28 -2.29 .032 23.13 12.67 35.10 75.94 
Visits 1 – 3 .77[.47-.91] -5.68 20.99 -1.27 .218 24.52 11.76 32.57 57.76 
Visits 2 – 3 .74[.36-.89] 3.82 23.46 0.76 .454 25.68 13.09 36.27 70.86 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of perceived typical speech loudness for participants with PD, their 
primary communication partners, and control participants. 
 
3.4.1.1 Retest analysis of self-rated typical speech 
loudness for participants with Parkinson’s disease 
 
The ICC values related to the repeated measurement of self-rated typical speech loudness 
across the three pairwise visits was found to be the following:  visit 1 versus visit 2 ICC = 
.59, p = .023, visit 1 versus visit 3 ICC = .50, p = .066, and visit 2 versus visit 3 ICC = 
.85, p < .001. These results suggest that self-rated typical speech loudness as measured in 
the present study did not demonstrate good retest reliability in IWPD because ICC values 
across two of three comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for self-rated typical speech loudness 
scores was -0.39 % (SD = 26.74) and this difference was not significant t(22) = -0.07, p = 
.945. The mean differences in retest values ranged from -55 – 69 %. The mean difference 
between visit 1 and visit 3 for self-ratings of typical speech loudness scores was -1.14 % 
(SD = 28.94) and this difference was not significant t(21) = -0.18, p = .856. The mean 
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differences in retest values ranged from -45 – 73 %. The mean difference between visit 2 
and visit 3 for self-ratings of typical speech loudness scores was -0.77 % (SD = 18.96) 
and this difference was not significant t(21) = -0.19, p = .850. The mean differences in 
retest values ranged from -47 – 28 %. Additionally, the following CR values were 
obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 43.67 and CR% 
= 84.04%, for visit 1 vs visit 3, CR = 48.85 and CR% = 93.32%, and for visit 2 vs visit 3, 
CR = 27.62 and CR% = 53.16%. Based on the CR, an observed change in self-rated 
typical speech loudness on at least 27.62 – 48.85 % would suggest a fairly large amount 
of measurement error ranging from 53.16 – 93.32% variation in the self-ratings of typical 
speech loudness of IWPD. These results suggest that the measure of self-rated typical 
speech loudness demonstrates unacceptable repeatability for IWPD. 
3.4.1.2 Retest analysis of self-rated typical speech 
loudness for control participants 
 
The ICC values related to the repeated measurement of self-rated typical speech loudness 
across the three pairwise visits was found to be the following:  visit 1 versus visit 2 ICC = 
.53, p = .015, visit 1 versus visit 3 ICC = .25 p = .213, and visit 2 versus visit 3 ICC = 
.30, p = .180. These results suggest that self-rated typical speech loudness as measured in 
the present study did not demonstrate good retest reliability in healthy speakers because 
all of the ICC values across all comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for self-rated typical speech loudness was 
-7.47 % (SD = 18.95) and this difference was significant t(29) = -2.16, p = .039. The 
mean difference between visit 1 and visit 3 for self-rated typical speech loudness was -
6.40 % (SD = 24.72) and this difference was not significant t(29) = -1.42, p = .167. The 
mean differences in retest values ranged from -53 – 79 %. The mean difference between 
visit 2 and visit 3 for self-rated typical speech loudness was 1.07 % (SD = 21.95) and this 
difference was not significant t(29) = 0.27, p = .792. The mean differences in retest 
values ranged from -52 – 75 %. Additionally, the following CR values were obtained for 
the following visit comparisons: for visit 1 vs visit 2, CR = 32.56 and CR% = 41.43%, for 
visit 1 vs visit 3, CR = 45.44 and CR% = 52.79%, and for visit 2 vs visit 3, CR = 39.48 
and CR% = 46.45%. Based on the CR, an observed change in the self-rated typical 
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speech loudness of at least 32.56 – 45.44 % would suggest a fairly large amount of 
measurement error ranging from 41.43 – 52.79% variation in the self-ratings of typical 
speech loudness of control participants. These results suggest that the measure of self-
rated typical speech loudness demonstrates unacceptable repeatability for control 
participants. 
3.4.1.3 Retest analysis of proxy-rated typical speech 
loudness by primary communication partners 
 
The ICC values related to the repeated measurement of proxy-rated typical speech 
loudness across the three pairwise visits was found to be the following: visit 1 versus visit 
2 ICC = .70 p = .002, visit 1 versus visit 3 ICC = .77, p = .001, and visit 2 versus visit 3 
ICC = .74, p = .002. These results suggest that proxy-rated typical speech loudness as 
measured in the present study did not demonstrate good retest reliability by primary 
communication partners of IWPD because the ICC values across two of three 
comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for proxy-rated typical speech loudness 
scores was -10.17 % (SD = 21.28) and this difference was significant t(22) = -2.29, p = 
.032. The mean difference between visit 1 and visit 3 for proxy-ratings of typical speech 
loudness scores was -5.68 % (SD = 20.99) and this difference was not significant t(21) = -
1.27, p = .218. The mean differences in retest values ranged from -47 – 40 %. The mean 
difference between visit 2 and visit 3 for proxy-rated typical speech loudness scores was 
3.82 % (SD = 23.46) and this difference was not significant t(21) = 0.76, p = .454. The 
mean differences in retest values ranged from -53 – 46 %. Additionally, the following CR 
values were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 
35.10 and CR% = 75.94%, for visit 1 vs visit 3, CR = 32.57 and CR% = 57.76%, and for 
visit 2 vs visit 3, CR = 36.27 and CR% = 70.86%. Based on the CR, an observed change 
in the proxy-rated typical speech loudness of at least 32.57 – 36.27 % would suggest a 
large amount of measurement error ranging from 57.76 – 75.94% variation in the proxy-
ratings of typical speech loudness made by primary communication partners of IWPD. 
These results suggest that the measure of proxy-rated typical speech loudness 
demonstrates unacceptable repeatability for primary communication partners. 
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3.5 Statistical Analysis for Objective 3: Speech Intelligibility 
 
In order to answer the question ‘Do speech intelligibility measures differ over time 
between and within participants with PD and control participants?’, a separate two-
factor repeated measures ANOVA was performed on each of the three dependent 
intelligibility measures (i.e., SIT transcription scores, SIT VAS scores, conversational 
intelligibility scores). Each of the two-factor repeated measures ANOVAs involved a 
“Group” factor with two separate levels [PD, control] and a “Visit” factor with three 
levels [visit 1, visit 2, and visit 3]. Whenever the ANOVA resulted in a significant main 
effect for the factor “Visit”, a post-hoc analysis was performed using pairwise 
comparisons. 
3.5.1 SIT transcription scores 
 
SIT transcription scores were obtained by calculating the percentage of correct words 
transcribed by listeners of SIT sentences 13, 14, and 15. Descriptive statistics for SIT 
transcription scores can be found in Table 17. The results of the two-way repeated 
measures ANOVA for the dependent measure of SIT transcription scores revealed a 
significant main effect of “Group” F(1,49) = 12.50, p = .001 with participants with PD 
having a significantly lower (-3.92 %) marginal mean (M = 94.20, SD = 3.94) to that of 
control participants (M = 98.12, SD = 3.93). In contrast, there was no significant main 
effect of “Visit” on SIT transcription scores F(2,98) = 1.96, p = .146 indicating that the 
marginal mean of the SIT transcription score at visit 1 (M = 96.42, SD = 4.21) was 
similar than the mean SIT transcription score at visit 2 (M = 95.48, SD = 5.36) and visit 3 
(M = 96.59, SD = 4.36). Additionally, no significant “Group” by “Visit” interaction was 
found F(2,98) = 1.08, p = .342 for SIT transcription scores. This non-significant 
interaction is illustrated in Figure 6.  
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Table 17: Descriptive Statistics of Speech Intelligibility Measures for Participants 
with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 SIT transcription 
scores 
mean(SD) 
SIT VAS 
scores 
mean(SD) 
Conversational intelligibility 
VAS scores 
mean(SD) 
Participants with PD 
Visit 1 94.27(6.09) 79.16(11.26) 79.95(14.93) 
Visit 2 92.20(8.53) 78.10(15.01) 80.55(14.03) 
Visit 3 95.06(6.29) 79.38(10.06) 80.75(15.58) 
Control participants 
Visit 1 98.41(1.33) 91.12(2.91) 93.79(3.00) 
Visit 2 97.89(2.40) 90.99(2.88) 92.15(5.25) 
Visit 3 98.15(1.75) 90.81(4.25) 92.74(3.39) 
Marginal means 
Participants with PD 94.20(3.94) 79.82(6.89) 80.74(9.38) 
Control participants 98.12(3.93) 90.91(6.89) 92.88(9.37) 
Visit 1 96.42(4.21) 85.41(7.71) 86.96(10.36) 
Visit 2 95.48(5.36) 85.64(7.57) 86.74(10.00) 
Visit 3 96.59(4.36) 85.03(7.43) 86.74(10.64) 
Note. This table illustrates the means and standard deviations for the different speech 
intelligibility measures for participants with PD and control participants across visits. 
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Figure 6: Means of Speech Intelligibility Test Transcription Scores for Participants 
with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 6. This figure demonstrates the changes in SIT transcription scores for participants 
with PD and control participants across visits. Error bars represent standard deviations. 
 
3.5.1.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of SIT transcription scores. These 
analyses were performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) 
SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, 
and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-
2, 1-3, and 2-3. Separate retest analyses were performed on the participants with PD and 
control participants. Results for retest analyses of SIT transcription scores are 
summarized in Table 18. 
  
Participants with PD 
Control participants 
(%
) 
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Table 18: Retest Analyses of Sentence Intelligibility Transcription Scores for 
Participants with Parkinson's Disease and Control Participants Across Visits 1, 2, 
and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .74[.40-.89] 2.07 6.62 1.50 .148 7.41 3.38 10.47 11.10 
Visits 1 – 3 .77[.44-.90] -.578 5.47 -0.50 .625 6.19 2.97 8.22 8.92 
Visits 2 – 3 .76[.43-.90] -1.98 6.08 -1.53 .141 7.49 3.67 10.17 10.70 
Control participants 
Visits 1 – 2 .28[-.54-.66] 0.46 2.51 1.00 .328 1.94 1.65 4.56 4.63 
Visits 1 – 3 .05[-1.03-.55] 0.27 2.17 0.67 .509 1.55 1.51 4.20 4.29 
Visits 2 – 3 .42[-.25-.73] -0.22 2.56 -0.46 .651 2.10 1.60 4.43 4.51 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of SIT transcription scores for participants with PD and control 
participants. 
 
3.5.1.1.1 Retest analysis of SIT transcription scores of 
participants with Parkinson’s disease 
 
The ICC values related to the repeated measurement of SIT transcription scores across 
the three pairwise visits was found to be the following:  visit 1 versus visit 2 ICC = .74, p 
= .001, visit 1 versus visit 3 ICC = .77, p = .001, and visit 2 versus visit 3 ICC = .76, p = 
.001. These results suggest that SIT transcription scores as measured in the present study 
demonstrated good retest reliability in IWPD because the ICC values across all 
comparisons were above or approached our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for SIT transcription scores was 2.07 % 
(SD = 6.62) and this difference was not significant t(22) = 1.50, p = .148. The mean 
differences in retest values ranged from -7.14 – 18.25 %. The mean difference between 
visit 1 and visit 3 for SIT transcription scores was -0.58 % (SD = 5.47) and this difference 
was not significant t(21) = -0.50, p = .625. The mean differences in retest values ranged 
from -15.87 – 9.52 %. The mean difference between visit 2 and visit 3 for SIT 
transcription scores was -1.98% (SD = 6.08) and this difference was not significant t(21) 
= -1.53, p = .141. The mean differences in retest values ranged from -19.05 – 7.14 %. 
Additionally, the following CR values were obtained for the following visit comparisons: 
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for visit 1 vs visit 2, CR = 10.47 and CR% = 11.10%, for visit 1 vs visit 3, CR = 8.22 and 
CR% = 8.92%, and for visit 2 vs visit 3, CR = 10.17 and CR% = 10.70%. Based on the 
CR, an observed change in the SIT transcription scores of at least 8.22 – 10.47% would 
suggest an acceptable amount of measurement error ranging from 8.92 – 11.10% 
variation in the SIT transcription scores of IWPD. These results suggest that the measure 
of SIT transcription scores demonstrates fairly good repeatability for IWPD. 
3.5.1.1.2 Retest analysis of SIT transcription scores for 
control participants 
 
The ICC values related to the repeated measurement of SIT transcription scores across 
the three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = .28, p 
= .200, visit 1 versus visit 3 ICC = .05, p = .443, and visit 2 versus visit 3 ICC = .42, p = 
.081. These results suggest that SIT transcription scores as measured in the present study 
did not demonstrate good retest reliability in healthy speakers because all of the ICC 
values across all comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for SIT transcription scores was 0.46 % 
(SD = 2.51) and this difference was not significant t(28) = 1.00, p = .328. The mean 
differences in retest values ranged from -3.17 – 4.76 %. The mean difference between 
visit 1 and visit 3 for SIT transcription scores was 0.27 % (SD = 2.17) and this difference 
was not significant t(29) = 0.67, p = .509. The mean differences in retest values ranged 
from -3.17 – 5.56 %. The mean difference between visit 2 and visit 3 for SIT 
transcription scores was -0.22 % (SD = 2.56) and this difference was not significant t(28) 
= -0.46, p = .651. The mean differences in retest values ranged from -4.76 – 4.76 %. 
Additionally, the following CR values were obtained for the following visit comparisons: 
for visit 1 vs visit 2, CR = 4.56 and CR% = 4.63%, for visit 1 vs visit 3, CR = 4.20 and 
CR% = 4.63%, and for visit 2 vs visit 3, CR = 4.43 and CR% = 4.51%. Based on the CR, 
an observed change in the SIT transcription scores of at least 4.20 – 4.56 % would 
suggest an acceptable amount of measurement error ranging from 4.29 – 4.63% variation 
in the SIT transcription scores of control participants. These results suggest that the 
measure of SIT transcription scores demonstrates good repeatability for control 
participants. 
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3.5.2 SIT VAS scores 
 
SIT VAS scores were calculated for each speaker as percent intelligibility based on 
listeners ratings of SIT sentences 13, 14, and 15. Descriptive statistics for SIT VAS 
scores can be found in Table 17. The results of the two-way repeated measures ANOVA 
for the dependent measure of SIT VAS scores revealed a significant main effect of 
“Group” F(1,49) = 32.58, p < .001 with participants with PD having a significantly lower 
(-11.09 %) marginal mean (M = 79.82, SD = 6.89) to that of control participants (M = 
90.91, SD = 6.89). In contrast, there was no significant main effect of “Visit” on SIT 
VAS scores F(2,98) = 0.372, p = .690 indicating that the marginal mean of the SIT VAS 
score at visit 1 (M = 85.41, SD = 7.71) was similar than the mean SIT VAS score at visit 
2 (M = 85.64, SD = 7.57) and visit 3 (M = 85.03, SD = 7.43). Additionally, no significant 
“Group” by “Visit” interaction was found F(2,98) = 0.11, p = .896 for SIT VAS scores. 
This non-significant interaction is illustrated in Figure 7.  
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Figure 7: Means of Speech Intelligibility Test Visual Analogues Scale Scores for 
Participants with Parkinson's Disease and Control Participants Across Visits 1, 2, 
and 3 
 
Figure 7. This figure demonstrates the changes in SIT VAS scores for participants with 
PD and control participants across visits. Error bars represent standard deviations. 
 
3.5.2.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of SIT VAS scores. These analyses were 
performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) SEM across visits 
1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) 
pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 
2-3.  Separate retest analyses were performed on the participants with PD and control 
participants. Results for retest analyses of SIT VAS scores are summarized in Table 19. 
  
Participants with PD 
Control participants 
(%
) 
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Table 19: Retest Analyses of Speech Intelligibility Test Visual Analogue Scale Scores 
for Participants with Parkinson's Disease and Control Participants Across Visits 1, 
2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .84[.61-.93] 1.06 10.08 0.51 .618 13.27 5.31 14.70 18.57 
Visits 1 – 3 .89[.73-.95] 0.40 6.89 0.27 .787 10.68 3.54 9.81 12.56 
Visits 2 – 3 .87[.69-.95] 0.92 7.15 0.60 .554 12.78 4.61 12.76 16.08 
Control participants 
Visits 1 – 2 .81[.59-.91] 0.05 2.37 0.12 .903 2.90 1.26 3.50 3.84 
Visits 1 – 3 .71[.39-.86] 0.31 3.47 0.49 .630 3.64 1.96 5.43 5.97 
Visits 2 – 3 .77[.51-.89] 0.32 3.17 0.54 .596 3.63 1.74 4.82 5.31 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of SIT VAS scores for participants with PD and control participants. 
 
3.5.2.1.1 Retest analysis of SIT VAS scores for 
participants with Parkinson’s disease 
 
The ICC values related to the repeated measurement of SIT VAS scores across the three 
pairwise visits were found to be the following:  visit 1 versus visit 2 ICC = .84, p < .001, 
visit 1 versus visit 3 ICC = .89, p < .001, and visit 2 versus visit 3 ICC = .87, p < .001. 
These results suggest that SIT VAS scores as measured in the present study demonstrated 
good retest reliability in IWPD because all of the ICC values across all comparisons were 
above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for SIT VAS scores was 1.06 % (SD = 
10.08) and this difference was not significant t(22) = 0.51, p = .618. The mean 
differences in retest values ranged from -18.97 – 35.18 %. The mean difference between 
visit 1 and visit 3 for SIT VAS scores was 0.40 % (SD = 6.89) and this difference was not 
significant t(21) = 0.27, p = .787. The mean differences in retest values ranged from -
10.84 – 16.13 %. The mean difference between visit 2 and visit 3 for SIT VAS scores 
was 0.92 % (SD = 7.15) and this difference was not significant t(21) = 0.60, p = .554. The 
mean differences in retest values ranged from -15.97 – 17.53 %. Additionally, the 
following CR values were obtained for the following visit comparisons: for visit 1 vs visit 
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2, CR = 14.70 and CR% = 18.57%, for visit 1 vs visit 3, CR = 9.81 and CR% = 12.56%, 
and for visit 2 vs visit 3, CR = 12.76 and CR% = 16.08%. Based on the CR, an observed 
change in the SIT VAS scores of at least 9.81 – 14.70% would suggest the possibility of 
an acceptable amount of measurement error ranging from 12.56 – 18.57% variation in the 
SIT VAS scores of IWPD. These results suggest that the measure of SIT VAS scores 
demonstrates marginal repeatability for IWPD. 
3.5.2.1.2 Retest analysis of SIT VAS scores for control 
participants 
 
The ICC values related to the repeated measurement of SIT VAS scores across the three 
pairwise visits was found to be the following:  visit 1 versus visit 2 ICC = .81, p < .001, 
visit 1 versus visit 3 ICC = .71, p = .001, and visit 2 versus visit 3 ICC = .77, p < .001. 
These results suggest that SIT VAS scores as measured in the present study demonstrated 
good retest reliability in healthy speakers because the ICC values two 2 of three 
comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for SIT VAS scores was 0.05 % (SD = 
2.37) and this difference was not significant t(28) = 0.12, p = .903. The mean differences 
in retest values ranged from -4.43 – 4.56 %. The mean difference between visit 1 and 
visit 3 for SIT VAS scores was 0.31 % (SD = 3.47) and this difference was not significant 
t(29) = 0.49, p = .630. The mean differences in retest values ranged from -7.22 – 9.03 %. 
The mean difference between visit 2 and visit 3 for SIT VAS scores was 0.32 % (SD = 
3.17) and this difference was not significant t(28) = 0.54, p = .596. The mean differences 
in retest values ranged from -2.83 – 8.57 %. Additionally, the following CR values were 
obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 3.50 and CR% = 
3.84%, for visit 1 vs visit 3, CR = 5.43 and CR% = 5.97%, and for visit 2 vs visit 3, CR = 
4.82 and CR% = 5.31%. Based on the CR, an observed change in the SIT VAS scores of 
at least 3.50 – 5.43% would suggest an acceptable amount of measurement error ranging 
from 3.84 – 5.97% variation in the SIT VAS scores of control participants. These results 
suggest that the measure of SIT VAS scores demonstrates good repeatability for control 
participants. 
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3.5.3 Conversational intelligibility VAS scores 
 
Conversational intelligibility VAS scores were obtained by listeners indicating the 
percent intelligibility of a speaker for a conversational speech sample. Descriptive 
statistics for conversational intelligibility VAS scores can be found in Table 17. The 
results of the two-way repeated measures ANOVA for the dependent measure of 
conversational intelligibility VAS scores revealed a significant main effect of “Group” 
F(1,49) = 21.09, p < .001 with participants with PD having a significantly lower (-12.14 
%) marginal mean (M = 80.74, SD = 9.38) to that of control participants (M = 92.88, SD 
= 9.37). In contrast, there was no significant main effect of “Visit” on conversational 
intelligibility VAS scores F(2,98) = 0.031, p = .970 indicating that the marginal mean of 
the conversational intelligibility VAS score at visit 1 (M = 86.96, SD = 10.36) was similar 
to the marginal mean of the conversation VAS score at visit 2 (M = 86.74, SD = 10.00) 
and at visit 3 (M = 86.74, SD = 10.64). Additionally, no significant “Group” by “Visit” 
interaction was found F(2,98) = 1.00, p = .371 for conversational intelligibility VAS 
scores. This non-significant interaction is illustrated in Figure 8.  
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Figure 8: Means of Conversational Intelligibility Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 8. This figure demonstrates the changes in conversational intelligibility scores for 
participants with PD and control participants across visits. Error bars represent standard 
deviations. 
 
3.5.3.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of conversational intelligibility VAS 
scores. These analyses were performed via: 1) correlations (ICC) between visits 1-2, 1-3 
and 2-3, 2) SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing 
visits 1-2, 1-3, and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% 
involving visits 1-2, 1-3, and 2-3. Separate retest analyses were performed on the 
participants with PD and control participants. Results for retest analyses of conversational 
intelligibility VAS scores are summarized in Table 20. 
  
Participants with PD 
Control participants 
(%
) 
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Table 20: Retest Analyses of Conversational Intelligibility Scores for Participants 
with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .83[.60-.93] -0.59 11.20 -0.25 .802 14.49 1.76 4.88 5.21 
Visits 1 – 3 .93[.83-.97] -0.63 8.17 -0.36 .721 15.26 0.85 2.35 2.55 
Visits 2 – 3 .87[.68-.95] 0.58 10.21 0.27 .794 14.83 1.59 4.41 4.76 
Control participants 
Visits 1 – 2 .68[.33-.85] 1.63 4.10 2.14 .041 4.28 2.42 6.70 7.14 
Visits 1 – 3 .78[.54-.90] 1.05 2.60 2.22 .034 3.20 1.50 4.16 4.51 
Visits 2 – 3 .56[.06-.80] -0.56 4.92 -0.62 .543 4.42 2.93 8.12 8.76 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of conversational intelligibility scores for participants with PD and 
control participants. 
 
3.5.3.1.1 Retest analysis of VAS conversational intelligibility 
scores for participants with Parkinson’s disease 
 
The ICC values related to the repeated measurement of conversational intelligibility VAS 
scores across the three pairwise visits was found to be the following: visit 1 versus visit 2 
ICC = .83, p < .001, visit 1 versus visit 3 ICC = .93, p < .001, and visit 2 versus visit 3 
ICC = .87, p < .001. These results suggest that conversational intelligibility as measured 
in the present study demonstrated good retest reliability in IWPD because all of the ICC 
values across all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for conversational intelligibility VAS 
scores was -0.59 % (SD = 11.20) and this difference was not significant t(22) = -0.25, p = 
.802. The mean differences in retest values ranged from -30.25 – 21.22 %. The mean 
difference between visit 1 and visit 3 for conversational intelligibility VAS scores was -
0.63 % (SD = 8.17) and this difference was not significant t(21) = -0.36, p = .721. The 
mean differences in retest values ranged from -21.22 – 16.26 %. The mean difference 
between visit 2 and visit 3 for conversational intelligibility VAS scores was 0.58 % (SD = 
10.21) and this difference was not significant t(21) = 0.27, p = .794. The mean 
differences in retest values ranged from -27.59 – 19.52 %. Additionally, the following CR 
values were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 4.88 
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and CR% = 5.21%, for visit 1 vs visit 3, CR = 2.35 and CR% = 2.55%, and for visit 2 vs 
visit 3, CR = 4.41 and CR% = 4.76%. Based on the CR, an observed change in the 
conversational intelligibility VAS scores of at least 2.35 – 4.88% would suggest an 
acceptable amount of measurement error ranging from 2.55 – 5.21% variation in the 
conversation VAS scores of IWPD. These results suggest that the measure of 
conversational VAS scores demonstrates good repeatability for IWPD. 
3.5.3.1.2 Retest analysis of VAS conversational intelligibility 
scores for control participants 
 
The ICC values related to the repeated measurement of conversational intelligibility VAS 
scores across the three pairwise visits was found to be the following: visit 1 versus visit 2 
ICC = .68, p = .001, visit 1 versus visit 3 ICC = .78, p < .001, and visit 2 versus visit 3 
ICC = .56, p = .018. These results suggest that conversational intelligibility as measured 
in the present study did not demonstrate good retest reliability in healthy speakers 
because the ICC values across two of three comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for conversational intelligibility VAS 
scores was 1.63 % (SD = 4.10) and this difference was significant t(28) = 2.14, p = .041. 
The mean difference between visit 1 and visit 3 for conversational intelligibility VAS 
scores was 1.05 % (SD = 2.60) and this difference was significant t(29) = 2.22, p = .034. 
The mean difference between visit 2 and visit 3 for conversational intelligibility VAS 
scores was -0.56 % (SD = 4.92) and this difference was not significant t(28) = -0.62, p = 
.543. The mean differences in retest values ranged from -12.89 – 10.47 %. Additionally, 
the following CR values were obtained for the following visit comparisons: for visit 1 vs 
visit 2, CR = 6.70 and CR% = 7.14%, for visit 1 vs visit 3, CR = 4.16 and CR% = 4.51%, 
and for visit 2 vs visit 3, CR = 8.12 and CR% = 8.76%. Based on the CR, an observed 
change in the conversational intelligibility VAS scores of at least 4.16 – 8.12% would 
suggest an acceptable amount of measurement error ranging from 4.51 – 8.76% variation 
in the conversational intelligibility VAS scores of control participants. These results 
suggest that the measure of conversational intelligibility VAS scores demonstrates good 
repeatability for control participants. 
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3.6 Statistical Analysis for Objective 4: Self-Rated 
Communicative Participation 
 
In order to answer the question ‘Does self-rated communicative participation differ over 
time between and within participants with PD and control participants?’, a repeated 
measures MANOVA was performed to analyze the variability of self-rated 
communicative participation of the participants with PD and control participants over 
three time points for two of the four dependent measures related to communicative 
participation (CES question scores, VAPP subtest scores). The following factors were 
used in this analysis: one between-group independent factor with two levels “Group” 
[PD, control], one within-group independent factor with three levels “Visit” [visit 1, visit 
2, visit 3]. Additionally, a repeated measures ANOVA was performed to analyze the 
variability of self-rated communicative participation of the participants with PD and 
control participants over three time points for the remaining two of four dependent 
measures related to communicative participation (CPIB scores, LSUS scores). The 
following factors were used in this analysis: one between-group independent factor with 
two levels “Group” [PD, control], one within-group independent factor with three levels 
“Visit” [visit 1, visit 2, visit 3]. 
3.6.1 CES question scores 
 
Scores for each of the eight individual CES questions were obtained based on 
participants’ responses of 1, 2, 3, or 4 for each question. Descriptive statistics for 
individual CES question scores can be found in Table 21. The results of the repeated 
measures MANOVA for the dependent variables of the individual CES questions showed 
that there was a significant multivariate effect of “Group” F(8,41)  = 14.54, p < .001. The 
results of this repeated measures MANOVA can be found in Table 22. The results of 
subsequent univariate testing for each of the individual CES questions revealed the 
following results: 1) there was a significant univariate effect of “Group” F(1,48) = 67.63, 
p < .001 for CES question 1 (Having a conversation with a family member or friends at 
home) with participants with PD having a lower (-0.97) marginal mean (M = 2.92, SD = 
0.41) compared to control participants (M = 3.89, SD = 0.43); 2) there was a significant 
univariate effect of “Group” F(1,48) = 89.69, p < .001 for CES question 2 (Participating 
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in conversation with strangers in a quiet place) with participants with PD having a lower 
(-1.14) marginal mean (M = 2.71, SD = 0.41) compared to control participants (M = 3.85, 
SD = 0.43); 3) there was a significant univariate effect of “Group” F(1,48) = 82.13, p < 
.001 for CES question 3 (Conversing with a familiar person over the telephone) with 
participants with PD having a lower (-1.03) marginal mean (M = 2.86, SD = 0.41) 
compared to control participants (M = 3.89, SD = 0.38); 4) there was a significant 
univariate effect of “Group” F(1,48) = 91.67, p < .001 for CES question 4 (Conversing 
with a stranger over the telephone) with participants with PD having a lower (-1.26) 
marginal mean (M = 2.51, SD = 0.46) compared to control participants (M = 3.77, SD = 
0.48); 5) there was a significant univariate effect of “Group” F(1,48) = 78.29, p < .001 
for CES question 5 (Being part of a conversation in a noisy environment (social 
gathering)) with participants with PD having a lower (-1.33) marginal mean (M = 2.19, 
SD = 0.50) compared to control participants (M = 3.52, SD = 0.54); 6) there was a 
significant univariate effect of “Group” F(1,48) = 89.40, p < .001 for CES question 6 
(Speaking to a friend when you are emotionally upset or you are angry) with participants 
with PD having a lower (-1.26) marginal mean (M = 2.37, SD = 0.46) compared to 
control participants (M = 3.63, SD = 0.48); 7) there was a significant univariate effect of 
“Group” F(1,48) = 98.29, p < .001 for CES question 7 (Having a conversation while 
traveling in a car) with participants with PD having a lower (-1.19) marginal mean (M = 
2.59, SD = 0.41) compared to control participants (M = 3.78, SD = 0.43); and 8) there 
was a significant univariate effect of “Group” F(1,48) = 69.19, p < .001 for CES question 
8 (Having a conversation with someone at a distance (across a room)) with participants 
with PD having a lower (-1.29) marginal mean (M = 2.29, SD = 0.55) compared to 
control participants (M = 3.58, SD = 0.54). 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
98 
Table 21: Descriptive Statistics of Self- and Proxy-Rated Individual Questions of the 
Communication Effectiveness Survey for Participants with Parkinson's Disease, 
Primary Communication Partners of Participants with Parkinson’s Disease, and 
Control Participants Across Visits 1, 2, and 3 
 CES Q1 
mean(SD) 
CES Q2 
mean(SD) 
CES Q3 
mean(SD) 
CES Q4 
mean(SD) 
CES Q5 
mean(SD) 
CES Q6 
mean(SD) 
CES Q7 
mean(SD) 
CES Q8 
mean(SD) 
Participants with PD 
Visit 1 3.00(0.60) 2.83(0.72) 3.05(0.65) 2.65(0.78) 2.30(0.76) 2.57(0.90) 2.70(0.70) 2.30(0.63) 
Visit 2 2.87(0.81) 2.78(0.60) 2.87(0.69) 2.39(0.58) 2.04(0.56) 2.30(0.63) 2.61(0.66) 2.35(0.65) 
Visit 3 2.82(0.59) 2.50(0.67) 2.73(0.77) 2.45(0.74) 2.09(0.87) 2.23(0.81) 2.45(0.67) 2.18(0.91) 
Control participants 
Visit 1 3.77(0.43) 3.67(0.55) 3.80(0.41) 3.60(0.56) 3.27(0.69) 3.45(0.57) 3.73(0.45) 3.27(0.74) 
Visit 2 3.87(0.35) 3.90(0.31) 3.90(0.31) 3.87(0.35) 3.53(0.57) 3.70(0.53) 3.73(0.45) 3.57(0.63) 
Visit 3 3.97(0.18) 3.97(0.18) 3.93(0.25) 3.83(0.38) 3.70(0.53) 3.77(0.43) 3.80(0.48) 3.77(0.43) 
Primary communication partners 
Visit 1 3.30(0.76) 3.30(0.56) 3.17(0.72) 2.83(0.83) 2.65(0.88) 3.00(0.87) 3.04(0.64) 2.57(0.90) 
Visit 2 3.30(0.82) 3.00(0.67) 3.13(0.81) 2.52(0.85) 2.43(0.84) 2.55(0.86) 2.91(1.00) 2.39(0.84) 
Visit 3 3.36(0.73) 3.00(0.76) 3.18(0.66) 2.73(0.88) 2.36(0.90) 2.67(0.80) 3.09(0.68) 2.32(0.95) 
Marginal means 
Participants 
with PD 
2.92(0.41) 2.71(0.41) 2.86(0.41) 2.51(0.46) 2.19(0.50) 2.37(0.46) 2.59(0.41) 2.29(0.55) 
Control 
participants 
3.89(0.43) 3.85(0.43) 3.89(0.38) 3.77(0.48) 3.52(0.54) 3.63(0.48) 3.78(0.43) 3.58(0.54) 
Communication 
partners 
3.35(0.60) 3.13(0.55) 3.18(0.55) 2.71(0.64) 2.51(0.69) 2.73(0.64) 3.03(0.55) 2.46(0.69) 
PD and control 
visit 1 
3.42(0.49) 3.27(0.64) 3.41(0.49) 3.14(0.71) 2.85(0.71) 3.03(0.71) 3.24(0.57) 2.82(0.71) 
PD and control 
visit 2 
3.40(0.57) 3.33(0.42) 3.38(0.57) 3.12(0.49) 2.82(0.57) 2.99(0.57) 3.17(0.57) 3.00(0.64) 
PD and control 
visit 3 
3.39(0.42) 3.25(0.49) 3.32(0.57) 3.15(0.57) 2.89(0.71) 2.98(0.64) 3.15(0.57) 2.97(0.71) 
PD and partners 
visit 1 
3.19(0.71) 3.12(0.65) 3.10(0.71) 2.76(0.84) 2.57(0.78) 2.81(0.91) 2.88(0.65) 2.48(0.78) 
PD and partners 
visit 2 
3.12(0.84) 2.88(0.65) 3.00(0.78) 2.45(0.78) 2.26(0.71) 2.41(0.78) 2.76(0.84) 2.41(0.78) 
PD and partners 
visit 3 
3.10(0.65) 2.76(0.71) 2.95(0.71) 2.62(0.84) 2.21(0.91) 2.43(0.78) 2.79(0.71) 2.24(0.97) 
Note. This table illustrates the means and standard deviations for the individual questions 
of the Communicative Effectiveness Survey for participants with PD, their primary 
communication partners, and control participants across visits. 
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Table 22: Multivariate Testing Analysis of Self-Rated Individual Questions of the 
Communicative Effectiveness Survey for Participants with Parkinson's Disease and 
Control Participants Across Visits 1, 2, and 3 
 Df hypothesis Df error F value p value 
“Group” 8 41 14.54 <.001 
“Visit” 16 180 0.68 .810 
“Group”*”Visit” 16 180 2.90 <.001 
Note. This table illustrates the main effects of “Group” and “Visit”, and the “Group” by 
“Visit” interaction found from multivariate analyses of the individual questions of the 
Communicative Effectiveness Survey for participants with PD and control participants. 
 
The results of the repeated measures MANOVA for the dependent variables of the 
individual CES questions showed that there was no significant multivariate effect of 
“Visit” F(16,180) = 0.68, p = .810. In contrast, there was a significant “Group” by “Visit” 
interaction on the individual CES questions F(16,180) = 2.90, p < .001. The results of this 
repeated measures MANOVA can be found in Table 22. A closer look at the “Visit” 
factor via subsequent univariate testing for each of the individual CES questions revealed 
the following results: 1) There was no significant univariate effect of “Visit” F(2,96) = 
0.10, p = .901, but there was a significant “Group” by “Visit” interaction F(2,96) = 4.06, 
p = .020 for CES question 1 (Having a conversation with a family member or friends at 
home). This significant interaction is illustrated in Figure 9. These results indicated that 
the marginal mean of the CES question 1 score at visit 1 (M = 3.42, SD = 0.49) was 
similar to the marginal mean of the CES question 1 score at visit 2 (M = 3.40, SD = 0.57) 
and visit 3 (M = 3.39, SD = 0.42). It appears that at visit 1 the group difference between 
the ratings of participants with PD and control participants on CES question 1 is smaller 
than the group differences that were found at visit 2 and visit 3. 2) There was no 
significant univariate effect of “Visit” F(2,96) = 0.71, p = .496, but there was a 
significant “Group” by “Visit” interaction F(2,96) = 8.87, p < .001 for CES question 2 
(Participating in conversation with strangers in a quiet place). This significant 
interaction is illustrated in Figure 10. These results indicated that the marginal mean of 
CES question 2 at visit 1 (M = 3.27, SD = 0.64) was similar to the marginal mean the 
CES question 2 score at visit 2 (M = 3.33, SD = 0.42) and visit 3 (M = 3.25, SD = 0.49). It 
appears that at visit 1 the group difference between the ratings of participants with PD 
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and control participants on CES question 2 is smaller than the group differences that were 
found at visit 2 and visit 3. 3) There was no significant univariate effect of “Visit” 
F(2,96) = 0.58, p = .563 or “Group” by “Visit” interaction F(2,96) = 2.61, p = .078 for 
CES question 3 (Conversing with a familiar person over the telephone). This interaction 
is illustrated in Figure 11. 4) There was no significant univariate effect of “Visit” F(2,96) 
= 0.07, p = .934, but there was a significant “Group” by “Visit” interaction F(2,96) = 
5.25, p =.007 for CES question 4 (Conversing with a stranger over the telephone). This 
significant interaction is illustrated in Figure 12. These results indicated that the marginal 
mean of CES question 4 at visit 1 (M = 3.14, SD = 0.71) was similar to the marginal 
mean of the CES question 4 score at visit 2 (M = 3.12, SD = 0.49) and visit 3 (M = 3.15, 
SD = 0.57). 5) There was no significant univariate effect of “Visit” F(2,96) = 0.22, p = 
.807, but there was a significant “Group” by “Visit” interaction F(2,96) = 10.17, p < .001 
for CES question 5 (Being part of a conversation in a noisy environment (social 
gathering). This significant interaction is illustrated in Figure 13. These results indicated 
that the marginal mean of the CES question 5 score at visit 1 (M = 2.85, SD = 0.71) was 
similar to the marginal mean of the CES question 5 score at visit 2 (M = 2.82, SD = 0.57) 
and visit 3 (M = 2.89, SD =0.71). 6) There was no significant univariate effect of “Visit” 
F(2,96) = 0.16, p = .850, but there was a significant “Group” by “Visit” interaction 
F(2,96) = 6.36, p = .003 for CES question 6 (Speaking to a friend when you are 
emotionally upset or you are angry). This significant interaction is illustrated in Figure 
14. These results indicated that the marginal mean of the CES question 6 score at visit 1 
(M = 3.03, SD = 0.71) was similar to the marginal mean of the CES question 6 score at 
visit 2 (M = 2.99, SD = 0.57) and visit 3 (M = 2.98, SD = 0.64). 7) There was no 
significant univariate effect of “Visit” F(2,96) = 0.49, p = .617 or “Group” by “Visit” 
interaction F(2,96) = 1.38, p = .256 for CES question 7 (Having a conversation while 
traveling in a car). This interaction is illustrated in Figure 15. 8) There was no significant 
univariate effect of “Visit” F(2,96) = 2.14, p = .123, but there was a significant “Group” 
by “Visit” interaction F(2,96) = 6.78, p = .002 for CES question 8 (Having a 
conversation with someone at a distance (across a room)). This significant interaction is 
illustrated in Figure 16. These results indicated that the marginal mean of the CES 
question 8 score at visit 1 (M = 2.82, SD = 0.71) was similar to the marginal mean of the 
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CES question 8 score at visit 2 (M = 3.00, SD = 0.64) and visit 3 (M = 2.97, SD = 0.71). 
The results of univariate testing for the individual CES question scores are provided in 
Table 23.  
Figure 9: Means of Communicative Effectiveness Survey Question 1 (Having a 
Conversation with a Family Member or Friends at Home) Scores for Participants 
with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 9. This figure demonstrates the changes in mean CES question 1 (Having a 
conversation with a family member or friends at home) scores for participants with PD 
and control participants across visits. Error bars represent standard deviations. 
  
Participants with PD 
Control participants 
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Figure 10: Means of Communicative Effectiveness Survey Question 2 (Participating 
in Conversation with Strangers in a Quiet Place) Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 10. This figure demonstrates the changes in mean CES question 2 (Participating 
in conversation with strangers in a quiet place) scores for participants with PD and 
control participants across visits. Error bars represent standard deviations. 
  
Participants with PD 
Control participants 
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Figure 11: Means of Communicative Effectiveness Survey Question 3 (Conversing 
with a Familiar Person over the Telephone) Scores for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 11. This figure demonstrates the changes in mean CES question 3 (Conversing 
with a familiar person over the telephone) scores for participants with PD and control 
participants across visits. Error bars represent standard deviations. 
  
Participants with PD 
Control participants 
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Figure 12: Means of Communicative Effectiveness Survey Question 4 (Conversing 
with a Stranger over the Telephone) Scores for Participants with Parkinson's Disease 
and Control Participants Across Visits 1, 2, and 3 
Figure 12. This figure demonstrates the changes in mean CES question 4 (Conversing 
with a stranger over the telephone) scores for participants with PD and control 
participants across visits. Error bars represent standard deviations. 
  
Participants with PD 
Control participants 
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Figure 13: Means of Communicative Effectiveness Survey Question 5 (Being Part of 
a Conversation in a Noisy Environment (Social Gathering)) Scores for Participants 
with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 13. This figure demonstrates the changes in mean CES question 5 (Being part of a 
conversation in a noisy environment (social gathering)) scores for participants with PD 
and control participants across visits. Error bars represent standard deviations. 
  
Participants with PD 
Control participants 
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Figure 14: Means of Communicative Effectiveness Survey Question 6 (Speaking to a 
Friend When You are Emotionally Upset or You are Angry) Scores for Participants 
with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 14. This figure demonstrates the changes in mean CES question 6 (Speaking to a 
friend when you are emotionally upset or you are angry) scores for participants with PD 
and control participants across visits. Error bars represent standard deviations. 
  
Participants with PD 
Control participants 
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Figure 15: Means of Communicative Effectiveness Survey Question 7 (Having a 
Conversation While Traveling in a Car) Scores for Participants with Parkinson's 
Disease and Control Participants Across Visits 1, 2, and 3 
Figure 15. This figure demonstrates the changes in mean CES question 7 (Having a 
conversation while traveling in a car) scores for participants with PD and control 
participants across visits. Error bars represent standard deviations. 
  
Participants with PD 
Control participants 
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Figure 16: Means of Communicative Effectiveness Survey Question 8 (Having a 
Conversation with Someone at a Distance (Across a Room)) Scores for Participants 
with Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
Figure 16. This figure demonstrates the changes in mean CES question 8 (Having a 
conversation with someone at a distance (across a room)) scores for participants with PD 
and control participants across visits. Error bars represent standard deviations. 
  
Participants with PD 
Control participants 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
109 
Table 23: Univariate Testing Analysis of the Variability of Self-Rated Individual 
Questions of the Communicative Effectiveness Survey for Participants with 
Parkinson’s Disease and Control Participants Across Visits 1, 2, and 3 
 Df hypothesis Df error F value p value 
       “Group” 
CES question 1 1 48 67.63 <.001 
CES question 2 1 48 89.69 <.001 
CES question 3 1 48 82.13 <.001 
CES question 4 1 48 91.67 <.001 
CES question 5 1 48 78.29 <.001 
CES question 6 1 48 89.40 <.001 
CES question 7 1 48 98.29 <.001 
CES question 8 1 48 69.19 <.001 
        “Visit” 
CES question 1 2 96 0.10 .901 
CES question 2 2 96 0.71 .496 
CES question 3 2 96 0.58 .563 
CES question 4 2 96 0.07 .934 
CES question 5 2 96 0.22 .807 
CES question 6 2 96 0.16 .850 
CES question 7 2 96 0.49 .617 
CES question 8 2 96 2.14 .123 
“Group”*”Visit” 
CES question 1 2 96 4.06 .020 
CES question 2 2 96 8.87 <.001 
CES question 3 2 96 2.61 .078 
CES question 4 2 96 5.25 .007 
CES question 5 2 96 10.17 <.001 
CES question 6 2 96 6.36 .003 
CES question 7 2 96 1.38 .256 
CES question 8 2 96 6.78 .002 
Note. This table illustrates the significant and non-significant univariate effects of 
“Group”, significant and non-significant univariate effects of “Visit”, and “Group” by 
“Visit” interactions found from univariate analyses of the individual questions of the CES 
for participants with PD and control participants. 
 
3.6.1.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of individual CES questions. These 
analyses were performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) 
SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, 
and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-
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2, 1-3, and 2-3. Separate retest analyses were performed on the participants with PD and 
control participants.  
3.6.1.1.1 Retest analysis of CES question 1 (Having a 
conversation with a family member or friends at home) 
scores for participants with Parkinson’s disease 
 
Results for retest analyses of CES question 1 scores for participants with PD are 
summarized in Table 24. The ICC values related to the repeated measurement of CES 
question 1 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .70, p = .004, visit 1 versus visit 3 ICC = .56, p = .032, and visit 2 
versus visit 3 ICC = .68, p = .008. These results suggest that CES question 1 scores as 
measured in the present study did not demonstrate good retest reliability in IWPD 
because all of the ICC values across all comparisons were below our criterion of .75.  
Table 24: Retest Analyses of Communicative Effectiveness Survey Question 1 
(Having a Conversation with a Family Member or Friends at Home) for Participants 
with Parkinson's Disease, Primary Communication Partners of Participants with 
Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .70[.29-.87] 0.13 0.69 0.90 .377 0.71 0.39 1.08 36.05 
Visits 1 – 3 .56[-.03-.81] 0.18 0.66 1.28 .213 0.60 0.39 1.09 38.09 
Visits 2 – 3 .68[.20-.87] 0.05 0.72 0.39 .771 0.71 0.40 1.11 39.37 
Control participants 
Visits 1 – 2 .81[.60-.91] -0.10 0.31 -1.80 .083 0.39 0.17 0.47 12.56 
Visits 1 – 3 .35[-.23-.67] -0.20 0.41 -2.69 .012 0.33 0.27 0.74 19.02 
Visits 2 – 3 .55[.08-.78] -0.10 0.31 -1.80 .083 0.28 0.19 0.52 13.03 
Primary communication partners 
Visits 1 – 2 .79[.49-.91] 0.00 0.67 0.00 1.000 0.79 0.36 1.00 30.41 
Visits 1 – 3 .46[-.35-.78] -0.05 0.90 -0.24 .815 0.75 0.55 1.52 45.96 
Visits 2 – 3 .52[-.18-.80] -0.05 0.90 -0.24 .815 0.78 0.54 1.49 44.34 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CES question 1 scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CES question 1 scores was 0.13 (SD 
= 0.69) and this difference was not significant t(22) = 0.90, p = .377. The mean 
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differences in retest values ranged from -1 – 2. The mean difference between visit 1 and 
visit 3 for CES question 1 scores was 0.18 (SD = 0.66) and this difference was not 
significant t(21) = 1.28, p = .213. The mean differences in retest values ranged from -1 – 
1. The mean difference between visit 2 and visit 3 for CES question 1 scores was 0.05 
(SD = 0.72) and this difference was not significant t(21) = 0.30, p = .77. The mean 
differences in retest values ranged from -1 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.08 and 
CR% = 36.05%, for visit 1 vs visit 3, CR = 1.09 and CR% = 38.096%, and for visit 2 vs 
visit 3, CR = 1.11 and CR% = 39.37%. Based on the CR, an observed change in the CES 
question 1 scores of at least 1.08 – 1.11 would suggest a fairly large amount of 
measurement error ranging from 36.05 – 39.37% variation in the CES question 1 scores 
of IWPD. These results suggest that the measure of CES question 1 scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.1.1.2 Retest analysis of CES question 1 (Having a 
conversation with a family member or friends at 
home) scores for control participants 
 
Results for retest analyses of CES question 1 scores for control participants are 
summarized in Table 24. The ICC values related to the repeated measurement of CES 
question 1 scores across the three pairwise visits was found to be the following:  visit 1 
versus visit 2 ICC = .81, p < .001, visit 1 versus visit 3 ICC = .35, p = .095, and visit 2 
versus visit 3 ICC = .55, p = .015. These results suggest that CES question 1 scores as 
measured in the present study did not demonstrate good retest reliability in healthy 
speakers because the ICC values across two of three comparisons were below our 
criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 1 scores was -0.10 (SD 
= 0.31) and this difference was not significant t(29) = -1.80, p = .083. The mean 
differences in retest values ranged from -1 – 0. The mean difference between visit 1 and 
visit 3 for CES question 1 scores was -0.20 (SD = 0.41) and this difference was 
significant t(29) = -2.69, p = .012. The mean difference between visit 2 and visit 3 for 
CES question 1 scores was -0.10 (SD = 0.31) and this difference was significant t(29) = -
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1.80, p = .083. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 0.47 and CR% = 12.56%, for visit 1 vs visit 
3, CR = 0.74 and CR% = 19.02%, and for visit 2 vs visit 3, CR = 0.52 and CR% = 
13.03%. Based on the CR, an observed change in the CES question 1 scores of at least 
0.47 – 0.74 would suggest the possibility of an acceptable amount of measurement error 
ranging from 12.56 – 19.02% variation in the CES question 1 scores of control 
participants. These results suggest that the measure of CES question 1 scores 
demonstrates marginal repeatability for control participants. 
3.6.1.1.3 Retest analysis of CES question 2 (Participating 
in conversation with strangers in a quiet place) 
scores for participants with Parkinson’s disease 
 
Results for retest analyses of CES question 2 scores for participants with PD are 
summarized in Table 25. The ICC values related to the repeated measurement of CES 
question 2 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .70, p = .004, visit 1 versus visit 3 ICC = .83, p < .001, and visit 2 
versus visit 3 ICC = .65, p = .007. These results suggest that CES question 2 scores as 
measured in the present study did not demonstrate good retest reliability in IWPD 
because the ICC values across two of three comparisons were below our criterion of .75.  
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Table 25: Retest Analyses of Communicative Effectiveness Survey Question 2 
(Participating in Conversation with Strangers in a Quiet Place) for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with 
Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .70[.29-.88] 0.04 0.64 0.33 .747 0.66 0.36 1.01 35.53 
Visits 1 – 3 .83[.47-.94] 0.32 0.48 3.13 .005 0.70 0.29 0.79 28.57 
Visits 2 – 3 .65[.20-.85] 0.23 0.61 1.72 .096 0.64 0.38 1.04 41.69 
Control participants 
Visits 1 – 2 .48[-.02-.74] -0.23 0.50 -2.54 .017 0.45 0.32 0.89 24.30 
Visits 1 – 3 .20[-.41-.58] -0.30 0.53 -3.07 .005 0.41 0.37 1.01 26.00 
Visits 2 – 3 .65[.28-.83] -0.07 0.25 -1.44 .161 0.25 0.15 0.42 10.46 
Primary communication partners 
Visits 1 – 2 .00[-1.15-.56] 0.30 0.88 1.67 .110 0.62 0.62 1.71 51.83 
Visits 1 – 3 .33[-.47-.71] 0.32 0.84 1.78 .090 0.67 0.55 1.51 50.45 
Visits 2 – 3 .72[.30-.88] 0.00 0.69 0.00 1.000 0.72 0.38 1.05 35.00 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CES question 2 scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CES question 2 scores was 0.04 (SD 
= .64) and this difference was not significant t(22) = 0.33, p = .747. The mean differences 
in retest values ranged from -1 – 1. The mean difference between visit 1 and visit 3 for 
CES question 2 scores was 0.32 (SD = 0.48) and this difference was significant t(21) = 
3.13, p = .005. The mean difference between visit 2 and visit 3 for CES question 2 scores 
was 0.23 (SD = 0.61) and this difference was not significant t(21) = 1.74, p = .096. The 
mean differences in retest values ranged from -1 – 1. Additionally, the following CR 
values were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.01 
and CR% = 35.53%, for visit 1 vs visit 3, CR = 0.79 and CR% = 28.57%, and for visit 2 
vs visit 3, CR = 1.04 and CR% = 41.69%. Based on the CR, an observed change in the 
CES question 2 scores of at least 0.79 – 1.04 would suggest a large amount of 
measurement error ranging from 28.57 – 41.69% variation in the CES question 2 scores 
of IWPD. These results suggest that the measure of CES question 2 scores demonstrates 
unacceptable repeatability for IWPD. 
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3.6.1.1.4 Retest analysis of CES question 2 (Participating 
in conversation with strangers in a quiet place) 
scores for control participants 
 
Results for retest analyses of CES question 2 scores for control participants are 
summarized in Table 25. The ICC values related to the repeated measurement of CES 
question 2 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .48, p = .026, visit 1 versus visit 3 ICC = .20, p = .229, and visit 2 
versus visit 3 ICC = .65, p = .003. These results suggest that CES question 2 scores as 
measured in the present study did not demonstrate good retest reliability in healthy 
speakers because all of the ICC values across all comparisons were below our criterion of 
.75. 
 
The mean difference between visit 1 and visit 2 for CES question 2 scores was -0.23 (SD 
= 0.50) and this difference was significant t(29) = -0.25, p = .017. The mean difference 
between visit 1 and visit 3 for CES question 2 scores was -0.30 (SD = 0.53) and this 
difference was significant t(29) = -3.07, p = .005. The mean difference between visit 2 
and visit 3 for CES question 2 was -0.07 (SD = 0.25) and this difference was not 
significant t(29) = -1.44, p = .161. The mean differences in retest values ranged from -1 – 
0. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2, CR = 0.89 and CR% = 24.30%, for visit 1 vs visit 3, 
CR = 1.01 and CR% = 26.00%, and for visit 2 vs visit 3, CR = 0.42 and CR% = 10.46%. 
Based on the CR, an observed change in the CES question 2 scores of at least 0.42 – 1.32 
would suggest a fairly large amount of measurement error ranging from 10.46 – 26.00% 
variation in the CES question 2 scores of control participants. These results suggest that 
the measure of CES question 2 scores demonstrates unacceptable repeatability for control 
participants. 
3.6.1.1.5 Retest analysis of CES question 3 (Conversing 
with a familiar person over the telephone) scores 
for participants with Parkinson’s disease 
 
Results for retest analyses of CES question 3 scores for participants with PD are 
summarized in Table 26. The ICC values related to the repeated measurement of CES 
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question 3 across the three pairwise visits was found to be the following:  visit 1 versus 
visit 2 ICC = .48, p = .068, visit 1 versus visit 3 ICC = .32, p = .190, and visit 2 versus 
visit 3 ICC = .44, p = .100. These results suggest that CES question 3 scores as measured 
in the present study did not demonstrate good retest reliability y in IWPD because all of 
the ICC values across all comparisons were below our criterion of .75. 
Table 26: Retest Analyses of Communicative Effectiveness Survey Question 3 
(Conversing with a Familiar Person over the Telephone) for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with 
Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .48[-.22-.78] 0.18 0.80 1.07 .296 0.67 0.48 1.34 43.90 
Visits 1 – 3 .32[-.58-.72] 0.29 0.90 1.45 .162 0.71 0.59 1.63 56.71 
Visits 2 – 3 .44[-.37-.77] 0.14 0.89 0.72 .480 0.73 0.55 1.52 55.51 
Control participants 
Visits 1 – 2 .77[.52-.89] -0.10 0.31 -1.78 .083 0.36 0.17 0.48 12.71 
Visits 1 – 3 .62[.23-.82] -0.13 0.35 -2.11 .043 0.34 0.21 0.58 14.87 
Visits 2 – 3 .88[.75-.94] -0.03 0.18 -1.00 .326 0.28 0.10 0.27 6.88 
Primary communication partners 
Visits 1 – 2 .33[-.64-.72] 0.04 0.98 0.21 .833 0.77 0.63 1.74 54.81 
Visits 1 – 3 .37[-.58-.74] 0.00 0.87 0.0 1.000 0.69 0.55 1.52 48.51 
Visits 2 – 3 .71[.29-.88] -0.05 0.72 -0.30 .771 0.74 0.40 1.10 34.66 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CES question 3 scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CES question 3 scores was 0.18 (SD 
= 0.80) and this difference was not significant t(21) = 1.07, p = .296. The mean 
differences in retest values ranged from -1 – 1. The mean difference between visit 1 and 
visit 3 for CES question 3 scores was 0.29 (SD = 0.90) and this difference was not 
significant t(20) = 1.45, p = .162. The mean differences in retest values ranged from -1 – 
3. The mean difference between visit 2 and visit 3 for CES question 3 scores was 0.14 
(SD = 0.89) and this difference was not significant t(21) = 0.72, p = .480. The mean 
differences in retest values ranged from -1 – 2. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR =1.34 and 
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CR% = 43.90%, for visit 1 vs visit 3, CR = 1.63 and CR% = 56.71%, and for visit 2 vs 
visit 3, CR = 1.52 and CR% = 55.51%. Based on the CR, an observed change in the CES 
question 3 scores of at least 1.34 – 1.63 would suggest a large amount of measurement 
error ranging from 43.90 – 56.71% variation in the CES question 3 scores of IWPD. 
These results suggest that the measure of CES question 3 scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.1.1.6 Retest analysis of CES question 3 (Conversing 
with a familiar person over the telephone) scores 
for control participants 
 
Results for retest analyses of CES question 3 scores for control participants are 
summarized in Table 26. The ICC values related to the repeated measurement of CES 
question 3 scores across the three pairwise visits was found to be the following:  visit 1 
versus visit 2 ICC = .77, p < .001, visit 1 versus visit 3 ICC = .62, p = .003, and visit 2 
versus visit 3 ICC = .88, p < .001. These results suggest that CES question 3 scores as 
measured in the present study demonstrated good retest reliability in healthy speakers 
because the ICC values across two of three comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 3 scores was -0.10 (SD 
= 0.31) and this difference was not significant t(29) = -1.80, p = .083. The mean 
differences in retest values ranged from -1 – 0. The mean difference between visit 1 and 
visit 3 for CES question 3 scores was -0.13 (SD = 0.35) and this difference was 
significant t(29) = -2.11, p = .043. The mean difference between visit 2 and visit 3 for 
CES question 3 scores was -0.03 (SD = 0.18) and this difference was not significant t(29) 
= -1.00, p = .326. The mean differences in retest values ranged from -1 – 0. Additionally, 
the following CR values were obtained for the following visit comparisons: for visit 1 vs 
visit 2, CR = 0.48 and CR% = 12.71%, for visit 1 vs visit 3, CR = 0.58 and CR% = 
14.87%, and for visit 2 vs visit 3, CR = 0.27 and CR% = 6.88%. Based on the Cr, an 
observed change in the CES question 3 scores of at least 0.27 – 0.58 would suggest the 
possibility of an acceptable amount of measurement error ranging from 6.88 – 14.87% 
variation in the CES question 3 scores of control participants. These results suggest that 
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the measure of CES question 3 scores demonstrates marginal repeatability for control 
participants. 
3.6.1.1.7 Retest analysis of CES question 4 (Conversing 
with a stranger over the telephone) scores for 
participants with Parkinson’s disease 
 
Results for retest analyses of CES question 4 scores for participants with PD are 
summarized in Table 27. The ICC values related to the repeated measurement of CES 
question 4 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .64, p = .007, visit 1 versus visit 3 ICC = .70, p = .004, and visit 2 
versus visit 3 ICC = .70, p = .005. These results suggest that CES question 4 scores as 
measured in the present study did not demonstrate good retest reliability in IWPD 
because all of the ICC values across all comparisons were below our criterion of .75. 
Table 27: Retest Analyses of Communicative Effectiveness Survey Question 4 
(Conversing with a Stranger over the Telephone) for Participants with Parkinson's 
Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .64[.19-.85] 0.26 0.69 1.82 .083 0.69 0.41 1.14 43.11 
Visits 1 – 3 .70[.29-.87] 0.18 0.73 1.16 .257 0.76 0.42 1.15 48.26 
Visits 2 – 3 .70[.26-.87] -0.05 0.65 -0.33 .747 0.66 0.36 1.01 41.17 
Control participants 
Visits 1 – 2 .33[-.27-.66] -0.27 0.58 -2.50 .018 0.47 0.38 1.06 29.41 
Visits 1 – 3 .43[-.12-.72] -0.23 0.57 -2.25 .032 0.48 0.36 1.00 25.86 
Visits 2 – 3 .53[-.01-.78] 0.03 0.41 0.44 .662 0.37 0.25 0.69 18.11 
Primary communication partners 
Visits 1 – 2 .61[.12-.83] 0.30 0.8 1.67 .110 0.84 0.52 1.45 51.35 
Visits 1 – 3 .55[-.10-.82] 0.09 0.97 0.44 .665 0.86 0.57 1.59 63.07 
Visits 2 – 3 .81[.55-.92] -0.23 0.69 -1.556 .135 0.87 0.38 1.04 38.26 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CES question 4 scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CES question 4 scores was 0.26 (SD 
= 0.69) and this difference was not significant t(22) = 1.82, p = .083. The mean 
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differences in retest values ranged from -1 – 1. The mean difference between visit 1 and 
visit 3 for CES question 4 scores was 0.18 (SD = 0.73) and this difference was not 
significant t(21) = 1.16, p = .257. The mean differences in retest values ranged from -1 – 
1. The mean difference between visit 2 and visit 3 for CES question 4 scores was -0.05 
(SD = .65) and this difference was not significant t(21) = -0.33, p = .747. The mean 
differences in retest values ranged from -1 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.14 and 
CR% = 43.11%, for visit 1 vs visit 3, CR = 1.15 and CR% = 48.26%, and for visit 2 vs 
visit 3, CR = 1.01 and CR% = 41.17%. Based on the CR, an observed change in the CES 
question 4 scores of at least 1.01 – 1.15 would suggest a fairly large amount of 
measurement error ranging from 41.17 – 48.26% variation in the CES question 4 scores 
of IWPD. These results suggest that the measure of CES question 4 scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.1.1.8 Retest analysis of CES question 4 (Conversing 
with a stranger over the telephone) scores for 
control participants 
 
Results for retest analyses of CES question 4 scores for control participants are 
summarized in Table 27. The ICC values related to the repeated measurement of CES 
question 4 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .33, p = .116,  visit 1 versus visit 3 ICC = .43, p = .051, visit 2 versus 
visit 3 ICC = .53, p = .027. These results suggest that CES question 4 scores as measured 
in the present study did not demonstrate good retest reliability in healthy speakers 
because all of the ICC values across all comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 4 scores was -0.27 (SD 
= 0.58) and this difference was significant t(29) = -2.50, p = .018. The mean difference 
between visit 1 and visit 3 for CES question 4 scores was -0.23 (SD = 0.57) and this 
difference was significant t(29) = -2.25, p = .032. The mean difference between visit 2 
and visit 3 for CES question 4 scores was 0.03 (SD = 0.41) and this difference was not 
significant t(29) = 0.44, p = .662. The mean differences in retest values ranged from -1 – 
1. Additionally, the following CR values were obtained for the following visit 
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comparisons: for visit 1 vs visit 2, CR = 1.06 and CR% = 29.41%, for visit 1 vs visit 3, 
CR = 1.00 and CR% = 25.86%, and for visit 2 vs visit 3, CR = 0.69 and CR% = 18.11%. 
Based on the CR, an observed change in the CES question 4 scores of at least 0.69 – 1.06 
would suggest a fairly large amount of measurement error ranging from 18.11 – 29.41% 
variation in the CES question 4 scores of control participants. These results suggest that 
the measure of CES question 4 scores demonstrates unacceptable repeatability for control 
participants. 
3.6.1.1.9 Retest analysis of CES question 5 (Being part of 
a conversation in a noisy environment (social 
gathering)) scores for participants with 
Parkinson’s disease 
 
Results for retest analyses of CES question 5 scores for participants with PD are 
summarized in Table 28. The ICC values related to the repeated measurement of CES 
question 5 across the three pairwise visits was found to be the following:  visit 1 versus 
visit 2 ICC = .70, p = .002, visit 1 versus visit 3 ICC = .28, p = .221, and visit 2 versus 
visit 3 ICC = .63, p = .017. These results suggest that CES question 5 scores as measured 
in the present study did not demonstrate good retest reliability in IWPD because all of the 
ICC values across all comparisons were below our criterion of .75. 
Table 28: Retest Analyses of Communicative Effectiveness Survey Question 5 (Being 
Part of a Conversation in a Noisy Environment (Social Gathering)) for Participants 
with Parkinson's Disease, Primary Communication Partners of Participants with 
Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t 
value 
p 
value 
SD 
pool
ed 
SE
M 
CR CR% 
Participants with PD 
Visits 1 – 2 .70[.32-.87] 0.26 0.62 2.02 .056 0.67 0.37 1.01 44.03 
Visits 1 – 3 .28[-.67-.60] 0.27 1.03 1.24 .229 0.82 0.69 1.92 94.12 
Visits 2 – 3 .63[.08-.85] 0.00 0.76 0.00 1.000 0.73 0.45 1.23 58.98 
Control participants 
Visits 1 – 2 .70[.36-.86] -0.27 0.58 -2.50 .018 0.63 0.35 0.96 29.36 
Visits 1 – 3 .57[.05-.80] -0.43 0.63 -3.79 .001 0.62 0.40 1.12 31.66 
Visits 2 – 3 .69[.36-.85] -0.17 0.53 -1.72 .096 0.55 0.31 0.85 22.94 
Primary communication partners 
Visits 1 – 2 .62[.13-.84] 0.22 0.90 1.16 .260 0.86 0.53 1.47 55.43 
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Visits 1 – 3 .75[.40-.89] 0.32 0.78 1.91 .069 0.89 0.45 1.23 50.73 
Visits 2 – 3 .80[.52-.92] 0.05 0.72 0.30 .771 0.87 0.39 1.08 45.69 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CES question 5 scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CES question 5 scores was 0.26 (SD 
= 0.62) and this difference approached significance t(22) = 2.02, p = .056. The mean 
differences in retest values ranged from -1 – 2. The mean difference between visit 1 and 
visit 3 for CES question 5 scores was 0.27 (SD = 1.03) and this difference was not 
significant t(21) = 1.24, p = .229. The mean differences in retest values ranged from -2 – 
3. The mean difference between visit 2 and visit 3 for CES question 5 scores was 0.00 
(SD = 0.76) and this difference was not significant t(21) = 0.00, p = 1.000. The mean 
differences in retest values ranged from -1 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.01 and 
CR% = 44.03%, for visit 1 vs visit 3, CR = 1.92 and CR% = 94.12%, and for visit 2 vs 
visit 3, CR = 1.23 and CR% = 58.98%. Based on the CR, an observed change in the CES 
question 5 scores of at least 1.01 – 1.92 would suggest a large amount of measurement 
error ranging from 44.03 – 94.12% variation in the CES question 5 scores of IWPD. 
These results suggest that the measure of CES question 5 scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.1.1.10 Retest analysis of CES question 5 (Being part of 
a conversation in a noisy environment (social 
gathering)) scores for control participants 
 
Results for retest analyses of CES question 5 scores for control participants are 
summarized in Table 28. The ICC values related to the repeated measurement of CES 
question 5 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .70, p < .001, visit 1 versus visit 3 ICC = .57, p = .003, and visit 2 
versus visit 3 ICC = .69, p = .001. These results suggest that CES question 5 scores as 
measured in the present study did not demonstrate good retest reliability in healthy 
speakers because all of the ICC values across all comparisons were below our criterion of 
.75. 
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The mean difference between visit 1 and visit 2 for CES question 5 scores was -0.27 (SD 
= 0.58) and this difference was significant t(29) = -2.50, p = .018. The mean difference 
between visit 1 and visit 3 for CES question 5 scores was -0.43 (SD = 0.63) and this 
difference was significant t(29) = -3.79, p = .001. The mean difference between visit 2 
and visit 3 for CES question 5 scores was -0.17 (SD = 0.53) and this difference was not 
significant t(29) = -1.72, p = .096. The mean differences in retest values ranged from -1 – 
1. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2. CR = 0.96 and CR% = 29.36%, for visit 1 vs visit 3, 
CR = 1.12 and CR% = 31.66%, and for visit 2 vs visit 3, CR = 0.85 and CR% = 22.94%. 
Based on the Cr, an observed change in the CES question 5 scores of at least 0.85 – 1.12 
would suggest a fairly large amount of measurement error ranging from 22.94 – 31.66% 
variation in the CES question 5 scores of control participants. These results suggest that 
the measure of CES question 5 scores demonstrates unacceptable repeatability for control 
participants. 
3.6.1.1.11 Retest analysis of CES question 6 (Speaking to 
a friend when you are emotionally upset or you 
are angry) scores for participants with 
Parkinson’s disease 
 
Results for retest analyses of CES question 6 scores for participants with PD are 
summarized in Table 29. The ICC values related to the repeated measurement of CES 
question 6 scores across the three pairwise visits was found to be the following:  visit 1 
versus visit 2 ICC = .46, p = .074, visit 1 versus visit 3 ICC = .03, p = .469, visit 2 versus 
visit 3 ICC = .50, p = .064. These results suggest that CES question 6 scores as measured 
in the present study did not demonstrate good retest reliability in IWPD because all of the 
ICC values across all comparisons were below our criterion of .75. 
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Table 29: Retest Analyses of Communicative Effectiveness Survey Question 6 
(Speaking to a Friend When You are Emotionally Upset or You are Angry) for 
Participants with Parkinson's Disease, Primary Communication Partners of 
Participants with Parkinson’s Disease, Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .46[-.23-.77] 0.26 0.92 1.37 .186 0.78 0.57 1.58 61.53 
Visits 1 – 3 .03[-1.25-.59] 0.32 1.21 1.23 .231 0.86 0.84 2.34 101.56 
Visits 2 – 3 .50[-.23-.80] 0.05 0.84 0.25 .803 0.73 0.51 1.42 63.73 
Control participants 
Visits 1 – 2 .36[-.28-.69] -0.37 0.96 -2.08 .046 0.55 0.44 1.22 35.35 
Visits 1 – 3 .41[-.15-.71] -0.43 0.90 -2.64 .013 0.50 0.39 1.07 29.03 
Visits 2 – 3 .84[.66-.92] -0.07 0.37 -1.00 .326 0.48 0.19 0.53 14.18 
Primary communication partners 
Visits 1 – 2 .63[.13-.84] 0.45 0.86 2.49 .021 0.87 0.53 1.46 48.58 
Visits 1 – 3 .50[-.16-.79] 0.33 0.97 1.58 .130 0.84 0.59 1.64 64.19 
Visits 2 – 3 .65[.14-.86] -0.14 0.85 -0.77 .452 0.83 0.49 1.36 50.98 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CES question 6 scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CES question 6 scores was 0.26 (SD 
= 0.92) and this difference was not significant t(22) = 1.37, p = .186. The mean 
differences in retest values ranged from -1 – 2. The mean difference between visit 1 and 
visit 3 for CES question 6 scores was 0.32 (SD = 1.21) and this difference was not 
significant t(21) = 1.23, p = .231. The mean differences in retest values ranged from -2 – 
3. The mean difference between visit 2 and visit 3 for CES question 6 scores was 0.05 
(SD = 0.84) and this difference was not significant t(21) = 0.25, p = .803 The mean 
differences in retest values ranged from -2 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.58 and 
CR% = 61.53%, for visit 1 vs visit 3, CR = 2.34 and CR% = 101.56%, and for visit 2 vs 
visit 3, CR = 1.42 and CR% = 63.73%. Based on the CR, an observed change in the CES 
question 6 scores of at least 1.42 – 2.34 would suggest a large amount of measurement 
error ranging from 61.53 – 101.56% variation in the CES question 6 scores of IWPD. 
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These results suggest that the measure of CES question 6 scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.1.1.12 Retest analysis of CES question 6 (Speaking to 
a friend when you are emotionally upset or you 
are angry) scores for control participants 
 
Results for retest analyses of CES question 6 scores for control participants are 
summarized in Table 29. The ICC values related to the repeated measurement of CES 
question 6 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .36, p = .107, visit 1 versus visit 3 ICC = .41, p = .057, visit 2 versus 
visit 3 ICC = .84, p < .001. These results suggest that CES question 6 scores as measured 
in the present study did not demonstrate good retest reliability in healthy speakers 
because the ICC values across two of three comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 6 scores was -0.37 (SD 
= 0.96) and this difference was significant t(29) = -2.08, p = .046. The mean difference 
between visit 1 and visit 3 for CES question 6 scores was -0.43 (SD = 0.90) and this 
difference was significant t(29) = -2.64, p = .013. The mean difference between visit 2 
and visit 3 for CES question 6 scores was -0.07 (SD = 0.37) and this difference was not 
significant t(29) = -1.00, p = .326. The mean differences in retest values ranged from -1 – 
1. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2, CR = 1.22 and CR% = 35.35%, for visit 1 vs visit 3, 
CR = 1.07 and CR% = 29.03%, and for visit 2 vs visit 3, CR = 0.53 and CR% = 14.18%. 
Based on the CR, an observed change in the CES question 6 scores of at least 0.53 – 1.22 
would suggest a fairly large amount of measurement error ranging from 14.18 – 35.35% 
variation in the CES question 6 scores of control participants. These results suggest that 
the measure of CES question 6 scores demonstrates unacceptable repeatability for control 
participants. 
3.6.1.1.13 Retest analysis of CES question 7 (Having a 
conversation while travelling in a car) scores for 
participants with Parkinson’s disease 
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Results for retest analyses of CES question 7 scores for participants with PD are 
summarized in Table 30. The ICC values related to the repeated measurement of CES 
question 7 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .37, p = .148, visit 1 versus visit 3 ICC = .57, p = .025, visit 2 versus 
visit 3 ICC = .21, p = .299. These results suggest that CES question 7 scores as measured 
in the present study did not demonstrate good retest reliability in IWPD because all of the 
ICC values across all comparisons were below our criterion of .75. 
Table 30: Retest Analyses of Communicative Effectiveness Survey Question 7 
(Having a Conversation While Traveling in a Car) for Participants with Parkinson's 
Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .37[-.52-.74] 0.09 0.85 0.49 .628 0.68 0.54 1.50 55.40 
Visits 1 – 3 .57[.02-.82] 0.23 0.75 1.42 .171 0.69 0.45 1.24 47.68 
Visits 2 – 3 .21[-.94-.68] 0.14 0.89 0.72 .480 0.67 0.59 1.64 66.83 
Control participants 
Visits 1 – 2 .80[.58-.91] 0.00 0.37 0.00 1.000 0.45 0.20 0.56 14.95 
Visits 1 – 3 .55[.06-.79] -0.07 0.52 -0.70 .489 0.47 0.31 0.86 23.18 
Visits 2 – 3 .70[.37-.86] -0.07 0.45 -0.81 .423 0.47 0.25 0.71 18.58 
Primary communication partners 
Visits 1 – 2 .34[-.59-.72] 0.13 1.06 0.59 .560 0.84 0.68 1.89 62.15 
Visits 1 – 3 .50[-.26-.79] 0.00 0.76 0.00 1.000 0.66 0.47 1.29 44.44 
Visits 2 – 3 .43[-.41-.76] -0.14 1.04 -0.62 .544 0.86 0.65 1.79 57.87 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CES question 7 scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CES question 7 scores was 0.09 (SD 
= 0.85) and this difference was not significant t(22) = 0.49, p = .628. The mean 
differences in retest values ranged from -1 – 3. The mean difference between visit 1 and 
visit 3 for CES question 7 scores was 0.23 (SD = 0.75) and this difference was not 
significant t(21) = 1.42, p = .171. The mean differences in retest values ranged from -1 – 
2. The mean difference between visit 2 and visit 3 for CES question 7 scores was 0.14 
(SD = 0.89) and this difference was not significant t(21) = 0.72, p = .480. The mean 
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differences in retest values ranged from -1 – 2. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.50 and 
CR% = 55.40%, for visit 1 vs visit 3, CR = 1.24 and CR% = 47.68%, and for visit 2 vs 
visit 3, CR = 1.64 and CR% = 66.83%. Based on the CR, an observed change in the CES 
question 7 scores of at least 1.24 – 1.64 would suggest a large amount of measurement 
error ranging from 47.68 – 66.83% variation in the CES question 7 scores of IWPD. 
These results suggest that the measure of CES question 7 scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.1.1.14 Retest analysis of CES question 7 (Having a 
conversation while traveling in a car) scores for 
control participants 
 
Results for retest analyses of CES question 7 scores for control participants are 
summarized in Table 30. The ICC values related to the repeated measurement of CES 
question 7 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .80, p < .001, visit 1 versus visit 3 ICC = .55, p = .018, and visit 2 
versus visit 3 ICC = .70, p = .001. These results suggest that CES question 7 scores as 
measured in the present study did not demonstrate good retest reliability in healthy 
speakers because the ICC values across two of three comparisons were below our 
criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 7 scores was 0.00 (SD 
= 0.37) and this difference was not significant t(29) = 0.00, p = 1.000. The mean 
differences in retest values ranged from -1 – 1. The mean difference between visit 1 and 
visit 3 for CES question 7 scores was -0.07 (SD = 0.52) and this difference was not 
significant t(29) = -0.70, p = .489. The mean differences in retest values ranged from -1 – 
1. The mean difference between visit 2 and visit 3 for CES question 7 scores was -0.07 
(SD = 0.45) and this difference was not significant t(29) = -0.81, p = .423. The mean 
differences in retest values ranged from -1 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 0.56 and 
CR% = 14.95%, for visit 1 vs visit 3, CR = 0.86 and CR% = 23.18%, and for visit 2 vs 
visit 3, CR = 0.71 and CR% = 18.58%. Based on the CR, an observed change in the CES 
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question 7 scores of at least 0.56 – 0.86 would suggest the possibility of an acceptable 
amount of measurement error ranging from 14.95 – 23.18% variation in the CES question 
7 scores of control participants. These results suggest that the measure of CES question 7 
scores demonstrates marginal repeatability for control participants. 
3.6.1.1.15 Retest analysis of CES question 8 (Having a 
conversation with someone at a distance (across 
a room)) scores for participants with Parkinson’s 
disease 
 
Results for retest analyses of CES question 8 scores for participants with PD are 
summarized in Table 31. The ICC values related to the repeated measurement of CES 
question 8 scores across the three pairwise visits was found to be the following:  visit 1 
versus visit 2 ICC = .77, p = .001, visit 1 versus visit 3 ICC = .68, p = .006, and visit 2 
versus visit 3 ICC = .59, p = .023. These results suggest that CES question 8 scores as 
measured by the present study did not demonstrate good retest reliability in IWPD 
because the ICC values across two of three comparisons were below our criterion of .75. 
Table 31: Retest Analyses of Communicative Effectiveness Survey Question 8 
(Having a Conversation with Someone at a Distance (Across a Room)) for 
Participants with Parkinson's Disease, Primary Communication Partners of 
Participants with Parkinson’s Disease, and Control Participants Across Visits 1, 2, 
and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .77[.45-.90] -0.04 0.56 -0.37 .714 0.64 0.31 0.85 36.97 
Visits 1 – 3 .68[.24-.87] 0.14 0.77 0.83 .418 0.78 0.44 1.23 52.18 
Visits 2 – 3 .59[.03-.83] 0.18 0.85 1.00 .329 0.79 0.51 1.40 64.34 
Control participants 
Visits 1 – 2 .67[.31-.85] -0.30 0.65 -2.52 .017 0.69 0.39 1.09 33.44 
Visits 1 – 3 .59[-.03-.82] -0.50 0.57 -4.79 <.001 0.61 0.39 1.07 30.07 
Visits 2 – 3 .72[.41-.87] -0.20 0.48 -2.26 .031 0.54 0.29 0.79 20.97 
Primary communication partners 
Visits 1 – 2 .65[.18-.85] 0.17 0.8 0.94 .357 0.87 0.52 1.43 55.51 
Visits 1 – 3 .65[.18-.85] 0.27 0.94 1.37 .186 0.93 0.55 1.52 63.45 
Visits 2 – 3 .80[.51-.92] 0.09 0.75 0.57 .576 0.90 0.40 1.11 47.88 
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Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CES question 8 scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CES question 8 scores was -0.04 (SD 
= 0.56) and this difference was not significant t(22) = -0.37, p = .714. The mean 
differences in retest values ranged from -1 – 1. The mean difference between visit 1 and 
visit 3 for CES question 8 scores was 0.14 (SD = 0.77) and this difference was not 
significant t(22) = 0.83, p = .418. The mean differences in retest values ranged from -1 – 
2. The mean difference between visit 2 and visit 3 for CES question 8 scores was 0.18 
(SD = 0.85) and this difference was not significant t(21) = 1.00, p = .329. The mean 
differences in retest values ranged from -1 – 2. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 0.85 and 
CR% = 36.97%, for visit 1 vs visit 3, CR = 1.23 and CR% = 52.18%, and for visit 2 vs 
visit 3, CR = 1.40 and CR% = 64.34%. Based on the CR, an observed change in the CES 
question 8 scores of at least 0.85 – 1.40 would suggest a fairly large amount of 
measurement error ranging from 36.97 – 64.34% variation in the CES question 8 scores 
of IWPD. These results suggest that the measure of CES question 8 scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.1.1.16 Retest analysis of CES question 8 (Having a 
conversation with someone at a distance (across 
a room)) scores for control participants 
 
Results for retest analyses of CES question 8 scores for control participants are 
summarized in Table 31. The ICC values related to the repeated measurement of CES 
question 8 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .67, p = .001, visit 1 versus visit 3 ICC = .59, p = .001, and visit 2 
versus visit 3 ICC = .72, p < .001. These results suggest that CES question 8 scores as 
measured in the present study did not demonstrate good retest reliability in healthy 
speakers because all of the ICC values across all comparisons were below our criterion of 
.75. 
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The mean difference between visit 1 and visit 2 for CES question 8 scores was -0.30 (SD 
= 0.65) and this difference was significant t(29) = -2.52, p = .017. The mean difference 
between visit 1 and visit 3 for CES question 8 scores was -0.50 (SD = 0.57) and this 
difference was significant t(29) = -4.79, p < .001. The mean difference between visit 2 
and visit 3 for CES question 8 scores was -0.20 (SD = 0.48) and this difference was 
significant t(29) = -2.26, p = .031. Additionally, the following CR values were obtained 
for the following visit comparisons: for visit 1 vs visit 2, CR = 1.09 and CR% = 33.44%, 
for visit 1 vs visit 3, CR = 1.07 and CR% = 30.07%, and for visit 2 vs visit 3, CR = 0.79 
and CR% = 20.97%. Based on the CR, an observed change in the CES question 8 scores 
of at least 0.79 – 1.09 would suggest a fairly large amount of measurement error ranging 
from 20.97 – 30.07% variation in the CES question 8 scores of control participants. These 
results suggest that the measure of CES question 8 scores demonstrates unacceptable 
repeatability for control participants. 
3.6.2 VAPP subsection scores 
 
Scores for the VAPP self-perceived voice problem, daily communication, social 
communication, and emotion subsections were obtained by summing up the converted 
scores for each question within a subsection. Raw scores for each question were obtained 
by measuring the location of an individual’s response of each VAS. These raw scores 
were then divided by a factor of 10. VAPP total scores were obtained by summing up the 
total scores of each of the above-mentioned subsections. VAPP activity limitation scores 
were obtained by summing up the converted scores from the first question of each 
described situation assessing the degree of activity limitation from the daily 
communication and social communication subsections. VAPP participation restriction 
scores were obtained by summing up the converted scores from the second question of 
each described situation assessing the degree of participation restriction from the daily 
communication and social communication subsection. Descriptive statistics for VAPP 
subsection scores can be found in Table 32. The results of the repeated measures 
MANOVA for the dependent variables of the individual VAPP subsections showed that 
there was a significant multivariate effect of “Group” F(7,43) = 14.56, p < .001. The 
results of this repeated measures MANOVA can be found in Table 33. The results of 
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subsequent univariate testing for each of the individual VAPP subsections revealed the 
following results: 1) there was a significant univariate effect of “Group” F(1,49) = 71.94, 
p < .001 for the VAPP voice problem score with participants with PD having a greater 
(+3.04) marginal mean (M = 3.29, SD = 1.28) compared to control participants (M = 0.25, 
SD = 1.26); 2) there was a significant univariate effect of “Group” F(1,49) = 66.31, p < 
.001 for the VAPP daily communication score with participants with PD having a greater 
(+34.84) marginal mean (M = 39.92, SD = 15.03) compared to the control participants (M 
= 5.08, SD = 15.06); 3) there was a significant univariate effect of “Group” F(1,49) = 
51.45, p < .001 for the VAPP social communication score with participants with PD 
having a greater (+9.56) marginal mean (M = 10.86, SD = 4.67) compared to control 
participants (M = 1.30, SD = 4.71); 4) there was a significant univariate effect of “Group” 
F(1,49) = 46.53, p < .001 for the VAPP emotion score with participants with PD having a 
greater (+17.07) marginal mean (M = 19.38, SD = 8.80) compared to control participants 
(M = 2.31, SD = 8.82); 5) there was a significant univariate effect of “Group” F(1,49) = 
70.39, p < .001 for the VAPP activity limitation scores with participants with PD having a 
greater (+25.69) marginal mean (M = 29.44, SD = 10.77) compared to control 
participants (M = 3.75, SD = 10.79); 6) there was a significant univariate effect of 
“Group” F(1,49) = 44.57, p < .001 for the VAPP participation restriction scores with 
participants with PD having a greater (+21.02) marginal mean (M = 23.81, SD = 11.04) 
compared to control participants (M = 2.79, SD = 11.06); and 7) there was a significant 
univariate effect of “Group” F(1,49) = 56.84, p < .001 for the VAPP total score with 
participants with PD having a greater (+66.74) marginal mean (M = 75.92, SD = 31.12) 
compared to control participants (M = 9.18, SD = 31.11).  
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Table 32: Descriptive Statistics of Self- and Proxy-Rated Individual Subsections of 
the Voice Activity and Participation Profile for Participants with Parkinson's 
Disease, Primary Communication Partners of Participants with Parkinson’s 
Disease, and Control Participants Across Visits 1, 2, and 3 
 Voice 
problem 
mean(SD) 
Daily 
comm. 
mean(SD) 
Social 
comm. 
mean(SD) 
Emotion 
mean(SD) 
Activity 
limitation 
mean(SD) 
Participation 
restriction 
mean(SD) 
Total 
mean(SD) 
Participants with PD 
Visit 1 3.43(2.43) 38.18(24.93) 10.65(7.07) 20.35(15.52) 29.01(17.36) 22.20(17.73)  74.99(51.49) 
Visit 2 3.41(2.10) 39.05(20.55) 9.23(6.87) 17.77(13.76) 28.43(15.05) 21.97(15.03)  71.43(43.26) 
Visit 3 3.25(2.63) 45.60(30.35) 12.85(9.61) 22.39(17.89) 32.48(21.17) 28.31(21.77)  86.43(61.52) 
Control participants 
Visit 1 0.24(0.30) 5.08(4.80) 1.26(1.37) 2.39(2.60) 3.90(3.83) 2.45(2.67)  9.21(8.76) 
Visit 2 0.21(0.25) 5.10(4.89) 1.16(0.98) 2.17(1.80) 3.66(3.46) 2.80(2.73)  8.84(7.64) 
Visit 3 0.31(0.40) 5.06(4.50) 1.48(1.48) 2.36(2.26) 3.68(3.40) 3.14(2.97)  9.49(8.40) 
Primary communication partners 
Visit 1 2.97(2.28) 33.63(27.07) 7.83(7.05) 15.51(12.61) 24.34(19.33) 18.86(17.60)  61.69(47.73) 
Visit 2 3.38(2.44) 39.34(28.56) 9.64(7.62) 19.01(14.81) 27.89(20.06) 22.83(19.15)  73.10(53.42) 
Visit 3 2.81(2.20) 39.14(25.61) 9.65(7.29) 17.57(13.38) 29.10(20.47) 21.26(15.01)  70.75(47.57) 
Marginal means 
Participants  
with PD 
3.29(1.28) 39.92(15.03) 10.86(4.67) 19.38(8.80) 29.44(10.77) 23.81(11.04)  75.92(31.12) 
Control 
participants 
0.25(1.26) 5.08(15.06) 1.30(4.71) 2.31(8.82) 3.75(10.79) 2.79(11.06)  9.18(31.11) 
Primary 
communication  
partners 
3.10(2.02) 37.59(24.58) 9.08(7.13) 17.55(13.04) 27.33(18.11) 21.08(16.60)  69.06(47.80) 
PD and control 
visit 1 
1.88(1.57) 21.53(17.28) 5.99(4.93) 11.27(10.57) 16.38(12.14) 12.45(12.14)  42.10(35.35) 
PD and control 
visit 2 
1.75(1.36) 21.70(14.28) 5.37(4.64) 9.59(9.00) 15.93(10.50) 12.41(10.43)  39.68(29.71) 
PD and control 
visit 3 
1.69(1.71) 24.27(19.42) 6.89(6.28) 11.67(11.21) 17.48(13.85) 15.04(14.00)  45.88(39.35) 
PD and 
partners visit 1 
3.29(2.36) 36.06(26.82) 9.33(7.28) 18.00(14.43) 26.82(18.95) 20.79(18.16)  68.90(51.02) 
PD and 
partners visit 2 
3.35(2.30) 38.91(25.64) 9.62(7.48) 18.13(14.43) 28.15(18.30) 22.44(17.84)  72.07(50.10) 
PD and 
partners visit 3 
2.94(2.36) 41.30(27.54) 10.97(8.46) 19.27(15.28) 30.19(20.72) 24.10(18.36) 76.51(53.90) 
Note. This table illustrates the means and standard deviations for the individual 
subsection scores of the VAPP for participants with PD, their primary communication 
partners, and control participants across visits. 
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Table 33: Multivariate Testing Analysis of Self-Rated Individual Subsections of the 
Voice Activity and Participation Profile for Participants with Parkinson's Disease 
and Control Participants for Visits 1, 2, and 3 
 Df hypothesis Df error F value p value 
“Group” 7 43 14.56 <.001 
“Visit” 13 37 2.60 .011 
“Group”*”Visit” 13 37 2.75 .008 
Note. This table illustrates the main effects of “Group” and “Visit”, and the “Group” by 
“Visit” interaction found from multivariate analyses of the individual questions of the 
VAPP for participants with PD and control participants. 
 
The results of the repeated measures MANOVA for the dependent variables of the 
individual VAPP subsections showed that there was a significant multivariate effect of 
“Visit” F(13,37) = 2.60, p = .011. The results of this repeated measures MANOVA can 
be found in Table 33. A closer look at the factor “Visit”, using subsequent univariate 
analyses revealed the following results: 1) there was no significant univariate effect of 
“Visit” F(2,98) = 0.40, p = .674 for the VAPP self-perceived voice problem score; 2) 
there was no significant univariate effect of “Visit” F(2,98) = 1.35, p = .264 for the 
VAPP daily communication score; 3) there was a significant univariate effect of “Visit” 
F(2,98) = 3.51, p = .034 for the VAPP social communication score which indicated that 
the marginal mean of VAPP social communication score at visit 1 (M = 5.99, SD = 4.93) 
was greater (+0.62) than the marginal mean  of VAPP social communication score at visit 
2 (M = 5.37, SD = 4.64) and lower (-0.90) than the marginal mean of the VAPP social 
communication score at visit 3 (M = 6.89, SD = 6.28); 4) there was no significant 
univariate effect of “Visit” F(2,98) = 1.58, p = .210 for the VAPP emotion score; 5) there 
was no significant univariate effect of “Visit” F(2,98) = 0.72, p = .490 for the VAPP 
activity limitation score; 6) there was a significant univariate effect of “Visit” F(2,98) = 
3.19, p = .046 for the VAPP participation restriction score which indicated that the 
marginal mean of VAPP participation restriction score at visit 1 (M = 12.45, SD = 12.14) 
was greater (+0.04) than the marginal mean of VAPP participation restriction score at 
visit 2 (M = 12.41, SD = 10.43) and was lower (-2.59) than the marginal mean of the 
VAPP participation restriction score at visit 3 (M = 15.04, SD = 14.00); 7) there was no 
significant univariate effect of “Visit” F(2,98) = 1.46, p = .238 for the VAPP total score. 
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It is important to note that this multivariate effect of “Visit” needs to be qualified because 
of the finding of a significant “Group” by “Visit” interaction F(13,37) = 2.75, p = .008 
for the individual VAPP subsections. The results of this repeated measures MANOVA 
can be found in Table 33. Subsequent univariate analyses revealed the following results: 
1) There was no significant “Group” by “Visit” interaction F(2,98) = 0.74, p = .480 for 
the VAPP self-perceived voice problem score. This interaction is illustrated in Figure 17. 
2) There was no significant “Group” by “Visit” interaction F(2,98) = 1.37, p = .258 for 
the VAPP daily communication score. This interaction is illustrated in Figure 18. 3) 
There was no significant “Group” by “Visit” interaction F(2,98) = 2.18, p = .119 for the 
VAPP social communication score. This interaction is illustrated in Figure 19. 4) There 
was no significant “Group” by “Visit” interaction F(2,98) = 1.27, p = .286 for the VAPP 
emotion score. This interaction is illustrated in Figure 20. 5) There was no significant 
“Group” by “Visit” interaction F(2,98) = 0.78, p = .463 for the VAPP activity limitation 
score. This interaction is illustrated in Figure 21. 6) There was no significant “Group” by 
“Visit” interaction F(2,98) = 2.11, p = .127 for the VAPP participation restriction score. 
This interaction is illustrated in Figure 22. 7) There was no significant “Group” by 
“Visit” interaction F(2,98) = 1.17, p = .313 for the VAPP total score. This interaction is 
illustrated in Figure 23. The results from the univariate analysis for the individual VAPP 
subsection scores are provided in Table 34. 
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Figure 17: Means of Voice Activity and Participation Profile Self-Perceived Voice 
Problem Subsection Scores for Participants with Parkinson's Disease and Control 
Participants Across Visits 1, 2, and 3 
 
Figure 17. This figure demonstrates the changes in mean VAPP self-perceived voice 
problem subsection scores for participants with PD and control participants across visits. 
Error bars represent standard deviations. 
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Figure 18: Means of Voice Activity and Participation Profile Daily Communication 
Subsection Scores for Participants with Parkinson's Disease and Control 
Participants Across Visits 1, 2, and 3 
 
Figure 18. This figure demonstrates the changes in mean VAPP daily communication 
subsection scores for participants with PD and control participants across visits. Error 
bars represent standard deviations. 
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Figure 19: Means of Voice Activity and Participation Profile Social Communication 
Subsection Scores for Participants with Parkinson's Disease and Control 
Participants Across Visits 1, 2, and 3 
 
Figure 19. This figure demonstrates the changes in mean VAPP social communication 
subsection scores for participants with PD and control participants across visits. Error 
bars represent standard deviations. 
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Figure 20: Means of Voice Activity and Participation Profile Emotion Subsection 
Scores for Participants with Parkinson's Disease and Control Participants Across 
Visits 1, 2, and 3 
 
Figure 20. This figure demonstrates the changes in mean VAPP emotion subsection 
scores for participants with PD and control participants across visits. Error bars represent 
standard deviations. 
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Figure 21: Means of Voice Activity and Participation Profile Activity Limitation 
Subsection Scores for Participants with Parkinson's Disease and Control 
Participants Across Visits 1, 2, and 3 
 
Figure 21. This figure demonstrates the changes in mean VAPP activity limitation 
subsection scores for participants with PD and control participants across visits. Error 
bars represent standard deviations. 
  
Participants with PD 
Control participants 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
138 
Figure 22: Means of Voice Activity and Participation Profile Participation 
Restriction Subsection Scores for Participants with Parkinson's Disease and Control 
Participants Across Visits 1, 2, and 3 
 
Figure 22. This figure demonstrates the changes in mean VAPP participation restriction 
subsection scores for participants with PD and control participants across visits. Error 
bars represent standard deviations. 
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Figure 23: Means of Voice Activity and Participation Profile Total Subsection Scores 
for Participants with Parkinson's Disease and Control Participants Across Visits 1, 
2, and 3 
 
Figure 23. This figure demonstrates the changes in mean VAPP total subsection scores 
for participants with PD and control participants across visits. Error bars represent 
standard deviations. 
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Table 34: Univariate Testing Analysis of Self-Rated Individual Subsections of the 
Voice Activity and Participation Profile for Participants with Parkinson's Disease 
and Control Participants for Visits 1, 2, and 3 
 Df hypothesis Df error F value p value 
“Group” 
Voice problem 1 49 71.94 <.001 
Daily communication 1 49 66.31 <.001 
Social communication 1 49 51.45 <.001 
Emotion 1 49 46.53 <.001 
Activity limitation 1 49 70.39 <.001 
Participation restriction 1 49 44.57 <.001 
Total 1 49 56.84 <.001 
“Visit” 
Voice problem 2 98 0.40 .674 
Daily communication 2 98 1.35 .264 
Social communication 2 98 3.51 .034 
Emotion 2 98 1.58 .210 
Activity limitation 2 98 0.72 .490 
Participation restriction 2 98 3.19 .046 
Total 2 98 1.46 .238 
“Group”*“Visit” 
Voice problem 2 98 0.74 .480 
Daily communication 2 98 1.37 .258 
Social communication 2 98 2.18 .119 
Emotion 2 98 1.27 .286 
Activity limitation 2 98 0.78 .463 
Participation restriction 2 98 2.11 .127 
Total 2 98 1.17 .313 
Note. This table illustrates the significant and non-significant univariate effects of 
“Group”, significant and non-significant univariate effects of “Visit”, and “Group” by 
“Visit” interactions found from univariate analyses of the individual subsections of the 
VAPP for participants with PD and control participants. 
 
3.6.2.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of individual VAPP subsection scores. 
These analyses were performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 
2) SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-
3, and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 
1-2, 1-3, and 2-3. Separate retest analyses were performed on the participants with PD 
and control participants.  
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3.6.2.1.1 Retest analysis of VAPP self-perceived voice 
problem scores for participants with Parkinson’s 
disease 
 
Results for retest analyses of the VAPP self-perceived voice problem scores for 
participants with PD are summarized in Table 35. The ICC values related to the repeated 
measurement of VAPP self-perceived voice problem scores across the three pairwise 
visits was found to be the following:  visit 1 versus visit 2 ICC = .77, p = .001, visit 1 
versus visit 3 ICC = .59, p = .026, and visit 2 versus visit 3 ICC = .65, p = .013. These 
results suggest that VAPP self-perceived voice problem scores as measured in the present 
study did not demonstrate good retest reliability in IWPD because the ICC values across 
two of three comparisons were below our criterion of .75. 
Table 35: Retest Analyses of Voice Activity and Participation Profile Self-Perceived 
Voice Problem Subsection Scores for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .77[.44-.91] -0.05 2.01 -0.13 .900 2.27 1.09 3.02 87.96 
Visits 1 – 3 .59[-.00-.83] 0.34 2.73 0.58 .569 2.53 1.62 4.49 131.70 
Visits 2 – 3 .65[.13-.86] 0.22 2.40 0.43 .673 2.38 1.41 3.90 120.00 
Control participants 
Visits 1 – 2 .67[.31-.84] 0.03 0.28 0.53 .601 0.28 0.16 0.44 183.08 
Visits 1 – 3 .29[-.50-.66] -0.07 0.46 -0.84 .407 0.35 0.30 0.83 392.96 
Visits 2 – 3 .23[-.59-.63] -0.10 0.44 -1.21 .236 0.33 0.29 0.81 261.53 
Primary communication partners 
Visits 1 – 2 .80[.53-.91] -0.40 1.95 -1.00 .330 2.36 1.06 2.93 98.49 
Visits 1 – 3 .92[.80-.97] 0.26 1.25 0.97 .343 2.24 0.63 1.76 51.93 
Visits 2 – 3 .80[.53-.92] 0.59 1.88 1.47 .156 2.32 1.04 2.88 102.41 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of VAPP self-perceived voice problem subsection scores for participants 
with PD, their primary communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for VAPP self-perceived voice problem 
scores was -0.05 (SD = 2.01) and this difference was not significant t(21) = -0.13, p = 
.900. The mean differences in retest values ranged from -5.8 – 3.8. The mean difference 
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between visit 1 and visit 3 for VAPP self-perceived voice problem scores was 0.34 (SD = 
2.73) and this difference was not significant t(21) = 0.58, p = .569. The mean differences 
in retest values ranged from -7.0 – 4.5.  The mean difference between visit 2 and visit 3 
for VAPP self-perceived voice problem scores was 0.22 (SD = 2.40) and this difference 
was not significant t(20) = 0.43, p = .673. The mean differences in retest values ranged 
from -6.60 – 3.70. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 3.02 and CR% = 87.96%, for visit 1 vs visit 
3, CR = 4.49 and CR% = 131.70%, and for visit 2 vs visit 3, CR = 3.90 and CR% = 
120.00%. Based on the CR, an observed change in the VAPP self-perceived voice 
problem scores of at least 3.02 – 4.49 would suggest a large amount of measurement error 
ranging from 87.96 – 131.70% variation in the VAPP self-perceived voice problem scores 
of IWPD. These results suggest that the measure of VAPP self-perceived voice problem 
scores demonstrates unacceptable repeatability for IWPD. 
3.6.2.1.2 Retest analysis of VAPP self-perceived voice 
problem scores for control participants 
 
Results for retest analyses of the VAPP self-perceived voice problem scores for control 
participants are summarized in Table 35. The ICC values related to the repeated 
measurement of VAPP self-perceived voice problem scores across the three pairwise 
visits was found to be the following:  visit 1 versus visit 2 ICC = .67, p = .002, visit 1 
versus visit 3 ICC = .29, p = .182, and visit 2 versus visit 3 ICC = .23, p = .241. These 
results suggest that VAPP self-perceived voice problem scores as measured in the present 
study did not demonstrate good retest reliability in healthy speakers because all of the 
ICC values across all comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP self-perceived voice problem 
scores was 0.03 (SD = 0.28) and this difference was not significant t(29) = .53, p = .601. 
The mean differences in retest values ranged from -0.70 – 0.50. The mean difference 
between visit 1 and visit 3 for VAPP self-perceived voice problem scores was -0.07 (SD = 
0.46) and this difference was not significant t(29) = -0.84, p = .407. The mean differences 
in retest values ranged from -0.70 – 0.90. The mean difference between visit 2 and visit 3 
for VAPP self-perceived voice problem scores was -0.10 (SD = 0.44) and this difference 
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was not significant t(29) = -1.21, p = .236. The mean differences in retest values ranged 
from -1.90 – 1.10. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 0.44 and CR% = 183.08%, for visit 1 vs 
visit 3, CR = 0.83 and CR% = 392.96%, and for visit 2 vs visit 3, CR = 0.81 and CR% = 
261.53%. Based on the CR, an observed change in the VAPP self-perceived voice 
problem scores of at least 0.44 – 0.83 would suggest a large amount of measurement error 
ranging from 183.33 – 392.96% variation in the VAPP self-perceived voice problem 
scores of control participants. These results suggest that the measure of VAPP self-
perceived voice problem scores demonstrates unacceptable repeatability for control 
participants. 
3.6.2.1.3 Retest analysis of VAPP daily communication 
scores for participants with Parkinson’s disease 
 
Results for retest analyses of the VAPP daily communication scores for participants with 
PD are summarized in Table 36. The ICC values related to the repeated measurement of 
VAPP daily communication scores across the three pairwise visits was found to be the 
following:  visit 1 versus visit 2 ICC = .88, p < .001, visit 1 versus visit 3 ICC = .76, p = 
.001, and visit 2 versus visit 3 ICC = .81, p < .001. These results suggest that VAPP daily 
communication scores as measured in the present study demonstrated good retest 
reliability in IWPD because all of the ICC values across all comparisons were above our 
criterion of .75. 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
144 
Table 36: Retest Analyses of Voice Activity and Participation Profile Daily 
Communication Subsection Scores for Participants with Parkinson's Disease, 
Primary Communication Partners of Participants with Parkinson’s Disease, and 
Control Partners Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .88[.72-.95] -0.87 15.05 -0.28 .784 22.85 7.91 21.92 57.42 
Visits 1 – 3 .76[.44-.90] -7.05 24.29 -1.36 .188 27.77 13.61 37.69 96.51 
Visits 2 – 3 .81[.56-.92] -6.53 20.38 -1.50 .148 25.92 11.30 31.29 68.63 
Control participants 
Visits 1 – 2 .78[.54-.90] -0.02 4.14 -0.02 .983 4.85 2.27 6.30 123.92 
Visits 1 – 3 .79[.57-.90] 0.02 3.89 0.02 .981 4.65 2.13 5.91 115.80 
Visits 2 – 3 .84[.66-.92] 0.03 3.54 0.05 .959 4.70 1.88 5.21 102.90 
Primary communication partners 
Visits 1 – 2 .88[.72-.95] -5.71 17.84 -1.54 .139 27.82 9.64 26.70 79.39 
Visits 1 – 3 .90[.77-.96] -4.99 15.51 -1.51 .146 26.35 8.33 23.08 58.67 
Visits 2 – 3 .95[.87-.98] 0.36 12.76 0.13 .895 27.13 6.07 16.80 42.93 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of VAPP daily communication subsection scores for participants with 
PD, their primary communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for VAPP daily communication scores 
was -0.87 (SD = 15.05) and this difference was not significant t(22) = -0.28, p = .784. 
The mean differences in retest values ranged from -32.20 – 24.40. The mean difference 
between visit 1 and visit 3 for VAPP daily communication scores was -7.05 (SD = 24.29) 
and this difference was not significant t(21) = -1.36, p = .188. The mean differences in 
retest values ranged from -71.60 – 37.60. The mean difference between visit 2 and visit 3 
for VAPP daily communication scores was -6.53 (SD = 20.38) and this difference was not 
significant t(21) = -1.50, p = .148. The mean differences in retest values ranged from -
49.10 – 23.20. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 21.92 and CR% = 57.42%, for visit 1 vs 
visit 3, CR = 37.69 and CR% = 96.51%, and for visit 2 vs visit 3, CR = 31.29 and CR% = 
68.63%. Based on the CR, an observed change in the VAPP daily communication scores 
of at least 21.92 – 37.69 would suggest a large amount of measurement error ranging 
from 57.42 – 96.51% variation in the VAPP daily communication scores of IWPD. These 
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results suggest that the measure of VAPP daily communication scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.2.1.4 Retest analysis of VAPP daily communication 
scores for control participants 
 
Results for retest analyses of the VAPP daily communication scores for control 
participants are summarized in Table 36. The ICC values related to the repeated 
measurement of VAPP daily communication scores across the three pairwise visits was 
found to be the following:  visit 1 versus visit 2 ICC = .78, p < .001, visit 1 versus visit 3 
ICC = .79, p < .001, and visit 2 versus visit 3 ICC = .84, p < .001. These results suggest 
that VAPP daily communication scores as measured in the present study demonstrated 
good retest reliability in healthy speakers because all of the ICC values across all 
comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP daily communication scores 
was -0.02 (SD = 4.14) and this difference was not significant t(29) = -0.02, p = .983. The 
mean differences in retest values ranged from -12.20 – 9.60. The mean difference 
between visit 1 and visit 3 for VAPP daily communication scores was 0.02 (SD = 3.89) 
and this difference was not significant t(29) = 0.02, p = .981. The mean differences in 
retest values ranged from -7.80 – 9.10. The mean difference between visit 2 and visit 3 
for VAPP daily communication scores was 0.03 (SD = 3.54) and this difference was not 
significant t(29) = 0.05, p = .959. The mean differences in retest values ranged from -6.3 
– 8.1. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2, CR = 6.30 and CR% = 123.92%, for visit 1 vs visit 3, 
CR = 5.91 and CR% = 115.80%, and for visit 2 vs visit 3, CR = 5.21 and CR% = 
102.90%. Based on the CR, an observed change in the VAPP daily communication scores 
of at least 5.21 – 6.30 would suggest a large amount of measurement error ranging from 
102.90 – 123.92% variation in the VAPP daily communication scores of control 
participants. These results suggest that the measure of VAPP daily communication scores 
demonstrates unacceptable repeatability for control participants. 
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3.6.2.1.5 Retest analysis of VAPP social communication 
scores for participants with Parkinson’s disease 
 
Results for retest analyses of the VAPP social communication scores for participants with 
PD are summarized in Table 37. The ICC values related to the repeated measurement of 
VAPP social communication scores across the three pairwise visits was found to be the 
following:  visit 1 versus visit 2 ICC = .84, p < .001, visit 1 versus visit 3 ICC = .82, p < 
.001, and visit 2 versus visit 3 ICC = .74, p = .001. These results suggest that VAPP 
social communication scores as measured in the present study demonstrated good retest 
reliability in IWPD because the ICC values across all comparisons were above or 
approached our criterion of .75. 
Table 37: Retest Analyses of Voice Activity and Participation Profile Social 
Communication Subsection Scores for Participants with Parkinson's Disease, 
Primary Communication Partners of Participants with Parkinson’s Disease, and 
Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .84[.62-.93] 1.41 5.17 1.31 .203 6.97 2.79 7.72 72.52 
Visits 1 – 3 .82[.58-.93] -2.06 6.51 -1.48 .153 8.44 3.58 9.91 107.41 
Visits 2 – 3 .74[.38-.89] -3.34 7.21 -2.17 .041 8.35 4.26 11.80 91.81 
Control participants 
Visits 1 – 2 .57[.09-.80] 0.09 1.31 0.39 .699 1.19 0.78 2.16 171.70 
Visits 1 – 3 .60[.15-.81] -0.23 1.53 -0.81 .424 1.43 0.90 2.50 215.37 
Visits 2 – 3 .78[.53-.89] -0.32 1.05 -1.67 .107 1.26 0.59 1.63 110.19 
Primary communication partners 
Visits 1 – 2 .90[.75-.96] -1.81 4.19 -2.07 .050 7.34 2.32 6.43 82.12 
Visits 1 – 3 .92[.79-.97] -1.71 3.69 -2.18 .041 7.17 2.03 5.62 58.28 
Visits 2 – 3 .89[.74-.96] 0.014 4.81 0.01 .990 7.46 2.47 6.85 70.99 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of VAPP social communication subsection scores for participants with 
PD, their primary communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for VAPP social communication scores 
was 1.41 (SD = 5.17) and this difference was not significant t(22) = 1.31, p = .203. The 
mean differences in retest values ranged from -4.70 – 14.10. The mean difference 
between visit 1 and visit 3 for VAPP social communication scores was -2.06 (SD = 6.51) 
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and this difference was not significant t(21) = -1.48, p = .153. The mean differences in 
retest values ranged from -14.30 – 12.30. The mean difference between visit 2 and visit 3 
for VAPP social communication scores was -3.34 (SD = 7.21) and this difference was 
significant t(21) = -2.17, p = .041. Additionally, the following CR values were obtained 
for the following visit comparisons: for visit 1 vs visit 2, CR = 7.72 and CR% = 72.52%, 
for visit 1 vs visit 3, CR = 9.91 and CR% = 107.41%, and for visit 2 vs visit 3, CR = 
11.80 and CR% = 91.81%. Based on the CR, an observed change in the VAPP social 
communication scores of at least 7.72 – 11.80 would suggest a large amount of 
measurement error ranging from 72.52 – 107.41% variation in the VAPP social 
communication scores of IWPD. These results suggest that the measure of VAPP social 
communication scores demonstrates unacceptable repeatability for IWPD. 
3.6.2.1.6 Retest analysis of VAPP social communication 
scores for control participants 
 
Results for retest analyses of the VAPP social communication scores for control 
participants are summarized in Table 37. The ICC values related to the repeated 
measurement of VAPP social communication scores across the three pairwise visits was 
found to be the following:  visit 1 versus visit 2 ICC = .57, p = .015, visit 1 versus visit 3 
ICC = .60, p = .009, and visit 2 versus visit 3 ICC = .78, p < .001. These results suggest 
that VAPP social communication scores as measured in the present study did not 
demonstrate good retest reliability in healthy speakers because the ICC values across two 
of three comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP social communication scores 
was 0.09 (SD = 1.31) and this difference was not significant t(29) = 0.39, p = .699. The 
mean differences in retest values ranged from -2.10 – 4.60. The mean difference between 
visit 1 and visit 3 for VAPP social communication scores was -0.223 (SD = 1.53) and this 
difference was not significant t(29) = -0.81, p = .424. The mean differences in retest 
values ranged from -3.20 – 4.70. The mean difference between visit 2 and visit 3 for 
VAPP social communication scores was -0.32 (SD = 1.05) and this difference was not 
significant t(29) = -1.67, p = .107. The mean differences in retest values ranged from -3.5 
– 1.3. Additionally, the following CR values were obtained for the following visit 
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comparisons: for visit 1 vs visit 2, CR = 2.16 and CR% = 171.70%, for visit 1 vs visit 3, 
CR = 2.50 and CR% = 215.37%, and for visit 2 vs visit 3, CR = 1.63 and CR% = 
110.19%. Based on the CR, an observed change in the VAPP social communication 
scores of at least 1.63 – 2.50 would suggest a large amount of measurement error ranging 
from 110.19 – 215.37% variation in the VAPP social communication scores of control 
participants. These results suggest that the measure of VAPP social communication 
scores demonstrates unacceptable repeatability for control participants. 
3.6.2.1.7 Retest analysis of VAPP emotion scores for 
participants with Parkinson’s disease 
 
Results for retest analyses of the VAPP emotion scores for participants with PD are 
summarized in Table 38. The ICC values related to the repeated measurement of VAPP 
emotion scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .81, p < .001, visit 1 versus visit 3 ICC = .75, p = .002, and visit 2 
versus visit 3 ICC = .81, p < .001. These results suggest that VAPP emotion scores as 
measured in the present study demonstrated good retest reliability in IWPD because all of 
the ICC values across all comparisons were above our criterion of .75. 
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Table 38: Retest Analyses of Voice Activity and Participation Profile Emotion 
Subsection Scores for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .81[.56-.92] 2.59 11.71 1.06 .301 14.67 6.39 17.71 87.02 
Visits 1 – 3 .75[.38-.89] -1.70 15.37 -0.52 .609 16.75 8.37 23.19 130.53 
Visits 2 – 3 .81[.55-.92] -4.44 12.55 -1.66 .112 15.96 6.96 19.27 86.06 
Control participants 
Visits 1 – 2 .64[.23-.83] 0.22 2.32 0.52 .607 2.24 1.34 3.72 155.50 
Visits 1 – 3 .77[.52-.89] 0.02 2.12 0.06 .952 2.44 1.17 3.24 149.12 
Visits 2 – 3 .76[.48-.88] -0.20 1.82 -0.59 .559 2.04 1.00 2.77 117.47 
Primary communication partners 
Visits 1 – 2 .75[.43-.90] -3.50 12.08 -1.39 .179 13.75 6.88 19.05 122.82 
Visits 1 – 3 .93[.84-.97] -1.73 6.55 -1.24 .230 13.00 3.44 9.53 50.12 
Visits 2 – 3 .84[.62-.93] 1.68 10.65 0.74 .468 14.11 5.65 15.64 89.00 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of VAPP emotion subsection scores for participants with PD, their 
primary communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for VAPP emotion scores was 2.59 (SD = 
11.71) and this difference was not significant t(22) = 1.06, p = .301. The mean 
differences in retest values ranged from -16.40 – 24.30. The mean difference between 
visit 1 and visit 3 for VAPP emotion scores was -1.70 (SD = 15.37) and this difference 
was not significant t(21) = -0.52, p = .609. The mean differences in retest values ranged 
from -53.50 – 25.20. The mean difference between visit 2 and visit 3 for VAPP emotion 
scores was -4.44 (SD = 12.55) and this difference was not significant t(21) = -1.66, p = 
.112. The mean differences in retest values ranged from -42.80 – 12.40. Additionally, the 
following CR values were obtained for the following visit comparisons: for visit 1 vs visit 
2, CR = 17.71 and CR% = 87.02%, for visit 1 vs visit 3, CR = 23.19 and CR% = 
130.53%, and for visit 2 vs visit 3, CR = 19.27 and CR% = 86.06%. Based on the CR, an 
observed change in the VAPP emotion scores of at least 17.71 – 23.19 would suggest a 
large amount of measurement error ranging from 86.06 – 130.53% variation in the VAPP 
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emotion scores of IWPD. These results suggest that the measure of VAPP emotion scores 
demonstrates unacceptable repeatability for IWPD. 
3.6.2.1.8 Retest analysis of VAPP emotion scores for 
control participants 
 
Results for retest analyses of the VAPP emotion scores for control participants are 
summarized in Table 38. The ICC values related to the repeated measurement of VAPP 
emotion scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .64, p = .004, visit 1 versus visit 3 ICC = .77, p < .001, and visit 2 
versus visit 3 ICC = .76, p < .001. These results suggest that VAPP emotion scores as 
measured in the present study demonstrated good retest reliability in healthy speakers 
because the ICC values across two of three comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP emotion scores was 0.22 (SD = 
2.32) and this difference was not significant t(29) = 0.52, p = .607. The mean differences 
in retest values ranged from -3.10 – 8.20. The mean difference between visit 1 and visit 3 
for VAPP emotion scores was 0.02 (SD = 2.12) and this difference was not significant 
t(29) = 0.06, p = .952. The mean differences in retest values ranged from -4.60 – 4.40. 
The mean difference between visit 2 and visit 3 for VAPP emotion scores was -0.20 (SD 
= 1.82) and this difference was not significant t(29) = -0.59, p = .559. The mean 
differences in retest values ranged from -4.30 – 5.10. Additionally, the following CR 
values were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 3.72 
and CR% = 155.50%, for visit 1 vs visit 3, CR = 3.24 and CR% = 149.12%, and for visit 
2 vs visit 3, CR = 2.77 and CR% = 117.47%. Based on the CR, an observed change in the 
VAPP emotion scores of at least 2.77 – 3.72 would suggest a large amount of 
measurement error ranging from 117.47 – 155.50% variation in the VAPP emotion scores 
of control participants. These results suggest that the measure of VAPP emotion scores 
demonstrates unacceptable repeatability for control participants. 
3.6.2.1.9 Retest analysis of VAPP activity limitation scores 
for participants with Parkinson’s disease 
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Results for retest analyses of the VAPP activity limitation scores for participants with PD 
are summarized in Table 39. The ICC values related to the repeated measurement of 
VAPP activity limitation scores across the three pairwise visits was found to be the 
following: visit 1 versus visit 2 ICC = .89, p < .001, visit 1 versus visit 3 ICC = .78, p = 
.001, and visit 2 versus visit 3 ICC = .80, p < .001. These results suggest that VAPP 
activity limitation scores as measured in the present study demonstrated good retest 
reliability in IWPD because all of the ICC values across all comparisons were above our 
criterion of .75. 
Table 39: Retest Analyses of Voice Activity and Participation Profile Activity 
Limitation Subsection Scores for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .89[.74-.95] 0.58 10.42 0.27 .791 16.25 5.39 14.93 51.45 
Visits 1 – 3 .78[.46-.91] -3.37 16.79 -0.94 .357 19.36 9.08 25.15 88.47 
Visits 2 – 3 .80[.54-.92] -3.90 14.87 -1.23 .232 18.37 8.21 22.75 70.05 
Control participants 
Visits 1 – 2 .77[.52-.89] 0.24 3.19 0.41 .687 3.65 1.75 4.85 124.32 
Visits 1 – 3 .83[.65-.92] 0.22 2.77 0.43 .672 3.62 1.49 4.14 113.01 
Visits 2 – 3 .80[.57-.90] -0.02 2.84 -0.04 .969 3.43 1.53 4.25 115.47 
Primary communication partners 
Visits 1 – 2 .93[.83-.97] -3.54 9.77 -1.74 .096 19.70 5.21 14.44 59.31 
Visits 1 – 3 .94[.83-.98] -4.33 9.03 -2.25 .036 19.91 4.88 13.51 48.43 
Visits 2 – 3 .97[.92-.97] -1.00 7.43 -0.63 .537 20.27 3.51 9.72 33.41 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of VAPP activity limitation subsection scores for participants with PD, 
their primary communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for VAPP activity limitation scores was 
0.58 (SD = 10.42) and this difference was not significant t(22) = 0.27, p = .791. The mean 
differences in retest values ranged from -20.30 – 23.20. The mean difference between 
visit 1 and visit 3 for VAPP activity limitation scores was -3.37 (SD = 16.79) and this 
difference was not significant t(21) = -0.94, p = .357. The mean differences in retest 
values ranged from -45.10 – 28.60. The mean difference between visit 2 and visit 3 for 
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VAPP activity limitation scores was -3.90 (SD = 14.87) and this difference was not 
significant t(21) = -1.23, p = .232. The mean differences in retest values ranged from -
36.20 – 23.20. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 14.93 and CR% = 51.45%, for visit 1 vs 
visit 3, CR = 25.15 and CR% = 88.47%, and for visit 2 vs visit 3, CR = 22.75 and CR% = 
70.05%. Based on the CR, an observed change in the VAPP activity limitation scores of 
at least 14.93 – 25.15 would suggest a large amount of measurement error ranging from 
51.45 – 88.47% variation in the VAPP activity limitation scores of IWPD. These results 
suggest that the measure of VAPP activity limitation scores demonstrates unacceptable 
repeatability for IWPD. 
3.6.2.1.10 Retest analysis of VAPP activity limitation scores 
for control participants 
 
Results for retest analyses of the VAPP activity limitation scores for control participants 
are summarized in Table 39. The ICC values related to the repeated measurement of 
VAPP activity limitation scores across the three pairwise visits was found to be the 
following:  visit 1 versus visit 2 ICC = .77, p < .001, visit 1 versus visit 3 ICC = .83, p < 
.001, and visit 2 versus visit 3 ICC = .80, p < .001. These results suggest that VAPP 
activity limitation scores as measured in the present study demonstrated good retest 
reliability in healthy speakers because all of the ICC values across all comparisons were 
above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP activity limitation scores was 
0.24 (SD = 3.19) and this difference was not significant t(29) = 0.41, p = .687. The mean 
differences in retest values ranged from -7.20 – 6.80. The mean difference between visit 1 
and visit 3 for VAPP activity limitation scores was 0.22 (SD = 2.77) and this difference 
was not significant t(29) = 0.43, p = .672. The mean differences in retest values ranged 
from -5.10 – 6.80. The mean difference between visit 2 and visit 3 for VAPP activity 
limitation scores was -0.02 (SD = 2.84) and this difference was not significant t(29) = -
0.04, p = .969. The mean differences in retest values ranged from -6.60 – 4.20. 
Additionally, the following CR values were obtained for the following visit comparisons: 
for visit 1 vs visit 2, CR = 4.85 and CR% = 124.32%, for visit 1 vs visit 3, CR = 4.14 and 
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CR% = 113.01%, and for visit 2 vs visit 3, CR = 4.25 and CR% = 115.47%. Based on the 
CR, an observed change in the VAPP activity limitation scores of at least 4.14 – 4.85 
would suggest a large amount of measurement error ranging from 113.01 – 124.32% 
variation in the VAPP activity limitation scores of control participants. These results 
suggest that the measure of VAPP activity limitation scores demonstrates unacceptable 
repeatability for control participants. 
3.6.2.1.11 Retest analysis of VAPP participation restriction 
scores for participants with Parkinson’s disease 
 
Results for retest analyses of the VAPP participation restriction scores for participants 
with PD are summarized in Table 40. The ICC values related to the repeated 
measurement of VAPP participation restriction scores across the three pairwise visits 
was found to be the following:  visit 1 versus visit 2 ICC = .90, p < .001, visit 1 versus 
visit 3 ICC = .83, p < .001, and visit 2 versus visit 3 ICC = .82, p < .001. These results 
suggest that VAPP participation restriction scores as measured in the present study 
demonstrated good retest reliability in IWPD because all of the ICC values across all 
comparisons were above our criterion of .75. 
Table 40: Retest Analyses of Voice Activity and Participation Profile Participation 
Restriction Subsection Scores for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .90[.76-.96] 0.22 10.07 0.11 .917 16.44 5.20 14.40 64.85 
Visits 1 – 3 .83[.59-.93] -5.60 14.72 -1.79 .089 19.85 8.19 22.67 103.21 
Visits 2 – 3 .82[.56-.93] -6.10 14.12 -2.03 .056 18.71 7.94 21.98 77.65 
Control participants 
Visits 1 – 2 .64[.24-.83] -0.35 2.80 -0.68 .503 2.70 1.62 4.49 183.17 
Visits 1 – 3 .53[.02-.77] -0.69 3.20 -1.18 .249 2.82 1.94 5.36 191.53 
Visits 2 – 3 .87[.73-.94] -0.34 1.91 -0.98 .337 2.85 1.03 2.85 90.73 
Primary communication partners 
Visits 1 – 2 .88[.72-.95] -3.97 11.67 -1.63 .117 18.39 6.37 17.65 93.57 
Visits 1 – 3 .84[.61-.93] -2.14 12.44 -0.81 .430 16.36 6.54 18.12 79.38 
Visits 2 – 3 .85[.65-.94] 1.60 12.64 0.59 .559 17.20 6.66 18.46 86.82 
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Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of VAPP participation restriction subsection scores for participants with 
PD, their primary communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for VAPP participation restriction scores 
was 0.22 (SD = 10.07) and this difference was not significant t(22) = 0.11, p = .917. The 
mean differences in retest values ranged from -16.60 – 23.30. The mean difference 
between visit 1 and visit 3 for VAPP participation restriction scores was -5.60 (SD = 
14.72) and this difference was not significant t(21) = -1.79, p = .089. The mean 
differences in retest values ranged from -40.80 – 22.80. The mean difference between 
visit 2 and visit 3 for VAPP participation restriction scores was -6.10 (SD = 14.12) and 
this difference approached significance t(21) = -2.03, p = .056. The mean differences in 
retest values ranged from -37.20 – 19.40. Additionally, the following CR values were 
obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 14.40 and CR% 
= 64.85%, for visit 1 vs visit 3, CR = 22.67 and CR% = 103.21%, and for visit 2 vs visit 
3, CR = 21.98 and CR% = 77.65%. Based on the CR, an observed change in the VAPP 
participation restriction scores of at least 14.40 – 22.67 would suggest a large amount of 
measurement error ranging from 64.85 – 103.21% variation in the VAPP participation 
restriction scores of IWPD. These results suggest that the measure of VAPP participation 
restriction scores demonstrates unacceptable repeatability for IWPD. 
3.6.2.1.12 Retest analysis of VAPP participation restriction 
scores for control participants 
 
Results for retest analyses of the VAPP participation restriction scores for control 
participants are summarized in Table 40. The ICC values related to the repeated 
measurement of VAPP participation restriction scores across the three pairwise visits 
was found to be the following:  visit 1 versus visit 2 ICC = .64, p = .004, visit 1 versus 
visit 3 ICC = .53, p = .023, and visit 2 versus visit 3 ICC = .87, p < .001. These results 
suggest that VAPP participation restriction scores as measured in the present study did 
not demonstrate good retest reliability in healthy speakers because the ICC values across 
two of three comparisons were below our criterion of .75. 
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The mean difference between visit 1 and visit 2 for VAPP participation restriction scores 
was -0.35 (SD = 2.80) and this difference was not significant t(29) = -0.68, p = .503. The 
mean differences in retest values ranged from -9.20 – 7.60. The mean difference between 
visit 1 and visit 3 for VAPP participation restriction scores was -0.69 (SD = 3.20) and 
this difference was not significant t(29) = -1.18, p = .249. The mean differences in retest 
values ranged from -7.70 – 9.60. The mean difference between visit 2 and visit 3 for 
VAPP participation restriction scores was -0.34 (SD = 1.91) and this difference was not 
significant t(29) = -0.98, p = .337. The mean differences in retest values ranged from -
4.60 – 3.10. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2, CR = 4.49 and CR% = 183.17%, for visit 1 vs visit 3, 
CR = 5.36 and CR% = 191.53%, and for visit 2 vs visit 3, CR =2.85 and CR% = 90.73%. 
Based on the CR, an observed change in the VAPP participation restriction scores of at 
least 2.85 – 5.36 would suggest a large amount of measurement error ranging from 90.73 
– 191.53% variation in the VAPP participation restriction scores of control participants. 
These results suggest that the measure of VAPP participation restriction scores 
demonstrates unacceptable repeatability for control participants. 
3.6.2.1.13 Retest analysis of VAPP total scores for 
participants with Parkinson’s disease 
 
Results for retest analyses of the VAPP total scores for participants with PD are 
summarized in Table 41. The ICC values related to the repeated measurement of VAPP 
total scores across the three pairwise visits was found to be the following: visit 1 versus 
visit 2 ICC = .88, p < .001, visit 1 versus visit 3 ICC = .80, p < .001, and visit 2 versus 
visit 3 ICC = .82, p < .001. These results suggest that VAPP total scores as measured in 
the present study demonstrated good retest reliability in IWPD because all of the ICC 
values across all comparisons were above our criterion of .75. 
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Table 41: Retest Analyses of Voice Activity and Participation Profile Total 
Subsection Scores for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .88[.73-.95] 3.56 31.14 0.55 .589 47.55 16.47 45.63 60.85 
Visits 1 – 3 .80[.53-.92] -10.33 46.54 -1.04 .310 56.73 25.37 70.27 98.38 
Visits 2 – 3 .82[.58-.93] -14.55 40.45 -1.69 .106 53.18 22.56 62.50 72.31 
Control participants 
Visits 1 – 2 .74[.45-.88] 0.37 7.54 0.27 .788 8.22 4.19 11.61 126.05 
Visits 1 – 3 .76[.50-.89] -0.28 7.58 -0.20 .841 8.58 4.20 11.65 131.74 
Visits 2 – 3 .84[.66-.92] -0.65 6.02 -0.59 .557 8.03 3.21 8.90 93.74 
Primary communication partners 
Visits 1 – 2 .88[.71-.95] -11.41 32.55 -1.68 .107 50.65 17.55 48.61 78.79 
Visits 1 – 3 .94[.85-.98] -7.93 22.36 -1.66 .111 47.65 11.67 32.33 44.23 
Visits 2 – 3 .92[.81-.97] 2.87 27.87 0.48 .634 50.58 14.31 39.63 56.01 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of VAPP total subsection scores for participants with PD, their primary 
communication partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for VAPP total scores was 3.56 (SD = 
31.14) and this difference was not significant t(22) = 0.55, p = .589. The mean 
differences in retest values ranged from -54.50 – 68.50. The mean difference between 
visit 1 and visit 3 for VAPP total scores was -10.33 (SD = 46.54) and this difference was 
not significant t(21) = -1.04, p = .310. The mean differences in retest values ranged from 
-144.90 – 73.00. The mean difference between visit 2 and visit 3 for VAPP total scores 
was -14.55 (SD = 40.45) and this difference was not significant t(21) = -1.69, p = .106. 
The mean differences in retest values ranged from -114.80 – 35.00. Additionally, the 
following CR values were obtained for the following visit comparisons: for visit 1 vs visit 
2, CR = 45.63 and CR% = 60.85%, for visit 1 vs visit 3, CR = 70.27 and CR% = 98.38%, 
and for visit 2 vs visit 3, CR = 62.50 and CR% = 72.31%. Based on the CR, an observed 
change in the VAPP total scores of at least 45.63 – 70.27 would suggest a large amount 
of measurement error ranging from 60.85 – 98.38% variation in the VAPP total scores of 
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IWPD. These results suggest that the measure of VAPP total scores demonstrates 
unacceptable repeatability for IWPD. 
3.6.2.1.14 Retest analysis of VAPP total scores for control 
participants 
 
Results for retest analyses of the VAPP total scores for control participants are 
summarized in Table 41. The ICC values related to the repeated measurement of VAPP 
total scores across the three pairwise visits was found to be the following: visit 1 versus 
visit 2 ICC = .74, p < .001, visit 1 versus visit 3 ICC = .76, p < .001, and visit 2 versus 
visit 3 ICC = .84, p < .001. These results suggest that VAPP total scores as measured in 
the present study demonstrated good retest reliability in healthy speakers because the ICC 
values across all comparisons either were above or approached our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP total scores was 0.37 (SD = 
7.54) and this difference was not significant t(29) = 0.27, p = .788. The mean differences 
in retest values ranged from -17.80 – 17.80. The mean difference between visit 1 and visit 
3 for VAPP total scores was -0.28 (SD = 7.58) and this difference was not significant 
t(29) = -0.20, p = .841. The mean differences in retest values ranged from -15.30 – 21.60. 
The mean difference between visit 2 and visit 3 for VAPP total scores was -0.65 (SD = 
6.02) and this difference was not significant t(29) = -0.59, p = .557. The mean differences 
in retest values ranged from -12.60 – 14.90. Additionally, the following CR values were 
obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 11.61 and CR% 
= 126.05%, for visit 1 vs visit 3, CR = 11.65 and CR% = 131.74%, and for visit 2 vs visit 
3, CR = 8.90 and CR% = 93.74%. Based on the CR, an observed change in the VAPP 
total scores of at least 8.90 – 11.65 would suggest a large amount of measurement error 
ranging from 93.74 – 131.74% variation in the VAPP total scores of control participants. 
These results suggest that the measure of VAPP total scores demonstrates unacceptable 
repeatability for control participants. 
3.6.3 CPIB scores 
 
CPIB scores were obtained by converting the raw total score to a standardized score 
using the conversion table indicated by Baylor and colleagues (2013). Descriptive 
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statistics for CPIB standardized scores can be found in Table 42. The results of the two-
way repeated measures ANOVA for the dependent variable of the CPIB standardized 
scores showed that there was a significant main effect of “Group” F(1, 50) = 130.74, p < 
.001 with participants with PD having a lower (-17.06) marginal mean (M = 52.01, SD = 
5.30) compared to control participants (M = 69.07, SD = 5.31). In contrast, there was no 
significant main effect of “Visit” on the CPIB score F(2,100) = 2.44, p = .092. It is 
important to note that this main effect of “Visit” needs to be qualified because of the 
finding of a significant “Group” by “Visit” interaction F(2,49) = 8.20, p = .001 for the 
CPIB score. This significant interaction is illustrated in Figure 24. A closer look at the 
factor “Visit”, using pairwise post-hoc analyses indicated that the marginal mean of the 
CPIB score at visit 1 (M = 61.02, SD = 6.56) was similar to the marginal mean of the 
CPIB score at visit 2 (M = 60.79, SD = 5.34) and visit 3 (M = 59.82, SD = 5.70). Results 
of post-hoc analyses involving comparisons of these group differences at each visit 
provided additional information about this significant “Group” by “Visit” interaction. For 
the post-hoc comparison related to visit 1, the participants with PD had a mean CPIB 
score (M = 53.44, SD = 6.49) that was significantly lower (-15.15) than the mean CPIB 
score of control participants (M = 68.59, SD = 6.50), t(2,51) = -8.36, p < .001. For the 
post-hoc comparison related to visit 2, the participants with PD had a mean CPIB score 
(M = 52.61, SD = 5.27) that was significantly lower (-16.35) than the mean CPIB score of 
control participants (M = 68.96, SD = 5.27), t(2,51) = -10.69, p < .001. For the post-hoc 
comparison related to visit 3, the participants with PD had a mean CPIB score (M = 
49.96, SD = 5.64) that was significantly lower (-19.71) than the mean CPIB score of 
control participants (M = 69.67, SD = 5.64), t(2,50) = 12.46, p < .001. Thus, it appears 
that the CPIB score of participants with PD decreased from visit 1 to visit 3, whereas the 
CPIB scores of control participants increased from visit 1 to visit 3. 
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Table 42: Descriptive Statistics of Self- and Proxy-Rated Communicative 
Participation Item Bank for Participants with Parkinson's Disease, Primary 
Communication Partners of Participants with Parkinson’s Disease, and Control 
Participants Across Visits 1, 2, and 3 
 CPIB Standardized Score 
mean(SD) 
Participants with PD 
Visit 1 53.63(8.41) 
Visit 2 53.03(6.81) 
Visit 3 49.96(7.80) 
Control participants 
Visit 1 68.59(4.44) 
Visit 2 68.96(3.97) 
Visit 3 69.67(3.27) 
Primary communication partners 
Visit 1 56.27(8.94) 
Visit 2 54.83(8.58) 
Visit 3 52.84(10.77) 
Marginal means 
Participants with PD 52.01(5.30) 
Control participants 69.07(5.31) 
Primary communication partners 54.58(7.83) 
PD and control visit 1 61.02(6.56) 
PD and control visit 2 60.79(5.34) 
PD and control visit 3 59.82(5.70) 
PD and communication partners visit 1 54.85(8.89) 
PD and communication partners visit 2 53.62(7.76) 
PD and communication partners visit 3 51.40(9.42) 
Note. This table illustrates the means and standard deviations for the standardized scores 
of the CPIB for participants with PD, their primary communication partners, and control 
participants across visits. 
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Figure 24: Means of Communicative Participation Item Bank Scores for 
Participants with Parkinson's Disease and Control Participants Across Visits 1, 2, 
and 3 
 
Figure 24. This figure demonstrates the changes in mean CPIB scores for participants 
with PD and control participants across visits. Error bars represent standard deviations. 
3.6.3.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of CPIB scores. These analyses were 
performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) SEM across visits 
1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) 
pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 
2-3. Separate retest analyses were performed on the participants with PD and control 
participants.  
3.6.3.1.1 Retest analysis of CPIB scores for participants 
with Parkinson’s disease 
 
Results for retest analyses of CPIB scores for participants with PD are summarized in 
Table 43.The ICC values related to the repeated measurement of CPIB scores across the 
Participants with PD 
Control participants 
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three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = .87, p < 
.001, visit 1 versus visit 3 ICC = .84, p < .001, and visit 2 versus visit 3 ICC = .84, p < 
.001. These results suggest that CPIB scores as measured in the present study 
demonstrated good retest reliability in IWPD because all of the ICC values across all 
comparisons were above our criterion of .75. 
Table 43: Retest Analyses of Communicative Participation Item Bank Scores for 
Participants with Parkinson's Disease, Primary Communication Partners of 
Participants with Parkinson’s Disease, and Control Participants Across Visits 1, 2, 
and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .87[.68-.94] 0.60 5.34 0.54 .596 7.65 2.64 7.64 14.25 
Visits 1 – 3 .84[.52-.94] 3.48 5.43 3.00 .007 8.11 3.24 8.99 16.95 
Visits 2 – 3 .84[.41-.88] 2.65 4.96 2.50 .021 7.32 2.93 8.11 16.24 
Control participants 
Visits 1 – 2 .87[.73-.94] -0.36 2.87 -0.69 .493 4.21 1.52 4.21 6.13 
Visits 1 – 3 .84[.65-.92] -1.08 2.81 -2.10 .045 3.90 1.56 4.32 6.26 
Visits 2 – 3 .73[.45-.87] -0.71 3.33 -1.17 .250 3.64 1.89 5.23 7.51 
Primary communication partners 
Visits 1 – 2 .78[.49-.91] 1.44 7.47 0.93 .364 8.76 4.11 11.38 20.23 
Visits 1 – 3 .76[.43-.90] 3.42 8.48 1.89 .072 9.90 4.85 13.43 24.50 
Visits 2 – 3 .87[.70-.95] 1.79 6.54 1.29 .213 9.74 3.51 9.72 18.40 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of CPIB scores for participants with PD, their primary communication 
partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for CPIB standardized scores was 0.60 
(SD = 5.34) and this difference was not significant t(22) = 0.54, p = .596. The mean 
differences in retest values ranged from -7.50 – 14.50. The mean difference between visit 
1 and visit 3 for CPIB scores was 3.48 (SD = 5.43) and this difference was significant 
t(21) = 3.00, p = .007. The mean difference between visit 2 and visit 3 for CPIB scores 
was 2.65 (SD = 4.96) and this difference was significant t(21) = 2.50, p = .021. 
Additionally, the following CR values were obtained for the following visit comparisons: 
for visit 1 vs visit 2, CR = 7.64 and CR% = 14.25%, for visit 1 vs visit 3, CR = 8.99 and 
CR% = 16.95%, and for visit 2 vs visit 3, CR = 8.11 and CR% = 16.24%. Based on the 
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CR, an observed change in the CPIB scores of at least 7.64 – 8.99 would suggest the 
possibility of an acceptable amount of measurement error ranging from 14.25 – 16.95% 
variation in the CPIB scores of IWPD. These results suggest that the measure of CPIB 
scores demonstrates marginal repeatability for IWPD. 
3.6.3.1.2 Retest analysis of CPIB scores for control 
participants 
 
Results for retest analyses of CPIB scores for control participants are summarized in 
Table 43. The ICC values related to the repeated measurement of CPIB scores across the 
three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = .87, p < 
.001, visit 1 versus visit 3 ICC = .84, p < .001, and visit 2 versus visit 3 ICC = .73, p < 
.001. These results suggest that CPIB scores as measured in the present study 
demonstrated good retest reliability in control participants because the ICC values across 
all comparisons either were above or approached our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CPIB scores was -0.36 (SD = 2.87) 
and this difference was not significant t(29) = -0.69, p = .493. The mean differences in 
retest values ranged from -8.80 – 6.80. The mean difference between visit 1 and visit 3 
for CPIB was -1.08 (SD = 2.81) and this difference was significant t(29) = -2.10, p = 
.045. The mean difference between visit 2 and visit 3 for CPIB scores was -0.71 (SD = 
3.33) and this difference was not significant t(29) = -1.17, p = .250. The mean differences 
in retest values ranged from -8.80 – 8.80. Additionally, the following CR values were 
obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 4.21 and CR% = 
6.13%, for visit 1 vs visit 3, CR = 4.32 and CR% = 6.26%, and for visit 2 vs visit 3, CR = 
5.23 and CR% = 7.51%. Based on the CR, an observed change in CPIB scores of at least 
4.21 – 5.23 would suggest an acceptable amount of measurement error ranging from 6.13 
– 7.51% variation in CPIB scores of control participants. These results suggest that the 
measure of CPIB scores demonstrates good repeatability for control participants. 
3.6.4 LSUS scores 
 
LSUS scores were obtained based on whether participants indicated that the first, second, 
third, fourth, or fifth categories was indicative of their typical level of speech usage. 
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Descriptive statistics for LSUS scores can be found in Table 44. The results of the two-
way repeated measures ANOVA for the dependent variables of the LSUS score showed 
that there was a significant main effect of “Group” F(1,50) = 12.30, p = .001 with 
participants with PD having a lower (-0. 58) marginal mean (M = 1.99, SD = 0.61) 
compared to control participants (M = 2.57, SD = 0.60). In contrast, there was no 
significant main effect of “Visit” on the LSUS score F(2,100) = 0.77, p = .465. It is 
important to note that this main effect of “Visit” needs to be qualified because of the 
finding of a “Group” by “Visit” interaction that trended towards significance F(2,100) = 
2.79, p = .066 for the LSUS score. This significant interaction is illustrated in Figure 25.  
A closer look at the factor “Visit”, using pairwise post-hoc analyses indicated that the 
marginal mean of the LSUS score at visit 1 (M = 2.27, SD = 0.72) was similar to the 
marginal mean of the LSUS score at visit 2 (M = 2.34, SD = 0.65) and visit 3 (M = 2.22, 
SD = 0.72). It appears that at visit 1 the group difference between the LSUS scores of 
participants PD and control participants greater than the group differences that were 
found at visit 2 and visit 3. Results of a post-hoc analyses involving comparisons of these 
group differences at each visit provided additional information about this significant 
“Group” by “Visit” interaction. For the post-hoc comparison related to visit 1, the 
participants with PD had a mean LSUS score (M = 1.91, SD = 0.73) that was significantly 
lower (-0.67) than the mean LSUS score of control participants (M = 2.67, SD = 0.76),  
t(2,51) = 3.64, p = .001.  For the post-hoc comparison related to visit 2, the participants 
with PD had a mean LSUS score (M = 2.00, SD = 0.74) that was significantly lower (-
0.63) than the mean LSUS score of control participants (M = 2.63, SD = 0.61),  t(2,51) = -
3.41, p = .001.  In contrast, the post-hoc comparisons related to group differences were 
not significant at visit 3 t(2,50) = -1.75, p = .087. Thus, it appears that although the LSUS 
score of participants with PD was significantly lower than that of control participants at 
visit 1 and visit 2, it increased to a level that was not significantly different from control 
participants at visit 3. 
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Table 44: Descriptive Statistics of Self- and Proxy-Rated Level of Speech Usage 
Scale for Participants with Parkinson's Disease, Primary Communication Partners 
of Participants with Parkinson’s Disease, and Control Participants Across Visits 1, 
2, and 3 
 LSUS score 
mean(SD) 
Participants with PD 
Visit 1 1.91(0.73) 
Visit 2 2.00(0.74) 
Visit 3 2.05(0.72) 
Control participants 
Visit 1 2.67(0.76) 
Visit 2 2.63(0.61) 
Visit 3 2.40(0.72) 
Primary communication partners 
Visit 1 2.13(0.92) 
Visit 2 2.04(0.93) 
Visit 3 1.82(0.73) 
Marginal means 
Participants with PD 1.99(0.61) 
Control participants 2.57(0.60) 
Primary communication partners 1.99(0.70) 
PD and control visit 1 2.27(0.72) 
PD and control visit 2 2.34(0.65) 
PD and control visit 3 2.22(0.72) 
PD and communication partners visit 1 1.98(0.80) 
PD and communication partners visit 2 2.05(0.86) 
PD and communication partners visit 3 1.93(0.73) 
Note. This table illustrates the means and standard deviations for the LSUS for 
participants with PD, their primary communication partners, and control participants 
across visits. 
 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
165 
Figure 25: Means of Level of Speech Usage Scale Scores for Participants with 
Parkinson's Disease and Control Participants Across Visits 1, 2, and 3 
 
Figure 25. This figure demonstrates the changes in mean LSUS scores for participants 
with PD and control participants across visits. Error bars represent standard deviations. 
 
3.6.4.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of LSUS scores. These analyses were 
performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) SEM across visits 
1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) 
pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 
2-3. Separate retest analyses were performed on the participants with PD and control 
participants.  
3.6.4.1.1 Retest analysis of LSUS scores for participants 
with Parkinson’s disease 
 
Results for retest analyses of LSUS scores for participants with PD are summarized in 
Table 45. The ICC values related to the repeated measurement of LSUS scores across the 
Participants with PD 
Control participants 
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three pairwise visits was found to be the following:  visit 1 versus visit 2 ICC = .75, p = 
.001, visit 1 versus visit 3 ICC = .72, p = .002, and visit 2 versus visit 3 ICC = .85, p < 
.001. These results suggest that LSUS scores as measured in the present study 
demonstrated good retest reliability in IWPD because the ICC values across all 
comparisons were above or approached our criterion of .75. 
Table 45: Retest Analyses of Level of Speech Usage Scale for Participants with 
Parkinson's Disease, Primary Communication Partners of Participants with 
Parkinson’s Disease, and Control Participants Across Visits 1, 2, and 3 
 ICC 
[95% CI] 
Average 
mean 
difference 
SD 
difference 
t value p value SD 
pooled 
SEM CR CR% 
Participants with PD 
Visits 1 – 2 .75[.40-.89] -0.09 0.67 -0.62 .539 0.74 0.37 1.02 53.30 
Visits 1 – 3 .72[.34-.88] -0.18 0.66 -1.28 .213 0.73 0.38 1.06 53.13 
Visits 2 – 3 .85[.63-.94] 0.00 0.53 0.00 1.000 0.73 0.28 0.78 38.21 
Control participants 
Visits 1 – 2 .76[.49-.89] 0.03 0.61 0.30 .769 0.69 0.34 0.94 35.02 
Visits 1 – 3 .46[-.08-.74] 0.27 0.87 1.68 .103 0.74 0.54 1.51 57.29 
Visits 2 – 3 .57[.12-.79] 0.23 0.73 1.76 .090 0.67 0.48 1.21 50.50 
Primary communication partners 
Visits 1 – 2 .70[.28-.87] 0.09 0.90 0.46 .648 0.93 0.51 1.40 65.89 
Visits 1 – 3 .60[.07-.83] 0.27 0.88 1.45 .162 0.83 0.53 1.45 71.32 
Visits 2 – 3 .80[.52-.91] 0.23 0.69 1.56 .135 0.84 0.37 1.04 56.90 
Note. This table illustrates the retest analyses performed to examine the repeatability and 
retest reliability of LSUS scores for participants with PD, their primary communication 
partners, and control participants. 
 
The mean difference between visit 1 and visit 2 for LSUS scores was -0.09 (SD = 0.67) 
and this difference was not significant t(22) = -0.62, p = .539. The mean differences in 
retest values ranged from -1 – 2. The mean difference between visit 1 and visit 3 for 
LSUS scores was -0.18 (SD = 0.66) and this difference was not significant t(21) = -1.28, 
p = .213. The mean differences in retest values ranged from -1 – 1. The mean difference 
between visit 2 and visit 3 for LSUS scores was 0.00 (SD = 0.53) and this difference was 
not significant t(21) = 0.00, p = 1.00. The mean differences in retest values ranged from -
1 – 1. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2, CR = 1.02 and CR% = 53.30%, for visit 1 vs visit 3, 
CR = 1.06 and CR% = 53.13%, and for visit 2 vs visit 3, CR = 0.78 and CR% = 38.21%. 
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Based on the CR, an observed change in the LSUS scores of at least 0.78 – 1.06 would 
suggest a fairly large amount of measurement error ranging from 38.21 – 53.30% 
variation in the LSUS scores of IWPD. These results suggest that the measure of LSUS 
scores demonstrates unacceptable repeatability for IWPD. 
3.6.4.1.2 Retest analysis of LSUS scores for control 
participants 
 
Results for retest analyses of LSUS scores for control participants are summarized in 
Table 45. The ICC values related to the repeated measurement of LSUS scores across the 
three pairwise visits was found to be the following: visit 1 versus visit 2 ICC = .76, p < 
.001, visit 1 versus visit 3 ICC = .46, p = .043, and visit 2 versus visit 3 ICC = .57, p = 
.011. These results suggest that LSUS scores as measured in the present study did not 
demonstrate good retest reliability in healthy speakers because the ICC values across two 
of three comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for LSUS scores was 0.03 (SD = 0.61) 
and this difference was not significant t(29) = 0.30, p = .769. The mean differences in 
retest values ranged from -1 – 1. The mean difference between visit 1 and visit 3 for 
LSUS scores was 0.27 (SD = 0.87) and this difference was not significant t(29) = 1.68, p 
= .103. The mean differences in retest values ranged from -1 – 3. The mean difference 
between visit 2 and visit 3 for LSUS scores was 0.23 (SD = 0.73) and this difference was 
not significant t(29) = 1.76, p = .090. The mean differences in retest values ranged from -
1 – 2. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2, CR = 0.94 and CR% = 35.02%, for visit 1 vs visit 3, 
CR = 1.51 and CR% = 57.29%, and for visit 2 vs visit 3, CR = 1.21 and CR% = 50.50%. 
Based on the CR, an observed change in the LSUS of at least 0.94 – 1.51 would suggest a 
fairly large amount of measurement error ranging from 35.02 – 57.29% variation in the 
LSUS scores of control participants. These results suggest that the measure of LSUS 
scores demonstrates unacceptable repeatability for control participants. 
3.7 Statistical Analysis for Objective 5: Self- and Proxy-
Rated Communicative Participation 
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In order to answer the question ‘Do ratings of communicative participation differ over 
time between and within participants with PD and their primary communication 
partners?’, a repeated measures MANOVA was performed to analyze the variability of 
self-rated communicative participation of the participants with PD and their primary 
communication partner over three time points for two of the four dependent measures 
related to communicative participation (CES question scores, VAPP subtest scores). The 
following factors were used in this analysis: one between-group independent factor with 
two levels “Group” [PD, communication partners], one within-group independent factor 
with three levels “Visit” [visit 1, visit 2, visit 3]. Additionally, a repeated measures 
ANOVA was performed to analyze the variability of self-rated communicative 
participation of the participants with PD and their primary communication partner over 
three time points for the remaining two of the four dependent measures related to 
communicative participation (CPIB scores, LSUS scores). The following factors were 
used in this analysis: one between-group independent factor with two levels “Group” 
[PD, communication partners], one within-group independent factors with three levels 
“Visit” [visit 1, visit 2, visit 3]. 
3.7.1 CES question scores 
 
Scores for each of the eight individual CES questions were obtained based on 
participants’ responses of 1, 2, 3, or 4 for each question. Descriptive statistics for 
individual CES question scores can be found in Table 21. The results of the repeated 
measures MANOVA for the dependent variables of the individual CES questions showed 
that there was no significant multivariate effect of “Group” F(8,33)  = 1.83, p = .106. The 
results of this repeated measures MANOVA can be found in Table 46. The results of 
subsequent univariate testing for each of the individual CES questions revealed the 
following results: 1) there was a significant univariate effect of “Group” F(1,40) = 5.48, p 
= .024 for CES question 1 (Having a conversation with a family member or friends at 
home) with participants with PD having a lower (-0.43) marginal mean (M = 2.92, SD = 
0.60) compared to their primary communication partners (M = 3.35, SD = 0.60); 2) there 
was a significant univariate effect of “Group” F(1,40) = 6.47, p = .015 for CES question 
2 (Participating in conversation with strangers in a quiet place) with participants with 
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PD having a lower (-0.42) marginal mean (M = 2.71, SD = 0.55) compared to their 
primary communication partners (M = 3.13, SD = 0.55); 3) there was a univariate effect 
of “Group” that trended towards significance for F(1,40) = 3.65, p = .063 for CES 
question 3 (Conversing with a familiar person over the telephone) with participants with 
PD having a lower (-0.32) marginal mean (M = 2.86, SD = 0.55) compared to their 
primary communication partners (M = 3.18, SD = 0.5); 4) there was no significant 
univariate effect of “Group” F(1,40) = 1.03, p = .316 for CES question 4 (Conversing 
with a stranger over the telephone); 5) there was no significant univariate effect of 
“Group” F(1,40) = 2.38, p = .131 for CES question 5 (Being part of a conversation in a 
noisy environment (social gathering)); 6) there was a univariate effect of “Group” that 
trended towards significance F(1,40) = 3.68, p = .062 for CES question 6 (Speaking to a 
friend when you are emotionally upset or you are angry) with participants with having a 
lower (-0.36) marginal mean (M = 2.37, SD = 0.64) compared to their primary 
communication partners (M = 2.73, SD = 0.64); 7) there was a significant univariate 
effect of “Group” F(1,40) = 7.50, p = .009 for CES question 7 (Having a conversation 
while traveling in a car) with participants with PD having a lower (-0.44) marginal mean 
(M = 2.59, SD = 0.55) compared to their primary communication partners (M = 2.59, SD 
= 0.55); and 8) there was no significant univariate effect of “Group” F(1,40) = 0.66, p = 
.423 for CES question 8 (Having a conversation with someone at a distance (across a 
room)). 
Table 46: Multivariate Testing Analysis of the Variability of Self-Rated Individual 
Questions of the Communicative Effectiveness Survey for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 
 Df hypothesis Df error F value p value 
“Group” 8 33 1.83 .106 
“Visit” 16 148 2.12 .010 
“Group”*”Visit” 16 148 0.41 .977 
Note. This table illustrates the main effects of “Group” and “Visit”, and the “Group” by 
“Visit” interaction found from multivariate analyses of the individual questions of the 
CES for participants with PD and their primary communication partners. 
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In contrast, the results of the repeated measures MANOVA for the dependent variables of 
the individual CES questions showed that there was a significant main effect of “Visit” 
F(16,148) = 2.12, p = .010. The results of this repeated measures MANOVA can be 
found in Table 46. A closer look at the factor “Visit” via subsequent univariate testing for 
each of the individual CES questions revealed the following results: 1) there was no 
significant univariate effect of “Visit” F(2,80) = 0.34, p = .710 for CES question 1 
(Having a conversation with a family member or friends at home); 2) there was a 
significant univariate effect of “Visit” F(2,80) = 5.73, p = .005 for CES question 2 
(Participating in conversation with strangers in a quiet place), which indicated that the 
marginal mean of the CES question 2 score at visit 1 (M = 3.12, SD = 0.65) was greater 
than the mean of the CES question 2 score at visit 2 (M = 2.88, SD = 0.65) and visit 3 (M 
= 2.76, SD = 0.71); 3) there was no significant univariate effect of “Visit” F(2,80) = 0.57, 
p = .567 for CES question 3 (conversing with a familiar person over the telephone); 4) 
there was a significant univariate effect of “Visit” F(2,80) = 3.29, p = .043, which 
indicated that the marginal mean of the CES question 4 (Conversing with a stranger over 
the telephone) score at visit 1 (M = 2.76, SD = 0.84) was greater than the mean of the 
CES question 4 score at visit 2 (M = 2.45, SD = 0.78) and visit 3 (M = 2.62, SD = 0.84); 
5) there was a significant univariate effect of “Visit” F(2,80) = 5.09, p = .008, which 
indicated that the marginal mean of the CES question 5 (Being part of a conversation in a 
noisy environment (social gathering)) score at visit 1 (M = 2.57, SD = 0.78) was 
significantly greater than the mean of the CES question 5 score at visit 2 (M = 2.26, SD = 
0.71) and visit 3 (M = 2.21, SD = 0.91); 6) there was a significant univariate effect of 
“Visit” F(2,80) = 2.17, p = .009, which indicated that the marginal mean of the CES 
question 6 (Speaking to a friend when you are emotionally upset or you are angry) score 
at visit 1 (M = 2.81, SD = 0.91) was greater than the mean of the CES question 6 score at 
visit 2 (M = 2.41, SD = 0.78) and visit 3 (M = 2.43, SD = 0.78); 7) there was no 
significant univariate effect of “Visit” F(2,80) = 0.40, p = .670 for CES question 7 
(Having a conversation while traveling in a car), and 8) there was no significant 
univariate effect of “Visit” F(2,80) = 1.90, p = .157 for CES question 8 (Having a 
conversation with someone at a distance (across a room)). The univariate analysis results 
of the individual CES question scores are provided in Table 47.  
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Table 47: Univariate Testing Analysis of the Variability of Self-Rated Individual 
Questions of the Communicative Effectiveness Survey for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 
 Df hypothesis Df error F value p value 
“Group” 
CES question 1 1 40 5.48 .024 
CES question 2 1 40 6.47 .015 
CES question 3 1 40 3.65 .063 
CES question 4 1 40 1.03 .316 
CES question 5 1 40 2.38 .131 
CES question 6 1 40 3.68 .062 
CES question 7 1 40 7.50 .009 
CES question 8 1 40 0.66 .423 
“Visit” 
CES question 1 2 80 0.34 .710 
CES question 2 2 80 5.73 .005 
CES question 3 2 80 0.57 .567 
CES question 4 2 80 3.29 .043 
CES question 5 2 80 5.09 .008 
CES question 6 2 80 2.17 .009 
CES question 7 2 80 0.40 .670 
CES question 8 2 80 1.90 .157 
“Group”*“Visit” 
CES question 1 2 80 0.71 .493 
CES question 2 2 80 1.02 .367 
CES question 3 2 80 0.57 .567 
CES question 4 2 80 0.18 .835 
CES question 5 2 80 0.03 .975 
CES question 6 2 80 0.35 .707 
CES question 7 2 80 0.59 .555 
CES question 8 2 80 0.46 .635 
Note. This table illustrates the significant and non-significant univariate effects of 
“Group”, significant and non-significant univariate effects of “Visit”, and “Group” by 
“Visit” interactions found from univariate analyses of the individual questions of the CES 
for participants with PD and their primary communication partners. 
 
Additionally, the results of the repeated measures MANOVA for the dependent variables 
of the individual CES questions showed that there was no significant “Group” by “Visit” 
interaction F(16,148) = 0.41, p = .977. The results of this repeated measures MANOVA 
can be found in Table 46.  The non-significant interactions for CES question 1, 2, 3, 4, 5, 
6, 7, and 8 scores can be found in Figures 26, 27, 28, 29, 30, 31, 32, and 33, respectively. 
Subsequent univariate testing for each of the individual CES questions revealed no 
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significant “Group” by “Visit” interaction for each of the individual CES questions. 
These results suggest that self- and proxy-ratings of the CES may be consistent over time 
for participants with PD and their primary communication partners. 
Figure 26: Means of Communicative Effectiveness Survey Question 1 (Having a 
Conversation with a Family Member or Friends at Home) scores for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 26. This figure demonstrates the changes in mean CES question 1 (Having a 
conversation with a family member or friends at home) scores for participants with PD 
and their primary communication across visits. Error bars represent standard deviations. 
  
Participants with PD 
Primary communication 
partners 
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Figure 27: Means of Communicative Effectiveness Survey Question 2 (Participating 
in Conversation with Strangers in a Quiet Place) Scores for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 27. This figure demonstrates the changes in mean CES question 2 (Participating 
in conversation with strangers in a quiet place) scores for participants with PD and their 
primary communication across visits. Error bars represent standard deviations. 
  
Participants with PD 
Primary communication 
partners 
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Figure 28: Means of Communicative Effectiveness Survey Question 3 (Conversing 
with a Familiar Person over the Telephone) Scores for Participants with Parkinson's 
Disease and Primary Communication Partners of Participants with Parkinson’s 
Disease Across Visits 1, 2, and 3 
 
Figure 28. This figure demonstrates the changes in mean CES question 3 (Conversing 
with a familiar person over the telephone) scores for participants with PD and their 
primary communication across visits. Error bars represent standard deviations. 
  
Participants with PD 
Primary communication 
partners 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
175 
Figure 29: Means of Communicative Effectiveness Survey Question 4 (Conversing 
with a Stranger over the Telephone) Scores for Participants with Parkinson's Disease 
and Primary Communication Partners of Participants with Parkinson’s Disease 
Across Visits 1, 2, and 3 
 
Figure 29. This figure demonstrates the changes in mean CES question 4 (Conversing 
with a stranger over the telephone) scores for participants with PD and their primary 
communication across visits. Error bars represent standard deviations. 
  
Participants with PD 
Primary communication 
partners 
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Figure 30: Means of Communicative Effectiveness Survey Question 5 (Being Part of 
a Conversation in a Noisy Environment (Social Gathering)) Scores for Participants 
with Parkinson's Disease and Primary Communication Partners of Participants 
with Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 30. This figure demonstrates the changes in mean CES question 5 (Being part of a 
conversation in a noisy environment (social gathering)) scores for participants with PD 
and their primary communication across visits. Error bars represent standard deviations. 
  
Participants with PD 
Primary communication 
partners 
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Figure 31: Means of Communicative Effectiveness Survey Question 6 (Speaking to a 
Friend When You are Emotionally Upset or You are Angry) Scores for Participant 
with Parkinson's Disease and Primary Communication Partners of Participants 
with Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 31. This figure demonstrates the changes in mean CES question 6 (Speaking to a 
friend when you are emotionally upset or you are angry) scores for participants with PD 
and their primary communication across visits. Error bars represent standard deviations. 
  
Participants with PD 
Primary communication 
partners 
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Figure 32: Means of Communicative Effectiveness Survey Question 7 (Having a 
Conversation While Traveling in a Car) Scores for Participants with Parkinson's 
Disease and Primary Communication Partners of Participants with Parkinson’s 
Disease Across Visits 1, 2, 3 
 
Figure 32. This figure demonstrates the changes in mean CES question 7 (Having a 
conversation while traveling in a car) scores for participants with PD and their primary 
communication across visits. Error bars represent standard deviations. 
  
Participants with PD 
Primary communication 
partners 
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Figure 33: Means of Communicative Effectiveness Survey Question 8 (Having a 
Conversation with Someone at a Distance (Across a Room)) Scores for Participants 
with Parkinson's Disease and Primary Communication Partners of Participants 
with Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 33. This figure demonstrates the changes in mean CES question 8 (Having a 
conversation with someone at a distance (across a room)) scores for participants with PD 
and their primary communication across visits. Error bars represent standard deviations. 
 
3.7.1.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of individual CES question scores. These 
analyses were performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) 
SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, 
and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-
2, 1-3, and 2-3. Separate retest analyses were performed on the participants with PD and 
their primary communication partner.  
Participants with PD 
Primary communication 
partners 
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3.7.1.1.1 Retest analysis of CES question 1 (Having a 
conversation with a family member or friends at 
home) scores for participants with Parkinson’s 
disease 
 
See objective 4 for retest analyses of CES question 1 for participants with PD. 
3.7.1.1.2 Retest analysis of CES question 1 (Having a 
conversation with a family member or friends at 
home) scores for primary communication 
partners 
 
Results for retest analyses of CES question 1 scores for primary communication partners 
are summarized in Table 24. The ICC values related to the repeated measurement of CES 
question 1 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .79, p < .001, visit 1 versus visit 3 ICC = .46, p = .090, visit 2 versus 
visit 3 ICC = .60, p = .010. These results suggest that CES question 1 scores as measured 
in the present study did not demonstrate good retest reliability in primary communication 
partners of IWPD because the ICC values across two of three comparisons were below 
our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 1 scores was 0.00 (SD 
= 0.67) and this difference was not significant t(22) = 0.00, p = 1.000. The mean 
differences in retest values ranged from -2 – 1. The mean difference between visit 1 and 
visit 3 for CES question 1 scores was -0.05 (SD = 0.90) and this difference was not 
significant t(21) = -0.24, p = .815. The mean differences in retest values ranged from -3 – 
1. The mean difference between visit 2 and visit 3 for CES question 1 scores was -0.05 
(SD = 0.90) and this difference was not significant t(21) = -0.24, p = .815. The mean 
differences in retest values ranged from -3 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.00 and 
CR% = 30.41%, for visit 1 vs visit 3, CR = 1.52 and CR% = 45.96%, and for visit 2 vs 
visit 3, CR = 1.49 and CR% = 44.34%. Based on the CR, an observed change in the CES 
question 1 scores of at least 1.00 – 1.52 would suggest a fairly large amount of 
measurement error ranging from 30.41 – 45.96% variation in the CES question 1 scores 
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of primary communication partners of IWPD. These results suggest that the measure of 
CES question 1 scores demonstrates unacceptable repeatability for primary 
communication partners of IWPD. 
3.7.1.1.3 Retest analysis of CES question 2 (Participating 
in conversation with strangers in a quiet place) 
scores for participants with Parkinson’s disease 
 
See objective 4 for retest analyses of CES question 2 for participants with PD. 
3.7.1.1.4 Retest analysis of CES question 2 (Participating 
in conversation with strangers in a quiet place) 
scores for primary communication partners 
 
Results for retest analyses of CES question 2 scores for primary communication partners 
are summarized in Table 25. The ICC values related to the repeated measurement of CES 
question 2 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .00, p = .500, visit 1 versus 3 ICC = .33, p = .164, visit 2 versus visit 
3 ICC = .72, p = .004. These results suggest that CES question 2 scores as measured in 
the present study did not demonstrate good retest reliability in primary communication 
partners of IWPD because all of the ICC values across all comparisons were below our 
criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 2 scores was 0.30 (SD 
= 0.88) and this difference was not significant t(22) = 1.67, p = .110. The mean 
differences in retest values ranged from -1 – 2. The mean difference between visit 1 and 
visit 3 for CES question 2 scores was 0.32 (SD = 0.84) and this difference was not 
significant t(21) = 1.78, p = .090. The mean differences in retest values ranged from -1 – 
2. The mean difference between visit 2 and visit 3 for CES question 2 scores was 0.00 
(SD = 0.69) and this difference was not significant t(21) = 0.00, p = 1.000. The mean 
differences in retest values ranged from -2 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.71 and 
CR% = 51.83%, for visit 1 vs visit 3, CR = 1.51 and CR% = 50.45%, and for visit 2 vs 
visit 3, CR = 1.05 and CR% = 35.00%. Based on the CR, an observed change in the CES 
question 2 scores of at least 1.05 – 1.71 would suggest a large amount of measurement 
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error ranging from 35.00 – 51.83% variation in the CES question 2 scores of primary 
communication partners of IWPD. These results suggest that the measure of CES 
question 2 scores demonstrates unacceptable repeatability for primary communication 
partners of IWPD. 
3.7.1.1.5 Retest analysis of CES question 3 (Conversing 
with a familiar person over the telephone) scores 
for participants with Parkinson’s disease 
 
See objective 4 for retest analyses of CES question 3 for participants with PD. 
3.7.1.1.6 Retest analysis of CES question 3 (Conversing 
with a familiar person over the telephone) scores 
for primary communication partners 
 
Results for retest analyses of CES question 3 scores for primary communication partners 
are summarized in Table 26. The ICC values related to the repeated measurement of CES 
question 3 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .33, p = .185, visit 1 versus visit 3 ICC = .37, p = .155, and visit 2 
versus visit 3 ICC = .71, p = .004.. These results suggest that CES question 3 scores as 
measured in the present study did not demonstrate good retest reliability in primary 
communication partners of IWPD because all of the ICC values across all comparisons 
were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 3 scores was 0.13 (SD 
= 0.69) and this difference was not significant t(22) = 0.21, p = .833. The mean 
differences in retest values ranged from -2 – 3. The mean difference between visit 1 and 
visit 3 for CES question 3 scores was 0.18 (SD = 0.66) and this difference was not 
significant t(21) = 0.00, p = 1.000. The mean differences in retest values ranged from -2 – 
1. The mean difference between visit 2 and visit 3 for CES question 3 scores was 0.05 
(SD = 0.72) and this difference was not significant t(21) = -0.30, p = .771. The mean 
differences in retest values ranged from -2 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.74 and 
CR% = 54.81%, for visit 1 vs visit 3, CR = 1.52 and CR% = 48.51% and for visit 2 vs 
visit 3, CR = 1.10 and CR% = 34.66%. Based on the CR, an observed change in the CES 
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question 3 scores of at least 1.10 – 1.74 would suggest a large amount of measurement 
error ranging from 34.66 – 54.81% variation in the CES question 3 scores of primary 
communication partners of IWPD. These results suggest that the measure of CES 
question 3 scores demonstrates unacceptable repeatability for primary communication 
partners of IWPD. 
3.7.1.1.7 Retest analysis of CES question 4 (Conversing 
with a stranger over the telephone) scores for 
participants with Parkinson’s disease 
 
See objective 4 for retest analyses of CES question 4 for participants with PD. 
3.7.1.1.8 Retest analysis of CES question 4 (Conversing 
with a stranger over the telephone) scores for 
primary communication partners 
 
Results for retest analyses of CES question 4 scores for primary communication partners 
are summarized in Table 27. The ICC values related to the repeated measurement of CES 
question 4 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .61, p = .012, visit versus and visit 3 ICC = .55, p = .040, and visit 2 
versus visit 3 ICC = .81, p < .001. These results suggest that CES question 4 scores as 
measured in the present study did not demonstrate good retest reliability in primary 
communication partners of IWPD because the ICC values across two of three 
comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 4 scores was 0.30 (SD 
= 0.88) and this difference was not significant t(22) = 1.67, p = .110. The mean 
differences in retest values ranged from -1 – 3. The mean difference between visit 1 and 
visit 3 for CES question 4 scores was 0.09 (SD = 0.97) and this difference was not 
significant t(21) = 0.44, p = .665. The mean differences in retest values ranged from -2 – 
1. The mean difference between visit 2 and visit 3 for CES question 4 scores was -0.23 
(SD = 0.69) and this difference was not significant t(21) = -1.56, p = .135. The mean 
differences in retest values ranged from -2 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.45 and 
CR% = 51.35%, for visit 1 vs visit 3, CR = 1.59 and CR% = 63.07%, and for visit 2 vs 
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visit 3, CR = 1.04 and CR% = 38.26%. Based on the Cr, an observed change in the CES 
question 4 scores of at least 1.04 – 1.59 would suggest a large amount of measurement 
error ranging from 38.26 – 63.07% variation in the CES question 4 scores of primary 
communication partners of IWPD. These results suggest that the measure of CES 
question 4 scores demonstrates unacceptable repeatability for primary communication 
partners of IWPD. 
3.7.1.1.9 Retest analysis of CES question 5 (Being part of 
a conversation in a noisy environment (social 
gathering)) scores for participants with 
Parkinson’s disease 
 
See objective 4 for retest analyses of CES question 5 for participants with PD. 
3.7.1.1.10 Retest analysis of CES question 5 scores (Being 
part of a conversation in a noisy environment 
(social gathering)) for primary communication 
partners 
 
Results for retest analyses of CES question 5 for primary communication partners scores 
are summarized in Table 28. The ICC values related to the repeated measurement of CES 
question 5 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .62, p = .013, visit 1 versus visit 3 ICC = .75, p = .001, and visit 2 
versus visit 3 ICC = .80, p < .001. These results suggest that CES question 5 scores as 
measured in the present study demonstrated good retest reliability in primary 
communication partners of IWPD because the across two of three comparisons were 
above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 5 scores was 0.22 (SD 
= 0.90) and this difference was not significant t(22) = 1.16, p = .260. The mean 
differences in retest values ranged from -1 – 2. The mean difference between visit 1 and 
visit 3 for CES question 5 scores was 0.32 (SD = 0.78) and this difference approached 
significance t(21) = 1.91, p = .069. The mean differences in retest values ranged from -1 
– 2. The mean difference between visit 2 and visit 3 for CES question 5 scores was 0.05 
(SD = 0.72) and this difference was not significant t(21) = 0.30, p = .771. The mean 
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differences in retest values ranged from -1 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.47 and 
CR% = 55.43%, for visit 1 vs visit 3, CR = 1.23 and CR% = 50.73%, and for visit 2 vs 
visit 3, CR = 1.08 and CR% = 45.69%. Based on the CR, an observed change in the CES 
question 5 scores of at least 1.08 – 1.47 would suggest a fairly large amount of 
measurement error with CR% values ranging from 45.69 – 55.43% for the CES question 
5 of primary communication partners of IWPD. These results suggest that the measure of 
CES question 5 scores demonstrates unacceptable repeatability for primary 
communication partners of IWPD. 
3.7.1.1.11 Retest analysis of CES question 6 (Speaking to 
a friend when you are emotionally upset or you 
are angry) scores for participants with 
Parkinson’s disease 
 
See objective 4 for retest analyses of CES question 6 for participants with PD. 
3.7.1.1.12 Retest analysis of CES question 6 (Speaking to 
a friend when you are emotionally upset or you 
are angry) scores for primary communication 
partners 
 
Results for retest analyses of CES question 6 scores for primary communication partners 
are summarized in Table 29. The ICC values related to the repeated measurement of CES 
question 6 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .63, p = .007, visit 1 versus visit 3 ICC = .50, p = .056, and visit 2 
versus visit 3 ICC = .65, p = .012. These results suggest that CES question 6 scores as 
measured in the present study did not demonstrate good retest reliability in primary 
communication partners of IWPD because all of the ICC values across all comparisons 
were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 6 scores was 0.45 (SD 
= 0.86) and this difference was significant t(21) = 2.49, p = .021. The mean difference 
between visit 1 and visit 3 for CES question 6 scores was 0.33 (SD = 0.97) and this 
difference was not significant t(20) = 1.58, p = .130. The mean differences in retest 
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values ranged from -2 – 2. The mean difference between visit 2 and visit 3 for CES 
question 6 scores was -0.14 (SD = 0.85) and this difference was not significant t(20) = -
0.77, p = .452. The mean differences in retest values ranged from -2 – 1. Additionally, the 
following CR values were obtained for the following visit comparisons: for visit 1 vs visit 
2, CR = 1.46 and CR% = 48.58%, for visit 1 vs visit 3, CR = 1.64 and CR% = 64.19%, 
and for visit 2 vs visit 3, CR = 1.36 and CR% = 50.98%. Based on the CR, an observed 
change in the CES question 6 scores of at least 1.36 – 1.64 would suggest a large amount 
of measurement error ranging from 48.58 – 64.19% variation in the CES question 6 
scores of primary communication partners of IWPD. These results suggest that the 
measure of CES question 6 scores demonstrates unacceptable repeatability for primary 
communication partners of IWPD. 
3.7.1.1.13 Retest analysis of CES question 7 (Having a 
conversation while traveling in a car) scores for 
participants with Parkinson’s disease 
 
See objective 4 for retest analyses of CES question 7 for participants with PD. 
3.7.1.1.14 Retest analysis of CES question 7 (Having a 
conversation while traveling in a care) scores for 
primary communication partners 
 
Results for retest analyses of CES question 7 scores for primary communication partners 
are summarized in Table 30. The ICC values related to the repeated measurement of CES 
question 7 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .34, p = .174, visit 1 versus visit 3 ICC = .50, p = .069, and visit 2 
versus visit 3 ICC = .43, p = .110. These results suggest that CES question 7 scores as 
measured in the present study did not demonstrate good retest reliability in primary 
communication partners of IWPD because all of the ICC values across all comparisons 
were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CES question 7 scores was 0.13 (SD 
= 1.06) and this difference was not significant t(22) = 0.59, p = .560. The mean 
differences in retest values ranged from -2 – 3. The mean difference between visit 1 and 
visit 3 for CES question 7 scores was 0.00 (SD = 0.76) and this difference was not 
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significant t(21) = 0.00, p = 1.000. The mean differences in retest values ranged from -2 – 
1. The mean difference between visit 2 and visit 3 for CES question 7 scores was -0.14 
(SD = 1.04) and this difference was not significant t(21) = -0.617, p = .544. The mean 
differences in retest values ranged from -3 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.89 and 
CR% = 62.15%, for visit 1 vs visit 3, CR = 1.29 and CR% = 44.44%, and for visit 2 vs 
visit 3, CR = 1.79 and CR% = 57.87%. Based on the CR, an observed change in the CES 
question 7 scores of at least 1.29 – 1.89 would suggest a large amount of measurement 
error ranging from 44.44 – 62.15% variation in the CES question 7 scores of primary 
communication partners of IWPD. These results suggest that the measure of CES 
question 7 scores demonstrates unacceptable repeatability for primary communication 
partners of IWPD. 
3.7.1.1.15 Retest analysis of CES question 8 (Having a 
conversation with someone at a distance (across 
a room)) scores for participants with Parkinson’s 
disease 
 
See objective 4 for retest analyses of CES question 8 for participants with PD. 
3.7.1.1.16 Retest analysis of CES question 8 (Having a 
conversation with someone at a distance (across 
a room)) scores for primary communication 
partners 
 
Results for retest analyses of CES question 8 scores for primary communication partners 
are summarized in Table 31. The ICC values related to the repeated measurement of CES 
question 8 scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .65, p = .009, visit 1 versus visit 3 ICC = .65, p = .009, and visit 2 
versus visit 3 ICC = .80, p < .001. These results suggest that CES question 8 scores as 
measured in the present study did not demonstrate good retest reliability in primary 
communication partners of IWPD because the ICC values across two of three 
comparisons were below .8075 
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The mean difference between visit 1 and visit 2 for CES question 8 scores was 0.17 (SD 
= 0.89) and this difference was not significant t(22) = 0.94, p = .357. The mean 
differences in retest values ranged from -1 – 2. The mean difference between visit 1 and 
visit 3 for CES question 8 scores was 0.27 (SD = 0.94) and this difference was not 
significant t(21) = 1.37, p = .186. The mean differences in retest values ranged from -2 – 
2. The mean difference between visit 2 and visit 3 for CES question 8 scores was 0.09 
(SD = 0.75) and this difference was not significant t(21) = 0.57, p = .576. The mean 
differences in retest values ranged from -2 – 1. Additionally, the following CR values 
were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 1.43 and 
CR% = 55.51%, for visit 1 vs visit 3, CR = 1.52 and CR% = 63.45%, and for visit 2 vs 
visit 3, CR = 1.11 and CR% = 47.88%. Based on the CR, an observed change in the CES 
question 8 scores of at least 1.11 – 1.52 would suggest a large amount of measurement 
error ranging from 47.88 – 63.45% variation in the CES question 8 scores of primary 
communication partners of IWPD. These results suggest that the measure of CES 
question 8 scores demonstrates unacceptable repeatability for primary communication 
partners of IWPD. 
3.7.2 VAPP subsection scores 
 
Scores for the VAPP self-perceived voice problem, daily communication, social 
communication, and emotion subsections were obtained by summing up the converted 
scores for each question within a subsection. Raw scores for each question were obtained 
by measuring the location of an individual’s response of each VAS. These raw scores 
were then divided by a factor of 10. VAPP total scores were obtained by summing up the 
total scores of each of the above-mentioned subsections. VAPP activity limitation scores 
were obtained by summing up the converted scores from the first question of each 
described situation assessing the degree of activity limitation from the daily 
communication and social communication subsections. VAPP participation restriction 
scores were obtained by summing up the converted scores from the second question of 
each described situation assessing the degree of participation restriction from the daily 
communication and social communication subsection. Descriptive statistics for VAPP 
subsection scores can be found in Table 32. The results of the repeated measures 
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MANOVA for the dependent variables of the individual VAPP subsections showed that 
there was no significant multivariate effect of “Group” F(6,36)  = 0.43, p = .852. 
Additionally, the results of the repeated measures MANOVA for the dependent variables 
of the individual VAPP subsections showed that there was no significant multivariate 
effect of “Visit” F(12,156) = 1.58, p = .103 and no significant “Group” by “Visit” 
interaction F(12,156) = 0.81, p = .640. The results of this repeated measures MANOVA 
can be found in Table 48. Subsequent univariate testing for each of the individual VAPP 
subsections revealed no significant univariate effects of visit and no significant “Group” 
by “Visit” interactions for each of the individual VAPP subsections. These values are 
described in Table 49. The non-significant interactions for VAPP self-perceived voice 
problem, daily communication, social communication, emotion, activity limitation, 
participation restriction, and total scores can be found in Figures 34, 35, 36, 37, 38, 39, 
and 40, respectively. These results suggest that self- and proxy- ratings of the VAPP may 
be consistent over time for participants with PD and their primary communication 
partners. 
Table 48: Multivariate Testing Analysis of the Variability of Self-Rated Individual 
Subsections of the Voice Activity and Participation Profile for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 
 Df hypothesis Df error F value p value 
“Group” 6 36 0.43 .852 
“Visit” 12 156 1.58 .103 
“Group”*”Visit” 12 156 0.81 .640 
Note. This table illustrates the main effects of “Group” and “Visit”, and the “Group” by 
“Visit” interaction found from multivariate analyses of the individual questions of the 
VAPP for participants with PD and control participants. 
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Table 49: Univariate Testing Analysis of the Variability of Self-Rated Individual 
Subsections of the Voice Activity and Participation Profile for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 
 Df hypothesis Df error F value p value 
“Group” 
Voice problem 1 41 0.10 .753 
Daily communication 1 41 0.10 .758 
Social communication 1 41 0.69 .416 
Emotion 1 41 0.21 .648 
ALS 1 41 0.15 .704 
PRS 1 41 0.29 .593 
Total 1 41 0.22 .640 
“Visit” 
Voice problem 2 82 1.02 .364 
Daily communication 2 82 1.85 .164 
Social communication 2 82 2.37 .100 
Emotion 2 82 0.300 .742 
ALS 2 82 1.779 .175 
PRS 2 82 1.503 .229 
Total 2 82 1.080 .344 
“Group”*“Visit” 
Voice problem 2 82 0.413 .663 
Daily communication 2 82 0.625 . 538 
Social communication 2 82 2.038 .137 
Emotion 2 82 1.925 .152 
ALS 2 82 0.617 .542 
PRS 2 82 1.496 .230 
Total 2 82 1.378 .258 
Note. This table illustrates the significant and non-significant univariate effects of 
“Group”, significant and non-significant univariate effects of “Visit”, and “Group” by 
“Visit” interactions found from univariate analyses of the individual subsections of the 
VAPP for participants with PD and their primary communication partners. 
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Figure 34: Means of Voice Activity and Participation Profile Self-Perceived Voice 
Problem Subsection Scores for Participants with Parkinson's Disease and Primary 
Communication Partners of Participants with Parkinson’s Disease Across Visits 1, 
2, and 3 
 
Figure 34. This figure demonstrates the changes in mean VAPP self-perceived voice 
problem subsection scores for participants with PD and their primary communication 
across visits. Error bars represent standard deviations. 
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Figure 35: Means of Voice Activity and Participation Profile Daily Communication 
Subsection Scores for Participants with Parkinson's Disease and Primary 
Communication Partners of Participants with Parkinson’s Disease Across Visits 1, 
2, and 3 
 
Figure 35. This figure demonstrates the changes in mean VAPP daily communication 
subsection scores for participants with PD and their primary communication across visits. 
Error bars represent standard deviations. 
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Figure 36: Means of Voice Activity and Participation Profile Social Communication 
Subsection Scores for Participants with Parkinson's Disease and Primary 
Communication Partners of Participants with Parkinson’s Disease Across Visits 1, 
2, and 3 
 
Figure 36. This figure demonstrates the changes in mean VAPP social communication 
subsection scores for participants with PD and their primary communication across visits. 
Error bars represent standard deviations. 
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Figure 37: Means of Voice Activity and Participation Profile Emotion Subsection 
Scores for Participants with Parkinson's Disease and Primary Communication 
Partners of Participants with Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 37. This figure demonstrates the changes in mean VAPP emotion subsection 
scores for participants with PD and their primary communication across visits. Error bars 
represent standard deviations. 
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Figure 38: Means of Voice Activity and Participation Profile Activity Limitation 
Subsection Scores for Participants with Parkinson's Disease and Primary 
Communication Partners of Participants with Parkinson’s Disease Across Visits 1, 
2, and 3 
 
Figure 38. This figure demonstrates the changes in mean VAPP activity limitation 
subsection scores for participants with PD and their primary communication across visits. 
Error bars represent standard deviations. 
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Figure 39: Means of Voice Activity and Participation Profile Participation 
Restriction Subsection Scores for Participants with Parkinson's Disease and Primary 
Communication Partners of Participants with Parkinson’s Disease Across Visits 1, 
2, and 3 
 
Figure 39. This figure demonstrates the changes in mean VAPP participation restriction 
subsection scores for participants with PD and their primary communication across visits. 
Error bars represent standard deviations.  
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Figure 40: Means of Voice Activity and Participation Profile Total Subsection Scores 
for Participants with Parkinson's Disease and Primary Communication Partners of 
Participants with Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 40. This figure demonstrates the changes in mean VAPP total subsection scores 
for participants with PD and their primary communication across visits. Error bars 
represent standard deviations. 
 
3.7.2.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of individual VAPP subsection scores. 
These analyses were performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 
2) SEM across visits 1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-
3, and 2-3, 4) pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 
1-2, 1-3, and 2-3. Separate retest analyses were performed on the participants with PD 
and their primary communication partner.  
Participants with PD 
Primary communication 
partners 
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3.7.2.1.1 Retest analysis of VAPP self-perceived voice 
problem scores for participants with Parkinson’s 
disease 
 
See objective 4 for retest analyses of VAPP self-perceived voice problem scores for 
participants with PD. 
3.7.2.1.2 Retest analysis of VAPP self-perceived voice 
problem scores for primary communication 
partners 
 
Results for retest analyses of the VAPP self-perceived voice problem scores are 
summarized in Table 35. The ICC values related to the repeated measurement of VAPP 
self-perceived voice problem scores across the three pairwise visits was found to be the 
following: visit 1 versus visit 2 ICC = .80, p < .001, visit 1 versus visit 3 ICC = .92, p < 
.001, and visit 2 versus visit 3 ICC = .80, p < .001. These results suggest that VAPP self-
perceived voice problem scores as measured in the present study demonstrated good 
retest reliability in primary communication partners of IWPD because all of the ICC 
values across all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP self-perceived voice problem 
scores was -0.40 (SD = 1.95) and this difference was not significant t(22) = -1.00, p = 
.330. The mean differences in retest values ranged from -7.20 – 3.80. The mean 
difference between visit 1 and visit 3 for VAPP self-perceived voice problem scores was 
0.26 (SD = 1.25) and this difference was not significant t(21) = 0.97, p = .343. The mean 
differences in retest values ranged from -1.40 – 3.60. The mean difference between visit 2 
and visit 3 for VAPP self-perceived voice problem scores was 0.59 (SD = 1.88) and this 
difference was not significant t(21) = 1.47, p = .156. The mean differences in retest 
values ranged from -1.80 – 7.10. Additionally, the following CR values were obtained for 
the following visit comparisons: for visit 1 vs visit 2, CR = 2.93 and CR% = 98.49%, for 
visit 1 vs visit 3, CR = 1.76 and CR% = 51.93%, and for visit 2 vs visit 3, CR = 2.88 and 
CR% = 102.41%. Based on the CR, an observed change in the VAPP self-perceived voice 
problem scores of at least 1.76 – 2.93 would suggest a large amount of measurement error 
ranging from 51.93 – 102.41% variation in the VAPP self-perceived voice problem of 
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primary communication partners of IWPD. These results suggest that the measure of 
VAPP self-perceived voice problem scores demonstrates unacceptable repeatability for 
primary communication partners of IWPD. 
3.7.2.1.3 Retest analysis of VAPP daily communication 
scores for participants with Parkinson’s disease 
 
See objective 4 for retest analyses of VAPP daily communication scores for participants 
with PD. 
3.7.2.1.4 Retest analysis of VAPP daily communication 
scores for primary communication partners 
 
Results for retest analyses of the VAPP daily communication scores are summarized in 
Table 36. The ICC values related to the repeated measurement of VAPP daily 
communication scores across the three pairwise visits was found to be the following: visit 
1 versus visit 2 ICC = .88, p < .001, visit 1 versus visit 3 ICC = .90, p < .001, and visit 2 
versus visit 3 ICC = .95, p < .001. These results suggest that VAPP daily communication 
scores as measured in the present study demonstrated good retest reliability in primary 
communication partners of IWPD because all of the ICC values across all comparisons 
were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP daily communication scores 
was -5.71 (SD = 17.84) and this difference was not significant t(22) = -1.54, p = .139. 
The mean differences in retest values ranged from -78.20 – 10.10. The mean difference 
between visit 1 and visit 3 for VAPP daily communication scores was -4.99 (SD = 3.31) 
and this difference was not significant t(21) = -1.51, p = .146. The mean differences in 
retest values ranged from -43.80 – 17.10. The mean difference between visit 2 and visit 3 
for VAPP daily communication scores was 0.36 (SD = 12.76) and this difference was not 
significant t(21) = 0.13, p = .895. The mean differences in retest values ranged from -
25.70 – 34.40. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 26.70 and CR% = 79.39%, for visit 1 vs 
visit 3, CR = 23.08 and CR% = 58.67%, and for visit 2 vs visit 3, CR = 16.80 and CR% = 
42.93%. Based on the CR, an observed change in the VAPP daily communication scores 
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of at least 16.80 – 26.70 would suggest a fairly large amount of measurement error 
ranging from 42.93 – 79.39% variation in the VAPP daily communication scores of 
primary communication partners of IWPD. These results suggest that the measure of 
VAPP daily communication scores demonstrates unacceptable repeatability for primary 
communication partners of IWPD. 
3.7.2.1.5 Retest analysis of VAPP social communication 
scores for participants with Parkinson’s disease 
 
See objective 4 for retest analyses of VAPP social communication scores for participants 
with PD. 
3.7.2.1.6 Retest analysis of VAPP social communication 
scores for primary communication partners 
 
Results for retest analyses of the VAPP social communication scores for primary 
communication partners are summarized in Table 37. The ICC values related to the 
repeated measurement of VAPP social communication scores across the three pairwise 
visits was found to be the following: visit 1 versus visit 2 ICC = .90, p < .001, visit 1 
versus visit 3 ICC = .92, p < .001, and visit 2 versus visit 3 ICC = .89, p < .001. These 
results suggest that VAPP social communication scores as measured in the present study 
demonstrated good retest reliability in primary communication partners of IWPD because 
all of the ICC values across all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP social communication scores 
was -1.81 (SD = 4.19) and this difference was significant t(22) = -2.07, p = .050. The 
mean difference between visit 1 and visit 3 for VAPP social communication scores was -
1.71 (SD = 3.69) and this difference was significant t(21) = -2.18, p = .041. The mean 
difference between visit 2 and visit 3 for VAPP social communication scores was 0.01 
(SD = 4.81) and this difference was not significant t(21) = 0.01, p = .990. The mean 
differences in retest values ranged from -10.60 – 9.70. Additionally, the following CR 
values were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 6.43 
and CR% = 82.12%, for visit 1 vs visit 3, CR = 5.62 and CR% = 58.28%, and for visit 2 
vs visit 3, CR = 6.85 and CR% = 70.99%. Based on the CR, an observed change in the 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
201 
VAPP social communication scores of at least 5.62 – 6.85 would suggest a fairly large 
amount of measurement error ranging from 58.28 – 82.12% variation in the VAPP social 
communication scores of primary communication partners of IWPD. These results 
suggest that the measure of VAPP social communication scores demonstrates 
unacceptable repeatability for primary communication partners of IWPD. 
3.7.2.1.7 Retest analysis of VAPP emotion scores for 
participants with Parkinson’s disease 
 
See objective 4 for retest analyses of VAPP emotion scores for participants with PD. 
3.7.2.1.8 Retest analysis of VAPP emotion scores for 
primary communication partners 
 
Results for retest analyses of the VAPP emotion scores for primary communication 
partners are summarized in Table 38. The ICC values related to the repeated 
measurement of VAPP emotion scores across the three pairwise visits was found to be the 
following: visit 1 versus visit 2 ICC = .75, p = .001, visit 1 versus visit 3 ICC = .93, p < 
.001, and visit 2 versus visit 3 ICC = .84, p < .001. These results suggest that VAPP 
emotion scores as measured in the present study demonstrated good retest reliability in 
primary communication partners of IWPD because all of the ICC values across all 
comparisons were above our criterion of .75. 
The mean difference between visit 1 and visit 2 for VAPP emotion scores was -
3.50 (SD = 12.08) and this difference was not significant t(22) = -1.39, p = .179. The 
mean differences in retest values ranged from -43.80 – 15.20. The mean difference 
between visit 1 and visit 3 for VAPP emotion scores was -1.73 (SD = 6.55) and this 
difference was not significant t(21) = -1.24, p = .230. These results indicate that the mean 
differences in retest values ranged from -15.6 – 8.6. The mean difference between visit 2 
and visit 3 for VAPP emotion scores was 1.68 (SD = 10.65) and this difference was not 
significant t(21) = 0.74, p = .468. The mean differences in retest values ranged from -
15.50 – 12.60. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 19.05 and CR% = 122.82%, for visit 1 vs 
visit 3, CR = 9.53 and CR% = 50.12%, and for visit 2 vs visit 3, CR = 15.64 and CR% = 
89.00%. Based on the CR, an observed change in the VAPP emotion scores of at least 
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9.53 – 19.05 would suggest a fairly large amount of measurement error ranging from 
50.12 – 122.82% variation in the VAPP emotion scores of primary communication 
partners of IWPD. These results suggest that the measure of VAPP emotion scores 
demonstrates unacceptable repeatability for primary communication partners of IWPD. 
3.7.2.1.9 Retest analysis of VAPP activity limitation scores 
for participants with Parkinson’s disease 
 
See objective 4 for retest analyses of VAPP activity limitation scores for participants with 
PD. 
3.7.2.1.10 Retest analysis of VAPP activity limitation scores 
for primary communication partners 
 
Results for retest analyses of the VAPP activity limitation scores for primary 
communication partners are summarized in Table 39. The ICC values related to the 
repeated measurement of VAPP activity limitation scores across the three pairwise visits 
was found to be the following:  visit 1 versus visit 2 ICC = .93, p < .001, visit 1 versus 
visit 3 ICC = .98, p < .001, and visit 2 versus visit 3 ICC = .97, p < .001. These results 
suggest that VAPP activity limitation scores as measured in the present study 
demonstrated good retest reliability in primary communication partners of IWPD because 
all of the ICC values across all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP activity limitation scores was -
3.54 (SD = 9.77) and this difference was not significant t(22) = -1.74, p = .096. The mean 
differences in retest values ranged from -42.30 – 7.20. The mean difference between visit 
1 and visit 3 for VAPP activity limitation scores was -4.33 (SD = 9.03) and this difference 
was significant t(21) = -2.25, p = .036. The mean difference between visit 2 and visit 3 
for VAPP activity limitation scores was -1.00 (SD = 7.43) and this difference was not 
significant t(21) = -0.63, p = .537. The mean differences in retest values ranged from -
16.20 – 18.60. Additionally, the following CR values were obtained for the following 
visit comparisons: for visit 1 vs visit 2, CR = 14.44 and CR% = 59.31%, for visit 1 vs 
visit 3, CR = 13.51 and CR% = 48.43%, and for visit 2 vs visit 3, CR = 9.72 and CR% = 
33.41%. Based on the CR, an observed change in the VAPP activity limitation scores of 
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at least 9.72 – 14.44 would suggest a fairly large amount of measurement error ranging 
from 33.41 – 59.31% variation in the VAPP activity limitation scores of primary 
communication partners of IWPD. These results suggest that the measure of VAPP 
activity limitation scores demonstrates unacceptable repeatability for primary 
communication partners of IWPD. 
3.7.2.1.11 Retest analysis of VAPP participation restriction 
scores for participants with Parkinson’s disease 
 
See objective 4 for retest analyses of VAPP participation restriction scores for 
participants with PD. 
3.7.2.1.12 Retest analysis of VAPP participation restriction 
scores for primary communication partners 
 
Results for retest analyses of the VAPP participation restriction scores for primary 
communication partners are summarized in Table 40. The ICC values related to the 
repeated measurement of VAPP participation restriction score across the three pairwise 
visits was found to be the following:  visit 1 versus visit 2 ICC = .88, p < .001, visit 1 
versus visit 3 ICC = .84, p < .001, and visit 2 versus visit 3 ICC = .85, p < .001. These 
results suggest that VAPP participation restriction scores as measured in the present 
study demonstrated good retest reliability in primary communication partners of IWPD 
because all of the ICC values across all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP participation restriction scores 
was -3.97 (SD = 11.67) and this difference was not significant t(22) = -1.63, p = .117. 
The mean differences in retest values ranged from -49.50 – 16.00. The mean difference 
between visit 1 and visit 3 for VAPP participation restriction scores was -2.14 (SD = 
12.44) and this difference was not significant t(21) = -0.81, p = .430. The mean 
differences in retest values ranged from -26.80 – 33.30. The mean difference between 
visit 2 and visit 3 for VAPP participation restriction scores was 1.60 (SD = 12.64) and 
this difference was not significant t(21) = 0.59, p = .559. The mean differences in retest 
values ranged from -16.40 – 36.80. Additionally, the following CR values were obtained 
for the following visit comparisons: for visit 1 vs visit 2, CR = 17.65 and CR% = 93.57%, 
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for visit 1 vs visit 3, CR = 18.12 and CR% = 79.38%, and for visit 2 vs visit 3, CR = 
18.46 and CR% = 86.82%. Based on the CR, an observed change in the VAPP 
participation restriction scores of at least 17.65 – 18.46 would suggest a large amount of 
measurement error ranging from 79.38 – 93.57% variation in the VAPP participation 
restriction scores of primary communication partners of IWPD. These results suggest that 
the measure of VAPP participation restriction scores demonstrates unacceptable 
repeatability for primary communication partners of IWPD. 
3.7.2.1.13 Retest analysis of VAPP total scores for 
participants with Parkinson’s disease 
 
See objective 4 for retest analyses of VAPP total scores for participants with PD. 
3.7.2.1.14 Retest analysis of VAPP total scores for primary 
communication partners 
 
Results for retest analyses of the VAPP total scores for primary communication partners 
are summarized in Table 41. The ICC values related to the repeated measurement of 
VAPP total scores across the three pairwise visits was found to be the following: visit 1 
versus visit 2 ICC = .88, p < .001, visit 1 versus visit 3 ICC = .94, p < .001, and visit 2 
versus visit 3 ICC = .92, p < .001. These results suggest that VAPP total scores as 
measured in the present study demonstrated good retest reliability in primary 
communication partners of IWPD because all of the ICC values across all comparisons 
were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for VAPP total scores was -11.41 (SD = 
32.55) and this difference was not significant t(22) = -1.68, p = .107. The mean 
differences in retest values ranged from -142.80 – 22.40. The mean difference between 
visit 1 and visit 3 for VAPP total scores was -7.93 (SD = 22.36) and this difference was 
not significant t(21) = -1.66, p = .111. The mean differences in retest values ranged from 
-57.4 – 19.6. The mean difference between visit 2 and visit 3 for VAPP total scores was 
2.87 (SD = 27.87) and this difference was not significant t(21) = 0.48, p = .634. The mean 
differences in retest values ranged from -41.10 – 85.40. Additionally, the following CR 
values were obtained for the following visit comparisons: for visit 1 vs visit 2, CR = 
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48.61 and CR% = 78.79%, for visit 1 vs visit 3 CR = 32.33 and CR% = 44.23%, and for 
visit 2 vs visit 3, CR = 39.63 and CR% = 56.01%. Based on the CR, an observed change 
in the VAPP total scores of at least 32.33 – 48.61 would suggest a fairly large amount of 
measurement error ranging from 44.23 – 78.79% variation the VAPP total scores of 
primary communication partners of IWPD. These results suggest that the measure of 
VAPP total scores demonstrates unacceptable repeatability for primary communication 
partners of IWPD. 
3.7.3 CPIB scores 
 
CPIB scores were obtained by converting the raw total score to a standardized score 
using the conversion table indicated by Baylor and colleagues (2013). Descriptive 
statistics for CPIB standardized scores can be found in Table 42. The results of the two-
way repeated measures ANOVA for the dependent variable of the CPIB standardized 
scores showed that there was no significant main effect of “Group” F(1,42) = 1.18, p = 
.283 with participants with PD having a similar marginal mean (M = 52.01, SD = 7.83) 
compared to their primary communication partners (M = 54.58, SD = 7.83). In contrast, 
there was a significant main effect of “Visit” on the CPIB standardized scores F(2, 84) = 
6.33, p = .003. A closer look at the factor “Visit”, using pairwise post-hoc analyses 
indicated that the marginal mean of the CPIB score at visit 1 (M = 54.85, SD = 8.89) was 
greater than the marginal mean of the CPIB score at visit 2 (M = 53.62, SD = 7.76) and 
visit 3 (M = 51.40, SD = 9.42). Finally, there was no significant “Group” by “Visit” 
interaction F(2,84) = 0.12, p = .887 for the CPIB score. This interaction is illustrated in 
Figure 41. These results suggest that self-and proxy-rated CPIB scores are consistent over 
time. 
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Figure 41: Means of Communicative Participation Item Bank Scores for 
Participants with Parkinson's Disease and Primary Communication Partners of 
Participants with Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 41. This figure demonstrates the changes in mean CPIB scores for participants 
with PD and their primary communication across visits. Error bars represent standard 
deviations. 
3.7.3.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of CPIB scores. These analyses were 
performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) SEM across visits 
1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) 
pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 
2-3. Separate retest analyses were performed on the participants with PD and their 
primary communication partner.  
3.7.3.1.1 Retest analysis of CPIB scores for participants 
with Parkinson’s disease 
 
See objective 4 for retest analyses of CPIB scores for participants with PD. 
Participants with PD 
Primary communication 
partners 
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3.7.3.1.2 Retest analysis of CPIB scores for primary 
communication partners 
 
Results for retest analyses of CPIB scores for primary communication partners are 
summarized in Table 43. The ICC values related to the repeated measurement of CPIB 
scores across the three pairwise visits was found to be the following:  visit 1 versus visit 2 
ICC = .78, p < .001, visit 1 versus visit 3 ICC = .76, p = .001, and visit 2 versus visit 3 
ICC = .87, p < .001. These results suggest that CPIB scores as measured in the present 
study demonstrated good retest reliability in primary communication partners of IWPD 
because all of the ICC values across all comparisons were above our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for CPIB scores was 1.44 (SD = 7.47) 
and this difference was not significant t(22) = 0.93, p = .364. The mean differences in 
retest values ranged from -11.40 – 22.60. The mean difference between visit 1 and visit 3 
for CPIB scores was 3.42 (SD = 8.48) and this difference was not significant t(21) = 1.89, 
p = .072. The mean differences in retest values ranged from -10.20 – 35.00 The mean 
difference between visit 2 and visit 3 for CPIB scores was 1.79 (SD = 6.54) and this 
difference was not significant t(21) = 1.29, p = .213. The mean differences in retest 
values ranged from -10.20 – 18.30. Additionally, the following CR values were obtained 
for the following visit comparisons: for visit 1 vs visit 2, CR = 11.38 and CR% = 20.23%, 
for visit 1 vs visit 3, CR = 13.43 and CR% = 24.50%, and for visit 2 vs visit 3, CR = 9.72 
and CR% = 18.40%. Based on the CR, an observed change in the CPIB scores of at least 
9.72 – 13.43 would suggest the possibility of an acceptable amount of measurement error 
ranging from 18.40 – 24.50% variation in the CPIB scores of primary communication 
partners of IWPD. These results suggest that the measure of CPIB scores demonstrates 
marginal repeatability for primary communication partners of IWPD. 
3.7.4 LSUS scores 
 
LSUS scores were obtained based on whether participants indicated that the first, second, 
third, fourth, or fifth categories was indicative of their typical level of speech usage. 
Descriptive statistics for LSUS scores can be found in Table 44. The results of the two-
way repeated measures ANOVA for the dependent variable of the LSUS score showed 
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that there was no significant main effect of “Group” F(1,42) = 0.00, p = 1.00. 
Additionally, there was no significant main effect of “Visit” F(2,84) = 0.57, p = .568 and 
no significant “Group” by “Visit” interaction F(2,84) = 2.25, p = .112 for the LSUS 
score. This interaction is illustrated in Figure 42. These results suggest that participants 
with PD and their primary communication partners are consistent in their perceptions of 
typical level of speech usage, and those ratings do not appear to be fluctuate over time. 
Figure 42: Means of Level of Speech Usage Scale Scores for Participants with 
Parkinson's Disease and Primary Communication Partners of Participants with 
Parkinson’s Disease Across Visits 1, 2, and 3 
 
Figure 42. This figure demonstrates the changes in mean LSUS scores for participants 
with PD and their primary communication partners across visits. Error bars represent 
standard deviations. 
 
3.7.4.1 Retest analyses 
 
Following the primary statistical analyses described above, secondary retest analyses 
evaluated the retest reliability and repeatability of LSUS scores. These analyses were 
performed via: 1) correlations (ICC) between visits 1-2, 1-3 and 2-3, 2) SEM across visits 
1-2, 1-3, and 2-3, 3) mean difference t-tests comparing visits 1-2, 1-3, and 2-3, 4) 
Participants with PD 
Primary communication 
partners 
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pairwise CR involving visits 1-2, 1-3, and 2-3, and 5) CR% involving visits 1-2, 1-3, and 
2-3. Separate retest analyses were performed on the participants with PD and their 
primary communication partner.  
3.7.4.1.1 Retest analysis of LSUS scores for participants 
with Parkinson’s disease 
 
See objective 4 for retest analyses of LSUS scores for participants with PD. 
3.7.4.1.2 Retest analysis of LSUS scores for primary 
communication partners 
 
Results for retest analyses of LSUS scores for primary communication partners are 
summarized in Table 45. The ICC values related to the repeated measurement of LSUS 
scores across the three pairwise visits was found to be the following: visit 1 versus visit 2 
ICC = .70, p = .004, visit 1 versus visit 3 ICC = .60, p = .018, and visit 2 versus visit 3 
ICC = .80, p < .001. These results suggest that LSUS scores as measured in the present 
study did not demonstrate good retest reliability in primary communication partners of 
IWPD because the ICC values across 2 of 3 comparisons were below our criterion of .75. 
 
The mean difference between visit 1 and visit 2 for LSUS scores was 0.09 (SD = 0.90) 
and this difference was not significant t(22) = 0.46, p = .648. The mean differences in 
retest values ranged from -2 – 2. The mean difference between visit 1 and visit 3 for 
LSUS scores was 0.27 (SD = 0.88) and this difference was not significant t(21) = 1.45, p 
= .162. The mean differences in retest values ranged from -1 – 2. The mean difference 
between visit 2 and visit 3 for LSUS scores was 0.23 (SD = 0.69) and this difference was 
not significant t(21) = 1.56, p = .135. The mean differences in retest values ranged from -
1 – 2. Additionally, the following CR values were obtained for the following visit 
comparisons: for visit 1 vs visit 2, CR = 1.40 and CR% = 65.89%, for visit 1 vs visit 3, 
CR = 1.45 and CR% = 71.32%, and for visit 2 vs visit 3, CR = 1.04 and CR% = 56.90%. 
Based on the CR, an observed change in the LSUS scores of at least 1.04 – 1.45 would 
suggest a large amount of measurement error ranging from 56.90 – 71.32% variation in 
the LSUS scores of primary communication partners of IWPD. These results suggest that 
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the measure of LSUS scores demonstrates unacceptable repeatability for primary 
communication partners of IWPD. 
3.8 Statistical Analysis for Objective 7: Inter-Relationships 
Among Variables in Participants with Parkinson’s 
Disease 
 
In order to answer the question ‘Are measures of speech intensity, speech intelligibility, 
communicative participation, demographic factors, and non-speech factors related to one 
another in participants with PD?’, a matrix of inter-correlations was obtained via a series 
of three Pearson correlations (p < .05) applied to all possible pairwise combination of the 
experimental variables, demographic factors, and non-speech factors for participants with 
PD across each of the three experimental visits. The measures of speech intensity 
included in these analyses were: habitual speech intensity, maximum speech intensity, 
Lombard response function, magnitude production, and self-perception of typical speech 
loudness. The measures of speech intelligibility included in these analyses were: SIT 
transcription score, SIT VAS score, and conversational intelligibility VAS score. The 
measures of communicative participation included in these analyses were: CES questions 
1 through 8, VAPP self-perceived voice problem score, VAPP daily communication 
score, VAPP social communication score, VAPP emotion score, VAPP activity limitation 
score, VAPP participation restriction score, CPIB score, VAPP total scores, and LSUS 
score. The measures of demographic factors included in these analyses were: age, gender, 
and disease duration. The measures of non-speech factors included in these analyses 
were: GDS scores, disease severity as measured by overall UPDRS scores, and MOCA 
scores. Only significant correlations, above r £ .50, across the three visits were included 
and are presented below. This criterion value of r £ .50 was chosen as the minimum 
threshold since correlations greater than .50 are indicative of a moderate to a very strong 
relationship between variables (Mukaka, 2012). Since a primary goal of this study is to 
investigate the consistency of various measures related to hypophonia and 
communication in IWPD, focusing on significant correlations that minimally had a 
moderate relationship across all three experimental visits permitted us to identify the 
most salient variables related to each other. Results of all analyzed correlations are 
summarized in Tables 50, 51, and 52 for visits 1, 2, and 3 respectively.
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Table 50: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Communicative Participation Measures, 
Demographic Factors, and Non-Speech Factors for Participants with Parkinson's Disease for Visit 1 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
1. Habitual 
speech 
intensity 
– .61 
** 
.17 -.16 -.07 -.24 -.47 
* 
-.25 -.18 -.15 .08 -.02 .00 -.16 -.04 .10 -.24 .25 .24 .36 .29 . 31 . 33 .28 -.06 .14 -.41 
* 
.06 -.18 -.02 -.21 -.25 
2. Maximum 
speech 
intensity 
 – .56 
** 
.60 
** 
-.26 .14 .01 .04 -.23 .00 -.04 .00 -.02 -.04 .17 -.09 -.04 .04 .05 .01 .04 .05 .10 . 01 .10 -.01 -.12 -.18 -.39 
t 
-.15 .21 -.30 
3. Lombard 
response function 
  – .58 
** 
-.08 .30 .27 .23 -.30 -.06 .09 .10 -.13 -.09 -.15 -.31 .04 -.26 -.14 -.20 -.29 -.22 -.10 -.25 .03 -.30 .29 -.29 -.10 -.03 .26 -.17 
4. Magnitude 
production    
   – -.21 .42 .48 
* 
.34 
* 
-.13 .14 -.05 .12 .08 .01 .09 -.16 .27 -.24 -.27 -.44 -.32 -.31 -.27 -.32 
* 
.13 -.12 .33 -.27 -.26 -.12 .53 -.11 
** 
5. Typical speech  
loudness      
    – -.42 
* 
-.22 .06 .20 .22 .30 .18 -.07 .02 .12 .16 .13 -.44 
* 
-.32 -.17 -.35 -.33 -.39 
t 
-.21 .00 .03 .37 .18 .38 .15 -.19 .03 
7. 6. SIT  
8. transcription    
     – .85 
** 
.28 -.02 .09 -.17 -.06 -.02 .07 -.02 .13 
 
-.05 
 
.02 .03 .01 .01 .03 .04 .03 .22 -.21 .35 -.41 -.03 -.24 .52 
* 
.34 
7. SIT VAS           – .36 .15 .15 -.14 -.15 -.08 -.05 -.04 -.14 -.11 -.05 -.02 -.09 -.09 -.07 -.05 -.05 .24 -.23 .60 
** 
-.39 
t 
-.03 -.14 .65 
** 
.31 
8. Conversational 
intelligibility 
       – -.22 -.17 -.25 .02 -.06 .15 .07 -.13 -.03 -.21 -.16 -.10 -.14 -.12 -.16 -.04 .13 -.39 
t 
.29 -.41 
t 
.25 -.03 .09 .01 
9. CES Q1         – .53 
** 
.37 .10 .00 .34 .32 .12 .16 .00 .03 -.16 .01 -.01 -.03 .00 .51 
* 
.60 
** 
.16 -.05 -.47 
* 
.06 .26 .12 
10. CES Q2          – .53 
* 
.46 
* 
.18 .59 
** 
.52 
* 
.22 .47 
* 
-.50 
* 
-.52 
* 
-.53 
** 
-.48 
* 
-.51 
* 
-.57 
** 
-.43 
* 
.23 .26 .16 .17 -.32 -.06 .03 .32 
11. CES Q3           – .59 
** 
-.04 .46 
* 
.24 -.04 .43 
* 
-.49 
* 
-.50 
* 
-.55 
** 
-.43 
* 
-.46 
* 
-.45 
* 
-.45 
* 
.11 .27 -.04 -.07 -.21 -.29 -.20 -.04 
12. CES Q4            – .49 
* 
.56 
** 
.30 .41 
t 
.49 
* 
-.43 
* 
-.52 
* 
-.58 
** 
-.45 
* 
-.49 
* 
-.53 
** 
-.43 
* 
.02 .12 -.07 -.19 -.22 -.48 
* 
-.04 .09 
13. CES Q5             – .40 
t 
.27 .46 
* 
.17 .19 .08 -.13 -.03 .01 -.09 .10 -.19 .20 -.02 .17 -.32 -.33 .07 .46 
* 
14. CES Q6                 – .65 
** 
.32 .49 
* 
-.30 -.32 -.44 
* 
-.29 -.32 -.39 
t 
-.25 .15 .31 -.10 -.07 -.27 -.24 -.13 .40 
t 
15. CES Q7               – .32 .43 
* 
-.36 -.37 -.31 -.43 
* 
-.41 
t
  
-.46 
* 
-.31 .04 .33 -.12 -.22 -.08 .03 -.17 .06 
16. CES Q8                – .39 
t 
-.10 -.17 -.05 -.08 -.12 -.25 -.03 -.14 .23 -.17 .04 -.06 -.12 -.06 .27 
17. CPIB                 – -.69 
** 
-.74 
** 
-.83 
** 
-.68 
** 
-.76 
** 
-.76 
** 
-.76 
** 
-.19 .32 -.01 .04 -.10 .21 -.26 .19 
18. VAPP 
voice problem 
                 – .94 
** 
.76 
** 
.93 
** 
.95 
** 
.92 
** 
.90 
** 
.10 .11 -.26 .11 -.32 -.19 .24 -.07 
19. VAPP daily 
communication 
                  – .82 
** 
.92 
** 
.96 
** 
.97 
** 
.92 
** 
.20 .14 -.21 .04 -.28 -.04 .20 -.08 
20. VAPP 
social 
communication 
                   – .78 
** 
.85 
** 
.83 
** 
.87 
** 
-.02 -.06 -.26 -.03 .14 .05 .05 -.23 
21. VAPP 
emotion  
                    – .98 
** 
.94 
** 
.92 
** 
.25 .08 -.35 .11 -.29 -.14 .15 -.13 
22. VAPP total                      – .97 
** 
.97 
** 
.24 .09 -.29 .05 -.24 -.12 .19 -.15 
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23. VAPP 
activity 
limitation 
                      – .90 
** 
.25 .10 -.28 -.01 -.24 -.05 .18 -.18 
24. VAPP 
participation 
restriction  
                       – .22 .07 -.22 .03 -.18 -.16 .20 -.13 
25. LSUS 
      
                        – .16 .08 -.18 -.47 
* 
-.25 .39 
t 
-.04 
26. Age                          – -.18 -.14 -.45 
* 
.21 -.05 .03 
27. Gender                            – -.03 .15 -.03 .54 
** 
.36 
28. Disease 
duration 
                           – -.06 .20 -.29 .37 
29. GDS                             – .22 -.37 -.03 
30. UPDRS                              – -.34 -.05 
31. MOCA                               – .00 
32. Medication 
effectiveness 
                               – 
 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3. Correlations highlighted in blue were statistically significant 
and greater than or equal to .50. 
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Table 51: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Communicative Participation Measures, 
Demographic Factors, and Non-Speech Factors for Participants with Parkinson's Disease for Visit 2 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
1. Habitual 
speech 
intensity 
– .69 
** 
-.22 .09 .09 .01 -.09 -.02 -.10 .05 -.18 -.19 -.04 -.43 
* 
.20 -.21 .08 .30 .03 .25 .12 .15 .10 .15 -.02 .23 -.27 -.08 -.13 .00 -.04 -.08 
2. Maximum 
speech 
intensity 
 – -.09 .72 
** 
.11 .09 -.05 .24 -.02 .29 .03 -.05 -.11 -.23 .19 -.18 .42 
* 
.03 -.21 -.17 -.24 -.18 -.16 -.17 -.12 .12 -.09 -.34 .34 -.08 .23 -.29 
3. Lombard 
response function 
  – -.02 -.32 .22 .20 .20 .42 
* 
.11 .38 .21 .01 -.02 .24 .01 -.04 -.27 -.13 -.13 -.21 -.18 -.14 -.15 -.04 .09 .50 
* 
-.56 
** 
.10 -.03 .39 
t 
.05 
4. Magnitude 
production    
   – .04
  
.02 -.10 .21 .09 
 
.51 
 
.34 
* 
.18 
 
-.01 
 
.08 
 
.21 
 
.01 
 
.58 
 
-.17 
** 
-.29 -.44 -.38 
* 
-.35 -.27 -.35 -.32 .06 .11 -.29 .35 -.01 .18 -.25 
5. Typical speech  
loudness      
    – -.34 
 
-.37 
 
.16 
 
-.04 
 
.01 
 
-.27 
 
-.41 
* 
-.15 -.10 -.37 -.18 .12 .00 -.02 -.20 -.08 -.04 -.12 .05 .30 .19 .04 .24 -.24 -.06 .00 -.23 
9. 6. SIT  
10. transcription    
     – .76 
** 
.45 
* 
.12 -.11 .31 .28 .55 
** 
.14 .04 .16 .10 -.30 -.18 -.01 -.18 -.15 -.17 -.04 .18 -.20 .41 
t 
-.30 
 
.10 
 
-.26 
 
.52 
* 
.26 
7. SIT VAS           – .52 
* 
.08 -.24 .08 .24 .36 -.09 -.16 .16 -.03 -.45 
* 
-.09 .02 -.06 -.09 -.03 -.09 .20 -.38 .35 -.08 .03 
 
-.02 
 
.44 
* 
.39 
t 
8. Conversational 
intelligibility 
       – -.09 -.17 .01 .10 .22 -.08 -.12 .20 .24 -.66 
** 
-.34 
 
-.52 
* 
-.37 -.38 -.37 -.30 .32 -.38 .28 -.17 -.03 -.30 .31 .07 
9. CES Q1         – .68 
** 
.53 
** 
.21 .31 
 
.17 .50 
* 
.09 .12 -.09 -.02 .02 -.04 -.02 .01 -.02 .15 .40 
t 
.46 
* 
-.17 -.45 
* 
-.08 .54 
** 
.26 
10. CES Q2               – .48 
* 
.25 .16 .30 .58 
** 
.09 .49 
* 
-.10 -.24 -.24 -.28 -.22 -.13 -.26 .00 .45 
* 
.08 
 
-.16 
 
-.49 
* 
-.13 .21 .00 
11. CES Q3           – .47 
* 
.60 
** 
.30 .58 
** 
.31 .37 -.21 -.27 -.22 -.30 -.32 -.34 -.29 -.36 .15 .54 
** 
.01 
 
-.16 -.12 
 
.35 .40 
t 
12. CES Q4            – .50 
* 
.28 
 
.54 
** 
 
.59 
** 
.33 
 
-.50 
* 
-.54 
** 
-.39 
t 
-.37 -.50 
* 
-.48 
* 
-.53 
** 
-.42 
* 
-.10 .04 -.22 .15 -.25 .06 .03 
13. CES Q5             – .22 .29 
 
.46 
* 
.13 -.22 -.18 -.03 -.09 -.13 -.22 -.05 .00 .01 .29 .27 -.17 -.31 .27 .34 
14. CES Q6                 – -.03 .39t 41 
t 
-.12 -.26 -.27 -.15 -.25 -.34 -.23 .10 .25 -.17 -.04 -.17 -.08 -.10 .15 
15. CES Q7               – .23 .22 -.14 -.31 -.16 -.24 -.25 -.23 -.26 -.28 .12 .11 -.19 -.02 -.18 .13 .03 
16. CES Q8                – .00 -.25 -.15 -.22 .13 -.08 -.21 -.09 .10 -.09 -.21 -.04 -.18 -.45 
* 
.07 .12 
17. CPIB                 – -.60 
** 
-.79 
** 
-.71 
** 
-.75 
** 
-.80 
** 
-.77 
** 
-.78 
** 
-.25 .34 .09 -.08 -.16 .06 -.08 .11 
18. VAPP 
voice problem 
                 – .80 
** 
.76 
** 
.75 
** 
.81 
** 
.75 
** 
.76 
** 
.01 .23 -.36 .09 -.19 .07 -.14 -.12 
19. VAPP daily 
communication 
                  – .82 
** 
.88 
** 
.97 
** 
.95 
** 
.93 
** 
.26 .00 -.12 .15 -.12 .16 .05 -.01 
20. VAPP 
social 
communication 
                   – .85 
** 
.89 
** 
.80 
** 
.87 
** 
.17 .10 -.13 .17 .01 .31 .08 .02 
21. VAPP 
emotion  
                    – .95 
** 
.82 
** 
.91 
** 
.31 .03 -.29 .21 -.12 .09 .03 -.01 
22. VAPP total                      – .94 .97 .34 .04 -.22 .15 -.13 .11 .07 -.07 
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** ** 
23. VAPP 
activity 
limitation 
                      – .86 
** 
.26 -.02 -.17 .10 -.13 .10 .06 -.02 
24. VAPP 
participation 
restriction  
                       – .42 
* 
.06 -.14 .13 -.11 .09 .14 -.13 
25. LSUS 
      
                        – .10 -.13 .02 -.37 -.19 .36 -.05 
26. Age                          – -.18 -.14 -
.45
* 
.21 -.05 .03 
27. Gender                            – -.03 .15 -.03 .54 
** 
.36 
28. Disease 
duration 
                           – -.06 .20 -.29 .37 
29. GDS                             – .22 -.37 -.03 
30. UPDRS                              – -.34 -.05 
31. MOCA                               – .00 
32. Medication 
effectiveness 
                               – 
 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3. Correlations highlighted in blue were statistically significant 
and greater than or equal to .50. 
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Table 52: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Communicative Participation Measures, 
Demographic Factors, and Non-Speech Factors for Participants with Parkinson's Disease for Visit 3 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
1. Habitual 
speech 
intensity 
– .48 
* 
.12 -.16 -.27 .30 .13 .09 -.04 .03 -.22 -.11 -.25 -.44 
* 
.02 -.17 .10 -.15 -.13 -.08 -.10 -.11 -.12 -.09 -.12 .19 -.02 -.31 -.13 -.06 .13 .23 
2. Maximum 
speech 
intensity 
 – .38 .73 
** 
-.12 .60 
** 
.68 
** 
.43 
* 
-.13 -.16 -.11 .08 -.26 -.35 .02 -.25 .35 -.19 -.26 -.29 -.34 -.29 -.24 -.27 -.38 -.11 .10 -.46 
* 
-.32 -.21 .46 
* 
-.01 
3. Lombard 
response function 
  – 28 -.03 .54 
** 
.60 
** 
.49 
* 
.13 -.03 .18 .05 .16 .02 .27 -.07 .25 -.21 -.32 -.30 -.34 -.36 -.32 -.39 -.13 -.30 .50 
* 
-.46 
* 
.19 -.02 .32 .09 
4. Magnitude 
production    
   – .02 .38 .53 
* 
.32 .01 -.21 .07 .11 -.08 -.10 -.01 -.21 .35 -.07 -.25 -.32 -.35 -.28 -.20 -.29 -.32 -.18 .03 -.18 -.36 -.06 .40 
t 
-.20 
5. Typical speech  
loudness      
    – -.03 .01 .05 .17 .37 .37 .30 .20 .54 
** 
.46 
* 
.43 
* 
.16 -.23 -.04 -.13 -.02 -.04 -.09 .01 .16 .15 .07 .10 -.29 -.13 .22 -.01 
11. 6. SIT  
12. transcription    
     – 69 
** 
.27 .04 .06 .13 -.14 -.27 -.13 -.10 -.30 .09 -.04 .05 .06 .04 .05 .06 .07 -.06 -.21 .37 -.51 
* 
-.20 -.32 .64 
** 
-.04 
7. SIT VAS           – .58 
** 
-.03 -.08 .03 .09 .04 -.19 .03 -.02 .27 -.09 -.06 -.05 -.12 -.10 -.08 -.10 -.13 -.36 .46 
* 
-.41 
t 
-.04 -.24 .50 
* 
.17 
8. Conversational 
intelligibility 
       – -.07 .06 -.13 .05 .00 .04 .12 .12 .11 -.33 -.20 -.22 -.23 -.21 -.14 -.21 -.02 -.44 
* 
.09 -.50 
* 
.27 -.16 -.03 -.10 
9. CES Q1         – .72 
** 
.62 
** 
.31 .59 
** 
.69 
** 
.46 
* 
.51 
* 
.57 
** 
-.31 -.40 
t 
-.42 
t 
-.38 -.41 
t 
-.38 -.43 
* 
-.09 .13 .22 .20 -.02 .20 -.01 .18 
10. CES Q2               – .46 
* 
.38 .33 .65 
** 
.42 
* 
.55 
** 
.54 
** 
-.45 
* 
-.36 -.38 -.37 -.36 -.34 -.33 .05 .32 .07 .04 -.23 -.16 -.09 .26 
11. CES Q3           – .57 
** 
.61 
** 
.56 
** 
.53 
* 
.49 
* 
.30 -.17 -.24 -.22 -.10 -.20 -.25 -.22 -.15 -.07 .12 .19 -.04 -.20 .10 -.10 
12. CES Q4            – .68 
** 
.38 .52 
* 
.65 
** 
.63 
** 
-.39 -.52 
* 
-.46 
* 
-.37 -.48 
* 
-.53 
* 
-.48 
* 
-.31 .04 -.03 .05 -.14 -.45 
* 
-.06 .22 
13. CES Q5             – .51 
* 
.58 
** 
.70 
** 
.47 
* 
-.17 -.31 -.28 -.20 -.31 -.35 -.36 -.24 -.09 .16 .19 .18 .01 -.13 .20 
14. CES Q6                 – .59 
** 
.65 
** 
.34 -.21 -.17 -.26 -.14 -.19 -.18 -.20 -.10 .04 .05 .07 .16 .08 -.15 -.02 
15. CES Q7               – .56 
** 
.47 
* 
-.31 -.44 
* 
-.46 
* 
-.38 
 
-.47 
* 
-.50 
* 
-.48 
* 
-.40 .24 -.18 -.14 -.01 .12 -.17 .07 
16. CES Q8                – .41 
t 
-.21 -.25 -.27 -.16 -.23 -.27 -.22 -.01 .04 .08 .11 .13 -.28 -.07 .31 
17. CPIB                 – -.61 
** 
-.75 
** 
-.77 
** 
-.77 
** 
-.79 
** 
-.77 
** 
-.78 
** 
-.47 
* 
.29 .25 -.01 -.33 -.12 .08 .46 
* 
18. VAPP 
voice problem 
                 – .83 
** 
.77 
** 
.70 
** 
.80 
** 
.83 
** 
.75 
** 
.08 -.02 -.11 -.10 .08 .19 .22 -.21 
19. VAPP daily 
communication 
                  – .94 
** 
.91 
** 
.98 
** 
.98 
** 
.98 
** 
.21 -.15 -.02 -.01 .17 .12 .13 -.16 
20. VAPP 
social 
communication 
                   – .95 
** 
.96 
** 
.93 
** 
.94 
** 
.21 -.16 -.06 -.02 .29 .07 .06 -.14 
21. VAPP 
emotion  
                    – .96 
** 
.90 
** 
.93 
** 
.23 -.27 -.13 .06 .31 -.04 .02 -.16 
22. VAPP total                      – .98 
** 
.99 
** 
.26 -.18 -.09 -.01 .19 .02 .12 -.21 
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23. VAPP 
activity 
limitation 
                      – .96 
** 
.25 -.15 -.09 -.07 .17 .08 .14 -.25 
24. VAPP 
participation 
restriction  
                       – .29 -.14 -.05 .00 .12 -.01 .16 -.19 
25. LSUS 
      
                        – -.24 -.04 .32 -.10 -.11 .04 .02 
26. Age                          – -.18 -.14 -.45 
* 
.21 -.05 .03 
27. Gender                            – -.03 .15 -.03 .54 
** 
.36 
28. Disease 
duration 
                           – -.06 .20 -.29 .37 
29. GDS                             – .22 -.37 -.03 
30. UPDRS                              – -.34 -.05 
31. MOCA                               – .00 
32. Medication 
effectiveness 
                               – 
 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3. Correlations highlighted in blue were statistically significant 
and greater than or equal to .50.
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3.8.1 Speech intensity measures 
 
Three hundred ninety-five of 435 correlations involving speech intensity measures across 
all three visits were not significant. Twenty-four of the 40 significant correlations had 
correlation coefficients below our criterion threshold of .50, and were therefore, not 
included in our analyses since the strength of the relationship was considered relatively 
weak. However only those correlations that were significantly and highly correlated 
across all 3 visits have been reported. Maximum speech intensity was significantly and 
highly correlated with magnitude productions for visits 1, 2, and 3 for participants with 
PD r = .60, p = .003, r = .72, p < .001, and r = .73, p < .001 respectively.  
3.8.2 Speech intelligibility measures 
 
Two hundred thirty-eight of 270 correlations involving speech intelligibility measures 
across all 3 visits were not significant. Eleven of the 32 significant correlations had 
correlation coefficients below our criterion threshold of .50, and were therefore, not 
included in our analyses since the strength of the relationship was considered relatively 
weak. However only those correlations that were significantly and highly correlated 
across all three visits have been reported. SIT transcription scores and SIT VAS ratings 
were significantly and highly correlated across all three visits for participants with PD r = 
.85, p < .001, r = .76, p < .001, and r = .69, p < .001 respectively. These results suggest 
that VAS ratings and orthographic transcription percentage scores are moderately to 
strongly correlated as a means of evaluating sentence intelligibility in IWPD.  
3.8.3 Communicative participation measures 
 
Nine hundred fifty-two of 1173 correlations involving communicative participation 
measures across all three visits were not significant. Sixty-eight of the 221 significant 
correlations had correlation coefficients below our criterion threshold of .50, and were 
therefore not included in our analyses since the strength of the relationship was 
considered relatively weak. However only those correlations that were significantly and 
highly correlated across all three visits have been reported. The CPIB standardized score 
was significantly and highly correlated with the VAPP self-perceived voice problem score 
across all three visits in participants with PD r = -.69, p < .001, r = -.60, p = .003, and r 
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= -.61, p = .002 respectively. The CPIB standardized score was significantly and highly 
correlated with the VAPP total score in participants with PD across visits 1, 2, and 3 r = -
.76, p < .001, r = -.80, p < .001, and r = -.79, p < .001 respectively. These correlations 
were negative, suggesting that as the CPIB score decreased, the VAPP scores increased, 
and vice versa. A lower score on the CPIB suggests a greater impact on one’s 
communicative participation. A higher VAPP score suggests an increased impact that a 
voice problem has on one’s activity and participation.  Therefore, the negative 
correlations are the result of how the instruments are scaled. These results suggest that the 
CPIB and the VAPP voice problem and total scores are highly and significantly 
associated with each other.  
 
Forty-seven of 84 correlations involving the pairwise comparisons of the 8 questions 
within the CES were significant and moderately correlated. Only 38% of these significant 
correlations were significantly correlated across all three visits. Three of the 18 
correlations that were significant across all three visits fell above our criterion threshold 
of .5. The correlations of all pairwise comparisons of the eight questions within the CES 
ranged from r = -.04 – .66 for visit 1, r = -.03 – .68 for visit 2 and r = .31 – .72 for visit 3. 
The full correlation matrix related to these within test correlations for the CES at all three 
visits are provided in Tables 50, 51, and 52.  
 
All 63 correlations involving the pairwise comparisons of the seven subsections within 
the VAPP were significant and highly correlated. These correlations ranged from r = .76 
– .98 for visit 1, r = .75 – .97 for visit 2, and r = .75 – .99 for visit 3. The full correlation 
matrix related to these within test correlations for the VAPP at all three visits are 
provided in Tables 50, 51, and 52. These results suggest that, over time, IWPD 
consistently self-rate the impact of their voice problem on the VAPP.  
3.8.4 Demographic and non-speech factors 
 
Descriptive statistics for demographic and non-speech factors, including age, disease 
duration, GDS scores, UPDRS scores, MOCA scores, and medication effectiveness can 
be found in Table 53. Five hundred fifty of 588 correlations involving demographic and 
non-speech factors across all three visits were not significant. Twenty-one of the 38 
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significant correlations had correlation coefficients below our criterion threshold of .50, 
and were therefore, not included in our analyses since the strength of the relationship was 
considered relatively weak. However only those correlations that were significantly and 
highly correlated across all three visits have been reported. Gender and MOCA scores 
were significantly and moderately correlated across visits 1, 2, and 3 r = .54, p = .008, r 
= .54, p = .008, and r = .54, p = .008. These results suggest a sex difference between 
IWPD, wherein women with PD were more likely to present with higher scores on the 
MOCA than men. 
Table 53: Descriptive Statistics of Demographic and Non-Speech Factors for 
Participants with Parkinson's Disease and Control Participants 
 Age (years) 
mean(SD) 
Disease 
duration 
(years) 
mean(SD) 
GDS 
scores 
mean(SD) 
UPDRS 
scores 
mean(SD) 
MOCA 
scores 
mean(SD) 
MES  
scores 
mean(SD) 
Participants 
with PD 
69.48(5.57) 10.57(5.84) 2.48(3.03) 37.18(12.27) 24.70(3.43) 4.61(1.27) 
Control 
participants 
69.37(7.69) N/A .60(1.00) N/A 28.10(1.52) N/A 
Note. This table illustrates the means and standard deviations for the different 
demographic and non-speech factors for participants with PD and control participants. 
 
3.9 Statistical Analysis for Objective 8: Inter-Relationships 
Among Self- and Proxy-Measures in participants with 
Parkinson’s Disease 
 
In order to answer the question ‘Are measures of speech intensity, speech intelligibility, 
proxy ratings of communicative participation, demographic factors, and non-speech 
factors related to one another in participants with PD?’, a matrix of inter-correlations 
was obtained via a series of three Pearson correlations (p < .05) applied to all possible 
pairwise combination of the experimental variables, demographic factors, and non-speech 
factors for participants with PD across each of the three experimental visits. The 
measures of speech intensity included in these analyses were: habitual speech intensity, 
maximum speech intensity, Lombard response function, magnitude production, and 
proxy-perception of typical speech loudness. The measures of speech intelligibility 
included in these analyses were: SIT transcription score, SIT VAS score, and 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
220 
conversational intelligibility VAS score. The proxy measures of communicative 
participation included in these analyses were: CES questions 1 through 8, VAPP self-
perceived voice problem score, VAPP daily communication score, VAPP social 
communication score, VAPP emotion score, VAPP activity limitation score, VAPP 
participation restriction score, CPIB score, VAPP total scores, and LSUS score as rated 
by the primary communication partners of participants with PD. The measures of 
demographic factors included in these analyses were: age, gender, and disease duration. 
The measures of non-speech factors included in these analyses were: GDS scores, disease 
severity as measured by overall UPDRS scores, and MOCA scores. Only significant 
correlations, above r £ .50, across the three visits were included and are presented below. 
This criterion value of r £ .50 was chosen as the minimum threshold since correlations 
greater than .50 are indicative of a moderate to a very strong relationship between 
variables (Mukaka, 2012). Since a primary goal of this study is to investigate the 
consistency of various measures related to hypophonia and communication in IWPD, 
focusing on significant correlations that minimally had a moderate relationship across all 
three experimental visits permitted us to identify the most salient variables related to each 
other. Results of all analyzed correlations are summarized in Tables 54, 55, and 56 for 
visits 1, 2, and 3 respectively. 
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Table 54: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Proxy-Rated Communicative 
Participation Measures, Demographic Factors, and Non-Speech Factors for Participants with Parkinson's Disease for Visit 1 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
1. Habitual 
speech 
intensity 
– .61 
** 
.17 -.16 .06 -.24 -.47 
* 
-.25 -.28 -.18 -.39 
t 
-.31 -.31 -.34 .08 -.27 -.28 .05 .22 .19 .30 .27 .20 .30 -.07 .14 -.41 
* 
.06 -.18 -.02 -.21 -.25 
2. Maximum 
speech 
intensity 
 – .56 
** 
.60 
** 
-.04 .14 .01 .04 -.65 
** 
.08 -.21 -.02 -.01 -.24 .08 .05 -.23 .03 .10 .09 .10 .12 .15 .10 -.23 -.01 -.12 -.18 -.39 -.15 .21 -.30 
3. Lombard 
response function 
  – .58 
** 
-.06 .30 .27 .23 -.31 -.13 .09 .13 -.07 -.20 .04 -.08 -.07 .00 -.06 -.02 -.31 -.11 .02 -.09 -.11 -.30 .29 -.29 -.10 -.03 .26 -.17 
4. Magnitude 
production    
   – -.07 .42 
* 
.48 
* 
.34 -.48 
* 
.21 .16 .25 .30 .05 .19 .24 .03 .03 -.16 -.17 -.28 -.18 -.05 -.22 -.18 -.12 .33 -.27 -.26 -.12 .53 
** 
-.11 
5. Typical speech  
loudness      
    – .01 -.04 .14 .23 .06 .39 
t 
.41 
* 
.40 
t 
.36 .51 
* 
.50 
* 
.59 
** 
-.66 
** 
-.55 
** 
-.55 
** 
-.44 
* 
-.58 
** 
-.63 
** 
-.48 
* 
.15 -.24 .11 .13 .21 -.17 -.12 .17 
13. 6. SIT  
14. transcription    
     – .85 
** 
.28 -.01 .26 .40 
t 
.29 .04 -.03 .45 
* 
.23 .20 -.02 -.18 -.13 -.30 -.21 -.11 -.23 .30 -.21 .35 -.41 
t 
-.03 -.24 .52 
* 
.34 
7. SIT VAS           – .36 -.03 .12 .40 
t 
.33 .05 .05 .41 
t 
.20 .12 -.04 -.09 -.13 -.26 -.15 -.06 -.14 .27 -.23 .60 
** 
-.39 
t 
-.03 -.14 .65 
** 
.31 
8. Conversational 
intelligibility 
       – -.01 .06 .24 .18 .20 .15 -.02 .17 .14 -.22 -.33 -.41 
t 
-.41 
t 
-.36 -.24 -.39 
t 
-.03 -.39 
t 
.29 -.41 
t 
.25 -.03 .09 .01 
9. CES Q1         – .20 .31 .02 -.17 .00 -.03 -.13 -.18 .02 -.09 -.05 -.26 -.13 -.10 -.06 .26 .17 -.02 .01 .19 .06 -.19 .41 
t 
10. CES Q2               – .54 
** 
.51 
* 
.32 -.11 .22 .55 
** 
.41 
* 
-.16 -.20 -.13 -.18 -.20 -.21 -.16 -.26 -.05 -.02 .02 -.09 -.38 -.02 .37 
11. CES Q3           – .74 
** 
.39 
t 
.15 .48 
* 
.48 
* 
.66 
** 
-.44 
* 
-.35 -.44 
* 
-.64 
** 
-.46 
* 
-.39 
t 
-.30 .24 -.19 .38 -.07 .23 -.18 -.05 .38 
12. CES Q4            – .59 
** 
.46 
* 
.36 .75 
** 
.68 
** 
-.52 
** 
-.49 
* 
-.55 
** 
-.47 
* 
-.53 
** 
-.54 
** 
-.45 
* 
.15 -.13 .37 -.16 .00 -.35 .08 .23 
13. CES Q5             – .61 
** 
.43 
* 
.83 
** 
.52 
** 
-.46 
* 
-.56 
** 
-.53 
** 
-.35 -.53 
** 
-.53 
** 
-.55 
** 
-.05 -.17 .27 -.20 .32 -.22 .11 -.13 
14. CES Q6                 – .18 .42 
t 
.28 -.27 -.36 -
.45
* 
-.13 -.34 -.35 -.41 
t 
.42 .17 .23 -.27 .18 -.13 .16 -.21 
15. CES Q7               – .51 
* 
.35 -.37 -.22 -.27 -.16 -.23 -.29 -.14 .15 -.34 .41 
t 
-.01 .20 -.35 .44 
* 
.13 
16. CES Q8                – .61 
** 
-.60 
** 
-.59 
** 
-.53 
** 
-.28 -.57 
** 
-.63 
** 
-.56 
** 
-.20 -.28 .22 -.13 .13 -.40 
t 
.10 .12 
17. CPIB                 – -.77 
** 
-.80 
** 
-.72 
** 
-.72 
** 
-.83 
** 
-.83 
** 
-.73 
** 
.09 -.17 .42 
* 
.22 .16 -.27 -.10 .53 
* 
18. VAPP 
voice problem 
                 – .75 
** 
.78 
** 
.56 
** 
.79 
** 
.85 
** 
.67 
** 
.04 .31 -.38 -.09 -.28 .30 .17 -.18 
19. VAPP daily 
communication 
                  – .86 
** 
.73 
** 
.98 
** 
.97 
** 
.98 
** 
.00 .15 -.36 .09 -.29 .26 .08 -.34 
20. VAPP 
social 
communication 
                   – .76 
** 
.88 
** 
.84 
** 
.82 
** 
-.21 .17 -.31 .19 -.21 .48 
* 
.03 -.13 
21. VAPP 
emotion  
                    – .83 
** 
.66 
** 
.73 
** 
-.23 .21 -.38 .13 -.26 .19 .09 -.35 
22. VAPP total                      – .96 
** 
.96 
** 
-.06 .18 -.39 
t 
.09 -.30 .24 .11 -.37 
23. VAPP 
activity 
limitation 
                      – .92 
** 
.02 .14 -.39 
t 
-.10 -.28 .25 .13 -.38 
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24. VAPP 
participation 
restriction  
                       – -.01 .15 -.32 .16 -.28 .21 .06 -.30 
25. LSUS 
      
                        – .30 .11 -.37 .04 -.16 .20 -.03 
26. Age                          – -.18 -.14 -.45 
* 
.21 -.05 .03 
27. Gender                            – -.03 .15 -.03 .54 
** 
.36 
28. Disease 
duration 
                           – -.06 .20 -.29 .37 
29. GDS                             – .22 -.37 -.03 
30. UPDRS                              – -.34 -.05 
31. MOCA                               – .00 
32. Medication 
effectiveness 
                               – 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3 for proxy-rated dependent variables. Correlations highlighted in 
blue were statistically significant and greater than or equal to .50.
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Table 55: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Proxy-Rated Communicative 
Participation Measures, Demographic Factors, and Non-Speech Factors for Participants with Parkinson's Disease for Visit 2 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
1. Habitual 
speech 
intensity 
– .69 
** 
-.22 .09 -.01 .01 -.09 -.02 -.32 -.08 -.22 -.13 -.09 .02 -.20 -.22 .10 .01 -.07 -.01 -.18 -.06 .00 -.03 .03 .23 -.27 -.08 -.13 .00 -.04 -.08 
2. Maximum 
speech 
intensity 
 – -.09 .72 
** 
.16 .09 -.05 .24 -.57 
** 
-.27 -.41 
t 
-.11 -.13 -.12 -.50 
* 
-.33 .16 .05 .00 .04 -.25 -.04 .08 -.01 -.06 .12 -.09 -.34 -.34 -.08 .23 -.29 
3. Lombard 
response function 
  – -.02 .00 .22 .20 .20 .09 .03 .14 .13 .19 .08 .10 .19 -.02 .01 .01 -.05 .03 .01 .02 -.02 -.08 .09 .50 
* 
-.56 
** 
.10 -.03 .39 
t 
.05 
4. Magnitude 
production    
   – .22 .02 -.10 .21 -.54 
** 
-.30 -.43 
* 
-.12 -.09 -.10 -.52 
* 
-.23 .22 .07 -.02 .01 -.22 -.07 .02 -.05 -.11 .06 .11 -.29 -.35 -.09 .18 -.25 
5. Typical speech  
loudness      
    – -.11 -.18 .27 .26 .56 
** 
.40 
t 
49 
* 
.44 
* 
.21 .44 
* 
.48 
* 
.48 
* 
-.66 
** 
-.59 
** 
-.64 
** 
-.39 
t 
-.58 
** 
-.64 
** 
-.55 
** 
.51 
* 
.04 .25 -.13 -.12 -.36 .20 -.03 
15. 6. SIT  
16. transcription    
     – .76 
** 
.45 
* 
-.07 -.01 -.03 -.05 -.02 .14 -.06 .13 .16 .02 -.16 -.17 -.24 -.17 -.09 -.19 .24 -.20 .41 
t 
-.30 .10 -.26 .52 
* 
.26 
7. SIT VAS           – .52 
* 
-.13 -.12 -.11 -.20 -.12 .02 .05 .03 .04 .12 -.03 -.10 -.14 -.06 .01 -.10 .11 -.38 .35 -.08 .03 -.02 .44 
* 
.39 
t 
8. Conversational 
intelligibility 
       – -.03 .08 .21 .09 .08 .00 .24 .24 .24 -.34 -.24 -.32 -.40 
t 
-.30 -.27 -.22 .32 -.38 .28 -.17 -.03 -.30 .31 .07 
9. CES Q1         – .66 
** 
.89 
** 
.61 
** 
.33 .21 .81 
** 
.55 
** 
.17 -.38 -.29 -.32 -.15 -.30 -.38 -.26 .46 
* 
.20 -.02 .02 .21 -.12 -.24 .34 
10. CES Q2               – .75 
** 
.80 
** 
.64 
** 
.56 
** 
.61 
** 
.72 
** 
.54 
** 
-.64 
** 
-.61 
** 
-.56 
** 
-.42 
* 
-.58 
** 
-.62 
** 
-.56 
** 
.73 
** 
.28 .14 -.01 -.05 .12 .02 .32 
11. CES Q3           – .75 
** 
.51 
* 
.36 .86 
** 
.65 
** 
.34 -.61 
** 
-.49 
* 
-.52 
* 
-.43 
* 
-.51 
* 
-.54 
** 
-.45 
* 
.65 
** 
.16 .01 -.17 .31 -.05 -.25 .14 
12. CES Q4            – .69 
** 
.61 
** 
.54 
** 
.72 
** 
.62 
** 
-.66 
** 
-.64 
** 
-.60 
** 
-.62 
** 
-.64 
** 
-.60 
** 
-.60 
** 
.61 
** 
.31 .15 -.26 .06 -.10 -.01 .03 
13. CES Q5             – .88 
** 
.37 .84 
** 
.71 
** 
-.59 
** 
-.72 
** 
-.68 
** 
-.63 
** 
-.73 
** 
-.70 
** 
-.73 
** 
.61 
** 
.18 .34 -.14 .38 .15 -.02 .17 
14. CES Q6                 – .28 .72 
** 
.67 
** 
-.48 
* 
-.67 
** 
-.63 
** 
-.65 
** 
-.66 
** 
-.60 
** 
-.65 
** 
.54 
** 
.11 .25 -.12 .35 .11 -.08 .23 
15. CES Q7               – .64 
** 
.23 -.54 
** 
-.47 
* 
-.56 
** 
-.30 
 
-.46 
* 
-.55 
** 
-.40 
t 
.50 
* 
-.07 -.04 -.04 .33 -.23 -.25 .22 
16. CES Q8                – .69 
** 
-.64 
** 
-.77 
** 
-.75 
** 
-.56 
** 
-.74 
** 
-.80 
** 
-.73 
** 
.68 
** 
.07 .38 
t 
-.07 .34 -.17 .08 .32 
17. CPIB                 – -.73 
** 
-.91 
** 
-.83 
** 
-.87 
** 
-.93 
** 
-.87 
** 
-.92 
** 
.59 
** 
.10 .41 
* 
-.08 .19 -.07 -.04 .28 
18. VAPP 
voice problem 
                 – .81 
** 
.78 
** 
.76 
** 
.84 
** 
.84 
** 
.74 
** 
-.56 
** 
.10 -.30 -.07 -.32 .10 .18 -.06 
19. VAPP daily 
communication 
                  – .95 
** 
.84 
** 
.98 
** 
.97
** 
.97 
** 
-.62 
** 
-.05 -.37 .08 -.31 .11 .11 -.23 
20. VAPP 
social 
communication 
                   – .79 
** 
.95 
** 
.94 
** 
.94 
** 
-.58 
** 
-.01 -.29 .19 -.29 .20 .10 -.16 
21. VAPP 
emotion  
                    – .90 
** 
.77 
** 
.84 
** 
-.56 
** 
-.03 -.27 .18 -.30 -.08 .16 -.07 
22. VAPP total                      – .96 
** 
.98 
** 
-.61 
** 
-.03 -.35 .09 -.33 .03 .15 -.22 
23. VAPP 
activity 
limitation 
                      – .94 
** 
-.60 
** 
.00 -.35 -.01 -.32 .13 .16 -.29 
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24. VAPP 
participation 
restriction  
                       – -.59 
** 
-.08 -.35 .13 -.31 .01 .10 -.25 
25. LSUS 
      
                        – .08 .28 -.16 .17 -.10 .18 .17 
26. Age                          – -.18 -.14 -.45 
* 
.21 -.05 .03 
27. Gender                            – -.03 .15 -.03 .54 
** 
.36 
28. Disease 
duration 
                           – .06 .20 -.29 .37 
29. GDS                             – .22 -.37 -.03 
30. UPDRS                              – -.34 -.05 
31. MOCA                               – .00 
32. Medication 
effectiveness 
                               – 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3 for proxy-rated dependent variables. Correlations highlighted in 
blue were statistically significant and greater than or equal to .50.
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Table 56: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Proxy-Rated Communicative 
Participation Measures, Demographic Factors, and Non-Speech Factors for Participants with Parkinson's Disease for Visit 3 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
1. Habitual 
speech 
intensity 
– .23 -.33 .01 .20 -.08 -.11 .32 .20 .22 .14 .16 -.04 -.10 .39 -.01 .19 -.09 -.18 -.19 -.12 -.13 -.09 -.18 .05 .05 -.52 
* 
-.09 -.04 -.10 -.26 -.13 
2. Maximum 
speech 
intensity 
 – .38 .73 
** 
-.11 .60 
** 
.68 
** 
.43 
* 
-.18 .13 -.03 .14 .08 .03 .05 -.08 .10 .13 -.06 -.16 -.09 -.08 .05 -.27 -.31 -.11 .10 -.46 
* 
-.32 -.21 .46 
* 
.00 
3. Lombard 
response function 
  – .28 .03 .54 
** 
.60 
** 
.49 
* 
.19 .09 .06 -.05 .19 -.01 .11 .02 .07 -.13 -.15 -.15 -.21 -.21 -.18 -.20 -.15 -.30 .50 
* 
-.46 
* 
.19 -.02 .32 .09 
4. Magnitude 
production    
   – 02 .38 .53 .32 
* 
-.12 .04 -.13 -.01 .14 .03 .21 -.05 -.10 .18 .11 -.02 .08 .09 .20 -.09 -.24 -.18 .03 -.18 -.36 -.06 .40 
t 
-.20 
5. Typical speech  
loudness      
    – -.15 -.02 .18 .50 
* 
.59 
** 
.58 
** 
.37 .45 
* 
.34 .76 
** 
.54 
** 
.42 
t 
-.66 
** 
-.61 
** 
-.57 
** 
-.48 
* 
-.57 
** 
-.62 
** 
-.45 
* 
.33 .16 .08 .11 -.23 -.29 .08 .16 
17. 6. SIT  
18. transcription    
     – .69 
** 
.27 .07 .25 .02 -.04 -.12 -.08 -.09 -.26 -.13 .17 .17 .04 .03 .12 .18 .09 -.02 -.21 .37 -.51 
* 
-.20 -.32 .64 
** 
-.04 
7. SIT VAS           – .58 
** 
.11 .27 -.04 -.17 -.12 -.15 .09 -.24 -.08 .02 -.03 -.24 -.28 -.15 -.05 -.17 -.17 -.36 .46 
* 
-.41 
t 
-.04 -.24 .50 
** 
.17 
8. Conversational 
intelligibility 
       – .33 .33 .19 .03 .04 -.08 .30 -.15 .12 -.19 -.30 -.51 
* 
-.53 
* 
-.39 -.23 -.41 
t 
.00 -.44 
* 
.09 -.50 
* 
.27 -.16 -.03 -.10 
9. CES Q1         – .61 
** 
.55 
** 
.24 .30 .06 .60 
** 
.31 .40 
t 
-.65 
** 
-.49 
* 
-.55 
** 
-.61 
** 
-.57 
** 
-.56 
** 
-.40 
t 
.31 -.21 .20 .03 .25 -.21 -.20 .34 
10. CES Q2               – .66 
** 
.50 
** 
.49 
* 
.41 
t 
.55 
* 
.40 
t 
.60 
** 
-.49 
* 
-.52 
* 
-.56 
** 
-.56 
** 
-.55 
** 
-.54 
** 
-.43 
* 
.60 
** 
.03 .40 
t 
-.13 -.06 -.23 .24 .10 
11. CES Q3           – .74 
** 
.68 
** 
.59 
** 
.47 
* 
.59 
** 
.56 
** 
-.71 
** 
-.67 
** 
-.58 
** 
-.69 
** 
-.69 
** 
-.70 
** 
-.52 
* 
.46 
* 
.09 .26 .13 -.10 -.30 -.04 .42 
t 
12. CES Q4            – .85 
** 
.73 
** 
.36 .68 
** 
.75 
** 
-.49 
* 
-.71 
** 
-.56 
** 
-.54 
** 
-.64 
** 
-.60 
** 
-.65 
** 
.44 
* 
.20 .22 .01 -.01 -.24 .09 .26 
13. CES Q5             – .73 
** 
.48 
* 
.86 
** 
.76
** 
-.55 
** 
-.68 
** 
-.50 
** 
-.51 
* 
-.63 
** 
-.64 
** 
-.60 
** 
.47 
* 
.09 .27 .09 .08 -.06 .11 .19 
14. CES Q6                 – .42 
t 
.67 
** 
.63 
** 
-.45 
* 
-.55 
** 
-.36 -.42 
t 
-.50 
* 
-.52 
* 
-.43 
* 
.48 
* 
-.04 .30 .32 -.05 .03 .08 .10 
15. CES Q7               – .54 
** 
.61 
** 
-.69 
** 
-.61 
** 
-.56 
** 
-.51 
* 
-.60 
** 
-.61 
** 
-.51 
* 
.23 -.16 .05 .23 -.03 -.25 -.06 .09 
16. CES Q8                – .59 
** 
-.68 
** 
-.63 
** 
-.42 
t 
-.41 
t 
-.57 
** 
-.64 
** 
-.45 
* 
.43 
* 
-.05 .19 .34 .07 -.16 .06 .25 
17. CPIB                 – -.58 
** 
-.74 
** 
-.61 
** 
-.56 
** 
-.69 
** 
-.67 
** 
-.70 
** 
.38 .13 .24 .06 .05 -.08 -.02 .18 
18. VAPP 
voice problem 
                 – .81 
** 
.68 
** 
.72 
** 
.82 
** 
.90 
** 
.58 
** 
-.19 .19 -.25 -.27 -.17 .36 .21 -.47 
* 
19. VAPP daily 
communication 
                  – .89 
** 
.86 
** 
.98 
** 
.95 
** 
.91 
** 
-.25 .01 -.24 .02 -.27 .28 .14 -.33 
20. VAPP 
social 
communication 
                   – .92 
** 
.93 
** 
.79 
** 
.94 
** 
-.26 .11 -.21 .18 -.24 .43 
* 
.08 -.21 
21. VAPP 
emotion  
                    – .94 
** 
.84 
** 
.85 
** 
-.31 .17 -.28 .10 -.31 .30 .17 -.41 
t 
22. VAPP total                      – .95 
** 
.91 
** 
-.24 .08 -.27 .04 -.30 .28 .17 -.39 
t 
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23. VAPP 
activity 
limitation 
                      – .77 
** 
-.23 .05 -.30 -.09 -.31 .21 .19 -.45 
* 
24. VAPP 
participation 
restriction  
                       – -.15 .01 -.18 .20 -.23 .29 .09 -.20 
25. LSUS 
      
                        – -.01 .31 .01 .11 -.03 .28 -.12 
26. Age                          – -.18 -.14 -.45 
* 
.21 -.05 .03 
27. Gender                            – -.03 .15 -.03 .54 
** 
.36 
28. Disease 
duration 
                           – -.06 .20 -.29 .37 
29. GDS                             – .22 -.37 -.03 
30. UPDRS                              – -.34 -.05 
31. MOCA                               – .00 
32. Medication 
effectiveness 
                               – 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3 for proxy-rated dependent variables. Correlations highlighted 
in blue were statistically significant and greater than or equal to .50.  
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3.9.1 Speech intensity measures 
 
Three hundred sixty-five of 435 correlations involving speech intensity measures across 
all three visits were not significant. Twenty-six of the 70 significant correlations had 
correlation coefficients below our criterion threshold of .50 and were therefore not 
included in our analyses since the strength of the relationship was considered relatively 
weak. However only those correlations that were significantly and highly correlated 
across all three visits have been reported. Proxy-rated typical speech loudness was 
significant and moderately correlated with the VAPP voice problem score r = -.66, p = 
.001, r = -.66, p = .001, and r = -.66, p = .001 respectively, VAPP daily communication 
score r = -.55, p = .006, r = -.59, p = .003, and r = -.61, p = .003 respectively, VAPP 
social communication score r = -.55, p = .006, r = -.64, p = .001, and r = -.57, p = .006 
respectively, VAPP total score r = -.58, p = .004, r = -.58, p = .004, and r = -.57, p = 
.005 respectively, and VAPP activity limitation score r = -.63, p = .001, r = -.64, p = 
.001, and r = -.62, p = .002 respectively. These correlations were negative, suggesting 
that as the perceived typical speech loudness score decreased, the VAPP scores increased, 
and vice versa. A lower perceived typical speech loudness score suggests that the 
individual is perceived as communicating with a quieter or softer voice. A higher VAPP 
score suggests an increased impact that a voice problem has on one’s activity and 
participation. Therefore, the negative correlations are the result of how the instruments 
are scaled. These results suggest that one’s perceived reduced speech loudness is 
significantly and moderately associated with VAPP voice problem, daily communication, 
social communication, total and activity limitation scores. See Objective 7 for variables 
other than proxy-rated communicative participation that were significantly correlated 
with speech intensity measures.  
3.9.2 Speech intelligibility measures 
 
Two hundred forty of 270 correlations involving speech intelligibility measures across all 
three visits were not significant. Eleven of the 30 significant correlations had correlation 
coefficients below our criterion threshold of .50 and were therefore not included in our 
analyses since the strength of the relationship was considered relatively weak. However 
only those correlations that were significantly and highly correlated across all three visits 
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have been reported. There was no consistent pattern of results that emerged for 
correlations between proxy-rated communicative participation and speech intelligibility 
measures. See Objective 7 for variables other than proxy-rated communicative 
participation that were significantly correlated with speech intelligibility measures.  
3.9.3 Communicative participation measures 
 
Eight hundred seventeen of 1173 correlations involving communicative participation 
measures across all three visits were not significant. Fifty-seven of the 356 significant 
correlations had correlation coefficients below our criterion threshold of .50 and were 
therefore not included in our analyses since the strength of the relationship was 
considered relatively weak. However only those correlations that were significantly and 
highly correlated across all three visits have been reported. The 299 significant 
correlations that fell above our criterion threshold of .50 were scattered across various 
other variables and no consistent pattern emerged. Proxy-rated communicative 
participation evaluated via the CPIB was significantly and moderately correlated across 
all three visits with proxy-ratings of CES question 4: r = .68, p < .001, r = .62, p = .002, 
and r = .75, p < .001 respectively, CES question 5: r = .52, p = .010, r = .71, p < .001, 
and r = .76, p < .001 respectively, and CES question 8: r = .61, p = .002, r = .69, p < 
.001, and r = .59, p = .004 respectively. Question 4 of the CES corresponds to 
communicating with a stranger over the telephone, question 5 of the CES relates to 
communicating in a noisy environment, and question 8 of the CES corresponds with 
communicating with someone at a distance. These results suggest that overall 
communicative participation as measured by the CPIB is moderately associated with the 
communicative contexts of communicating with an unfamiliar speaker over the 
telephone, speaking in noise, and communicating across a distance. The latter two 
communicative situations are challenging since they both require the use of adequate 
speech intensity. Furthermore, the primary communication partners of participants with 
PD rated these communicative contexts consistently over the three visits, suggesting 
relative stability in perception of communicative effectiveness over time. 
 
The CPIB standardized score was also significantly and highly correlated with proxy-
ratings of the VAPP self-perceived voice problem score across all three visits by the 
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primary communication partners of the participants with PD: r = -.77, p < .001, r = -.73, 
p < .001, and r = -.58, p = .005 respectively. The CPIB standardized score was 
significantly and highly correlated with proxy-ratings of the VAPP total score across all 3 
visits by the primary communication partners of the participants with PD: r = -.83, p < 
.001, r = -.93, p < .001, and r = -.69, p < .001, respectively. These correlations were 
negative, suggesting that as the CPIB score decreased, the VAPP scores increased, and 
vice versa. A lower score on the CPIB suggests a greater impact on one’s communicative 
participation. A higher VAPP score suggests an increased impact that a voice problem 
has on one’s activity and participation. Therefore, the negative correlations are the result 
of how the instruments are scaled. These results suggest that the CPIB and the VAPP 
self-perceived voice problem and total scores are highly and significantly associated with 
each other.  
 
Fifty-six of 84 correlations involving the pairwise comparisons of the eight questions 
within the CES were significantly correlated. A total of 64% of these significant 
correlations were significantly correlated across all three visits. Thirty-two of the 35 
correlations that were significant across all three visits fell above our criterion threshold 
of .5. The correlations of all pairwise comparisons of the eight questions within the CES 
ranged from r = -.17 - .86 for visit 1, r = .06 - .85 for visit 2, and r = .21 - .89 for visit 3. 
The full correlation matrix related to these within test correlations for the CES at all three 
visits are provided in Tables 54, 55, and 56. These results suggest that the primary 
communication partners of our participants with PD rate their partners’ communicative 
effectiveness fairly consistently across select communicative situations/contests and time. 
 
All 63 correlations involving the pairwise comparisons of the seven subsections within 
the VAPP were significant and highly correlated. These correlations ranged from r = .56 - 
.98 for visit 1, r = .58 - .98 for visit 2, and r = .74 - .98. The full correlation matrix related 
to these within test correlations for the VAPP at all three visits are provided in Tables 54, 
55, and 56. These results suggest that, over time, the primary communication partners of 
IWPD consistently rate the impart of their partners’ voice problem on the VAPP 
3.9.4 Demographic and non-speech factors 
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Five hundred fifty-three of 588 correlations involving demographic and non-speech 
factors across all three visits were not significant. Eighteen of the 35 significant 
correlations had correlation coefficients below our criterion threshold of .50 and were 
therefore not included in our analyses since the strength of the relationship was 
considered relatively weak. However only those correlations that were significantly and 
highly correlated across all three visits have been reported. There was no consistent 
pattern of results that emerged for correlations between proxy-rated communicative 
participation and demographic and non-speech factors. See Objective 7for variables other 
than proxy-rated communicative participation that were significantly correlated with 
demographic and non-speech factors. These results suggest that proxy-rated 
communicative participation measures are not consistently correlated with demographic 
and non-speech factors for participants with PD. 
3.10 Statistical Analysis for Objective 9: Inter-
Relationships Among Variables in Control 
Participants 
 
In order to answer the question ‘Are measures of speech intensity, speech intelligibility, 
communicative participation, demographic factors, and non-speech factors related to one 
another in control participants?’, a matrix of inter-correlations was obtained via a series 
of three Pearson correlations (p < .05) applied to all possible pairwise combination of the 
experimental variables, demographic factors, and non-speech factors for control 
participants across each of the three experimental visits. The measures of speech intensity 
included in these analyses were: habitual speech intensity, maximum speech intensity, 
Lombard response function, magnitude production, and self-perceptions of typical speech 
loudness. The measures of speech intelligibility included in these analyses were: SIT 
transcription score, SIT VAS score, and conversational intelligibility VAS score. The 
measures of communicative participation included in these analyses were: CES questions 
1 through 8, VAPP self-perceived voice problem score, VAPP daily communication 
score, VAPP social communication score, VAPP emotion score, VAPP activity limitation 
score, VAPP participation restriction score, VAPP total score, CPIB score, and LSUS 
score. The measures of demographic factors included in these analyses were: age and 
gender. The measures of non-speech factors included in these analyses were: GDS and 
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MOCA scores. Only significant correlations above r £ .50 across the three visits were 
included and are presented below. This criterion value of r £ .50 was chosen as the 
minimum threshold since correlations greater than .50 are indicative of a moderate to a 
very strong relationship between variables (Mukaka, 2012). Since a primary goal of this 
study is to investigate the consistency of various measures related to hypophonia and 
communication in IWPD, focusing on significant correlations that minimally had a 
moderate relationship across all three experimental visits permitted us to identify the 
most salient variables related to each other. Results of all analyzed correlations are 
summarized in Tables 57, 58, and 59 for visits 1, 2, and 3 respectively. 
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Table 57: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Communicative Participation Measures, 
Demographic Factors, and Non-Speech Factors for Control Participants for Visit 1 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
1. Habitual 
speech 
intensity 
–    .74 
    ** 
.11 .08 -.11 -.13 -.11 -.12 .08 .04 .09 -.00 .09 -.03 -.07 .26 -.07 -.14 -.15 -.08 .05 -.13 -.19 -.18 .20 .22 -.12 .07 .03 
2. Maximum 
speech 
intensity 
 – .18 .57 
** 
.03 .08 .11 .17 .17 .14 .08 .04 .24 .18 .28 .34 
t 
-.03 -.32 -.31 -.20 -.11 -.28 -.39 
* 
-.20 .22 .00 .01 -.04 .06 
3. Lombard 
response function 
  – .02 -.08 .28 .20 .04 .05 -.02 -.07 -.08 -.22 .06 .02 -.02 .02 .03 .20 .16 .40 
* 
.28 .04    .46 
     * 
.02 -.23 .03 -.14 -.17 
4. Magnitude 
production    
   – .03 .14 .18 .35 
t 
.12 .11 .13 .18 .19 .21 .27 .22 .01 -.28 -.36 
* 
-.19 -.30 -.34 
t 
-.37 
* 
-.25 .11 -.05 .24 -.39 
* 
.06 
5. Typical speech  
loudness      
    – .40 
* 
.36 
t 
.36 
* 
.12 -.07 .15 -.23 -.18 -.25 .06 -.12 .21 -.30 -.12 -.03 -.20 -.15 -.14 -.06 .36 
* 
-.08 .24 .16 .06 
19. 6. SIT  
20. transcription    
     – .57 
** 
.45 
* 
.33 .26 .20 .00 -.12 .15 .23 -.08 .06 -.23 -.13 -.39 
* 
-.07 -.21 -.28 -.16 .16 -.04 .44 
* 
.08 .01 
7. SIT VAS           – .51 
** 
.11 .05 -.06 -.01 -.03 -.14 .12 -.15 .10 -.14 -.05 -.12 .07 -.06 -.16 -.01 .14 -.43 
* 
.47 
** 
.11 .21 
8. Conversational 
intelligibility 
       – .19 .10 .20 .08 .11 .26 .30 .09 .19 -.31 -.12 -.33 -.03 -.17 -.26 -.13 .32 -.34 
t 
.47 
** 
-.09 .30 
9. CES Q1         – .83 
** 
.71 
** 
.46 
* 
.56 
** 
.56 
** 
.74 
** 
.64 
** 
.60 
** 
-.36 
t 
-.49 
** 
-.60 
** 
-.34 
t 
-.47 
** 
-.64 
** 
-.20 .18 -.19 -.02 -.14 -.23 
10. CES Q2               – .62 
** 
.56 
** 
.52 
** 
.58 
** 
.75 
** 
.57 
** 
.37 
* 
-.38 
* 
-.57 
** 
-.66 
** 
-.42 
* 
-.54 
** 
-.66 
** 
-.32 -.03 -.15 .00 .00 -.04 
11. CES Q3           – .69 
** 
.32 .53 
** 
.45 
* 
.64 
** 
.68 
** 
-.44 
* 
-.46 
** 
-.66 
** 
-.38 
* 
-.48 
** 
-.61 
** 
-.29 .22 .09 .04 -.20 .03 
12. CES Q4            – .46 
** 
.44 
* 
.38 
* 
.68 
** 
.48 
** 
-.40 
* 
-
.48
** 
-.62 
** 
-.37 
* 
-.47 
** 
-.55 
** 
-.31 .16 .08 -.08 -.11 .09 
13. CES Q5             – .48 
** 
.57 
** 
.73 
** 
.27 .00 -.25 -.38 
* 
-.15 -.22 -.34 
t 
-.07 .11 -.19 -.06 -.14 -.09 
14. CES Q6                 – .59 
** 
.52 
** 
.41 
* 
-.12 -.20 -.54 
** 
-.12 -.21 -.39 
* 
-.01 .00 .02 -.19 -.22 -.12 
15. CES Q7               – .64 
** 
.46 
* 
-.33 -.36 
t 
-.48 
** 
-.29 
 
-.36 
t 
-.49 
** 
-.11 .03 -.43 
* 
.01 .06 -.11 
16. CES Q8                – .57 
** 
-.14 -.25 -.49 
** 
-.14 -.25 -.41 
* 
-.03 .23 -.01 -.06 -.13 .10 
17. CPIB                 – -.29 -.28 
* 
-.36 -.24 -.28 -.44 
* 
-.01 .18 -.19 .09 -.20 -.03 
18. VAPP 
voice problem 
                 –   .77 
   ** 
.61 
** 
.69 
** 
.80 
** 
.78 
** 
.64 
** 
-.29 .15 -.12 .03 -.08 
19. VAPP daily 
communication 
                  – .65 
** 
.90 
** 
.97 
** 
.93 
** 
.83 
** 
-.14 .02 .00 .06 .04 
20. VAPP 
social 
communication 
                   – .55 
** 
.74 
** 
.81 
** 
.58 
** 
-.11 .00 -.16 -.06 -.22 
21. VAPP 
emotion  
                    – .93 
** 
.76 
** 
.85 
** 
-.13 -.12 .01 .08 .04 
22. VAPP total                      – .92 
** 
.89 
** 
-.17 -.04 -.07 .04 -.03 
23. VAPP 
activity 
limitation 
                      – .67 
** 
 
-.17 .15 -.13 .06 .00 
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24. VAPP 
participation 
restriction  
                       – -.12 -.23 -.04 -.04 -.14 
25. LSUS 
      
                        – .13 .00 -.18 .09 
26. Age                          – -.37 
* 
-.08 -.04 
27. Gender                            – .10 .34 
t 
28. GDS                            – .14 
29. MOCA                             – 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3. Correlations highlighted in blue were statistically significant 
and greater than or equal to .50.
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Table 58: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Communicative Participation Measures, 
Demographic Factors, and Non-Speech Factors for Control Participants for Visit 2 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
1. Habitual 
speech 
intensity 
– .72 
** 
-.06 .04 .23 .30 .11 -.02 .12 .00 .00 .05 .20 .14 .34 
t 
.27 .43 
* 
-.25 -.27 -.27 -.18 -.28 -.33 -.22 -.02 -.04 .14 -.07 .13 
2. Maximum 
speech 
intensity 
 – -.05 .58 
** 
.00 .40 
* 
.34 .21 .18 .10 .10 .07 .08 -.01 .38 
* 
.22 .32 -.28 -.26 -.35 
t 
-.35 
t 
-.31 -.31 -.23 .04 -.19 .11 -.13 .18 
3. Lombard 
response function 
  – -.07 .12 -.16 .09 .12 .09 .19 .19 .15 -.12 .01 .17 -.08 .11 -.07 .06 -.18 -.06 .00 -.01 .06 .18 -.17 -.16 -.28 -.29 
4. Magnitude 
production    
   – -.22 .26 .42 
* 
.12 .05 .04 .04 .05 -.13 -.11 -.01 .06 -.08 -.25 -.13 -.16 -.31 -.18 -.10 -.16 .01 -.23 .18 -.10 .06 
5. Typical speech  
loudness      
    – .41 
* 
.26 .15 .26 .15 .15 .09 .30 .11 .14 .33 .10 -.26 -.22 -.33 -.28 -.26 -.29 -.16 .26 .05 .19 .14 .24 
21. 6. SIT  
22. transcription    
     – .61 
** 
.48 
** 
.18 .27 .27 -.02 .12 .15 .20 .27 .02 .07 -.05 -.06 .04 -.03 -.05 -.05 -.06 -.13 .23 .02 .60 
** 
7. SIT VAS           – .48 
** 
.31 .21 .21 .05 .14 .06 .39 
* 
.27 .24 -.23 -.01 .01 -.20 -.05 -.05 .08 -.07 -.54 
** 
.41 
* 
-.03 .32 
8. Conversational 
intelligibility 
       – .41 
* 
.50 
** 
.50 
** 
.20 .15 .15 .37 
t 
.12 .05 -.14 -.08 -.18 -.09 -.09 -.11 -.03 .16 -.57 
** 
.18 -.01 .27 
9. CES Q1         – .85 
** 
.85   
** 
.42 
* 
.55 
** 
.52 
** 
.65
** 
.68 
** 
.55 
** 
-.55 
** 
-.55 
** 
-.35 
t 
-.41 
* 
-.55 
** 
-.61 
** 
-.45 
* 
.09 -.12 .17 -.36 
t 
-.11 
10. CES Q2               – 1.00 
** 
.52 
** 
.51 
** 
.66 
** 
.55 
** 
.49 
** 
.27 -.17 -.44 
* 
-.31 -.15 -.40 
* 
-.45 
* 
-.46 
* 
.17 -.10 .02 -.36 
* 
-.05 
11. CES Q3           – .52 
** 
.51 
** 
.66 
** 
.53 
** 
.49 
** 
.27 -.17 -.44 
* 
-.31 -.15 -.40 
* 
-.45 
* 
-.46 
* 
.17 -.10 .02 -.36 
* 
-.05 
12. CES Q4            – .55 
** 
.34 
t 
.43 
* 
.52 
** 
.19 -.10 -.17 -.10 .05 -.16 -.17 -.24 -.08 -.06 .17 -.16 -.04 
13. CES Q5             – .54 
** 
.57 
** 
.77 
** 
.53 
** 
-.31 -.59 
** 
-.41 
* 
-.30 -.55 
** 
-.59 
** 
-.57 
** 
.28 -.14 .10 -.28 -.06 
14. CES Q6                 – .52 
** 
.53 
** 
.49 
** 
-.00 -.48 
** 
-.22 .00 -.37 
* 
-.42 
* 
-.51 
** 
.07 .06 -.24 -.49 
** 
-.22 
15. CES Q7               – .68 
** 
.74
** 
-.25 -.33 -.26 -.22 -.32 -.38 
* 
-.25 -.12 -.35 
t 
.10 -.17 -.06 
16. CES Q8                – .71 
** 
-.46 
* 
-.58 
** 
-.30 -.30 -.53 
** 
-.59 
** 
-.49 
** 
-.07 .01 .13 -.29 -.06 
17. CPIB                 – -.46 
* 
-.43 
* 
-.26 -.34 
t 
-.42 
* 
-.51 
** 
-.27 -.10 -.11 -.07 -.47 
** 
-.27 
18. VAPP 
voice problem 
                 – .62 
** 
.59 
** 
.82 
** 
.71 
** 
.70 
** 
.47 
** 
-.20 .09 -.27 .14 .13 
19. VAPP daily 
communication 
                  – .81 
** 
.75 
** 
.98 
** 
.97 
** 
.96 
** 
-.33 -.08 .01 .28 .20 
20. VAPP 
social 
communication 
                   – .84 
** 
.89 
** 
.85 
** 
.81 
** 
-.42 
* 
.02 -.01 .06 .15 
21. VAPP 
emotion  
                    – .86 
** 
.80 
** 
.65 
** 
-.32 .14 -.13 .01 .18 
22. VAPP total                      – .98 
** 
.93 
** 
-.35 
t 
-.04 -.05 .22 .20 
23. VAPP 
activity 
limitation 
                      – .89 
** 
-.33 -.05 -.05 .30 .17 
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24. VAPP 
participation 
restriction  
                       – -.34 
t 
-.15 .05 .22 .21 
25. LSUS 
      
                        – -.05 -.28 -.25 -.03 
26. Age                          – -.37 
* 
-.08 -.04 
27. Gender                            – .10 .34 
t 
28. GDS                            – .14 
29. MOCA                             – 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3. Correlations highlighted in blue were statistically significant 
and greater than or equal to .50.
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Table 59: Correlations of Speech Intensity Measures, Speech Intelligibility Measures, Communicative Participation Measures, 
Demographic Factors, and Non-Speech Factors for Control Participants for Visit 3 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
1. Habitual 
speech 
intensity 
– .74 
** 
.28 .15 .12 -.10 .21 -.01 -.12 -.12 .16 .08 .23 .15 -.09 .19 -.03 .15 -.26 -.23 -.22 -.24 -.24 -.26 .15 -.02 .06 .18 .04 
2. Maximum 
speech 
intensity 
 – .36 
t 
.54 
** 
.05 .02 .18 .14 -.20 -.20 -.03 -.08 .01 .01 -.27 .02 -.18 .09 -.24 -.25 -.27 -.23 -.21 -.23 .15 -.06 -.05 .04 .08 
3. Lombard 
response function 
  – .07 -.03 .12 .21 .07 -.03 -.03 .07 .15 -.10 .18 .12 .14 .00 .03 -.21 -.24 -.07 -.18 -.21 -.22 .15 -.10 -.01 .13 -.12 
4. Magnitude 
production    
   – -.16 .09 .28 .34 
t 
-.09 -.09 .02 -.21 -.03 -.08 -.20 -.05 -.19 -.12 -.14 -.12 -.21 -.16 -.11 -.14 -.17 -.01 .05 -.26 .05 
5. Typical speech  
loudness      
    – -.05 -.14 -.13 .11 .11 .22 .55 
** 
.40 
* 
.42 
* 
.05 .42 
* 
.14 -.33 -.51 
** 
-.44 
* 
-.38 
* 
-.49 
** 
-.54 
** 
-.43 
* 
.11 .17 -.11 .08 -.04 
23. 6. SIT  
24. transcription    
     – .34 
t 
.27 .06 .06 .08 .14 .00 .17 -.07 -.12 -.24 -.23 -.37 
* 
-.42 
* 
-.38 
* 
-.40 
* 
-.38 
* 
-.38 
* 
.13 .01 .03 .08 .19 
7. SIT VAS           – .73 
** 
.24 .24 .08 -.06 .06 -.04 .15 -.12 -.03 -.31 -.06 -.06 -.05 -.09 -.16 .01 .18 -.43 
* 
.64 
** 
.19 .17 
8. Conversational 
intelligibility 
       – .23 .23 -.02 -.12 .01 -.06 .05 -.20 -.03 -.30 .07 .08 .08 .05 -.01 .13 .25 -.41 
* 
.55 
** 
-.01 .39 
* 
9. CES Q1         – 1.00 
** 
.70 
** 
.42 
* 
.60 
** 
.34 
t 
.70 
** 
.34 
t 
.43 
* 
-.85 
** 
-.08 .10 .18 -.10 -.30 .05 -.16 -.21 .28 .11 .26 
10. CES Q2               – .70 
** 
.42 
* 
.60 
** 
.34 
t 
.70 
** 
.34 
t 
.43 
* 
-.85 
** 
-.08 .10 .18 -.10 -.30 .05 -.16 -.21 .28 .11 .26 
11. CES Q3           – .60 
** 
.61 
** 
.48 
** 
.45 
** 
.48 
** 
.26 -.58 
** 
-.35 
t 
-.16 -.01 -.35 
t 
-.50 
** 
-.33 -.04 .10 .12 -.24 .02 
12. CES Q4            – .60 
** 
.81 
** 
.56 
** 
.60 
** 
.43 
* 
-.45 
* 
-.57 
** 
-.44 
* 
-.24 .53 
** 
-.64 
** 
-.53 
** 
.13 .02 -.10 .00 -.03 
13. CES Q5             – .73
** 
.69 
** 
.73 
** 
.64 
** 
-.56 
** 
-.50 
** 
-.31 -.25 -.48 
** 
-.59 
** 
-.41 
* 
-.04 -.14 .04 -.10 .04 
14. CES Q6                 – .60 
** 
.63 
** 
.48 
** 
-.37 
* 
-.62 
** 
-.54 
** 
-.34 
t 
-.59 
** 
-.64 
** 
-.62 
** 
.20 -.19 -.19 -.14 -.07 
15. CES Q7               – .60 
** 
.79 
** 
-.55 
** 
-.09 .05 .19 -.06 -.21 -.01 -.16 -.27 .18 .11 .08 
16. CES Q8                – .65 
** 
-.25 -.36 
* 
-.21 -.05 -.31 -.42 
* 
-.31 -.13 .08 -.02 -.06 .14 
17. CPIB                 – -.27 .05 .18 .28 .09 -.02 .11 -.16 -.14 .08 -.07 .10 
18. VAPP 
voice problem 
                 – .35 
t 
.20 .18 .38 
* 
.52 
** 
.21 .00 .21 -.25 -.12 -.17 
19. VAPP daily 
communication 
                  – .96 
** 
.90 
** 
.99 
** 
.97 
** 
.98 
** 
-.21 .09 .16 .10 .21 
20. VAPP 
social 
communication 
                   – .94 
** 
.96 
** 
.89 
** 
.96 
** 
-.30 .07 .20 .10 .25 
21. VAPP 
emotion  
                    – .92 
** 
.81 
** 
.89 
** 
-.28 .05 .20 .05 .24 
22. VAPP total                      – .97 
** 
.97 
** 
-.24 .08 .14 .10 .21 
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23. VAPP 
activity 
limitation 
                      – .91 
** 
-.18 .12 .05 .08 .14 
24. VAPP 
participation 
restriction  
                       – -.26 .02 .24 .18 .28 
25. LSUS 
      
                        – -.23 .27 -.06 .21 
26. Age                          – -.37 
* 
-.08 -.04 
27. Gender                            – .10 .34 
t 
28. GDS                            – .14 
29. MOCA                             – 
Note. t indicates correlations that trended towards significance. * indicates correlations that were statistically significant at the p < .005 
level. ** indicates correlations that were statistically significant at the p < .001 level. Correlations highlighted in yellow were greater 
than or equal to .50 and statistically significant across visits 1, 2, and 3. Correlations highlighted in blue were statistically significant 
and greater than or equal to .50. 
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3.10.1 Speech intensity measures 
 
Three hundred sixty of 390 correlations involving speech intensity measures across all 
three visits were not significant. Twenty-one of the 30 significant correlations had 
correlation coefficients below our criterion threshold of .50 and were therefore not 
included in our analyses since the strength of the relationship was considered relatively 
weak. However only those correlations that were significantly and highly correlated 
across all three visits have been reported. Maximum speech intensity was significantly 
and highly correlated across all three visits for control participants with habitual speech 
intensity r = .74, p < .001, r = .72, p < .001, and r = .74, p < .001, and magnitude 
production r = .57, p = .001, r = .58, p = .001,  and r = .54, p = .002 respectively.  
3.10.2 Speech intelligibility measures 
 
Two hundred eight of 243 correlations involving speech intelligibility measures across all 
three visits were not significant. Seventeen of the 35 significant correlations had 
correlation coefficients below our criterion threshold of .50 and were therefore not 
included in our analyses since the strength of the relationship was considered relatively 
weak. However only those correlations that were significantly and highly correlated 
across all three visits have been reported. The 18 significant correlations that were above 
.50 were scattered across various other variables, and no consistent pattern emerged.  
3.10.3 Communicative participation measures 
 
Seven hundred forty-two of 1020 correlations involving communicative participation 
measures across all three visits were not significant. One hundred two of the 278 
significant correlations had correlation coefficients below our criterion threshold of .50, 
and therefore, not included in our analyses since the strength of the relationship was 
considered relatively weak. However only those correlations that were significantly and 
highly correlated across all three visits have been reported. Self-perceived communicative 
participation evaluated via the CPIB was significantly and highly correlated across all 
three visits with self-ratings of CES question 8: r = .57, p = .001, r = .71, p < .001, and r 
= .65, p < .001. Question 8 of the CES relates to communicating with someone at a 
distance. These results suggest that overall communicative participation as measured by 
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the CPIB is strongly associated with the communicative context of communicating across 
a distance. This communicative situation is challenging since it requires adequate speech 
intensity. Furthermore, the control participants rated this communicative context 
consistently over the three visits suggesting relative stability in perception of 
effectiveness over time. 
 
Seventy-eight of 84 correlations involving the pairwise comparisons of the 8 questions of 
the CES were significantly correlated.  A total of 85% of these significant correlations 
were significantly correlated across all three visits. Fifty-three of the 66 correlations that 
were significant across all three visits fell above our threshold criterion of .50. The 
correlations of all pairwise comparisons of the eight questions within the CES ranged 
from r = .38 - .83 for visit 1, r = .42 – 1.00 for visit 2, and r = .42 – 1.00 for visit 3. The 
full correlation matrix related to these within test correlations for the CES at all three 
visits are provided in Tables 57, 58, and 59. These results suggest that control participants 
rate their communicative effectiveness fairly consistently across communicative 
situations/contexts and time. 
 
Fifty-nine of 63 correlations involving the pairwise comparisons of the seven subsections 
within the VAPP were significantly correlated. A total of 86% of these significant 
correlations were correlated across all three visits. Forty-eight of the 51 correlations that 
were significant across all three visits fell above our threshold criterion of .50. These 
correlations of all pairwise comparisons of the 7 subsections within the VAPP ranged 
from r = .55 – .97 for visit 1, r = .47 – .98 for visit 2, and r = .38 – .99 for visit 3. The full 
correlation matrix related to these within test correlations for the VAPP at all three visits 
are provided in Tables 57, 58, and 59. These results suggest that with the exception of the 
VAPP self-perceived voice problem score, control participants consistently rate the 
impact of their voice problem on the VAPP. 
3.10.4 Demographic and non-speech factors 
 
Descriptive statistics for demographic and non-speech factors, including age, disease 
duration, GDS scores, UPDRS scores, MOCA scores, and medication effectiveness can 
be found in Table 53. Two hundred ninety-six of 318 of correlations involving 
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demographic and non-speech factors across all three visits were not significant. 
Seventeen of the 22 significant correlations significant correlations had correlation 
coefficients below our criterion threshold of .50, and therefore, not included in our 
analyses since the strength of the relationship was considered relatively weak. However 
only those correlations that were significantly and highly correlated across all three visits 
have been reported. For the five significant correlations that were above our threshold 
criterion of .50, there was no consistent pattern of results that emerged. 
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Chapter 4 
4 Discussion 
 
This study examined the temporal variability of speech intensity measures, speech 
intelligibility measures, and communicative participation measures in individuals with 
hypophonia and PD. This study also explored the relationships among speech intensity 
measures, speech intelligibility measures, self- and proxy-rated communicative 
participation, demographic factors, and non-speech factors. The first objective of this 
study addressed the temporal variability of speech intensity measures for participants 
with PD and control participants. The second objective of this study addressed the 
variability of perceived typical speech loudness for participants with PD, their primary 
communication partners, and control participants over three time points. The third 
objective of this study addressed the variability speech intelligibility measures for 
participants with PD and control participants. The fourth objective of this study addressed 
the variability of self-rated communicative participation measures for participants with 
PD and control participants. The fifth objective of this study addressed the variability of 
self- and proxy-rated communicative participation measures of participants with PD and 
their primary communication partners. The sixth objective of this study addressed the 
retest reliability and repeatability of measures of speech intensity, speech intelligibility, 
and communicative participation in participants with PD, their primary communication 
partners, and control participants. The seventh objective of this study addressed the 
relationships among speech intensity measures, speech intelligibility measures, self-rated 
communicative participation measures, demographic factors, and non-speech factors for 
participants with PD. The eighth objective of this study addressed the relationships 
among speech intensity measures, speech intelligibility measures, proxy-rated 
communicative participation measures, demographic factors, and non-speech factors for 
participants with PD. Finally, the ninth objective of this study addressed the relationships 
among speech intensity measures, speech intelligibility measures, self-rated 
communicative participation measures, demographic factors, and non-speech factors for 
control participants. 
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Several hypotheses were examined in relation to the variability of speech intensity 
measures, speech intelligibility measures, and communicative participation measures. It 
was predicted that IWPD would demonstrate greater temporal variability of speech 
intensity measures, speech intelligibility measures, and self-rated communicative 
participation measures compared to control participants. Greater variability in measures 
of speech intensity for IWPD was predicted in the present study as a previous study by 
Schalling and colleagues (2013) suggested the possibility of increased day-to-day 
variability and individual differences in IWPD. Greater variability in measures of speech 
intelligibility and self-rated communicative participation for IWPD was predicted in the 
current study, as a study by Fox and Ramig (1997) suggested that IWPD may 
demonstrate increased variability and individual differences in self-rated speech 
intelligibility and participation compared to control participants. 
 
Additionally, it was hypothesized that IWPD would have reduced measures of speech 
intensity, speech intelligibility, and self-rated communicative participation compared to 
control participants. It was further predicted that self-rated typical speech loudness and 
self-rated communicative participation would be reduced for IWPD compared to proxy 
ratings made by their primary communication partners. Reduced measures of speech 
intensity were predicted in the present study as previous studies have reported that IWPD 
and hypophonia demonstrate reduced habitual speech intensity ranging from 2 – 5 dB 
SPL in IWPD and hypophonia (Adams et al., 2010; Dykstra et al., 2012a; Dykstra et al., 
2015;  Fox & Ramig, 1997; Tjaden et al., 2013), reduced maximum intensity (Dykstra et 
al., 2012a), parallel but attenuated Lombard response (Adams et al., 2006a; Adams et al., 
2005; Dykstra et al., 2012a), a reduced magnitude production function (slope; Clark et 
al., 2014), and reduced ratings of self-loudness level (Andreetta et al., 2016; Clark et al., 
2014; Fox & Ramig, 1997; Ho et al., 2000) compared to control participants. Differences 
between self- and proxy-rated typical speech loudness for IWPD was predicted as 
previous studies have suggested that IWPD may not be aware of their speech intensity 
deficits (Clark et al., 2014; Ho et al., 2000). Reduced measures of speech intelligibility 
were predicted in the present study as previous studies have found reduced speech 
intelligibility in IWPD and hypophonia compared to healthy speakers (Adams et al., 
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2008; Andreetta et al., 2016; Feenaughty et al., 2014; Stipancic, Tjaden, & Wilding, 
2016; Sussman and Tjaden 2012; Tjaden, Sussman, & Wilding, 2014). Reduced measures 
of self-rated communicative participation were predicted in the present study as previous 
studies have found that IWPD rate their communicative participation lower in 
comparison to control participants (Donovan et al., 2008; Dykstra et al., 2015; Fox & 
Ramig, 1997;). Differences between self- and proxy-rated communicative participation 
was predicted as several previous studies reported lower proxy-rated PROs compared to 
self-rated PROs for IWPD (Donovan et al., 2008; Simberg et al., 2012). 
 
With regard to exploring relationships among the variables of interest in this study, it was 
hypothesized that measures of speech intensity, speech intelligibility, and self- and proxy-
rated communicative participation would all be correlated with one another. It was also 
predicted that increased disease duration, decreased perceived medication effectiveness, 
and reduced cognitive abilities would be correlated with measures of speech intensity, 
speech intelligibility, and self- and proxy-rated communicative participation in IWPD. 
Correlations among measures of self- and proxy-rated communicative participation were 
predicted as previous studies have identified relationships between the CPIB and other 
functional PROs measuring communicative participation (McAuliffe et al., 2016). 
Correlations among demographic and non-speech factors and measures of speech 
intensity, speech intelligibility, and self- and proxy-rated communicative participation 
were predicted as previous studies have identified associations between self-rated 
communicative participation and speech severity, fatigue, cognitive difficulties, and 
emotional difficulties (McAuliffe et al., 2016), disease severity and self-rated 
communicative participation (Donovan et al., 2008), self-rated communicative 
participation, age and gender (Yorkston et al., 2008), as well as gender and speech 
intensity (Sapir et al., 2007) in IWPD. 
 
The following sections will discuss the primary results of the present study and will relate 
these results to those of previous published studies. Subsequent sections will discuss 
limitations of the present study, recommendations for future studies, and the implications 
for clinical work and research. 
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4.1 Objective 1: Speech Intensity 
 
This objective examined the temporal variability of habitual speech intensity, maximum 
speech intensity, Lombard response function, and magnitude production in order to 
determine whether speech intensity measures differ over three time points between and 
within participants with PD and control participants. 
4.1.1 Habitual speech intensity 
 
The comparison of habitual speech intensity scores revealed no significant differences 
between the marginal means of habitual speech intensity of participants with PD and 
control participants. These findings are consistent with other studies that found similar 
measures of habitual speech intensity in IWPD (Matheron, Stathopoulos, Huber, & 
Sussman, 2017; Tjaden et al., 2013). Tjaden and colleagues (2013) examined speech 
acoustics and speech intelligibility during “habitual”, “clear”, and “loud” speech in 13 
IWPD and 15 healthy control participants. During the “habitual” speech condition, 
participants were asked to use their typical speech. During the “clear” speech condition, 
participants were asked to speak using a voice that was two times clearer than their 
typical speech. During the “loud” speech condition, participants were asked to speak 
using a voice that was two times louder than their typical speech. The authors reported 
that the speech intensity of IWPD was significantly reduced in the “clear” and “loud” 
speech conditions, but not in the “habitual” speech condition, compared to control 
participants.   
 
Additionally, Matheron and colleagues (2017) asked 42 IWPD and hypophonia and 20 
control participants to perform a speech task in no added noise and in the presence of 
multi-talker background noise in order to investigate laryngeal performance. The authors 
adjusted the intensity of background noise for each participant until their speech intensity 
was 3 – 5 dB SPL greater than their habitual speech intensity (Matheron et al., 2017). 
Their study revealed no significant differences between IWPD and hypophonia and 
control participants in no noise conditions (Matheron et al., 2017).  
 
However, a significant effect of “Visit” and a significant “Group” by “Visit” interaction 
was found, where the marginal means of habitual speech intensity for participants with 
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PD were significantly lower than the marginal means of habitual speech intensity for 
control participants at visit 1. No significant differences were found at visit 2 or visit 3. 
The difference in speech intensity during visit 1 was approximately 3 dB SPL less for 
participants with PD compared to control participants. This difference is consistent with 
previous literature, which reported a 2 – 5 dB SPL reduction in the speech intensity of 
IWPD and hypophonia compared to healthy speakers (Adams et al., 2006a; Adams et al., 
2005; Adams et al., 2006b; Adams, Winnell, & Jog, 2010; Dykstra et al., 2012a; Fox & 
Ramig, 1997; Matheron, et al., 2017). 
 
Fox and Ramig (1997) examined the speech intensity of 30 IWPD, and 14 control 
participants. Participants attended three visits during a four-day period, wherein they 
completed four speech tasks at every visit. The results demonstrated that the speech 
intensity of IWPD was 2-4 dB SPL lower than that of control participants.  
 
Additionally, Adams and colleagues (2010) explored the impact of interlocutor distance, 
background noise, and a concurrent task on speech intensity in 10 participants with PD 
and hypophonia and 14 control participants. In their study, participants engaged in 
conversation with an experimenter in 12 different experimental conditions – including: 
conversing in no noise, conversing in 50 and 65 dB SPL of background noise, conversing  
at an interlocutor distance of 1 m and 6 m, and conversing while performing a concurrent 
manual task (Adams et al., 2010). Adams and colleagues (2010) reported a 3 – 4 dB SPL 
reduction in the speech intensity of participants with PD compared to control participants.  
 
Finally, Dykstra and colleagues (2012a) examined the habitual conversational speech 
intensity of 30 individuals with hypophonia and 15 control participants. The authors 
found that participants with PD demonstrated reduced habitual intensity of approximately 
5 dB SPL compared to control participants (Dykstra et al., 2012a). However, although 
similar findings were reported, it is important to note that Dykstra and colleagues (2012a) 
explored conversational speech, while the present study asked participants to perform a 
reading task. 
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The results described above (Adams et al., 2005; Adams, Winnell, & Jog, 2010; Dykstra 
et al., 2012a; Fox & Ramig, 1997) are consistent with the significant group difference 
found in visit 1 of the present study, but not with the non-significant group difference 
found for the overall, grand mean, involving all three visits. The results of the current 
study suggest that following the completion of the speech tasks and communication 
questionnaires in visit 1, participants with PD may have been more aware of their speech 
production and may have focused on increasing their overall speech intensity or used 
greater effort during speech tasks during visits 2 and 3. It may also be possible that a 
performance effect occurred in participants with PD following visit 1. Performance 
effects have been previously observed in IWPD (Goberman & Elmer, 2005; Keintz, 
Bunton, & Joit, 2007). 
 
A study by Keintz and colleagues (2007) explored the impact of visual information on the 
speech intelligibility of eight IWPD and hypokinetic dysarthria. Participants were 
recorded while reading 120 sentences in a formal research setting. Listeners later 
orthographically transcribed each sentence in order to obtain a measure of sentence 
intelligibility. The conversational speech intelligibility of four of these eight participants 
was also assessed outside of the formal research testing situation. Ratings of speech 
intelligibility were not consistent between these two evaluations, with greater speech 
intelligibility observed in a research testing scenario compared to ratings obtained during 
typical conversational intelligibility performance. The authors suggested that IWPD 
exhibit a performance effect, wherein IWPD work to be more intelligible in clinical or 
research settings compared to when engaged in casual conversation (Keintz et al., 2007). 
It is possible that the improvement in speech intelligibility in testing situations is related 
to the deliberate use of clear speech by IWPD in testing contexts (Goberman & Elmer, 
2005). It is possible that following visit 1, participants were aware that the loudness of 
their speech was being studied. Therefore, participants may have been more focused on 
deliberately using clearer or louder speech during subsequent visits. This increased focus 
and awareness on their speech may have resulted in the performance effect described 
above. 
 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
247 
This variability across visits for participants with PD is consistent with the poor ratings of 
retest reliability calculated via ICC for both participants with PD and control participants. 
However, habitual speech intensity measures were found to have good repeatability, as 
measured by CR and CR%, for both participants with PD and control participants. 
Differences in a measure greater than the CR reflect the value under which the difference 
between any two repeat measurements on the same individual obtained under identical 
conditions should fall within 95% probability rather than detecting a difference that may 
be the result of measurement error (Vaz, et al., 2013). Previous studies have proposed 
that CR% values less than or equal to 10% are indicative of good repeatability (Lu et al., 
2007; Smidt, et al., 2002; Steffen & Seney, 2008). However, the studies that proposed 
CR% values indicative of good repeatability pertain to the pain, strength, mobility, and 
activities of daily living literature relating to populations with lateral epicondylitis, 
Parkinsonism, and chronic stroke (Lu et al., 2007; Smidt et al., 2002; Steffen & Seney, 
2008). The current study has adopted the proposed CR% values less than or equal to 10% 
as indicative of good repeatability. The current study also proposes CR% values between 
11 – 20 % to be indicative of marginal repeatability, and CR% values greater than 20% to 
be indicative of unacceptable repeatability. However, these values should be viewed as a 
starting point for developing appropriate CR and CR% within speech and communication 
measures and contexts for IWPD and hypophonia. 
 
As previously stated, results from the current study suggest habitual speech intensity 
measures were found to have good repeatability. These findings suggest that observed 
changes greater than approximately 5 – 7 dB over time would be beyond the estimated 
error of measurement and therefore reflect “real” changes in habitual intensity (i.e. 
related to treatment or experimental conditions) for both participants in PD and control 
participants. It should be noted that, while a change of 5 – 7 dB falls below the CR% 
value of 10%, such a change appears to be quite large within the context of previously 
reported treatment effects for habitual speech intensity in IWPD. For example, multiple 
studies have revealed that LSVT resulted in an increase of approximately 4 dB in the 
speech intensity of IWPD and hypophonia (Gustafsson, Södersten, Ternström, & 
Schalling, 2019; Ramig, Countryman, O’Brien, Hoehn, & Thompson, 1996; Ramig, 
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Countryman, Thompson, & Horii, 1995; Ramig, Fox, & Sapir, 2004; Ramig et al., 2001). 
Based on the previous treatment studies, it appears that a clinically meaningful difference 
in habitual intensity is lower than the minimum CR% of 10% that was tentatively adopted 
in the present study. A 4 dB difference is only slightly more than a CR% of about 5% 
(i.e., 70 dB mean / 4 dB change = 5.7%). As a result, it may be more beneficial to 
designate a CR% value of 5% as a measure of appropriate and acceptable repeatability in 
the measurement of treatment outcome in hypophonia secondary to PD. Therefore, based 
on the results of previous outcome studies (Gustafsson et al., 2019; Ramig et al., 1996; 
Ramig et al., 1995; Ramig et al., 2004; Ramig et al., 2001), CR% values of 5% may be 
more appropriate for measure of habitual speech intensity. If a CR% value of 5% were to 
be applied to the measure of habitual speech intensity in the present study, then habitual 
speech intensity would be deemed to demonstrate poor or marginal repeatability for both 
participants with PD and control participants. In general, it appears that additional retest 
studies are required to verify the estimated CR% of 10% for habitual intensity. In 
addition, if a CR% of 10% is verified, it will be important to determine if there are 
refinements that can be introduced into the measurement of habitual intensity that will 
reduce the measurement error to a value that is less than the clinically meaningful change 
in habitual intensity, that is estimated to be slightly above a CR% of 5%.  
4.1.2 Maximum speech intensity 
 
The comparison of maximum speech intensity scores revealed a significant difference 
between the maximum speech intensity of participants with PD and control participants, 
wherein the overall marginal means of participants with PD was 4.68 dB SPL lower than 
that of control participants. These results suggest that control participants have the ability 
to voluntarily increase their speech intensity to a greater level than participants with PD. 
A previous study by Adams and colleagues (2006b) revealed a similar but slightly greater 
difference between the maximum speech intensity of IWPD and control participants than 
what is reported in the current study. Adams and colleagues (2006b) asked 10 IWPD and 
10 control participants to repeat the phrase “I owe you a yo-yo, I owe you a yo-yo” using 
their maximum speech intensity. The authors reported that the maximum speech intensity 
of IWPD was reduced by 6.4 dB compared to control participants (Adams et al., 2006b). 
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Additionally, the observed difference of 4.68 dB between groups of participants in the 
present study is smaller than the difference that was reported in a 2012a study by Dykstra 
and others. Dykstra and colleagues (2012a) examined maximum conversational speech 
intensity of 30 individuals with hypophonia and 15 control participants. The authors 
found that participants with PD demonstrated reduced maximum intensity of 
approximately 10 dB SPL as compared to control participants (Dykstra et al., 2012a). A 
closer examination of the mean maximum speech intensity levels of participants with PD 
and control participants revealed a difference between the participants in the study by 
Dykstra and colleagues (2012a) compared to the current study. The mean maximum 
speech intensity levels of participants with PD were similar between the two studies, with 
intensity scores of 76.59 and 78.20 dB SPL in the study by Dykstra and colleagues 
(2012a) and the present study, respectively. The mean maximum speech intensity levels 
of control participants PD were more dissimilar between the two studies, with intensity 
scores of 87.07 and 82.88 dB SPL in the study by Dykstra and colleagues (2012a) and the 
present study, respectively. Thus, while participants with PD were found to produce 
similar maximum speech intensity levels in both studies, the control participants in the 
study by Dykstra and colleagues (2012a) produced greater levels of maximum speech 
intensity compared to the control participants in the present study. 
 
Furthermore, measures of maximum speech intensity were consistent over time for both 
participants with PD and control participants. These findings are consistent with the 
finding that maximum speech intensity demonstrated good retest reliability and good 
repeatability for participants with PD and control participants. Thus, maximum speech 
intensity is a reliable measure to evaluate changes over time in IWPD and healthy 
speakers, wherein observed changes (i.e. those associated with a treatment or 
experimental condition) of greater than approximately 2 – 6 dB and 3 – 5 dB would be 
above the estimated error of measurement (95% confidence range)  for maximum speech 
intensity and would therefore reflect a true change in the IWPD and control participants, 
respectively. Although the present study found that  a change of 2 – 6 dB (CR% = 3-7%) 
falls below the tentatively defined acceptable CR% value of 10%, it is reasonable to 
further evaluate this CR% in terms of a minimum clinically important difference within 
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the context of treatment effects for maximum speech intensity in IWPD and hypophonia. 
A 2016 study by Tanner, Rammage, and Liu examined the impact of a singing-based 
treatment program for IWPD. The authors reported that participants demonstrated a 
significant increase of 7 dB (estimated to be about a 9% increase) in their maximum 
speech intensity following the completion of the treatment program. The CR% results of 
the current study suggest that the 7 dB change reported by Tanner and colleagues (2016) 
would reflect about a 9% change and that this value falls above the greatest CR value of 6 
dB (CR% = 7%) obtained in the present study. Thus, it appears that the tentative 
interpretation of a CR% of 10% as an acceptable repeatability value for maximum 
intensity may be a bit too liberal. Since the results of the Tanner and colleagues (2016) 
study indicate a clinically meaningful difference of 9% for maximum speech intensity, it 
is suggested that a CR% of less than 9% should be used as the cutoff for a good 
repeatability related to maximum intensity in IWPD.  Therefore, based on the CR% of 
7% found in the present study it is concluded that maximum intensity is a measurement 
of IWPD that shows good reliability and repeatability.  
4.1.3 Lombard response function 
 
The comparison of Lombard response function revealed that participants with PD and 
control participants demonstrated similar slopes of their Lombard response when 
speaking in 60, 65, 70, and 75 dB SPL of multi-talker background noise. This similarity 
of Lombard response function was expected as previous studies found that the Lombard 
response function in IWPD was similar to the response of control participants (Adams et 
al., 2006a; Adams et al., 2005; Dykstra et al., 2012a).  
 
Adams and colleagues (2005) examined the relationship between speech intensity and 
type of background noise. In their study, 10 IWPD and hypophonia and 10 control 
participants repeated sentences in five multi-talker background noise conditions. The 
authors found that both groups of participants demonstrated a Lombard response. 
Furthermore, Adams and colleagues (2005) reported a lack of “Group” by “Noise” 
interaction, suggesting that the slope of the Lombard response of participants with PD 
was parallel compared to control participants. 
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Additionally, Adams and colleagues (2006a) investigated the effect of different types of 
background noise on speech intensity in 23 IWPD and hypophonia and 15 control 
participants. Adams and colleagues (2006a) asked participants engage in two minutes of 
conversation while in the presence of three types of background noise (i.e., multi-talker 
noise, instrumental music, and pink noise) presented at five different intensity levels 
ranging from 50 – 70 dB SPL. Similar to the findings of the present study and the finding 
of Adams and colleagues (2008), the authors reported that the Lombard sign was elicited 
in both groups of participants. However, due to a lack of “Group” by “Noise” interaction, 
Adams and colleagues (2008) suggested that the Lombard response function of 
participants with PD ran parallel to that of control participants.  
 
Finally, Dykstra and colleagues (2012a) explored the effect of various intensity levels of 
background noise (ranging in 5 dB increments from 50 – 70 dB SPL) on the 
conversational speech intensity of 30 IWPD and hypophonia and 15 control participants. 
The authors reported that both groups of participants demonstrated a Lombard response 
during the conversational speech task in background noise. Additionally, no significant 
“Group” by “Noise” interaction was found. Thus, Dykstra and colleagues (2012a) also 
suggested that the Lombard response pattern in IWPD was parallel compared to the 
response pattern of control participants.  
 
These studies also reported that while the speech intensity of IWPD was less intense 
compared to control participants, the Lombard response slope of IWPD paralleled that of 
control participants (Adams et al., 2006a; Adams et al., 2005; Dykstra et al., 2012a). The 
results from the present study are consistent with the findings from the above mentioned 
studies and suggests that IWPD may increase their speech intensity in the presence of 
background noise in a manner than parallels the Lombard response of control 
participants.  
 
Furthermore, a significant effect of visit was found in the present study, where the 
Lombard response function at visit 1 was significantly greater than the Lombard response 
function at visits 2 and 3. This pattern of results is similar to what was observed in the 
analysis of habitual speech intensity. However, since habitual speech intensity was not 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
252 
used to calculate Lombard response function, the performance effect observed in 
measures of habitual speech intensity for participant with PD cannot explain the possible 
performance effect observed in Lombard response function. It is possible that a 
performance effect similar to the effect observed with the analysis of habitual speech 
intensity occurred across participants for the Lombard response. Participants with PD 
may have habituated to the background noise and produced the target sentence, “She saw 
Patty buy two poppies” with a smaller range in their speech intensity during the task, 
thereby resulting in a flatter Lombard response function by their third visit as compared 
to their first visit. As previously discussed, the empirical literature suggests that IWPD 
can exhibit a performance effect, wherein increased effort is used by IWPD increase their 
intelligibility in clinical or research setting, often by using clearer and louder speech 
(Goberman & Elmer, 2005; Keintz et al., 2007). Thus, it is possible that participants with 
PD paid greater attention to their speech loudness following visit 1, resulting in greater 
levels of speech intensity across noise conditions in subsequent visits. These findings 
appear to be consistent with the performed retest analysis, as it was found that the 
Lombard response function did not demonstrate good retest reliability and unacceptable 
repeatability in IWPD. It is possible that a portion of the variability observed in measures 
of speech intensity, such as habitual speech intensity and Lombard response function, 
may be related to a performance effect rather than temporal variability. Additionally, this 
is the first study to attempt to develop and apply a measure of true change compared to 
measurement error of the function of Lombard response in IWPD. The approach taken in 
the present study was to calculate the slope of the Lombard response in several multi-
talker background noise conditions: 60, 65, 70, and 75 dB SPL. Further studies are 
required to continue to refine this slope method, and perhaps develop alternate methods 
of measuring the Lombard response function. 
4.1.4 Magnitude production 
 
The comparison of the magnitude production function revealed that participants with PD 
demonstrated a significantly smaller slope than did control participants. These findings 
are consistent with a previous empirical study (Clark et al., 2014). 
 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
253 
Clark and colleagues (2014) investigated loudness perception in IWPD and hypophonia. 
Seventeen participants with PD and 25 control participants took part in a magnitude 
production task, wherein participants read 5-word target sentences at their habitual 
speaking volume. The speech intensity used for this initial reading was assigned a value 
of 100. Participants then reproduced the sentence in varying magnitudes (25, 50, 100, 
200, and 400) compared to their initial performance. The authors reported that IWPD 
made smaller adjustments to their speech intensity compared to control participants 
across all levels of magnitude production. The results of the present study as well as those 
of Clark and colleagues (2014) suggest that the slope of the magnitude production 
function is less steep in IWPD compared to control participants. Additionally, the results 
of loudness perception of Clark and colleagues (2014) suggest that IWPD may 
demonstrate a deficit in their perception of loudness levels. It is possible that this deficit 
of loudness perception may in turn influence the ability of IWPD to plan and produce 
speech at greater intensities, thereby resulting in a shallower magnitude production slope. 
 
Furthermore, a significant effect of visit was found in the present study, where the 
magnitude production function at visit 1 was significantly greater than the magnitude 
production function at visits 2 and 3. Furthermore, the mean magnitude production slope 
for participants with PD was significantly lower than that of controls by 0.81 at visit 1 
only. This pattern of results is similar to what was observed in the analysis of habitual 
speech intensity and Lombard response function. Contrary to the calculations of Lombard 
response function, the measure of habitual speech intensity was used to calculate the 
slope of magnitude production. It is possible that visit differences in habitual speech 
intensity may have subsequently affected magnitude production function and accounted 
for a significant proportion of the variability observed in the measure. If a performance 
effect occurred in the measure of habitual speech intensity, one might have expected the 
performance effect to carry over to the other speech tasks involved in calculating 
magnitude production function. Additional research is needed in order to explore the role 
of habitual or reference speech intensity in the performance of magnitude production 
tasks and the calculation of magnitude production function. 
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Finally, the variability observed across visits for participants with PD is consistent with 
the unacceptable repeatability values found in the present study. However, magnitude 
production was found to have good retest reliability results for both participants with PD 
and control participants. In order to calculate the retest reliability of a measure, interclass 
correlations were used. These correlations provide information regarding the strength of 
the association between retests, and do not take into account any measurement error that 
may be present in the results. However, the CR is calculated using both the correlation 
and measurement error, resulting in a better estimate of the similarities of retest measures 
are likely to be for any given measure. Since the results varied for the different retest 
analyses performed in this study, it is unclear whether measures of magnitude production 
demonstrate significant variability over time in IWPD and control participants. 
Additional research is needed to refine or design alternative methods of measuring 
magnitude production speech tasks that are associated lower measurement error. 
4.2 Objective 2: Typical Speech Loudness 
 
This objective examined the temporal variability of perceived typical speech loudness, 
measured on a VAS. A score of 0% on the VAS indicated that the participant perceived 
their speech as “very quiet”, and a score of 100% indicated that they perceived their 
speech as “normal loudness”. This objective sought to determine whether participants 
with PD perceived their typical speech loudness differently over time, whether perceived 
ratings differed from ratings made by primary communicative partners, and if ratings 
differed as compared to control participants. The comparison of perceived typical speech 
loudness revealed that self-perceived typical speech loudness in participants with PD was 
significantly quieter compared to control participants. This difference between control 
participants and participants with PD is consistent with the findings of previous studies 
(Andreetta et al., 2016; Clark et al., 2014; Fox & Ramig, 1997; Ho et al., 2000).  
 
As part of their work assessing the efficacy of seven different speech amplification 
devices, Andreetta and colleagues (2016) measured self-perceived typical speech volume 
of 11 IWPD and hypophonia and 10 control participants. Participants indicated on a VAS 
scale, very similar to the one use in the present study, to indicate their typical speech 
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volume. The authors reported that IWPD rated their perceived typical speech intensity to 
be significantly lower compared to control participants.  
 
Additionally, in a 1997 study, Fox and Ramig explored the perceptions of speech in 
IWPD while using a rating scale very similar to the one used to measure perceived typical 
speech loudness in the present study. Fox and Ramig (1997) asked 30 IWPD and 14 
healthy control participants to rate nine perceptual variables, including perceived 
loudness, using a VAS at three separate time points. The authors reported that self-
perceived speech loudness ranged from 51.62 – 57.80 % across visits for IWPD. These 
values are similar to marginal mean score of 51.32 % for participants with PD in the 
current study. Additionally, significant differences were found between perceived speech 
loudness for participants with PD and control participants in both the current study and 
the work of Fox and Ramig (1997). These results suggest that IWPD may be aware of the 
differences in loudness of their speech compared to control participants or IWPD may be 
aware of their hypophonia. 
 
Ho and colleagues (2000) explored the perceived loudness level of self-produced speech 
stimuli of 15 IWPD and hypophonia and 15 control participants. Participants completed a 
reading task and engaged in conversation while using their soft, normal, and loud voice. 
Participants were then asked to adjust a volume control knob indicating the loudness level 
at which they had just spoken. These volume adjustments were completed immediately 
following each speech production and following a replay of the recorded sample. The 
authors found that IWPD significantly over-estimated their spoken loudness levels during 
both reading and conversational tasks compared to control participants. 
 
In a 2014 study, Clark and colleagues compared loudness perception in 17 IWPD and 
hypophonia and 25 control participants. Prior to beginning a magnitude estimation task, a 
70 dB SPL presentation of the target sentence was assigned a value of 100. Participants 
then rated the loudness of the target sentence when presented at 60, 65, 70, 75, and 80 dB 
SPL. The authors found that IWPD rated stimuli presented at higher intensity levels (75 
and 80 dB SPL) lower than did control participants. Participants with PD were also 
observed to rate stimuli presented at lower intensity levels (60 and 65 dB SPL) higher 
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than did control participants. Clark and colleagues (2014) suggested that IWPD have a 
flatter psychophysical loudness function and a more restricted range of intensity 
perception than control participants. As a result, the authors concluded that IWPD may 
demonstrate a deficit in the perception of their loudness levels, which may in turn 
influence their ability to produce speech at greater intensities. The reported differences 
between perceived and produced speech intensity levels in the studies by Clark and 
colleagues (2014) and Ho and colleagues (2000) may suggest impaired sensorimotor 
integration deficits in individuals with hypophonia and PD.  
 
However, it is important to note that both Clark and colleagues (2014) and Ho and 
colleagues (2000) asked their participants to perform loudness perception tasks that 
incorporated speech and auditory stimuli. In contrast, participants in the current study 
were asked to indicate their typical speech loudness via a questionnaire. It is possible that 
the observed difference in loudness perception between participants with PD and control 
participants appears to remain constant, regardless of the modalities used to measure 
perceived speech loudness. However, the relationship between ratings of self-perceived 
speech loudness, loudness ratings of self-productions of speech stimuli, and loudness 
ratings of externally presented speech stimuli is unknown. Additional research is 
recommended to explore this relationship, as well as identify the sensorimotor processes 
involved in each type of task.  
 
Additionally, it was interesting to note that self- and proxy-rated perceived typical speech 
loudness for participants with PD were quite similar, wherein the average scores of self- 
and proxy-rated typical speech loudness was found to be approximately 51% for IWPD. 
As previously mentioned, the findings for perceived speech loudness for IWPD in the 
present study were similar to the results of Fox and Ramig (1997). The findings of the 
current study lend support to the aforementioned suggestion that IWPD may be aware of 
the differences in their speech loudness (Fox & Ramig, 1997). These findings contradict 
the hypothesis that IWPD are unaware of their loudness deficits and may subsequently be 
unable to appropriate adjust their speech intensity during speech production (Clark et al., 
2014; Ho et al., 2000). Further research is needed to determine whether IWPD accurate 
perceive their speech loudness or demonstrate a lack of awareness of their reduced speech 
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loudness. Furthermore, participants rated their overall perception of typical speech 
loudness in the present study. This measure did not address potential deficits in the 
perception of moment-to-moment speech loudness. Further studies are also recommended 
to consider exploring differences in the overall versus moment-to-moment perceptions of 
typical speech loudness. 
 
Finally, while the lack of significant effect of visit might be indicative of consistency in 
the measure of perceived typical speech loudness, the results of the retest analyses do not 
support this interpretation. It was found that perceived typical speech loudness did not 
demonstrate good retest reliability or acceptable repeatability in participants with PD, 
control participants, or primary communication partners of IWPD. Additional research 
may be required in order to refine or design alternative methods of measuring self- and 
proxy-perceptions of typical speech loudness that are associated lower measurement 
error. 
4.3 Objective 3: Speech Intelligibility 
 
This objective examined the temporal variability of SIT transcription scores, SIT VAS 
scores, and VAS conversational intelligibility scores in order to determine whether 
speech intelligibility measures differ over time between and within participants with PD 
and control participants. 
4.3.1 SIT transcription scores 
 
The comparison of SIT transcription scores revealed that the marginal means of 
participants with PD demonstrated a significant reduction in their speech intelligibility 
compared to control participants. This finding is consistent previous findings in IWPD 
and hypophonia that demonstrate reduced speech intelligibility (Adams et al., 2008; 
Cannito et al., 2012; Sussman & Tjaden, 2012).  
 
Adams and colleagues (2008) explored speech intelligibility via the SIT in 25 IWPD and 
hypophonia and 15 control participants. Two listeners then orthographically transcribed 
the SIT sentences for all participants. The authors reported that the speech intelligibility 
of participants with PD was significantly reduced compared to control participants. The 
orthographically transcribed SIT score reported by Adams and colleagues (2008), 92.2% 
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for participants with PD and 99.3% for control participants, were similar to those found 
in the present study, 94.20% for participants with PD and 98.12% for control participants.  
 
Additionally, a study by Cannito and colleagues (2012) examined sentence intelligibility 
via orthographic transcription of the SIT in eight individuals with hypophonia before and 
after a loudness-training program. The authors reported average sentence intelligibility of 
participants with PD to be 81.11% pre-treatment. The sentence intelligibility values in the 
present study are somewhat higher than those reported in the previous study (Cannito et 
al. 2012). It appears that the study conducted by Cannito and colleagues (2012) included 
a greater number of IWPD who demonstrated severe dysarthria. Therefore, it is possible 
that the discrepancy between ratings of speech intelligibility reported by Cannito and 
colleagues (2012) and the present study may be attributed to our lack of participants with 
PD with severe dysarthria. Thus, future research may be required to examine the temporal 
variability of speech intelligibility in IWPD with more severe hypophonia and dysarthria. 
 
Sussman and Tjaden (2012) explored sentence intelligibility in dysarthric speakers with 
PD, dysarthric speakers with multiple sclerosis, and control participants. The authors 
assessed the sentence intelligibility of their participants via orthographic transcription of 
the SIT. Sussman and Tjaden (2012) reported that the speech intelligibility of female 
participants with PD was significantly reduced compared to control participants. 
However, the intelligibility scores of male participants with PD were not significantly 
different from control participants. One third of the participants in the present study were 
female, and yet a reduction in SIT transcriptions scores of participants with PD compared 
to control participants was observed. It may be that the participants with PD in Sussman 
and Tjaden’s (2012) study demonstrated a greater variety of speech features related to 
hypokinetic dysarthria compared to those IWPD recruited for the present study who 
exhibited hypophonia as their primary dysarthric feature. 
 
Finally, the non- significant difference in the overall mean SIT transcription scores across 
the three visits, suggests that these scores remained fairly consistent over time for both 
participants with PD and control participants. The consistency of the SIT transcription 
scores is further supported by the retest results. The retest results indicated that the SIT 
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transcription scores demonstrated good reliability and good repeatability for participants 
with PD. However, for the control participants, the retest analyses indicated that SIT 
transcription scores demonstrated good repeatability but did not demonstrate good retest 
reliability. Thus, SIT transcription scores are a reliable and repeatable measure 
(indicating an acceptable measurement error) and would be potentially useful for 
examining the effects of treatments or experimental conditions in IWPD. In order to 
determine if a CR% of 10% represents a clinically meaningful difference in the SIT 
transcription score, this difference value can be compared to previous treatment outcome 
studies of IWPD. A 2015 study by Martens and colleagues examined the impact of a 
speech rate and intonation treatment program on sentence intelligibility in IWPD. The 
authors reported that participants demonstrated a significant increase of 17.6 % in their 
sentence intelligibility following the completion of the treatment program. The CR% 
results of the current study suggest that the 17.6% change reported by Martens and 
colleagues (2015) is well above the CR value of 10 % that was obtained in the present 
study. Thus, the measurement error, as reflected by the CR%, appears to be well below 
the minimal clinically important CR% value that has been reported for one treatment 
study in IWPD (Martens et al., 2015).  
 
In contrast to the Martens and colleagues (2015) study, the 2012 study by Cannito and 
colleagues described above may suggest that a clinically meaningful difference may be 
less than a CR% of 10%. Cannito and colleagues (2012) reported a 4.71% increase in the 
sentence intelligibility in IWPD following LSVT. This change of 4.71% falls below the 
CR% range proposed in the current study for demonstrating a clinically important 
difference. However, it should be noted that the LSVT program is focused on improving 
speech intensity and does not directly focus on the treatment of intelligibility. Thus, the 
Cannito and colleagues (2012) study may not be suitable for estimating the clinically 
meaningful difference or the CR% for SIT transcription scores. Further treatment 
outcome studies of intelligibility of IWPD involving the SIT transcription score as an 
outcome measure are required in order to provide a better estimate of the clinically 
meaningful CR%. At the present time, the CR% of 10% found in the present study 
suggests that SIT transcription has good reliability and repeatability and has a 
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measurement error that is low enough to be used to detect clinically meaningful 
differences in treatment outcome studies. 
4.3.2 SIT VAS scores 
 
The comparison of SIT VAS scores revealed that participants with PD demonstrated a 
significant reduction in their speech intelligibility compared to control participants. This 
finding is consistent with other empirical studies that have used VAS scaling to explore 
speech intelligibility in IWPD (Feenaughty et al., 2014; Tjaden et al., 2014). Tjaden and 
colleagues (2014) explored the impact of reduced rate of speech, increased speech 
loudness and the use of clear speech on sentence intelligibility in IWPD, individuals with 
multiple sclerosis, and control participants. Measures of speech intelligibility were 
obtained via VAS evaluations of 25 sentences from the Harvard Psychoacoustic 
Sentences [The Institute of Electrical and Electronic Engineers, 1969]. The authors 
reported that the sentence intelligibility of participants with PD was significantly reduced 
compared to control participants. 
 
Additionally, Feenaughty and colleagues (2014) examined various acoustic measures and 
VAS ratings of sentence intelligibility in 12 IWPD and 12 control participants. Similarly 
to Tjaden and colleagues (2014), Feenaughty and colleagues (2014) used sentences from 
the Harvard Psychoacoustic Sentences [The Institute of Electrical and Electronic 
Engineers, (1969)] in their research. The authors reported that ratings sentence 
intelligibility of participants with PD were significantly lower compared to control 
participants. While the sentences used by Feenaughty and colleagues (2014) and Tjaden 
and colleagues (2014) differed from the current study, their findings that participants with 
PD demonstrate reduced speech intelligibility compared to control participants are 
consistent with the results of the present study. 
 
Furthermore, a difference of approximately 15% was observed between SIT transcription 
scores and SIT VAS scores, wherein the SIT transcription scores were greater than the 
SIT VAS scores for participants with PD. Differences between SIT transcription scores 
and SIT VAS scores have been investigated in previous literature (Abur, Enos, & Stepp, 
2018; Adams et al., 2008; Stipancic et al., 2016). 
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Stipancic and colleagues (2016) compared two different measures of sentence 
intelligibility in 16 IWPD, 30 individuals with multiple sclerosis, and 32 control 
participants. Fifty listeners orthographically transcribed and provided VAS ratings for the 
25 Harvard psychoacoustic sentences [Institute of Electrical and Electronics Engineers, 
1969] produced by each speaker. Speech intelligibility scores of IWPD were found to be 
approximately 25% lower than those of control participants for both orthographic 
transcription and VAS ratings. Additionally, VAS ratings were consistently found to be 
lower than orthographic transcription scores by approximately 10 – 15% across groups of 
speakers. Stipancic and colleagues (2016) then investigated the relationship between 
orthographic transcription scores and VAS ratings of sentence intelligibility. The authors 
reported strong associations between transcription scores and VAS ratings, ranging from 
.94 - .99 for participants with PD and ranging from .83 - .89 for control participants. The 
authors suggested that although the magnitude of scores for the measures of sentence 
intelligibility may differ, the overall patterns observed in these ratings remains constant. 
Abur and colleagues (2018) also explored the relationship between orthographic 
transcription scores and VAS ratings as measures of sentence intelligibility. Sixty-six 
naïve listeners either orthographically transcribed or provided VAS ratings for a subset of 
SIT sentences produced by 20 IWPD and five healthy speakers. The authors reported a 
strong relationship of .89 between SIT orthographic transcription and VAS scores. This 
relationship was consistent with the findings of Stipancic and colleagues (2016). 
 
Additionally, Adams and colleagues (2008) examined sentence intelligibility via the SIT 
in 25 IWPD and hypophonia and 15 control participants. Two listeners then measured 
speech intelligibility via orthographically transcription and VAS ratings of the SIT 
sentences for all participants. The authors reported that the speech intelligibility of 
participants with PD was significantly reduced compared to control participants for both 
SIT transcription and VAS scores. Adams and colleagues (2008) reported that SIT VAS 
ratings were 3.4 % and 2.6% lower than SIT transcription scores for participants with PD 
and control participants, respectively. These differences are smaller than those 
differences observed in the current study, where SIT VAS ratings were 14.38 % and 
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7.21% lower than SIT transcription scores for participants with PD and control 
participants, respectively.  
 
One possible reason for the discrepancy between SIT transcription and VAS scores may 
be due to SIT VAS scores capturing variables other than speech intelligibility in 
individuals with dysarthria, i.e. articulation impairments, comprehensibility, prosody, etc. 
(De Bodt et al., 2002; Kent, Kent, Vorperian, & Duffy, 1999; Kent et al., 1990). A 2002 
study by De Bodt and colleagues investigated how individual dimensions influence 
overall perceptions of speech intelligibility in 79 dysarthric speakers. Participants 
presented with the following types of dysarthria: flaccid, spastic, ataxic, hypokinetic, and 
mixed. Speech samples were collected from participants via the Grandfather passage or 
segments of spontaneous speech. Two experienced listeners then rated the speech 
samples on 4-point ratings scales for the following dimensions: voice quality, 
articulation, nasality, prosody, and overall speech intelligibility. The authors found that 
articulation was very strongly associated with perceived intelligibility. The authors also 
reported that all four dimensions contributed in some degree to ratings of speech 
intelligibility in dysarthric speakers. Thus, additional research is required to further 
explore whether SIT VAS ratings include perceptions of factors other than speech 
intelligibility in IWPD and hypophonia.  
 
Finally, as a result of the lack of significant difference in the mean of the SIT VAS scores 
across the three visits, it appears that these scores remain constant over time for 
participants with PD and control participants. The result of consistent SIT VAS scores 
over time is further supported by the findings from the retest analysis. The retest results 
suggested that the SIT VAS scores demonstrated good reliability and marginal 
repeatability for participants with PD and good reliability and good repeatability for 
control participants. Therefore, SIT VAS scores appear to be a reliable and fairly 
repeatable measure (indicating the possibility of an acceptable measurement error) for 
IWPD and healthy speakers, and would be potentially useful for examining the effects of 
treatments or experimental conditions in IWPD. 
4.3.3 VAS conversational intelligibility scores 
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The comparison of SIT VAS scores revealed that participants with PD demonstrated a 
significant reduction of approximately 12% in their conversational intelligibility 
compared to control participants. This difference between groups appears to be consistent 
with, but smaller than the differences reported by Adams and colleagues (2008). Adams 
and colleagues (2008) examined speech intelligibility in IWPD and hypophonia and 
healthy controls in the presence of varying intensity levels of background noise. Twenty-
five participants with PD and 15 age-matched control participants engaged in 
conversational speech tasks in various background noise conditions, including no added 
background noise, 60, 65, and 70 dB SPL. The conversational intelligibility scores of 
IWPD were approximately 20 – 30% lower than those of control participants across all 
noise conditions. The authors reported that conversational speech intelligibility scores in 
noise conditions were on average 5 – 10% lower than conversational intelligibility scores 
assessed in a quiet environment. Once this 5 – 10% adjustment is taken into account, the 
conversational intelligibility scores from the work of Adams and colleagues (2008) are 
consistent with the differences between IWPD and control participants in the current 
study. 
 
In contrast, a study by Dykstra and colleagues (2012b) explored conversational speech 
intelligibility in background noise in IWPD and healthy speakers. Two listeners rated 
conversational speech intelligibility 30 participants with hypophonia and 15 control 
participants via VAS ratings. All participants engaged in conversation in four background 
noise conditions: no added background noise, 60, 65, and 70 dB SPL. The authors 
reported lower conversational intelligibility in IWPD compared to control participants 
across all noise condition. However, only the differences observed in 60, 65, and 70 dB 
SPL were statistically significant. It should be noted that a larger difference in 
conversational intelligibility scores was observed between groups in the present study 
compared to the work of Dykstra and colleagues (2012b).  This discrepancy may be 
explained by any number of factors, including the presence of additional dysarthric 
features in participants with PD that may have had a greater impact on speech 
intelligibility or performance may have been influenced by the research testing 
environment (Keintz et al., 2007).  
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Additionally, the average VAS conversational intelligibility scores of participants with 
PD in the current study was approximately 81%. This finding is fairly consistent with the 
rating of SIT VAS scores observed in the current study. However, both of these 
intelligibility scores are approximately 12 – 15% lower than SIT transcription 
intelligibility scores. These results are fairly consistent with those of Adams and 
colleagues (2008).  Adams and colleagues (2008) compared SIT transcription scores, SIT 
VAS scores, and conversational intelligibility transcription scores in IWPD and 
hypophonia and control participants. The authors reported that conversational 
intelligibility transcription scores were 9.7 % and 5.3% lower than SIT transcription 
scores for participants with PD and control participants, respectively. These differences 
are fairly similar those observed in the current study, where VAS conversational 
intelligibility scores were 13.46 % and 5.24% lower than SIT transcription scores for 
participants with PD and control participants, respectively. While the scores are similar, it 
is important to note that Adams and colleagues (2008) examined transcribed scores 
whereas the current study explored VAS scores. However, the overall pattern of lower 
conversational intelligibility scores compared to SIT transcription scores is consistent 
across both studies. 
 
As previously discussed, a possible explanation for the discrepancy between VAS 
conversational intelligibility scores and SIT transcription scores may be related to VAS 
rating capturing other speech features in addition to speech intelligibility in individuals 
with dysarthria (Kent et al., 1999; Kent et al., 1990; De Bodt et al., 2002). Perceptions of 
voice quality, articulation, nasality, and prosody were found to contribute to ratings of 
speech intelligibility in dysarthric speakers (De Bodt et al., 2002). While it may be quite 
likely that other speech and voice features contribute to overall VAS ratings of speech 
intelligibility in IWPD, it is important to note that the participants in the study by De 
Bodt and colleagues (2002) presented with different types of dysarthria secondary to a 
variety of medical conditions. Additional research is recommended in order to further 
examine what other speech and voice dimensions may be assessed during VAS ratings of 
speech intelligibility. 
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Finally, based on the lack of a significant difference in the mean of the VAS 
conversational intelligibility scores across the three visits, these scores appear to be fairly 
consistent over time for both participants with PD and control participants. However, the 
consistency of the VAS conversational intelligibility scores is not supported by the retest 
results. The findings from the retest analyses were inconsistent. The retest results 
indicated that the VAS conversational intelligibility scores demonstrated good reliability 
and good repeatability for participants with PD. For the control participants, the retest 
results indicated that VAS conversational intelligibility scores demonstrated good 
repeatability but did not demonstrate good retest reliability. Thus, given the good 
reliability and good repeatability for participants with PD, these findings suggest that 
there is an acceptable level of measurement error in the VAS conversational intelligibility 
scores for their use in treatment outcome studies for IWPD. However, it is recommended 
that this retest analysis be replicated in future studies in order to verify the measurement 
error that was obtained for VAS conversational intelligibility scores in the present study. 
 
Moreover, in order to further examine CR% and clinically meaningful difference in the 
VAS conversational intelligibility score, the CR% value of the current study can be 
compared to previous treatment outcome studies of IWPD. A 2016 study by Andreetta 
and colleagues examined the efficacy of seven speech amplification devices (ADDvox, 
BoomVox, ChatterVox, Oticon Amigo, SoniVox, Spokeman, and Voicette) in IWPD and 
hypophonia. The authors reported that VAS conversational intelligibility scores when 
participants were using the BoomVox was significantly greater compared to the other 
speech amplification devices, as well as no device speech conditions. Andreetta and 
colleagues (2016) also reported a 39% improvement in conversational intelligibility 
scores of participants with PD following treatment with the BoomVox. This clinically 
meaningful change of 39% is much greater than the highest CR% of 2.55 – 5.21% found 
in the present study. This finding suggests that for certain treatment outcome studies, 
such as those related to the use of speech amplification devices in IWPD, the VAS 
conversational intelligibility score has a measurement error that is well below the 
clinically meaningful difference scores that are expected to be associated with treatment 
outcomes. 
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4.4 Objective 4: Self-Rated Communicative Participation 
 
This objective examined the temporal variability of CES question scores, VAPP 
subsection scores, CPIB scores, and LSUS scores in order to determine whether self-rated 
communicative participation differs over time between and within participants with PD 
and control participants. 
4.4.1 Communicative Effectiveness Survey 
 
The comparison of CES question scores revealed that overall, participants with PD self-
rated their communicative effectiveness significantly lower than control participants. 
These findings are consistent with previous studies that also reported IWPD self-rated 
their communicative effectiveness lower than control participants on the CES (Donovan 
et al., 2008; Dykstra et al., 2015).  
 
Donovan and colleagues (2008) compared self-rated communicative effectiveness via the 
CES in 25 individuals with hypokinetic dysarthria and PD and 25 control participants. 
The authors reported that IWPD had lower CES scores than control participants. These 
findings are similar to those reported in a previous study (Dykstra et al., 2015). Dykstra 
and colleagues (2015) explored self-rated communicative effectiveness in 30 IWPD and 
hypophonia and 15 control participants. The authors found that IWPD and hypophonia 
reported reduced scores on the CES compared to control participants. Furthermore, 
Dykstra and colleagues (2015) reported that participants with PD had lower scores on all 
CES items compared to control participants. These results are consistent with the current 
study, as univariate analyses revealed that participants with PD consistently rated 
themselves approximately 1 point lower than control participants on each of the eight 
communication situations included on the CES. These results suggest that participants 
with PD possess an awareness that they experience reduced communication effectiveness 
across different communicative situations.  
 
A closer look at the results of the current study revealed that larger differences between 
groups were present in CES question 5 (Being part of a conversation in a noisy 
environment (social gathering)), followed by CES question 8 (Having a conversation 
with someone at a distance (across a room)). These results are consistent with the 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
267 
findings of Dykstra and colleagues (2015), who reported that IWPD and hypophonia 
reported reduced scores of communicative effectiveness in communicative contexts and 
situations related to conversing over distances and conversing in background noise. The 
authors suggested that there may be a predictable hierarchy from more to less challenging 
communicative situations that are unique to individuals with hypophonia. It is likely that 
talking in noise and talking at a distance demands greater speech intensity than the other 
situations that are examined in the CES (i.e. talking on the phone). Thus, it is likely that 
both of these communicative situations present as particularly challenging for IWPD and 
hypophonia.  
 
Additionally, significant “Group” by “Visit” interactions were reported in the present 
study for each of the individual CES question – with the exception of question 3 
(Conversing with a familiar person over the telephone) and question 7 (Having a 
conversation while traveling in a car). For each interaction, it was observed that self-
rated communicative effectiveness increased over time for control participants, and 
decreased over time for participants with PD. It is possible that over the course of the 
study, participants became more aware of their communicative effectiveness in different 
communicative situations. During visits 2 and 3, multiple participants with PD and their 
primary communication partners reported that they had noticed and discussed with their 
partner particular trends in their communicative participation. Participants noted that they 
had not noticed or paid attention to communicative behaviours prior to being asked to 
consider and think about them in order to complete the communicative participation 
questionnaires. Miller and colleagues (2006) reported that when IWPD and hypophonia 
experience changes in their communicative functioning, such as reduced communicative 
participation, reduced confidence in their speaking abilities, and feelings of 
embarrassment at the reaction of others, they may be more likely to describe their 
communicative abilities as being impaired. They may also be concerned regarding the 
impact that changes in their speech production may have on their communicative 
effectiveness (Kwan & Whitehill, 2011; Miller et al., 2006). Miller and colleagues (2006) 
also reported that the negative perceptions held by IWPD of their communication 
partners’ reactions to communicative interactions, including embarrassment, impatience, 
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agitation, and lack of appreciation of speaking difficulties faced by IWPD can have 
adverse effects on the IWPD’s communicative participation and emotional response. It 
may be that the experience of completing self-ratings of their communication during the 
first visit led to subsequent reflection and an increased awareness of their reduced 
communication effectiveness, and this led to a lowering of their self-ratings of 
communication effectiveness when retested in visits 2 and 3. It is also possible that the 
experience of completing self-ratings of communication effectiveness, in the context of a 
study related to the communication in IWPD, may have made the control participants 
more aware of the positive aspects of their communication and this led to an increase in 
the ratings of communicative effectiveness in this cohort of participants. 
 
Finally, the variability observed in CES question scores over time is consistent with the 
results of the retest analyses. Each of the individual questions of the CES did not 
demonstrate good retest reliability for the participants with PD or control participants – 
with the exception of CES question 3 (Conversing with a familiar person over the 
telephone) which demonstrated good retest reliability for control participants only. 
Furthermore, the retest analyses indicated that each of the individual questions of the 
CES demonstrated unacceptable repeatability for participants with PD. The retest 
analyses also revealed that the individual questions of the CES demonstrated 
unacceptable repeatability for control participants – with the exceptions of CES question 
1 (Having a conversation with a family member or friends at home), CES question 3 
(Conversing with a familiar person over the telephone), and CES question 7 (Having a 
conversation while traveling in a car) which demonstrated marginal repeatability. Given 
the poor retest reliability and repeatability results, it becomes difficult to interpret the 
significant group by visit interaction obtained for several of the CES questions. While it 
was previously suggested that the IWPD showed a decrease in CES values from visit 1 to 
visits 2 or 3 (and the control participants showed an increase in CES values from visit 1 
to visits 2 or 3), it is possible that these changes are the result of measurement error and 
not the result of a ‘real’ change over time in the participants self-rating of communication 
effectiveness. This result is surprising as the CETI, the original questionnaire from which 
the CETI-M and CES were modified, was designed to track changes over time (Lomas et 
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al., 1989). However, it is possible that the CES in its present form (i.e. 4-point scale) may 
have a measurement error that is too high and thus unacceptable for the evaluation of 
treatment effects or the effects of experimental conditions in IWPD and hypophonia. It is 
recommended that future research explore whether modifications of the CES, such as 
having participants rate their communicative effectiveness using a VAS as opposed to a 
4-point Likert scale, will increase the reliability and repeatability of the CES. Thus, it is 
recommended that additional research be conducted to refine or design alternative 
methods of measuring self-rated communicative effectiveness that are associated with 
lower measurement error. 
4.4.2 Voice Activity and Participation Profile 
 
The comparison of self-rated VAPP scores revealed that participants with PD had greater 
scores across all VAPP subsections compared to control participants. These results 
suggest that our participants with PD rated themselves with significantly more activity 
limitations and participation restrictions in comparison to control participants. 
Additionally, an overall significant effect of visit was reported in the present study. 
Subsequent univariate analyses revealed that significant changes in VAPP scores were 
observed over time for VAPP social communication and VAPP participation restriction 
scores for both participants with PD and control participants. For these two subsections, 
the scores of both groups of participants were greater at visit 1 than their scores at visit 2 
but lower than those at visit 3. These observed changes were more prevalent in the scores 
of participants with PD compared to control participants. It would appear that the social 
communication and participation restriction subsections of the VAPP demonstrated 
greater variability and this was associated with the development of more severe self-
ratings of communicative participation and participation restrictions over time. 
 As previously discussed, many participants with PD shared with the researcher 
during visits 2 and/or 3 the impression that they had become more aware of their 
communicative activity and communicative participation following the completion of the 
participation-based PROs after visit 1. Subsequently, participants with PD reported 
becoming more aware of the changes that had occurred within their speech production 
and communicative participation over the course of their disease. These anecdotal reports 
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are consistent with previous studies (Miller et al., 2006). As previously discussed, Miller 
and colleagues (2006) reported that perceived communicative impairments were 
associated with reduced communicative participation, reduced confidence in speaking 
abilities, and increased feelings of embarrassment at the reaction of others. The authors 
also found that the negative perceptions of their communication partners’ reactions to the 
communicative interactions of the IWPD may result in adverse effects on the 
communicative participation and emotional response of the IWPD. These responses may 
lead to withdrawal, and barriers and restrictions in the communicative and social 
interactions of IWPD. 
 
Finally, the observed changes in VAPP subsection scores over time were not consistent 
with the retest analyses. The retest analyses of self-rated VAPP subsection scores 
demonstrated good retest reliability across many VAPP subsections for participants with 
PD and control participants, with several exceptions. The VAPP self-perceived voice 
problem scores for participants with PD did not demonstrate good retest reliability. 
Additionally, the VAPP self-perceived voice problem, social communication and 
participation restriction scores for control participants did not demonstrate good retest 
reliability. Additionally, all VAPP subsection scores demonstrated unacceptable 
repeatability for participants with PD and control participants. Measures of retest 
reliability provide information regarding the strength of the relationship between retests, 
and do not account for the presence of measurement error. Whereas measures of 
repeatability incorporate both correlations and measurement error and result in better 
estimates of the similarities of retest measures. Given the poor retest reliability and 
repeatability results, it becomes difficult to interpret the significant visit effects obtained 
for the VAPP subsections. While the previous interpretation of the ANOVA results 
suggested the IWPD  showed an increase in VAPP subsection scores from visit 1 to visits 
2 and/or 3, it is possible that these changes are the result of measurement error and not 
the result of a ‘real’ change over time in the participants’ VAPP-related self-ratings of 
communicative activity and participation. These inconsistent findings do not support the 
results of Ma and Yiu (2001), who reported good test-retest reliability for the VAPP. 
However, it is important to note that Ma & Yiu (2001) assessed the test-retest reliability 
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of the VAPP in individuals with dysphonia.  It is possible that higher levels of 
measurement error may be present in the VAPP when administered to IWPD and 
hypophonia. Ma & Yiu (2001) also used Pearson’s correlation coefficient in order to 
assess test-retest reliability. While these findings are consistent with most of the retest 
reliability results in the present study, it must be noted that neither Pearson’s r nor ICC 
take into account the degree of measurement error present in the measures. Additional 
research is recommended in order to refine or design alternative methods of measuring 
the impact of an individual’s voice impairment on activity limitation and participation 
restriction scores that are associated with lower measurement error in IWPD. 
4.4.3 Communicative Participation Item Bank 
 
The comparison of self-rated CPIB scores revealed that overall, participants with PD 
perceived their communicative participation to be lower than control participants’ self-
rated CPIB scores. No published studies have compared the CPIB scores of IWPD to 
control participants. Additionally, a significant “Group” by “Visit” interaction was found 
for CPIB scores.  CPIB scores were observed to increase over time for control 
participants, and were observed to decrease over time for participants with PD. It is 
possible that over the course of the study, participants became more aware of their 
communicative participation. It may be that such an increased awareness resulted in the 
observed changes in perceived communicative participation over time for participants 
with PD and control participants. As previously stated, several participants with PD 
became more aware of the impact of their voice on their activity and communicative 
participation over the course of the study. This observation is consistent with the work of 
Miller and colleagues (2006), who reported that greater perception of communicative 
impairments which may in turn result in negative emotions, withdrawal, and barriers and 
restrictions to the communicative and social interactions of IWPD. 
 
Finally, self-rated CPIB scores demonstrated good retest reliability and marginal 
repeatability for participants with PD, and good retest reliability and good repeatability 
for control participants. Thus, self-rated CPIB scores may be a reliable measure to 
evaluate changes over time in IWPD, wherein observed changes (i.e. those associated 
with a treatment or experimental condition) of greater than approximately 5 – 6 points 
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would be above the estimated error of measurement (95% confidence range) for 
standardized CPIB scores and would therefore reflect a true change in the IWPD. It is 
important to note that the CPIB was not intended to be used as a pre- and post-treatment 
outcome measure (Baylor et al., 2013). However, the good retest reliability and marginal 
repeatability findings from the present study suggest the possibility that the CPIB may be 
an effective and reliability measure to detect change over time in IWPD. Furthermore, 
these retest analyses suggest that the main effect of “Visit” and the “Group” by “Visit” 
interaction obtained from the above described ANOVA results are more likely to be 
related to a real effect compared to an effect of measurement error. These results also 
suggest that the similar “Group” by “Visit” interaction found in the CES analysis may 
reflect a real visit effect, despite the concerns regarding measurement error in the CES. 
4.4.4 Level of Speech Usage Scale 
 
The comparison of self-rated LSUS scores revealed that overall, participants with PD 
rated their level of speech usage lower than did control participants. As part of their 
evaluation of the efficacy of seven different speech amplification devices in IWPD, 
Andreetta and colleagues (2016) asked participants with PD and control participants to 
complete the LSUS. The authors found that level of speech usage reported by participants 
with PD was fairly evenly divided between Routine – frequent periods of talking on most 
days, Intermittent – quiet for long periods of time on many days, and Undemanding – 
quiet for long periods of time almost every day. However, their control participants 
reported their level of speech usage to be Intermittent – quiet for long periods of time on 
many days or Routine – frequent periods of talking on most days.  In the present study, 
participants with PD typically rated their level of speech usage to be Undemanding – 
quiet for long periods of time almost every day or Intermittent – quiet for long periods of 
time on many days. Control participants typically rated their level of speech usage to be 
Intermittent – quiet for long periods of time on many days or Routine – frequent periods 
of talking on most days. These results suggest that IWPD rate their speech usage to be 
less frequent on a day-to-day basis compared to healthy speakers. Thus, IWPD may be 
engaging less and have more limited opportunities to participate in situations that rely on 
communication. Measures of participation may be used to evaluate the functional 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
273 
outcomes of impaired activities, such as speech intensity and speech intelligibility 
(Baylor et al., 2009). The reduced measures of speech intensity and speech intelligibility 
found in IWPD in the present study may be related to the difference in the levels of 
speech usage observed in participants with PD and control participants. Level of speech 
usage may be a functional measure of the impact of communication challenges resulting 
from impaired speech intelligibility and deficits in the regulation of speech intensity in 
IWPD. However, it is important to note that many other factors, such as mild cognitive 
impairment, alterations in mood, and reduced mobility, may also contribute to reduced 
levels of speech usage in IWPD (McAuliffe et al., 2016). 
 
Finally, self-rated LSUS scores appear to have been fairly consistent over time for both 
participants with PD and control participants. However, other measures of 
communicative participation, specifically the CES, VAPP, and CPIB, were observed to 
change over the course of the study. It is possible that participants’ perceptions of their 
communicative participation shifted while the manner and degree to which they used 
their speech remained constant. The above reported stability in self-rated LSUS scores 
are inconsistent with the retest analyses. The results revealed that self-rated LSUS scores 
demonstrated good retest reliability for participants with PD but did not demonstrate 
good retest reliability for control participants. These results suggest that participants with 
PD are more reliable in their ratings of speech usage. It is possible that this difference 
between groups is related to the nature of the adjacent categorical levels on the LSUS that 
control participants may have varied across testing visits. It may be that the higher usage 
categories are more difficult for control participants to judge consistently, where the 
lower usage categories are easier to consistently select. Therefore, this discrepancy 
between groups may be related to the nature of the level items more than the consistency 
of the participant selections. Future studies may wish to explore item analysis of the 
LSUS in order to attempt to refine the reliability and validity of the measure. 
Additionally, the retest analyses also indicated that self-rated LSUS scores demonstrated 
unacceptable repeatability for both participants with PD and control participants. Thus, it 
is unclear whether self-rated LSUS scores demonstrate significant variability over time in 
IWPD and control participants. Additional studies are needed in order to refine or create 
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alternative methods of measuring self-rated levels of speech usage that are associated 
with lower measurement error. 
4.5 Objective 5: Self- and Proxy-Rated Communicative 
Participation 
 
This objective examined the temporal variability of CES question scores, VAPP 
subsection scores, CPIB scores, and LSUS scores in order to determine whether self- and 
proxy-rated communicative participation differ over time between and within participants 
with PD and their primary communication partners. 
4.5.1 Communicative Effectiveness Survey 
 
The comparison of self- and proxy-rated CES question scores revealed similar overall 
ratings between participants with PD and their primary communication partners. These 
findings are similar to those of Dykstra and colleagues (2015), and contrary to those of 
Donovan and colleagues (2008). Dykstra and colleagues (2015) compared self- and 
proxy-rated communicative effectiveness using the CES in 30 IWPD and hypophonia and 
their primary communication partners. The authors reported similar ratings of 
communicative effectiveness between IWPD and their primary communication partners. 
The findings of Dykstra and colleagues (2015) and the present study are in contrast to 
those of Donovan and colleagues (2008). Donovan and others (2008) compared ratings of 
communicative effectiveness via the CES in 25 individuals with hypokinetic dysarthria 
and PD and their 25 significant others. The authors noted that IWPD self-rated their 
communicative effectiveness significantly higher than did their communicative partners. 
The difference in the results of Donovan and colleagues (2008) compared to those of 
Dykstra and colleagues (2015) as well as the present study may be related to factors such 
as severity, or salient dysarthric features. For instance, in their study, Donovan and 
colleagues (2008) included IWPD with a diagnosis of hypokinetic dysarthria. These 
participants likely presented with a range of dysarthric features associated with 
hypokinetic dysarthria (i.e., articulatory imprecision, prosodic abnormalities, impairments 
in speech rate; Donovan et al., 2008). Whereas the current study as well as the study of 
Dykstra and colleagued (2015) recruited IWPD with hypophonia as their primary 
dysarthric feature. While Donovan and colleagues suggested that IWPD demonstrate 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
275 
reduced awareness with respect to their communicative effectiveness, it may be that this 
hypothesis is not applicable in IWPD with hypophonia as their primary dysarthric feature. 
 
Additionally, a significant effect of visit was found in the present study. Subsequent 
univariate analyses of the individual CES questions revealed a gradual reduction in 
ratings of communicative effectiveness over time. These significant findings were found 
for CES question 2 (Participating in conversation with strangers in a quiet place), CES 
question 4 (Conversing with a stranger over the telephone), CES question 5 (Being part 
of a conversation in a noisy environment (social gathering)), and CES question 6 
(Speaking to a friend when you are emotionally upset or you are angry). These findings 
suggest that there may be an unknown factor that is causing the reduction in ratings over 
time. However, it is possible that this reduction is due to random variation related to the 
measurement error. The findings of the retest analysis indicate that there was a fairly high 
level of measurement error. It was found that self- and proxy-rated CES questions do not 
demonstrate good retest reliability for the participants with PD or their primary 
communication partner – with the exception of CES question 5 (Being part of a 
conversation in a noisy environment (social gathering)) which demonstrated good retest 
reliability for the primary communication partners of participants with PD. Furthermore, 
the retest analyses indicated that each of the individual questions of the CES 
demonstrated unacceptable repeatability for both participants with PD and their primary 
communication partners. The results obtained from the primary communication partner 
for CES question 5 (Being part of a conversation in a noisy environment (social 
gathering)) can provide a useful illustration of the interpretive challenges that arise in the 
context of high levels of measurement error (i.e. poor repeatability). The univariate and 
post-hoc analysis revealed that there was a significant reduction in CES scores from visit 
1 to visit 3 (-0.36) for the combined scores of participants with PD and their primary 
communication partners. Similarly, the t-test results related to the visit 1 to visit 3 
comparison of proxy-ratings showed a reduction (-0.32) that approached significance. 
Thus, it appears that there may be a real reduction in CES question 5 (Being part of a 
conversation in a noisy environment (social gathering)) scores from visit 1 to visit 3. This 
is supported by the good reliability value (ICC = .75) for the visit 1 to visit 3 comparison. 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
276 
However, the visit 1 vs visit 3 showed poor repeatability (CR = 1.09 and CR% = 
44.86%). This poor repeatability was also shown for the other two visit comparisons 
(visit 1 versus visit 2, CR = 1.54 and CR% = 58.11%, and for visit 2 versus visit 3, CR = 
0.89 and CR% = 37.71%). These CR values (0.89 to 1.54) are at least two times the value 
of the visit 1 to visit 3 difference value (0.32). Thus, these repeatability results indicate 
that the measurement error was probably too high to detect a real difference between the 
visit 1 and visit 3 CES scores for question 5 (Being part of a conversation in a noisy 
environment (social gathering)).  
 
Given that the results for CES question 5 (Being part of a conversation in a noisy 
environment (social gathering)) showed some of the largest differences for the visit 
comparisons examined across all of the eight CES questions, it is likely that the high 
measurement error makes the interpretation of all of the visit comparisons related to the 
CES a challenge. In general, the high measurement error obtained for all of the 
communication partner CES questions makes it difficult to evaluate the across visit 
temporal variability of these CES results. Since the results varied for the retest analyses 
performed on the different CES questions in the present study, it is unclear whether CES 
questions scores demonstrate significant variability over time in IWPD and their primary 
communication partners. These findings are consistent with the above retest analyses 
findings for self-rated CES question scores for participants with PD and control 
participants. As previously discussed, these findings are unexpected as the CETI was 
designed to track changes over time (Lomas et al., 1989). Once again, it is possible that 
the CES in its present form (i.e. 4-point scale) may have a measurement error that is too 
high and thus unacceptable for the evaluation of treatment effects or the effects of 
experimental conditions in IWPD and hypophonia. Thus, it is recommended that future 
research explore whether changes of the CES, such as using VAS estimation as opposed 
to a 4-point Likert sale, will increase the reliability and repeatability of the CES. 
Additional research is needed to refine or create alternative methods of measuring 
perceived communicative effectiveness that are associated with lower measurement error. 
4.5.2 Voice Activity and Participation Profile 
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The comparison of self- and proxy-rated VAPP scores revealed that both participants 
with PD and their primary communication partners held similar perceptions of the 
IWPD’s voice problem, their activity limitations, and restrictions to their participation. 
These findings contradict those of Simberg and colleagues (2012), who reported that 
proxy-ratings of their partner’s voice functioning was less severe compared to the self-
ratings of IWPD. It may be possible that the discrepancy between the findings of Simberg 
and colleagues (2012) and the present study are related to differences in severity and 
dysarthric features of the IWPD in each study. Simberg and colleagues (2012) recruited 
participants to take part in a two-day treatment session, and likely had a more 
heterogenous groups of dysarthria symptoms and severity compared to the present study. 
Additional research exploring self- and proxy-rated perceptions of voice impairment in 
IWPD separated according to different dysarthric features may be warranted.  
 
Additionally, the results of the aforementioned multivariate testing would suggest that the 
self- and proxy-scores of each subsection of the VAPP are consistent over time for 
participants with PD and their primary communication partners. However, the results of 
the retest analysis make it difficult to interpret these temporal variability results for the 
VAPP. Each of the individual subsections of the VAPP did not demonstrate good retest 
reliability for the participants with PD. However, each of the individual subsections of the 
VAPP demonstrated good retest reliability for the primary communication partners of 
IWPD – with the exception of VAPP daily communication and total scores which did not 
demonstrate good retest reliability. Furthermore, the retest analyses indicated that each of 
the individual subsections of the VAPP demonstrated unacceptable repeatability for both 
participants with PD and their primary communication partners. As previously discussed, 
measures of retest reliability provide information with regards to the strength of the 
association between retests, and do not factor the presence of measurement error. 
However, measures of repeatability use both the correlation and measurement error, 
resulting in a better estimate of the similarities of retest measures. Since the results varied 
for the different retest analyses performed in this study, it becomes difficult to determine 
whether self- and proxy-rated VAPP subsection scores are a reliability measure of 
activity limitation and participation restrictions over time in IWPD. These inconsistent 
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findings do not support the results of Ma and Yiu (2001), who reported good test-retest 
reliability for the VAPP. However as previously mentioned, Ma & Yiu (2001) collected 
data from individuals with dysphonia and used a different means of calculating test-retest 
reliability compared to the current study. Additional research is recommended in order to 
refine or create alternative methods of measuring the impact of an individual’s voice on 
their activity limitations and participation restrictions that are associated with lower 
measurement error in IWPD. 
4.5.3 Communicative Participation Item Bank 
 
The comparison of self- and proxy-rated CPIB scores revealed similar perceptions of 
communicative participation in participants with PD and their primary communication 
partners. These results suggest that IWPD may demonstrate an awareness of their deficits 
in communicative participation comparably to their primary communication partners. 
 
Additionally, the comparison of self- and proxy-rated CPIB scores revealed significant 
differences among the three visits. The scores at visit 1 were higher than the scores at 
visits 2 and 3. The scores at visit 2 were higher than the scores at visit 3. These results 
suggest that there is significant variability in self- and proxy-perceptions of 
communicative participation, as CPIB scores decreased over time for both groups of 
participants. It is possible that participants became more attuned to their level of 
communicative participation over the course of the study. As previously mentioned, 
many participants with PD and their primary communication partners shared that they 
were more conscious of communicative behaviours and participation in different 
communicative situations in the days and weeks that followed visit 1. As a result, 
participants may have overestimated their degree of communicative participation prior to 
the study. These observations are consistent with the aforementioned work of Miller and 
colleagues (2006), who reported that perceived impairments to and IWPD’s 
communication was associated with reduced communicative participation, reduced 
confidence in speaking abilities, and increased feelings of embarrassment at the reaction 
of others. The authors also suggested that these negative feelings and perceptions may 
result in adverse effects on the communicative participation and emotional response of 
the IWPD. The increased variability reported may be associated with increased awareness 
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on the part of the participants with PD and their primary communication partners. Further 
research exploring this variability over time may shed some light on any shifts in 
awareness that occurred in participants with PD and their primary communication 
partners over time. 
 
Finally, retest analyses of self- and proxy-rated CPIB scores demonstrated good retest 
reliability for participants with PD and their primary communication partners. 
Additionally, these scores also demonstrated good repeatability for participants with PD 
and marginal repeatability for the primary communication partners of IWPD. Thus, self- 
and proxy-rated CPIB scores may be a fairly reliable measure to evaluate self- and proxy-
perceptions of change over time in IWPD, wherein observed changes (i.e., those 
associated with a treatment or experimental condition) of greater than approximately 5 – 
6 and 6 – 11 would be above the estimated error of measurement (95% confidence range) 
for standardized CPIB scores, and would therefore reflect a true change in the scores of 
IWPD and their primary communication partners, respectively. As previously mentioned, 
the CPIB was not intended to be used as a pre- and post-treatment outcome measure 
(Baylor et al., 2013). However, the good retest reliability and good repeatability findings 
from the present study suggest that the CPIB may be an effective and reliability measure 
to detect change over time in IWPD. Furthermore, these retest analyses suggest that the 
main effect of “Visit” obtained from the ANOVA results are more likely to be related to a 
‘real’ effect compared to an effect of measurement error. These results also suggest that 
the similar main effect of “Visit” found in the CES analysis may reflect a real visit effect, 
despite the aforementioned concerns regarding measurement error in the CES. 
4.5.4 Level of Speech Usage Scale 
 
The comparison of self- and proxy-rated LSUS scores revealed that participants with PD 
perceive their level of speech usage to be similar to the perceptions of their primary 
communication partners. These results suggest that IWPD and their primary 
communication partner demonstrate consistency in their perceptions of the degree to 
which IWPD use their speech on a day-to-day basis. 
 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
280 
Finally, while the lack of a significant effect of visit might be indicative of the 
consistency in self- and proxy-rated LSUS scores, the results of the retest analyses 
suggest the need for a cautious approach to this interpretation. It was found that LSUS 
scores demonstrated good retest reliability for participants with PD but did not 
demonstrate good retest reliability for their primary communication partners. The retest 
analyses also indicated that self- and proxy-rated LSUS scores demonstrated 
unacceptable repeatability for participants with PD and their primary communication 
partners. Thus, it is inclusive whether self- and proxy-rated LSUS scores are a reliable 
measure to evaluate changes over time in IWPD. Additional study is needed in order to 
further establish the test-retest reliability of the LSUS. Given the poor retest reliability 
and repeatability results, it becomes difficult to interpret the results obtained for the 
LSUS. It is possible that the consistency of self- and proxy-rated LSUS scores is the 
result of measurement error and not the result of a ‘real’ change over time in the 
participants’ perceived level of speech usage. Thus, it is recommended that additional 
research be conducted to refine or design alternative methods of measuring self- and 
proxy-rated levels of speech usage that are associated with lower measurement error in 
IWPD, 
4.6 Objective 7: Inter-Relationships Among Variables in 
Participants with Parkinson’s Disease 
 
This objective examined inter-relationships among speech intensity measures, speech 
intelligibility measures, self-rated communicative participation measures, demographic 
factors, and non-speech factors for participants with PD. 
4.6.1 Speech intensity measures 
 
The correlations involving speech intensity measures revealed a moderate association 
between maximum speech intensity and magnitude production in participants with PD. 
These results suggest that the greater an IWPD’s maximum speech intensity, the steeper 
their function of magnitude production as a greater range in their speech intensity would 
result in a sharper slope. A study by Clark and colleagues (2014) reported similar 
findings to the present study, in that IWPD demonstrated a smaller magnitude production 
slope compared to control participants. Clark and colleagues (2014) also suggested that 
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IWPD demonstrate a flatter psychophysical loudness function and a more restricted range 
of intensity perception compared to control participants. However, there was a sizable 
difference in the magnitude production slopes in the present study compared to the 
magnitude production slope in reported by Clark and colleagues (2014), 2.09 and 0.025, 
respectively. It is possible that a larger magnitude production slope was observed in the 
present study as the participants with PD might have presented with a greater range in 
their speech intensity compared to the IWPD who took part in the study by Clark and 
colleagues (2014). If IWPD are able to generate greater maximum speech intensities, it 
may directly influence their ability to increase their speech intensity during magnitude 
production tasks, resulting in a greater slope of magnitude production. 
 
It is also interesting to note that while the maximum speech intensity and function of 
magnitude production of IWPD was found to be reduced compared to controls in the 
present study, both groups of participants demonstrated a similar relationship between 
these maximum speech intensity and magnitude production. While Clark and colleagues 
(2014) have explored magnitude production in IWPD, no published studies have explored 
the relationship between magnitude production and maximum speech intensity. The 
results of the current investigation are consistent with some of the findings of Clark and 
colleagues (2014), yet there are some key differences between the two studies. Clark and 
colleagues (2014) had 17 IWPD and hypophonia and 25 control participants complete a 
magnitude production involving a five-word target sentence as part of their examination 
of loudness perception. During the magnitude production task, participants read the target 
sentence at their habitual speaking volume Participants were then asked to reproduce the 
target sentence in varying magnitudes (25, 50, 100, 200, and 400), where 100 was their 
habitual speaking volume. Similar to Clark and colleagues (2014), functions of 
magnitude production were calculated by asking participants to repeat a sentence at two 
and four times louder than their habitual speaking volume. However, the present study 
did not ask participants to reduce their speaking volume as part of a magnitude 
production task. Yet both the present study and the works of Clark and colleagues (2014) 
arrived at the same conclusion, suggesting that the slope of the magnitude production 
function is less steep in IWPD compared to control participants. Additional research is 
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recommended to further explore the relationship between maximum speech intensity and 
magnitude production. 
 
Finally, it is interesting to note that speech intensity measures and self-rated 
communicative effectiveness, as measured by the CES, were not found to be significantly 
correlated with one another at any of the three visits. This finding is consistent with those 
of Dykstra and colleagues (2015) who examined the relationship between speech 
intensity and self-rated communicative effectiveness in IWPD and hypophonia. Thirty 
IWPD and hypophonia and 15 control participants engaged in various speech tasks and 
completed the CES (Dykstra et al., 2015). The authors identified a non-significant 
relationship between speech intensity measures and self-rated communicative 
effectiveness (Dykstra et al., 2015). Dykstra and colleagues (2015) suggested that 
communicative participation is a distinct construct that differs from perceptual or acoustic 
measures of hypophonia, such as reduced speech intensity or reduced loudness. The 
results of the current study lend support to the possibility that communicative 
participation is a separate and distinctive construct from measures of speech intensity in 
the measurement of hypophonia in IWPD.  
 
Previous studies have hypothesized that the presentation of hypophonia in IWPD may be 
causally related to deficits in sensorimotor integration, as well as sensory and 
somatosensory deficits, as evidenced by reduced speech intensity and loudness perception 
(Clark et al., 2014; Conte et al., 2013; Ho et al., 2000). It has been suggested that the 
dopamine-modulated subcortical structures of the basal ganglia and cortico-striatal 
pathways connecting the ipsilateral caudate nucleus and dorsolateral prefrontal cortex, in 
addition to non-dopaminergic pathways and neural structures such as the striatum, are 
involved in the regulation of muscle tone and coordination, scaling the force, amplitude, 
and duration of movements, as well as learning, planning, and initiating movements 
(Arnold et al., 2014; Braak et al., 2004; Duffy, 2013; Kempler & Van Lanker, 2002; 
Sapir, 2014). All of which can be attributed to the presentation of the development and 
presentation of hypokinetic dysarthia features associated with PD, including hypophonia 
(Arnold et al., 2014; Duffy, 2013; Sapir, 2014). Thus, it is possible that sensory, 
somatosensory, and sensorimotor integration deficits may be related to a lack of self-
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awareness of reduced speech intensity. However, participants with PD did not 
demonstrate a lack of self-awareness of communicative effectiveness. This discrepancy in 
self-awareness may explain why speech intensity and CES scores were not associated 
with one another in the present study. This lack of significant correlations further 
supports the earlier suggestion that speech intensity and communicative participation are 
different constructs. 
4.6.2 Speech intelligibility measures 
 
The correlations involving speech intelligibility measures revealed the SIT transcription 
and SIT VAS scores were strongly associated with one another across all three visits in 
participants with PD. These findings suggest that both orthographic transcription and 
VAS ratings may be valid ways of assessing sentence intelligibility for IWPD. 
Additionally, it is possible that orthographic transcription and VAS ratings of the SIT 
measure and capture similar aspects of speech intelligibility in IWPD. 
4.6.3 Communicative participation 
 
The correlations involving the CPIB revealed a moderate association with self-rated 
VAPP self-perceived voice problem scores, and a moderate to good association with self-
rated VAPP total scores. These results suggest that as IWPD perceive a more negative 
impact of their voice with respect to their day-to-day functioning, the lower they will rate 
their overall communicative participation. While no published studies have examined the 
relationship between the CPIB and the VAPP, two studies have explored the relationship 
between the CPIB other functional questionnaires (Baylor et al., 2009; McAuliffe et al., 
2016). 
 
Baylor and colleagues (2009) conducted psychometric analyses of the CPIB on 208 
participants with spasmodic dysphonia. Participants completed the 141-item CPIB and 
the Voice Handicap Index (VHI). The authors then conducted Rasch analysis in order to 
identify the most appropriate items to include in the CPIB short form and correlated the 
CPIB and VHI. Baylor and colleagues (2009) found that the CPIB was moderately 
correlated with the VHI total score. Additionally, McAuliffe and colleagues (2016) 
explored the relationship between health-related quality of life measures and 
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communicative participation as measured via the CPIB in 378 IWPD in the United States 
and New Zealand. The authors reported that the CPIB was moderately correlated with the 
Physical, Mental, and Social Roles subsections of the Patient Reported Outcomes 
Measurement Information System (PROMIS; McAuliffe et al., 2016). The CPIB was also 
found to be strongly correlated with the Parkinson’s Disease Questionnaire – 8 (PDQ-8; 
McAuliffe et al., 2016). While relationships between the CPIB and subsections of the 
PROMIS, PDQ-8; and VHI have been explored (Baylor et al., 2009; McAuliffe et al., 
2016), additional research is required to further examine any relationships between the 
CPIB and other measures of communicative participation, such as the VAPP. 
 
The correlations amongst self-rated CES questions revealed weak associations between 
almost all of the individual CES question scores for participants with PD. A moderate 
relationship was found between CES question 1 (Having a conversation with a family 
member or friends at home) and CES question 2 (Participating in conversation with 
strangers in a quiet place). These communication contexts are both relatively 
unchallenging. Listeners who are familiar with dysarthric speech, such as close friends, 
family members, and spouses, have been found to better recognize and understand the 
speech of individuals with various types of dysarthria, including hypokinetic dysarthria 
(Depaul & Kent, 2000; Liss, Spitzer, Cavinesss, & Adler, 2002; Tjaden & Liss, 1995). 
Thus, it is plausible that IWPD and dysarthric speech might perceive their communicative 
effectiveness to be greater in situations wherein they are communicating with listeners 
who are familiar with them and their speech difficulties.  
 
Additionally, the presence of background noise has been found to have adverse effect on 
the conversational speech intelligibility of IWPD and hypophonia (Adams et al., 2008; 
Dykstra et al., 2012b). Adams and colleagues (2008) examined the conversational speech 
intelligibility of 25 IWPD and hypophonia in the presence of various background noise 
conditions, including: no added background noise, 60, 65, and 70 dB SPL. The authors 
reported that conversational speech intelligibility scores in noise conditions were on 
average 5 – 10% lower than conversational intelligibility scores assessed in a quiet 
environment (Adams et al., 2008). Furthermore, Dykstra and colleagues (2012a) also 
sought to assess conversational speech intelligibility in background noise in 30 
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individuals with hypophonia and PD. All participants engaged in conversational speech 
tasks in different background noise conditions, including: no added background noise, 60, 
65, and 70 dB SPL. Dykstra and colleagues (2012a) reported that the conversational 
speech intelligibility of IWPD decreased as the intensity of background noise increased, 
with intelligibility values of 89.63%, 77.47%, 68.98%, and 57.57% in no noise, 60 dB 
SPL, 65 dB SPL, and 70 dB SPL, respectively. Based on these findings, it was 
demonstrated that the conversational speech intelligibility of IWPD became further 
reduced with increasing levels of background noise (Adams et al., 2008; Dykstra et al., 
2012a). Since IWPD are more become less intelligible when speaking in background 
noise, it is possible that IWPD might perceive their communicative effectiveness to be 
greater in communicative situations and contexts that are quieter and involve familiar 
conversational partners. It is possible that the less challenging nature of both of these 
communicative situations may provide some explanation as to why CES question 1 
(Having a conversation with a family member or friends at home) and CES question 2 
(Participating in conversation with strangers in a quiet place) were significantly 
correlated with one another across all three visits for participants with PD.  
 
The correlations amongst self-rated VAPP subsection scores revealed good to excellent 
associations among all of the individual VAPP subsection scores for participants with 
PD. These findings suggest that IWPD are extremely consistent in their perception of the 
impact of their voice difficulties on their activity and participation over time. These 
results appear to be consistent with previous work exploring the test-retest reliability of 
the VAPP (Ma & Yiu, 2001). As part of its development, the VAPP was administered to 
25% of its original testing population two weeks following participants’ initial 
completion of the questionnaire (Ma & Yiu, 2001). The authors reported good test-retest 
reliability between the two administrations of the VAPP (Ma & Yiu, 2001). The VAPP 
was originally tested and validated for use on individuals with dysphonia (Ma & Yiu, 
2001) and was later validated on IWPD (Simberg et al., 2012). However, it is important 
to note that the present study revealed inconsistent results for the retest reliability and 
repeatability analyses for the individual VAPP subsection scores. Therefore, caution is 
recommended in the interpretation of the perceived consistency of VAPP subsection 
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scores. Additional research is recommended to further examine the test-retest reliability 
of the VAPP in IWPD and hypophonia. 
 
Finally, level of speech usage was not found to be related to other measures of 
communicative participation in participants with PD. These results contradict those 
reported by McAuliffe and colleagues (2016), who found that increased levels of speech 
usage were associated with increased communicative participation as measured by the 
CPIB in IWPD. It is possible that this difference is related to the degree of speech 
difficulties experienced by the IWPD. In the present study, participants with PD were 
selected due to the presence of hypophonia. However, McAuliffe and colleagues (2016) 
did not exclude participants on the basis of their presenting speech characteristics. It is 
possible that the IWPD who took part in McAuliffe and colleagues’ (2016) study 
demonstrated a greater variety of speech features related to hypokinetic dysarthria 
compared to the participants with PD in the present study who exhibited hypophonia as 
their primary dysarthric feature. 
4.6.4 Demographic and non-speech factors 
 
The correlations involving demographic and non-speech factors revealed a moderate 
correlation between gender and MOCA scores for participants with PD. These findings 
suggest the presence of sex differences in cognitive abilities in IWPD. In the present 
study, the MOCA scores of female participants with PD were on average 3.48 points 
higher than those of male participants with PD. Both male and female participants with 
PD had been diagnosed with PD for a similar duration of time and presented with similar 
UPDRS scores, approximately 10 years and 36 points. Several published studies have 
explored sex differences on various measures of speech intensity and communicative 
participation in IWPD (Fox & Ramig, 1997; Sapir et al., 2007; Yorkston et al., 2008).  
 
Sapir and colleagues (2007) explored the impact of LSVT on vowel intensity in 29 
IWPD.  Sapir and colleagues (2007) reported significant gender differences in intensity 
measures of the vowels, wherein men had higher vocal sound pressure level compared to 
women, and women demonstrated higher second formant values for /u/ as well as the 
ratio of second formants for /i/ and /u/ prior to receiving treatment. While the present 
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study did not specifically explore vowel intensity or formants, speech intensity was not 
found to be significantly correlated with gender over time. 
 
Fox and Ramig (1997) examined the impact of LSVT on speech intensity and nine self-
rated perceptual variables in 30 IWPD and 14 healthy controls. No gender differences 
were found in the speech intensity across all speech tasks (Fox & Ramig, 1997). These 
findings are consistent with those in the present study, as measures of speech intensity 
were not found to be significantly correlated with gender over time. Additionally, the 
work of Fox and Ramig (1997) did not reveal gender differences in the nine self-rated 
perceptual variables. These variables included self-perceived loudness, understandability, 
participation, and various voice quality variables (Fox & Ramig (1997). Similarly, results 
from the current study did not reveal significant correlations between gender and self-
perceived typical speech loudness or self-rated communicative participation. However, it 
is important to note that self-rated perceptual measures differed significantly between the 
two studies. Fox and Ramig (1997) asked participants to rate each variable using a VAS. 
Whereas the currently study used a similar method for perceptions of typical speech 
loudness, but validated and standardized questionnaires for measures of self-rate 
communicative participation. 
 
Yorkston and colleagues (2008) explored the relationships between self-rated 
participation and personal factors in 112 individuals with multiple sclerosis. Gender 
effects were observed, with men with multiple sclerosis demonstrating increased 
communicative participation compared to women with multiple sclerosis (Yorkston et al., 
2008). While Yorkston and colleagues (2008) explored relationships between variables in 
individuals presenting with a different movement disorder. It is interesting to note that 
gender was not significantly correlated with measures of communicative participation 
over time in the present study. It is possible that the different presentation of dysarthric 
features present in PD and multiple sclerosis may influence participation differently. 
 
Several studies have reported inconsistent results pertaining to MOCA scores and sex 
differences in healthy adults, with multiple studies demonstrating no effect of gender 
(Conti, Bonazzi, Laiacona, Masina, & Coralli, 2015; Kopecek, Stepankova, Lukavsky, 
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Ripova, Nikolai, & Bezdicek, 2017; Santangelo et al., 2015; Siciliano, Chiorri, Passaniti, 
Sant’Elia, Trojano, & Santangelo, 2019; Zheng, Teng, Varma, Mack, Mungas, Lu, & 
Chui, 2012), others showing females demonstrate lower MOCA scores (Liu, Luo, Tang, 
& Wong, 2018; Shaik et al., 2016),  while some studies  report  males demonstrate lower 
MOCA scores (Pavlovic, Abel, Barlow, Farrell, Weiner, & DeFina, 2018; Thomann et 
al., 2018), and, finally, one study revealing gender differences on the attention and 
delayed recall subsections of the MOCA (Ojeda, del Pino, Ibarretxe-Bilbao, Schretlen, & 
Peña, 2016). Additionally, prior to undergoing bariatric surgery, older men demonstrated 
greater MOCA scores compared to older women (Mohun, Spitznagel, Gunstad, Rochette, 
& Heinberg, 2018). A study by Niwald, Redlicka, and Miller (2018) revealed no gender 
differences in the cognitive status, measured via the MOCA, in individuals with multiple 
sclerosis. To date, no published studies have explored whether there exists a relationship 
between gender differences and cognitive abilities in IWPD and hypophonia. Additional 
research is recommended to develop a greater understanding of the effect of gender on 
cognition in IWPD suggested by the results of the present study. 
4.7 Objective 8: Inter-Relationships Among Proxy-
Measures in Participants with Parkinson’s Disease 
 
This objective examined inter-relationships among proxy-rated speech loudness and 
communicative participation measures for participants with PD. 
4.7.1 Proxy-rated speech loudness measures 
 
The correlations revealed that proxy-rated typical speech loudness was significantly 
correlated with all proxy-rated VAPP subsection scores for participants with PD – with 
the exception of VAPP participation restriction scores. These findings suggest that a 
lower proxy-rating of typical speech loudness of the IWPD is significantly and 
moderately associated with higher proxy-rated VAPP voice problem, daily 
communication, social communication, total and activity limitation scores. While few 
studies have explored communicative participation in IWPD (Donovan 2008; Dykstra et 
al., 2015), there are no published studies that have explored proxy-rated speech loudness 
in IWPD. While a previous study by McAuliffe and others (2016) also found 
communicative participation to be significantly associated with perceived speech severity 
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(standardized beta coefficient = 0.28), it is important to note that the methodology used 
by McAuliffe and colleagues (2016) was quite different than that of the present study. 
McAuliffe and others (2016) explored whether a variety of variables was associated with 
communicative participation as measured by the CPIB in 378 IWPD in the United States 
and New Zealand. However, self-rated speech severity and communicative participation 
were tested at a single time point (McAuliffe et al., 2016). Secondly, proxy-measures 
were not taken into account as the CPIB was used as a measure of self-rated 
communicative participation (McAuliffe et al., 2016). Finally, self-perceived speech 
severity was rated on the basis of “understandability” in the study by McAuliffe and 
colleagues (2016). While the results of these two studies cannot be directly compared, it 
is interesting to note that similar relationships were observed in measures of 
communicative participation and perceived speech difficulties. 
4.7.2 Speech intelligibility measures 
 
The correlations involving speech intelligibility measures and any proxy-rated speech 
loudness and proxy-rated communicative participation measures yielded no consistent 
patterns over the three visits. No published studies have investigated the relationship 
among measures of speech intelligibility and measures of proxy-rated speech loudness 
and proxy-rated communicative participation. However, the results from the present 
study suggest that proxy-rated measures of speech loudness and proxy-rated measures of 
communicative participation are not associated with measures of speech intelligibility in 
participants with PD. Thus, while measures of proxy-rated speech loudness and proxy-
rated communicative participation may provide a broader perspective an and individual’s 
experience with PD, ratings made by primary communication partners  do not appear to 
be useful in assessing the functional outcomes of impaired activities, such as speech 
intelligibility (Baylor et al., 2009).  
4.7.3 Proxy-rated communicative participation 
 
The correlations involving proxy-rated CPIB scores revealed a moderate association with 
proxy-rated CES question 4 (Conversing with a stranger over the telephone) scores, 
proxy-rated CES question 5 (Being part of a conversation in a noisy environment (social 
gathering)) scores, and proxy-rated CES question 8 (Having a conversation with 
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someone at a distance (across a room)) scores across all three visits for participants with 
PD. These findings suggest that proxy-measures of communicative participation, as 
measured by proxy-rated CPIB scores, is moderately associated with proxy-rated items 
on the CES related to effectiveness while conversing with an unfamiliar speaker over the 
telephone, speaking in noise, and communicating across a distance.  It may be possible 
that these communicative contexts are perceived by the primary communication partner 
of the IWPD to be particularly challenging. Such a conclusion would be consistent with a 
previous study by Dykstra and colleagues (2015), who compared self- and proxy-ratings 
of the CETI-M in 30 IWPD and hypophonia. The authors reported that primary 
communication partners perceived communicating in noise and over a distance to be the 
most challenging communicative contexts for their partners with PD. 
 
Additionally, correlations involving proxy-rated CPIB revealed a moderate to good 
association with proxy-rated VAPP self-perceived voice problem scores, and a moderate 
to excellent association with proxy-rated VAPP total scores. These results suggest that as 
primary communication partners of IWPD perceive a more negative impact of their 
partner’s voice on their day-to-day functioning, the lower they will rate their partner’s 
overall communicative participation. Simberg and colleagues (2012) evaluated a 15-day 
treatment on the speech and voice of 6 IWPD. Prior to beginning treatment, IWPD and 
their spouses completed the VAPP in order to obtain self- and proxy-ratings of voice 
function. Six months and one year post-treatment onset, self- and proxy-ratings of voice 
function were evaluated using the VAPP. The authors reported that proxy-ratings of voice 
functioning were less severe than the self-ratings of IWPD. Simberg and colleagues 
(2012) also found that the spouses of all participants with perceived positive changes in 
the speech and voice of their partner with PD following the treatment. The authors 
suggested that the proxy-rated VAPP provided valuable insight to the functional 
perspective of individuals with communication disorders. As mentioned above, the 
relationships between the CPIB and other functional patient reported outcome measures, 
including the PROMIS and VHI,  have been explored in previous studies (Baylor et al., 
2009; McAuliffe et al., 2016), additional research is required to further examine contrasts 
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and similarities between the CPIB and other measures of communicative participation, 
such as the CES and VAPP. 
 
The correlations amongst proxy-rated CES questions revealed moderate to good 
associations among many of the individual CES question scores. These findings suggest 
that the primary communication partners of IWPD perceive their partner’s 
communicative effectiveness to be consistent across different communicative situations 
over time relative to one another. The current study found the individual questions of the 
CES to demonstrate poor retest reliability and unacceptable repeatability for participants 
with PD, their primary communication partners, and control participants. While proxy-
rated CES question scores may have varied over time, the differences between scores 
may have remained relatively constant over time. It is possible that many of the scores 
demonstrated a similar pattern of temporal variability across all three visits. A more 
thorough investigation of the variability and degrees of change in proxy-rated CES scores 
over time is recommended for subsequent research. 
 
The correlations amongst proxy-rated VAPP subsection scores revealed moderate to 
excellent associations between all of the individual VAPP subsection scores. These 
findings suggest that the primary communication partners of IWPD may be extremely 
consistent in their perception of the impact of their partner’s voice difficulties on their 
activity and participation over time. It is important to note that retest reliability and 
repeatability analyses for the individual VAPP subsection scores yielded inconsistent 
results in the present study. The correlations performed in the present analyses and in the 
retest reliability analysis provide information with regard to the strength of the 
relationship under examination. These correlations do not incorporate measurement error. 
Since the retest analyses yielded inconsistent results, additional research is recommended 
to explore the test-retest reliability of the VAPP in IWPD and hypophonia to explore the 
influence of measurement error. 
4.7.4 Demographic and non-speech factors 
 
The correlations involving demographic non-speech factors, and any proxy-ratings 
yielded no consistent patterns over the three visits for participants with PD. These 
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findings suggest that the demographic and non-speech factors under examination in this 
study are not related to proxy-measures of speech loudness or proxy-measures of 
communicative participation related to participants with PD. 
4.8 Objective 9: Inter-Relationships Among Variables in 
Control Participants 
 
This objective examined inter-relationships among speech intensity measures, speech 
intelligibility measures, self-rated communicative participation measures, demographic 
factors, and non-speech factors for control participants. 
4.8.1 Speech intensity measures 
 
The correlations involving speech intensity measures revealed a moderate to good 
association between maximum speech intensity and habitual speech intensity, as well as 
maximum speech intensity and magnitude production in control participants across all 
three visits. These results suggest that the greater an individual’s habitual and maximum 
speech intensity, the steeper their function of magnitude production.  
4.8.2 Speech intelligibility measures 
 
The correlations involving speech intelligibility measures yielded no consistent patterns 
over the three visits for control participants. These findings suggest that the measures of 
speech intelligibility under examination in this study are not related to measures of 
speech intensity, measures of communicative participation, demographic and non-speech 
factors, or other measures of speech intelligibility in control participants. It is unclear 
whether the different measures of speech intelligibility are not associated with one 
another in control participants due to significant variability in control participants or if the 
presence of unknown confounding variables were present. Additionally, it may be that 
the small range of speech intelligibility scores observed in control participants may have 
contributed to the lack of consistent correlations between measures of speech 
intelligibility and other variables under examination in the present study. 
4.8.3 Communicative participation 
 
The correlations involving self-rated CPIB revealed a moderate association with CES 
question 8 (Having a conversation with someone at a distance (across a room)) across all 
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three visits for control participants. These findings suggest that communicative 
participation as measured by the CPIB is moderately associated with perceived 
communicative effectiveness while conversing at a distance. As previously discussed, the 
relationships between the CPIB and other functional questionnaires, including the 
PROMIS and VHI, in IWPD have been explored by Baylor and colleagues (2009) and 
McAuliffe and colleagues (2016). However, no published studies have explored the 
relationships between measures of communicative participation in control participants. 
Additional research is recommended to further examine associations between measures 
of communicative participation, including the CES, CPIB, and VAPP. 
 
The correlations amongst self-rated CES questions revealed moderate to excellent 
associations between many of the individual CES question scores for control participants. 
Similar to the results of correlations of proxy-rated CES questions scores for participants 
with PD, these findings suggest that control participants perceive their communicative 
effectiveness to be fairly consistent across different communicative situations relative to 
one another over time. The individual questions of the CES were found to demonstrate 
poor retest reliability and unacceptable repeatability for all participants. It is possible that 
self-rated CES question scores for control participant may have varied over time, while 
differences between scores may have remained relatively constant. An increase in one 
score across time points may have been consistent across other scores, resulting in CES 
question scores that were significantly correlated with one another across visits. 
Additional research examining the variability of individual CES scores over time is 
recommended. 
 
The correlations amongst self-rated VAPP subsection scores revealed moderate to 
excellent associations between many of the individual VAPP subsection scores. These 
findings suggest that control participants may be highly consistent and relatively uniform 
in their perception of the impact of their voice on their activity and participation over 
time. However, these results must be interpreted with caution as retest reliability and 
repeatability analyses for the individual VAPP subsection scores yielded inconsistent 
results in the current study. Thus, further exploration of the test-retest reliability of the 
VAPP is recommended. 
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4.8.4 Demographic and non-speech factors 
 
The correlations involving demographic and non-speech factors yielded no consistent 
patterns over the three visits for control participants. These findings suggest that the 
demographic and non-speech factors under examination in this study are not related to 
measures of speech intensity, speech intelligibility, communicative participation, or other 
demographic and non-speech factor in control participants. 
4.9 Study Limitations 
 
While this exploratory study yielded many interesting results, it is important to note that 
several limitations were present. The first limitation of this study is related to participant 
characteristics. The IWPD who took part in the present study presented with mild to 
moderate hypophonia and as a result, did not have dysarthria in the severe range. 
Furthermore, the current study included only those IWPD for whom hypophonia was 
their primary dysarthric feature. However, IWPD and hypokinetic dysarthria may present 
with a wide variety of distinctive speech features. As a result, the findings from the 
current study may not be generalizable to a wider variety of IWPD who may be 
experiencing more severe hypophonia or other features of hypokinetic dysarthria (i.e., 
imprecise consonant production or prosodic disturbances). Further study of the variability 
of speech intensity, speech intelligibility, and communicative participation in IWPD with 
a wide range of severity and speech symptoms is required in order to further understand 
and explore the impact of hypokinetic dysarthria secondary to PD. 
 
It would also be prudent to recruit an equal number of male and female speakers with PD 
and hypophonia. Such participant proportions may lend support the presence of sex 
differences in the variability of and relationships among measures of speech intensity, 
speech intelligibility and communicative participation.  
 
A second limitation of the study is related to the study’s overall design. Since participants 
were required to attend three experimental sessions and perform the same speech tasks at 
each visit, it is possible that performance effects occurred. The occurrence of 
performance effects may account for increased speech intensity during speech tasks at 
visits 2 and 3 as compared to visit 1. Furthermore, while precautions were taken in order 
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to deter the possibility of recall, such as the randomization of the order of questionnaires 
across participants and visits, participants were required to complete five questionnaires 
during each visit. It may be possible that completing these questionnaires primed our 
participants to pay greater attention to their speech loudness and communicative 
participation between visits. This greater focus on their speech loudness and 
communicative participation may account for some of the changes observed over time in 
self-rated communicative participation. Additional investigation into these changes via 
qualitative interviews is recommended as qualitative interviews would allow researchers 
to further explore and develop a deeper understanding of how IWPD perceived changes 
to their communicative participation. 
 
Another potential limitation of the present study is related to the sample of listeners. 
Despite a small sample size of three listeners, reliability between and within listeners was 
moderate to excellent for the majority of the speech intelligibility ratings. Similarly, 
multiple studies exploring sentence and conversational intelligibility in IWPD have 
recruited small samples of listeners (sample sizes ranging from 2 – 5 listeners) and 
reported good interrater and intra-rater reliability (e.g., Abur et al., 2018; Adams et al., 
2008; Dromey, 2003; Dykstra et al., 2015). Furthermore, Abur and colleagues (2018) 
compared the relationship between VAS and transcription scores of speech intelligibility 
between three listeners to 66 listeners. The authors reported a strong relationship (R2 > 
.82) between VAS and transcription intelligibility scores by three listeners. Abur and 
colleagues (2018) also suggested that the strength of the relationship between VAS and 
transcription estimates of speech intelligibility do not increase with additional listeners. 
Additionally, the listeners in the current study were speech language pathology students 
that were familiar listening to dysarthric speech. Two published studies have found that 
speech language pathologists are more likely to provide higher ratings of speech 
intelligibility compared to naïve listeners (Dagenais, Garcia, & Watts, 1998; Dagenais, 
Watts, Turnage, & Kennedy, 1999). However, a more recent study has suggested that 
various factors, including familiarity, may not significantly impact ratings of speech 
intelligibility when rated under standardized listening conditions (Pennington & Miller, 
2007). One final possible limitation of this study is that listeners may have experienced 
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fatigue as a result of listening to and rating speech samples. While listeners did take part 
in three separate listening sessions, each session was approximately two hours long. It is 
possible that listeners became fatigued from orthographic transcription and VAS rating 
tasks, which may have negatively impacted their transcriptions and ratings. 
4.10 Future Directions 
 
The results from the current study suggest the need for additional studies. Possible 
avenues for future directions include replication of the study while including some 
modifications to the methodology, and further exploration of the main findings. 
 
As previously mentioned, it is recommended that the participant population be widened 
to include IWPD who present with severe hypophonia, as well as other key features 
associated with hypokinetic dysarthria such as imprecise articulation and short rushes of 
speech. It is possible that different speech symptoms associated with PD may influence 
measures such as speech intelligibility and communicative participation differently. The 
use of such a methodology may yield results that are more generalizable to the overall 
population of IWPD. Furthermore, including IWPD with lower cognitive scores as well 
as including equal numbers of male and female participants might further assist with the 
generalizability of the results. 
 
As previously mentioned, it is possible that following the completion of each visit, 
participants may have become more attuned to their speech loudness and day-to-day 
communicative participation. This increased focus may have resulted in changes to their 
performance throughout the study. If this study were to be replicated with the addition of 
qualitative interviews further exploring participant views on their speech loudness and 
communicative participation, a more developed rationale for some of the observed 
changes could be identified. Finally, it is also possible that self-rated communicative 
participation questionnaires which use equal appearing intervals, such as the CES, may 
not capture all degrees of change. It is possible that measures which make use of a VAS, 
may demonstrate greater sensitivity to changes over time. Additional research may be 
warranted in order to explore whether modification of these PROs to use VAS may result 
in an increased sensitivity to the detection of changes over time. Such research would 
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necessitate validation studies exploring different scaling procedures in order to identify 
which one(s) would be most effective in identifying significant changes over time in 
questionnaires such as the CES and CPIB. 
4.11 Clinical Implications 
 
Several clinical implications may be drawn from the results of the current study regarding 
the assessment and management of individuals with hypophonia and PD. The consistency 
in self- and proxy-ratings in the present study suggest that both IWPD and their primary 
communication partner provide relatively consistent ratings of perceived speech loudness 
and communicative participation. Proxy-measures of perceived speech loudness and 
communicative participation as measured in the current study could be used in the event 
that the individual with PD is not able to provide this information, however, it should be 
underscored that it is best clinical practice to gather this information from the actual 
person versus his/her communication partner. 
 
Furthermore, clinicians may wish to consider, when evaluating treatment outcomes, that 
measures of speech intensity may be variable over time. Clinicians should be cognizant 
that a certain amount of temporal variability and possible measurement error may be 
present in some measures of speech intensity such as habitual speech intensity, Lombard 
response function, magnitude production, and perceived typical speech loudness; speech 
intelligibility (VAS conversational intelligibility scores), and communicative 
participation (CES, VAPP, and LSUS). However, maximum speech intensity, speech 
intelligibility, measured by SIT transcription and SIT VAS scores, and the CPIB appear 
to demonstrate less temporal variability and good reliability and repeatability.  
 
The CR% cutoff value of 10% used in the present study to denote measures with good 
repeatability and measures that would reflect a true change was adopted from the 
empirical literature outside of PD (Lu et al., 2007; Smidt, et al., 2002; Steffen & Seney, 
2008). However, the CR% value of 10% adopted by the present study may be too liberal 
for certain outcome measures, such as habitual speech intensity and maximum speech 
intensity. The present study suggests that CR% values slightly greater than 5% for 
habitual speech intensity and less than 9% for maximum speech intensity would be 
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indicative of a clinically meaningful change. Additionally, the present study appears to 
support the use of SIT transcription and VAS scores, VAS conversational intelligibility 
scores, and CPIB scores as treatment outcome measures in order to detect clinically 
meaningful differences. Whereas measures, such as the Lombard response function, 
magnitude production, perceived speech loudness, individual CES question scores, VAPP 
subsection scores, and LSUS scores, may need to be refined or alternative measures 
designed that are associated with lower measurement error. These proposed changes to 
the aforementioned measures may be useful in assessing meaningful clinical differences 
in order the measure to be effective treatment outcomes. Continued research in the area of 
variability, reliability, and repeatability in speech intensity and communicative 
participation measures in IWPD and hypophonia may better inform clinical practice and 
in time result in additional effective and efficient options for assessing an individual over 
the course of their treatment. 
4.12 Summary and Conclusion 
 
The current study explored the variability of acoustic and perceptual measures of speech 
intensity, speech intelligibility, and communicative participation measures in IWPD and 
hypophonia. This study also examined the relationships among speech intensity 
measures, speech intelligibility measures, self- and proxy ratings of communicative 
participation, demographic factors, and non-speech factors.  
  
The first objective addressed the variability of speech intensity measures for participants 
with PD and control participants. The results revealed a significant reduction in speech 
intensity for participants with PD compared to control participants at visit 1, but not at 
visits 2 and 3. These findings suggest that there is significant variability in habitual 
speech intensity over time. Significant differences were also found in maximum speech 
intensity for participants with PD and control participants. These results suggest that 
IWPD demonstrate a narrower range of speech intensity compared to control participants. 
Furthermore, these differences in measures of maximum speech intensity were consistent 
over time. Similar Lombard response slopes between participants with PD and control 
participants were also reported in the current study. These findings suggest that 
participants with PD may demonstrate a parallel but attenuated Lombard response 
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function compared to control participants. The results also revealed a significant 
difference in Lombard response function for participants with PD and to control 
participants at visit 1, but not at visits 2 and 3. Finally, participants with PD demonstrated 
significantly smaller magnitude production slope compared to control participants. These 
results suggest that IWPD demonstrate a less steep magnitude production function 
compared to control participants, and thus exhibit a narrower range of speech intensity. 
The results also revealed a significant difference in magnitude production for participants 
with PD compared to control participants at visit 1, but not at visits 2 and 3. The 
variability reported in three of the four speech intensity measures may be related to an 
increased awareness and focus on overall speech intensity and great subsequent speech 
effort for participants with PD. These results lend support to the hypothesis that IWPD 
would demonstrate greater variability of speech intensity measures compared to control 
participants. 
 
The second objective of this study addressed the variability of perceived typical speech 
loudness for participants with PD, their primary communication partners, and control 
participants. The results revealed similar ratings by participants with PD and their 
primary communication partners. These perceptions were significantly lower than the 
self-perceived typical speech loudness of control participants. These findings suggest that 
participants with PD and their primary communication partners perceived the speech 
loudness of IWPD to be flatter compared to control participants. While these findings 
support the hypothesis that self-rated typical speech loudness would be reduced for 
participants with PD compared to control participants, it does not support the prediction 
that self- and proxy-rated typical speech loudness would differ for participants with PD. 
Additionally, it was unclear whether there was variability in the perceived typical speech 
loudness over time. 
 
The third objective of this study addressed the variability speech intelligibility measures 
for participants with PD and control participants. This study found a significant reduction 
in all measures of speech intelligibility for participants with PD compared to control 
participants. A fairly large difference was observed in the SIT transcription and VAS 
scores for participants with PD. These differences are consistent with findings from 
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previous empirical studies (Abur, Enos, & Stepp, 2018; Adams et al., 2008; Stipancic et 
al., 2016). Orthographic transcription captures a listener’s accuracy of their transcription 
of each word. However, other aspects of the speech signal may be captured during VAS 
estimation, such as prosodic disturbances and perceived acceptability (Kent et al., 1999; 
Kent et al., 1990; De Bodt et al., 2002). These differences may explain the discrepancy 
between SIT transcription and VAS scores. Furthermore, SIT transcription and VAS 
scores were both found to be fairly consistent over time for both participants with PD and 
control participants. These findings do not support the prediction that participants with 
PD would demonstrate greater variability in speech intelligibility measures compared to 
control participants. Finally, it was unclear whether there was variability in 
conversational intelligibility scores over time. 
 
The fourth objective of this study addressed the variability self-rated communicative 
participation measures for participants with PD and control participants. The results 
revealed a significant difference between participants with PD and control participants 
across all self-rated measures of communicative participation. Participants with PD 
exhibited lower scores on the CES, CPIB and LSUS, and greater scores on the VAPP 
compared to control participants. These findings suggest that participants with PD may be 
aware of their level of speech usage and their speech and communication difficulties. 
Changes over time were observed for six of the eight CES questions, as well as the CPIB 
and the VAPP social communication and participation restriction subsections. The 
findings of observed changes in the CES and VAPP support the hypothesis that 
participants with PD would demonstrate greater variability in measures of communicative 
participation over time. However, it was unclear whether there was significant variability 
in VAPP subsection scores and LSUS scores. 
 
The fifth objective of this study addressed the variability of self- and proxy-rated 
communicative participation measures of participants with PD and their primary 
communication partners. This study revealed comparable self- and proxy-ratings across 
all measures of communicative participation for participants with PD. These results 
suggest that participants with PD demonstrate an awareness of their communication 
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difficulties. These findings do not support the prediction that self- and proxy-rated 
communicative participation measures would differ for participants with PD. 
 
The sixth objective of this study addressed the retest reliability and repeatability of 
measures of speech intensity, speech intelligibility, and communicative participation in 
participants with PD, their primary communication partners, and control participants. 
Habitual speech intensity was not found to demonstrate good retest reliability but did 
demonstrate fairly good repeatability for participants with PD and control participants. 
Maximum speech intensity was found to demonstrate good retest reliability and good 
repeatability for both participants with PD and control participants. SIT VAS scores were 
found to demonstrate good retest reliability and marginal repeatability for participants 
with PD and good retest reliability and good repeatability for control participants. 
Conversational intelligibility scores demonstrated good retest reliability and good 
repeatability for participants with PD and good repeatability but not good retest reliability 
for control participants. Measures of communicative participation typically did not 
demonstrate good retest reliability and unacceptable repeatability in participants with PD, 
their primary communication partners, and control participants. However, the CPIB 
demonstrate good retest reliability and marginal repeatability for participants with PD and 
their primary communication partners, and good retest reliability and good repeatability. 
These results suggest the possibility that select measures of speech intensity, speech 
intelligibility, and communicative participation demonstrate acceptable levels of 
measurement error and may be used to observe clinically meaningful change. 
 
The seventh objective of this study addressed the relationships among speech intensity 
measures, speech intelligibility measures, self-rated communicative participation 
measures, demographic factors, and non-speech factors for participants with PD. 
Maximum speech intensity and magnitude production were consistently correlated with 
one another, suggesting that the greater an individual’s maximum speech intensity, the 
greater their intensity range. Sentence intelligibility scores were consistently associated 
with one another. Additionally, the CPIB was consistently correlated with the VAPP self-
perceived voice problem and total subsection scores, and the VAPP subsections were 
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consistently correlated with one another. These results suggest good internal consistency 
among these different measures of speech intelligibility and communicative participation. 
Finally, the findings did not support the prediction that disease duration, medication 
effectiveness, and cognition would be correlated with measures of speech intensity, 
speech intelligibility, and self-rated communicative participation in IWPD. 
 
The eighth objective of this study addressed the relationships among speech intensity 
measures, speech intelligibility measures, proxy-rated communicative participation 
measures, demographic factors, and non-speech factors for participants with PD. 
Perceived typical speech loudness was associated with all but one VAPP subsection, 
suggesting that a greater perceived reduction in an IWPD’s loudness is associated with 
increased perceived impairment in the day-to-day functioning of their activity and 
participation. The CPIB was consistently correlated with select CES questions and VAPP 
subsections. These results suggest good internal consistency among many proxy-
measures of speech intensity and communicative participation. Finally, the findings did 
not support the prediction that disease duration, medication effectiveness, and cognition 
would be correlated with measures of proxy-rated communicative participation in IWPD. 
 
Finally, the ninth objective of this study addressed the relationships among speech 
intensity measures, speech intelligibility measures, self-rated communicative 
participation measures, demographic factors, and non-speech factors for control 
participants. Maximum speech intensity was consistently correlated with habitual speech 
intensity and magnitude production. These results suggest that most measures of speech 
intensity are related to one another in control participants. The CPIB was only 
consistently associated with CES question 8 (Having a conversation with someone at a 
distance (across a room)). These results suggest that the CPIB, CES, VAPP, and LSUS 
may be measuring different components of communicative participation in control 
participants. 
 
This study has contributed to the knowledge of the variability of speech intensity 
measures, speech intelligibility measures, and communicative participation measures in 
IWPD and hypophonia. The findings from the current study will contribute to the 
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
303 
growing understanding of hypophonia in PD. This study may also provide valuable 
information with regard to more comprehensive assessments and improved interpretation 
of treatment outcomes of IWPD in clinical practice. 
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Appendices 
Appendix A: Geriatric Depression Scale - 15-Item Short Form 
Instructions:  Choose the best answer for how you have felt over the past week. 
 
No. Question Answer Score 
1. Are you basically satisfied with your life? YES/NO  
2. Have you dropped many of your activities and interests? YES/NO  
3. Do you feel that your life is empty? YES/NO  
4. Do you often get bored? YES/NO  
5. Are you in good spirits most of the time? YES/NO  
6. Are you afraid that something bad is going to happen to you? YES/NO  
7. Do you feel happy most of the time? YES/NO  
8. Do you often feel helpless? YES/NO  
9. Do you prefer to stay at home, rather than going out and doing new things? YES/NO  
10. Do you feel you have more problems with memory than most people? YES/NO  
11. Do you think it is wonderful to be alive? YES/NO  
12. Do you feel pretty worthless the way you are now? YES/NO  
13. Do you feel full of energy? YES/NO  
14. Do you feel that your situation is hopeless? YES/NO  
15. Do you think that most people are better off than you are? YES/NO  
TOTAL  
 
 
Sheikh, J.I., & Yesavage, J.A. (1986). Geriatric Depression Scale (GDS): Recent 
evidence and development of a shorter version. Clinical Gerontologist, 5(1/2), 165 – 173. 
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Appendix B: Medication Effectiveness Scale 
With this scale, we ask you to rate the effectiveness of your medication. Please read the 
statement below. Then rate the effectiveness of your medication at managing your 
symptoms of Parkinson’s disease. If you feel your medication is very effective, mark the 
7. If you feel your medication is not at all effective, mark the 1. Feel free to use any 
number on the scale 
 
How effective is your medication at managing your symptoms of Parkinson’s disease?  
 
Not at all effective 1 2 3 4 5 6 7 Very effective 
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Appendix C: Typical Speech Loudness 
In this survey we ask you to rate your typical speech loudness. Please respond to the 
following questions by putting a cross (“X”) on the line which best represents your 
response. A cross towards the left side means your speech is very quiet while a cross 
towards the right side means your speech is normal loudness. 
 
What is your typical speech loudness? 
 
Very quiet Normal loudness 
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Appendix D: Communication Effectiveness Survey 
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Appendix E: Voice Activity and Participation Profile 
Please answer the following questions by putting a cross (“X”) on the line which best 
represents your answer. A cross towards the left side means you are never affected while a 
cross towards the right side means you are always affected. 
 
Self-perceived severity of voice problem 
 
1. How severe is your voice problem now? 
 
 Normal Severe 
 
Effect on job 
 
2. Is your job affected by voice problem? 
 
 Never Always 
 
3. In the last 6 months, have you thought of changing your job because of your voice 
problem? 
 
 Never Always 
 
4. Has your voice problem created any pressure on your job? 
 
 Never Always 
 
5. In the last 6 months, has your voice problem affected your decisions for your future 
career? 
 
 Never Always 
 
Effect on daily communication 
 
6. Do people ask you to repeat what you have just said because of your voice problem? 
 
 Never Always 
 
7. In the last 6 months, have you ever avoided talking to people because of your voice 
problem? 
 
 Never Always 
 
 
8. Do people have difficulty understanding you on the phone because of your voice 
problem? 
 
 Never Always 
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9. In the last 6 months, have you reduced the use of the telephone because of your voice 
problem? 
 
 Never Always 
 
10. Does your voice problem affect your communication in quiet environments? 
 
 Never Always 
 
11. In the last 6 months, have you ever avoided having conversations in quiet 
environments because of your voice problem? 
 
 Never Always 
 
12. Does your voice problem affect your communication in noisy environments? 
 
 Never Always 
 
13. In the last 6 months, have you ever avoided having conversations in noisy 
environments because of your voice problem? 
 
 Never Always 
 
14. Does your voice problem affect your message when speaking to a group of people? 
 
 Never Always 
 
15. In the last 6 months, have you ever avoided having conversations in a group because 
of your voice problem? 
 
 Never Always 
 
16. Does your voice problem affect getting your message across? 
 
 Never Always 
 
 
17. In the last 6 months, have you ever avoided speaking because of your voice problem? 
 
 Never Always 
 
Effect on social communication 
 
18. Does your voice problem affect you in social activities? 
 
 Never Always 
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19. In the last 6 months, have you ever avoided social activities because of your voice 
problem? 
 
 Never Always 
 
20. Are your family, friends, or co-workers annoyed by your voice problem? 
 
 Never Always 
 
21. In the last 6 months, have you ever avoided communicating with your family, friends, 
or co-workers because of your voice problem? 
 
 Never Always 
 
Effect on your emotion 
 
22. Do you feel upset about your voice problem? 
 
 Never Always 
 
23. Are you embarrassed by your voice problem? 
 
 Never Always 
 
24. Do you have low self-esteem because of your voice problem? 
 
 Never Always 
 
25. Are you worried about your voice problem? 
 
 Never Always 
 
 
26. Do you feel dissatisfied because of your voice problem? 
 
 Never Always 
 
27. Does your voice problem affect your personality? 
 
 Never Always 
 
28. Does your voice problem affect your self-image? 
 
 Never Always 
 
 
Ma, E.P.-M., & Yiu, E.M.-L. (2001). Voice activity and participation profile: Assessing the 
impact of voice disorders on daily activities. Journal of Speech, Language, and Hearing 
Research, 44, 511 – 524.  
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Appendix F: Communication Participation Item Bank 
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Appendix G: Level of Speech Usage Scale 
How Do You Use Your Speech? 
While communication is important to everyone, different people use their speech in different ways. Think of how you  
have typically used your speech over the past year. Choose the category below that best describes you. 
 
_____ Undemanding: 
Quiet for long periods of time almost every day: 
Almost never 
• talk for long periods 
• raise your voice above a conversational level, 
• participate in group discussions, give a speech or other presentation 
 
_____ Intermittent: 
Quiet for long periods of time on many days 
Most talking is typical conversational speech 
Occasionally: 
• talk for longer periods 
• raise voice above conversational level 
• participate in group discussions, give a speech or other presentation 
 
_____ Routine: 
Frequent periods of talking on most days 
Most talking is typical conversational speech 
Occasionally: 
• talk for longer periods 
• raise voice above conversational level 
• participate in group discussions, give a speech or other presentation 
 
_____ Extensive: 
Speech usage consistently goes beyond everyday conversational speech. 
Regularly: 
• talk for long periods 
• talk in a loud voice 
• participate in group discussions, give presentations or performances 
Although the demands of your speech are often high, you are able to continue with most  
work or social activities even if your speech is not perfect. 
 
_____ Extraordinary: 
Very high speech demands 
Regularly: 
• talk for long periods of time 
• talk with loud or expressive speech or 
• give presentations or performances. 
The success of your work or personal goals depends almost entirely on the quality of your  
speech and voice. 
 
Baylor, C., Yorkston, K.M., Eadie, T., Miller, R., & Amtmann, D. (2008). Levels of speech usage: A self-
report scale for describing how people use speech. Journal of Medical Speech-Language Pathology, 16(4), 
191 – 198. 
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Appendix H: Letter of Information for Participants with Parkinson's Disease 
Project Title:  
Examining the temporal variability of speech intensity, speech intelligibility, and 
communicative participation in individuals with hypophonia and Parkinson’s disease 
 
Principal Investigators: 
Allyson Page, PhD 
Associate Professor 
School of Communication Sciences and Disorders; Health and Rehabilitation Sciences 
Western University 
Tel: 519-661-2111 ext. 88940 
 
Scott Adams, PhD 
Professor 
School of Communication Sciences and Disorders; Health and Rehabilitation Sciences 
Western University 
Tel: 519-661-2111 ext. 88941 
 
Co-Investigators: 
Cynthia Mancinelli 
MClSc/PhD Candidate, Speech and Language Science 
Health and Rehabilitation Sciences 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director 
Movement Disorders Program; Clinical Neurological Sciences 
London Health Sciences Centre, University Campus, and Western University 
 
Letter of Information for Participants with Parkinson’s disease 
 
1. Invitation to Participate 
You are invited to participate in this research study investigating the variability of 
speech loudness, speech intelligibility, and communicative participation in 
individuals with Parkinson’s disease (PD) and hypophonia (reduced loudness). 
You have been invited to participate because you have been diagnosed with PD 
and hypophonia.  
 
2. Purpose of the Letter 
The purpose of this letter is to provide you with information required to make an 
informed decision regarding participation in this research study.  
 
3. Purpose of this Study 
The purpose of this study is to examine the variability of speech and psychosocial 
measures over time in individuals with a speech impairment resulting from 
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Parkinson's disease. Psychosocial measures refer to the self-assessment of 
communication in different social situations. For example, we could ask you to 
rate your effectiveness as a communicator when speaking to a stranger on the 
telephone. This study also aims to explore relationships among speech measures, 
psychosocial measures, and non-speech factors 
 
4. Inclusion Criteria 
To be eligible to participate in this study, you must: 
1. have been diagnosed with idiopathic PD for a minimum of 3 years 
2. be between 55 and 85 years of age 
3. speak English as your first language. 
5. Exclusion Criteria 
You are ineligible to participate if you:  
1. cannot read and/or write 
2. do not pass a 40 dB hearing screening test 
3. have a history of speech, language, hearing, or neurological impairments, 
with the exception of those that related to PD 
4. are currently receiving speech language therapy, or will be receiving 
speech language therapy within the next month 
5. have undergone deep brain stimulation surgery, or will be undergoing 
deep brain stimulation surgery within the next month 
6. receive a score below 21 on the Montreal Cognitive Assessment (a 
questionnaire used to assess cognitive ability). 
6. Study Procedures 
This study will be conducted over 3 visits. The first and second visits will occur 
within a 5-day period. The third visit will occur approximately 4 weeks following 
the second visit. The first and second visits will each last approximately 90 
minutes. The third visit will last approximately 60 minutes.   
 
During visit one, you will be asked to take a basic hearing screening. It is 
anticipated that completion of the hearing screening will take approximately 5 
minutes. The principle experimenter or another member of the research team will 
ask you questions regarding your date of birth, general medical history, 
neurological history, and speech and hearing history. You will also be asked to 
complete a series of seven questionnaires related to your speech and 
communication. These questionnaires will look at how you use your speech on a 
daily basis, your typical speech loudness, your effectiveness as a communicator in 
different social situations, your participation in communication settings, and the 
impact of your speech on everyday life. You will also be asked to complete two 
additional questionnaires that will examine your cognitive abilities and screen for 
depression. It is anticipated that completion of all nine questionnaires will take 
approximately 45 minutes. In addition, you will be asked to perform various 
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speech tasks. These speech tasks will include syllable repetition, reading aloud 
multiple sentences, and taking part in conversation while being audio-recorded 
with a microphone. Only the researchers will have access to the speech 
recordings. The audio files will be encrypted and stored on a secure computer at 
Western University. It is anticipated that the completion of the speech tasks will 
take approximately 20 minutes. 
 
During visit 2, you will be asked to complete the Unified Parkinson’s Disease 
Rating Scale (UPDRS; a scale used to assess your PD symptoms). It is anticipated 
that completion of the UPDRS will take approximately 20 minutes. You will also 
be asked to complete the same series of seven questionnaires related to speech and 
communication from visit 1. It is anticipated that completion of the questionnaires 
will take approximately 30 minutes. Additionally, you will be asked to perform 
the same speech tasks from visit 1. It is anticipated that completion of the speech 
tasks will take approximately 20 minutes. 
 
During visit 3, you will be asked to complete the same series of seven 
questionnaires from visits 1 and 2. It is anticipated that completion of the 
questionnaires will take approximately 30 minutes. In addition, you will be asked 
to perform the same speech tasks from visits 1 and 2. It is anticipated that the 
completion of the speech tasks will take approximately 20 minutes. 
 
It is anticipated that the total participation time for this study will be 
approximately 4 hours, upon completion of all 3-study visits. This study will 
involve 50 participants with PD, 50 communication partners of participants with 
PD, 20 healthy control participants, and 10 naïve listeners.  
 
If you agree to participate, you will be asked to come to the Principal 
Investigator’s Lab in Elborn College (Room 2212) at Western University for 
repeated administration of questionnaires, and multiple speech recordings. While 
at Elborn College, you will be provided with free parking.   
 
7. Possible Risks and Harms 
There are no known or anticipated physical risks or discomfort associated with 
participation in this study. The experiment will be conducted in a safe and 
hygienic university laboratory with adequate lighting and ventilation. You will be 
seated in a comfortable chair throughout the procedures. To help counteract any 
fatigue you may experience through the duration of the experiment, you will be 
given rest breaks at approximately ten-minute intervals or more frequently if 
requested. You have the right to withdrawal from the study any time. 
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As part of this study, the Geriatric Depression Scale (a questionnaire used for 
screening depression) will be used. In the event that this questionnaire indicates 
the presence of depression, your physician, Dr. Mandar Jog (co-investigator in 
this study), will be informed of the findings.  
 
As part of this this study, you will undergo a brief hearing screening. This hearing 
screening should not be considered a substitute for a formal hearing assessment 
conducted by a licensed audiologist. Should your hearing threshold results be 
above 40dB during our screening procedure, we will offer you a referral to the 
H.A. Leeper Speech and Hearing Audiology Clinic, located within Elborn College 
at Western University, or you may discuss an audiology referral with your family 
physician. 
 
8. Possible Benefits  
The procedures that will be used during this study are experimental in nature and 
will not provide any direct benefit to the participant’s medical condition. However, it 
is anticipated that results from this study may provide important information about 
the stability of speech and communication in individuals with PD and 
hypophonia. The potential benefits to society include the improvement of the 
understanding of hypophonia in individuals with PD, and the development of 
more effective tools for identifying the impact and severity of hypophonia in 
individuals with PD. 
 
9. Compensation 
You will not be compensated for your participation in this study. However, free 
on-site parking will be provided. A daily visitor’s parking pass will be provided to 
you upon your arrival to the Elborn College parking lot. 
 
10. Voluntary Participation 
Participation in this study is voluntary. You may refuse to participate, refuse to 
answer any questions, or withdraw from the study at any time with no effect on 
your future treatment or medical care. 
 
11. Confidentiality 
All data collected will remain confidential. Your name and any identifying 
information will be collected separately from the data. All data collected with no 
personal identifiers will be retained indefinitely. All data collected with personal 
identifiers will be retained for 15 years following publication. If you choose to 
withdraw from this study, your data will be immediately removed and destroyed 
from our database. Our research records will be locked in a cabinet in the 
principal investigator’s secure lab in Elborn College, Western University. Audio 
recordings from participants will be de-identified. The de-identified audio files 
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will be encrypted and stored on the secure hard drive of a single desktop computer 
in the principle investigator’s lab in Elborn College at Western University.  
Listener participants will make perceptual ratings from de-identified audio 
recordings. All other data collected will remain accessible only to the 
investigators of this study. Representatives of the University of Western Ontario 
Health Sciences Research Ethics Board may require access to your study-related 
documents to oversee the ethical conduct of this study. Representatives of Lawson 
Quality Assurance Education Program may require access to your study-related 
documents to ensure that proper laws and guidelines are being followed. You do 
not waive any legal rights by signing the consent form.   
 
12. Publication 
If the results of the study are published, your name will not be used and no 
information that discloses your identity will be released or published. If requested, 
you will be provided with a copy of any publication related to the results of this 
study when it becomes available. 
 
13. Contacts for Further Information 
If you require any further information regarding this research project or your 
participation in the study, you may contact Dr. Allyson Page at (519) 661-2111 
ext. 88940 and allyson.page@uwo.ca, or Dr. Scott Adams at (519) 661-2111 ext. 
88941 and sadams@uwo.ca . 
 
If you have any questions about your rights as a research participant or the 
conduct of this study, you may contact The Office of Human Research Ethics 
(519) 661-3036, email: ethics@uwo.ca.  
 
If you agree to participate in this study, please sign the consent form on the next 
page. 
 
 
Sincerely, 
 
Allyson Page, PhD   Scott Adams, PhD  Cynthia Mancinelli 
Associate Professor  Professor   MClSc/PhD candidate 
 
 
This letter is yours to keep for future reference.  
 
  
VARIABILITY IN SPEECH AND COMMUNICATION IN IWPD  
 
 
333 
Appendix I: Consent Form for Participants with Parkinson's Disease 
Consent Form for Participants with Parkinson’s Disease 
Project Title:  
Examining the temporal variability of speech intensity, speech intelligibility, and 
communicative participation in individuals with hypophonia and Parkinson’s disease 
 
Principal Investigators: 
Allyson Page, PhD 
Associate Professor 
School of Communication Sciences and Disorders 
Western University 
Tel: 519-661-2111 ext.  88940 
 
Scott Adams, PhD 
Professor 
School of Communication Sciences and Disorders 
Western University 
Tel: 519-661-2111 ext. 88941 
 
Co-Investigators: 
Cynthia Mancinelli 
MClSc/PhD Candidate, Speech and Language Science 
Health and Rehabilitation Sciences 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director 
Movement Disorders Program; Clinical Neurological Sciences 
London Health Sciences Centre, University Campus, and Western University 
 
I have read the Letter of Information and have had the nature of the study explained to 
me, and I agree to participate. All questions have been answered to my satisfaction. 
 
________________________________________________________________________ 
Signature of Research Participant   Printed Name   Date  
 
 
Signature of Person Obtaining Informed Consent Printed Name   Date 
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Appendix J: Letter of Information for Control Participants 
Project Title:  
Examining the temporal variability of speech intensity, speech intelligibility, and 
communicative participation in individuals with hypophonia and Parkinson’s disease 
 
Principal Investigators: 
Allyson Page, PhD 
Associate Professor 
School of Communication Sciences and Disorders; Health and Rehabilitation Sciences 
Western University 
Tel: 519-661-2111 ext. 88940 
 
Scott Adams, PhD 
Professor 
School of Communication Sciences and Disorders; Health and Rehabilitation Sciences 
Western University 
Tel: 519-661-2111 ext. 88941 
 
Co-Investigators: 
Cynthia Mancinelli 
MClSc/PhD Candidate, Speech and Language Science 
Health and Rehabilitation Sciences 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director 
Movement Disorders Program; Clinical Neurological Sciences 
London Health Sciences Centre, University Campus, and Western University 
 
Letter of Information for Participants without Parkinson’s Disease 
 
14. Invitation to Participate 
You are invited to participate in this research study investigating the variability of 
speech loudness, speech intelligibility, and communicative participation in 
individuals with Parkinson’s disease (PD) and hypophonia (speech loudness). 
You have been invited to participate because you have not been diagnosed with 
PD and/or hypophonia.  
 
15. Purpose of the Letter 
The purpose of this letter is to provide you with information required for you to 
make an informed decision regarding participation in this research study.  
 
16. Purpose of this Study 
The purpose of this study is to examine the variability of speech and psychosocial 
measures over time in individuals with a speech impairment resulting from 
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Parkinson's disease. Psychosocial measures refer to the self-assessment of 
communication in different social situations. For example, we could ask you to 
rate your effectiveness as a communicator when speaking to a stranger on the 
telephone. This study also aims to explore relationships among speech measures, 
psychosocial measures, and non-speech factors. 
 
17. Inclusion Criteria 
To be eligible to participate in this study, you must: 
4. be between 55 and 85 years of age 
5. have not been diagnosed with idiopathic PD  
6. speak English as your first language. 
18. Exclusion Criteria 
You are ineligible to participate if you:  
7. cannot read and/or write 
8. do not pass a 40 dB hearing screening test 
9. have a history of speech, language, hearing, or neurological impairments 
10. receive a score below 26 on the Montreal Cognitive Assessment (a 
questionnaire used to assess cognitive ability). 
19. Study Procedures 
This study will be conducted over 3 visits. The first and second visits will occur 
within a 5-day period. The third visit will occur approximately 4 weeks following 
the second visit. The first visit will last approximately 90 minutes. The second 
and third visits will each last approximately 60 minutes.   
 
During visit one, you will be asked to take a basic hearing test. It is anticipated 
that completion of the hearing screening will take approximately 5 minutes. The 
principle experimenter, or another member of the research team, will ask you 
questions regarding your date of birth, general medical history, neurological 
history, and speech and hearing history. You will also be asked to complete a 
series of seven questionnaires related to your speech and communication. These 
questionnaires will look at how you use your speech on a daily basis, your typical 
speech loudness, your effectiveness as a communicator in different social 
situations, your participation in different communication settings, and the impact 
of your speech on your everyday life. You will also be asked to complete two 
additional questionnaires that examine your cognitive abilities and screen for 
depression. It is anticipated that completion of all nine questionnaires will take 
approximately 45 minutes. In addition, you will be asked to perform various 
speech tasks. These speech tasks will include syllable repetition, reading aloud 
multiple sentences, and taking part in conversation while being audio-recorded 
with a microphone. Only the researchers will have access to these speech 
recordings. The audio files will be encrypted and stored on a secure computer at 
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Western University. It is anticipated that completion of the speech tasks will take 
approximately 20 minutes. 
 
During visit 2, you will be asked to complete the same series of seven 
questionnaires related to your speech and communication from visit 1. It is 
anticipated that completion of the questionnaires will take approximately 30 
minutes. Additionally, you will be asked to perform the same speech tasks from 
visit 1. It is anticipated that completion of the speech tasks will take 
approximately 20 minutes. 
 
During visit 3, you will be asked to complete the same series of seven 
questionnaires related to your speech and communication from visits 1 and 2. It is 
anticipated that completion of the questionnaires will take approximately 30 
minutes. Additionally, you will be asked to perform the same speech tasks from 
visits 1 and 2. It is anticipated that completion of the speech tasks will take 
approximately 20 minutes. 
 
It is anticipated that the total participation time for this study will be 3.5 hours 
upon completion of all 3-study visits. This study will involve 50 participants with 
PD, 50 communication partners of participants with PD, 20 healthy control 
participants, and 10 naïve listeners.  
 
If you agree to participate, you will be asked to come to the Principal 
Investigator’s Lab in Elborn College (Room 2212) at the University of Western 
Ontario for repeated administration of questionnaires, and multiple speech 
recordings. While at Elborn College, you will be provided with free parking.   
 
20. Possible Risks and Harms 
There are no known or anticipated physical risks or discomfort associated with 
participation in this study. The experiment will be conducted in a safe and 
hygienic laboratory with adequate lighting and ventilation. You will be seated in a 
comfortable chair throughout the procedures. To help counteract any fatigue you 
may experience through the duration of the experiment, you will be given rest 
breaks at approximately ten-minute intervals or more frequently if requested. You 
have the right to withdrawal from the study any time if you feel discomfort. 
 
As part of this study, the Geriatric Depression Scale (a questionnaire used for 
screening depression) will be used. In the event that this questionnaire indicates 
the presence of depression, you will be informed of the findings and 
recommended that you discuss the results with your family physician. You will 
also be provided with a list of clinics and helplines. 
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As part of this this study, you will undergo a brief hearing screening. This hearing 
screening should not be considered a substitute for a formal hearing assessment 
conducted by a licensed audiologist. Should your hearing threshold results be 
above 40dB during our screening procedure, we will offer you a referral to the 
H.A. Leeper Speech and Hearing Audiology Clinic, located within the School of 
Communication Sciences and Disorders at Western University, or you may 
discuss an audiology referral with your family physician. 
 
21. Possible Benefits  
The procedures that will be used during this study are experimental in nature and 
will not provide any direct benefit to the participant. However, it is anticipated that 
the results from this study may provide important information about the stability 
of speech and communication in individuals with PD and hypophonia. The 
potential benefits to society include the improvement of the understanding of 
hypophonia in individuals with PD, and the development of more effective tools 
for identifying the impact and severity of hypophonia in individuals with PD. 
 
22. Compensation 
You will not be compensated for your participation in this study. However, free 
on-site parking will be provided. A daily visitor’s parking pass will be provided to 
you upon your arrival to the Elborn College parking lot. 
 
23. Voluntary Participation 
Participation in this study is voluntary. You may refuse to participate, refuse to 
answer any questions, or withdraw from the study at any time, with no effects on 
your future treatment or medical care. 
 
24. Confidentiality 
All data collected will remain confidential. Your name and any identifying 
information will be collected separately from the data. All data collected with no 
personal identifiers will be retained indefinitely. All data collected with personal 
identifiers will be retained for 15 years following publication. If you choose to 
withdraw from this study, your data will be immediately removed and destroyed 
from our database. Our research records will be locked in a cabinet in the 
principal investigator’s secure lab in Elborn College, Western University. Audio 
recordings from participants will be de-identified. The de-identified audio files 
will be encrypted and stored on the secure hard drive of a single desktop computer 
in the principal investigator’s lab in Elborn College at Western University.  
Listener participants will make perceptual ratings from de-identified audio 
recordings. All other data collected will remain accessible only to the 
investigators of this study. Representatives of the University of Western Ontario 
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Health Sciences Research Ethics Board may require access to your study-related 
documents to oversee the ethical conduct of this study. Representatives of Lawson 
Quality Assurance Education Program may require access to your study-related 
documents to ensure that proper laws and guidelines are being followed. You do 
not waive any legal rights by signing the consent form.   
 
25. Publication 
If the results of the study are published, your name will not be used, and no 
information that discloses your identity will be released or published. If requested, 
you will be provided with a copy of any publication related to the results of this 
study when it becomes available. 
 
26. Contacts for Further Information 
If you require any further information regarding this research project or your 
participation in the study, you may contact Dr. Allyson Page at (519) 661-2111 
ext. 88940 and allyson.page@uwo.ca, or Dr. Scott Adams at (519) 661-2111 ext. 
88941 and sadams@uwo.ca . 
 
If you have any questions about your rights as a research participant or the 
conduct of this study, you may contact The Office of Human Research Ethics 
(519) 661-3036, email: ethics@uwo.ca.  
 
If you agree to participate in this study, please sign the consent form on the next 
page. 
 
 
Sincerely, 
 
Allyson Page, PhD   Scott Adams, PhD  Cynthia Mancinelli 
Associate Professor  Professor   MClSc/PhD candidate 
 
This letter is yours to keep for future reference.  
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Appendix K: Consent Form for Control Participants 
Consent Form for Participants without Parkinson’s Disease 
Project Title:  
Examining the temporal variability of speech intensity, speech intelligibility, and 
communicative participation in individuals with hypophonia and Parkinson’s disease 
 
Principal Investigators: 
Allyson Page, PhD 
Associate Professor 
School of Communication Sciences and Disorders 
Western University 
Tel: 519-661-2111 ext. 88940 
 
Scott Adams, PhD 
Professor 
School of Communication Sciences and Disorders 
Western University 
Tel: 519-661-2111 ext. 88941 
 
Co-Investigators: 
Cynthia Mancinelli 
MClSc/PhD Candidate, Speech and Language Science 
Health and Rehabilitation Sciences 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director 
Movement Disorders Program; Clinical Neurological Sciences 
London Health Sciences Centre, University Campus, and Western University 
 
I have read the Letter of Information and have had the nature of the study explained to 
me, and I agree to participate. All questions have been answered to my satisfaction. 
 
________________________________________________________________________ 
Signature of Research Participant   Printed Name   Date  
 
 
Signature of Person Obtaining Informed Consent Printed Name   Date 
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Appendix L: Letter of Information for Primary Communication Partners of 
Participants with Parkinson's Disease 
Project Title:  
Examining the temporal variability of speech intensity, speech intelligibility, and 
communicative participation in individuals with hypophonia and Parkinson’s disease 
 
Principal Investigators: 
Allyson Page, PhD 
Associate Professor 
School of Communication Sciences and Disorders; Health and Rehabilitation Sciences 
Western University 
Tel: 519-661-2111 ext. 88940 
 
Scott Adams, PhD 
Professor 
School of Communication Sciences and Disorders; Health and Rehabilitation Sciences 
Western University 
Tel: 519-661-2111 ext. 88941 
 
Co-Investigators: 
Cynthia Mancinelli 
MClSc/PhD Candidate, Speech and Language Science 
Health and Rehabilitation Sciences 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director 
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Letter of Information for Communication Partner Participants 
 
27. Invitation to Participate 
You are invited to participate in this research study investigating the variability of 
speech loudness, speech intelligibility, and communicative participation in 
individuals with Parkinson’s disease (PD) and hypophonia (reduced loudness). 
You have been invited to participate because you are the primary communication 
partner of an individual who has been diagnosed with PD and hypophonia. 
 
28. Purpose of the Letter 
The purpose of this letter is to provide you with information required to make an 
informed decision regarding participation in this research study.  
 
29. Purpose of this Study 
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The purpose of this study is to examine the variability of speech and psychosocial 
measures over time in individuals with a speech impairment resulting from 
Parkinson's disease. Psychosocial measures refer to the self-assessment of 
communication in different social situations. For example, we could ask you to 
rate your partner’s effectiveness as a communicator when speaking to a stranger 
on the telephone. This study also aims to explore relationships among speech 
measures, psychosocial measures, and non-speech factors.  
 
30. Inclusion Criteria 
To be eligible to participate in this study, you must: 
7. be between 18 and 85 years of age 
8. be the primary communication partner of a participant with PD, or 
someone who regularly converses with a participant with PD 
9. speak English as your first language. 
31. Exclusion Criteria 
You are ineligible to participate if you:  
11. cannot read and/or write 
12. do not pass a 40 dB hearing screening test 
13. are not the primary communication partner of a participant with PD, or 
someone who regularly converse with a participant with PD. 
32. Study Procedures 
If you agree to participate, you will be asked to attend 3 visits with your 
communication partner with PD. This study will be conducted over 3 visits. The 
first and second visits will occur within a 5-day period. The third visit will occur 
approximately 4 weeks following the second visit. The first and second visits will 
each last approximately 90 minutes. The third visit will last approximately 60 
minutes.   
 
During visit 1, you will first be asked to take basic hearing screening test and to 
provide your age. It is anticipated that completion of the hearing screening will 
take approximately 5 minutes. During all three visits, you will be asked to 
complete a series of seven questionnaires related to the speech and 
communication of your partner who has PD. These questionnaires will look at 
your perceptions of how your communication partner with PD uses his/her speech 
on a daily basis, his/her typical speech loudness, his/her effectiveness as a 
communicator in different social situations, his/her participation in 
communication settings, and the impact of his/her voice on their everyday life. It 
is anticipated that the seven questionnaires will take approximately 30 minutes to 
complete during each visit. It is anticipated that your total active participation 
time for this study is 1.5 hours over the course of all 3-study visits. It is 
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anticipated that the total participation time for your communication partner with 
PD is approximately 4 hours over the course of the three study visits.   
 
 
 
If you agree to participate you will be asked to come to the Principal 
Investigator’s Lab in Elborn College (Room 2212) at Western University for a 
hearing screening, and repeated administration of questionnaires. While at Elborn 
College, you will be provided with free parking.   
 
33. Possible Risks and Harms 
There are no known or anticipated physical risks or discomfort associated with 
participation in this study. The experiment will be conducted in a safe and 
hygienic university laboratory with adequate lighting and ventilation. You will be 
seated in a comfortable chair throughout the procedures. To help counteract any 
fatigue you may experience through the duration of the experiment, you will be 
given rest breaks at approximately ten-minute intervals, or more frequently if 
requested. You have the right to withdrawal from the study any time. 
 
As part of this this study, you will undergo a brief hearing screening. This hearing 
screening should not be considered a substitute for a formal hearing assessment 
conducted by a licensed audiologist. Should your hearing threshold results be 
above 40dB during our screening procedure, we will offer you a referral to the 
H.A. Leeper Speech and Hearing Audiology Clinic, located within Elborn College 
at Western University, or you may discuss an audiology referral with your family 
physician. 
 
34. Possible Benefits  
The procedures that will be used during this study are experimental in nature and 
will not provide any direct benefit to the participant. However, it is anticipated that 
results from this study may provide important information about the stability of 
speech and communication in individuals with PD and hypophonia. The potential 
benefits to society include the improvement of the understanding of hypophonia 
in individuals with PD, and the development of more effective tools for 
identifying the impact and severity of hypophonia in individuals with PD. 
 
35. Compensation 
You will not be compensated for your participation in this study. However, free 
on-site parking will be provided. A daily visitor’s parking pass will be provided to 
you upon your arrival to the Elborn College parking lot. 
 
36. Voluntary Participation 
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Participation in this study is voluntary. You may refuse to participate, refuse to 
answer any questions, or withdraw from the study at any time with no effects to 
you or your communication partner’s future treatment or medical care. 
 
37. Confidentiality 
All data collected will remain confidential. Your name and any identifying 
information will be collected separately from the data. All data collected with no 
personal identifiers will be retained indefinitely. All data collected with personal 
identifiers will be retained for 15 years following publication. If you choose to 
withdraw from this study, your data will be immediately removed and destroyed 
from our database. Our research records will be locked in a cabinet in the 
principal investigator’s secure lab in Elborn College, Western University. 
Representatives of the University of Western Ontario Health Sciences Research 
Ethics Board may require access to your study-related documents to oversee the 
ethical conduct of this study. Representatives of Lawson Quality Assurance 
Education Program may require access to your study-related documents to ensure 
that proper laws and guidelines are being followed. You do not waive any legal 
rights by signing the consent form.   
 
38. Publication 
If the results of the study are published, your name will not be used and no 
information that discloses your identity will be released or published. If requested, 
you will be provided with a copy of any publication related to the results of this 
study when it becomes available. 
 
39. Contacts for Further Information 
If you require any further information regarding this research project or your 
participation in the study, you may contact Dr. Allyson Page at (519) 661-2111 
ext. 88940 and allyson.page@uwo.ca, or Dr. Scott Adams at (519) 661-2111 ext. 
88941 and sadams@uwo.ca . 
 
If you have any questions about your rights as a research participant or the 
conduct of this study, you may contact The Office of Human Research Ethics 
(519) 661-3036, email: ethics@uwo.ca.  
 
If you agree to participate in this study, please sign the consent form on the next 
page. 
 
 
Sincerely, 
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Allyson Page, PhD   Scott Adams, PhD  Cynthia Mancinelli 
Associate Professor  Professor   MClSc/PhD candidate 
 
 
This letter is yours to keep for future reference.  
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Appendix M: Consent Form for Primary Communication Partners of Participants 
with Parkinson's Disease 
Consent Form for Communication Partner Participants 
Project Title:  
Examining the temporal variability of speech intensity, speech intelligibility, and 
communicative participation in individuals with hypophonia and Parkinson’s disease 
 
Principal Investigators: 
Allyson Page, PhD 
Associate Professor 
School of Communication Sciences and Disorders 
Western University 
Tel: 519-661-2111 ext. 88940 
 
Scott Adams, PhD 
Professor 
School of Communication Sciences and Disorders 
Western University 
Tel: 519-661-2111 ext. 88941 
 
Co-Investigators: 
Cynthia Mancinelli 
MClSc/PhD Candidate, Speech and Language Science 
Health and Rehabilitation Sciences 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director 
Movement Disorders Program; Clinical Neurological Sciences 
London Health Sciences Centre, University Campus, and Western University 
 
I have read the Letter of Information and have had the nature of the study explained to 
me, and I agree to participate. All questions have been answered to my satisfaction. 
 
________________________________________________________________________ 
Signature of Research Participant   Printed Name   Date  
 
 
Signature of Person Obtaining Informed Consent Printed Name   Date 
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Appendix N: Letter of Information for Listeners 
Project Title:  
Examining the temporal variability of speech intensity, speech intelligibility, and 
communicative participation in individuals with hypophonia and Parkinson’s disease 
 
Principal Investigators: 
Allyson Page, PhD 
Associate Professor 
School of Communication Sciences and Disorders; Health and Rehabilitation Sciences 
Western University 
Tel: 519-661-2111 ext. 88940 
 
Scott Adams, PhD 
Professor 
School of Communication Sciences and Disorders; Health and Rehabilitation Sciences 
Western University 
Tel: 519-661-2111 ext. 88941 
 
Co-Investigators: 
Cynthia Mancinelli 
MClSc/PhD Candidate, Speech and Language Science 
Health and Rehabilitation Sciences 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director 
Movement Disorders Program; Clinical Neurological Sciences 
London Health Sciences Centre, University Campus, and Western University 
 
Letter of Information for Listener Participants 
 
1. Invitation to Participate 
You are invited to participate in this research study investigating the variability of 
speech loudness, speech intelligibility, and communicative participation in 
individuals with Parkinson’s disease (PD) and hypophonia (speech loudness). 
You have been invited to participate because you have normal hearing ability and 
English is your first language. 
  
2. Purpose of the Letter 
The purpose of this letter is to provide you with information required for you to 
make an informed decision regarding participation in this research study.  
 
3. Purpose of this Study 
The purpose of this study is to examine the variability of speech and psychosocial 
measures over time in individuals with a speech impairment resulting from Parkinson's 
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disease. Psychosocial measures refer to the self-assessment of communication in different 
social situations. For example, this may be a rating of one’s effectiveness as a 
communicator when speaking to a stranger on the telephone. This study also aims to 
explore relationships among speech measures, psychosocial measures, and non-speech 
factors 
 
4. Inclusion Criteria 
To be eligible to participate as a listener in this study, you must be 18 years of age or 
older, have normal hearing ability, and speak English as your first language. 
 
5. Exclusion Criteria 
If you have a history of hearing, language, or cognitive impairments, cannot read 
or write, or do not pass a 25 dB hearing screening, you are not eligible to 
participate in this study. Additionally, you will be excluded from the study if you 
have extensive research or clinical experience with individuals with PD. 
 
6. Study Procedures 
If you agree to participate, you will first be asked to take a basic hearing screening 
and to provide your age as well as general information about your medical, speech 
and hearing, and neurological history. The study involves listening to pre-
recorded speech samples of individuals with PD. You will be asked to transcribe 
the audio samples heard. You will also be asked to rate the audio samples with 
regard to speech intelligibility.  
 
This study will involve 50 participants with PD, 50 communication partners of 
participants with PD, 20 healthy control participants, and 10 naïve listeners. It is 
anticipated that the entire experiment will take approximately 4 hours to complete 
over 2 two-hour sessions. The tasks will be conducted in Dr. Allyson Page’s lab, 
which is located in Elborn College, room 2504. There will be a total of 10 
listeners participating in this study. 
 
7. Possible Risks and Harms 
There are no known or anticipated risks or discomforts associated with 
participation in this study. The experiment will be conducted in a safe, hygienic, 
university laboratory with adequate lighting and ventilation. The experimental 
procedures will require minimal physical effort, you will be seated in a 
comfortable chair, and given rest breaks at approximately ten-minute intervals or 
more frequently if requested. 
 
As part of this this study, you will undergo a brief hearing screening. This hearing 
screening should not be considered a substitute for a formal hearing assessment 
conducted by a licensed audiologist. Should your hearing threshold results be 
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above 25dB during our screening procedure, we will offer you a referral to the 
H.A. Leeper Speech and Hearing Audiology Clinic, located within the Elborn 
College at Western University, or you may discuss an audiology referral with 
your family physician. 
 
8. Possible Benefits  
There is no direct benefit to participation in this study. The potential benefits to 
society include an improved understanding of the speech and psychosocial 
measures associated with PD. 
 
9. Compensation 
You will not be compensated for your participation in this study. However, free 
on-site parking will be provided. A daily visitor’s parking pass will be provided to 
you upon your arrival to the Elborn College parking lot. 
 
10. Voluntary Participation 
Participation in this study is voluntary. You may refuse to participate, refuse to 
answer any questions, or withdraw from the study at any time, with no effect on 
your academic status, course evaluation, or grades in any way.  
 
11. Confidentiality 
All data collected will remain confidential. Your name and any identifying 
information will be collected separately from the data. All data collected with no 
personal identifiers will be retained indefinitely. All data collected with personal 
identifiers will be retained for 15 years following publication. If you choose to 
withdraw from this study, your data will be immediately removed and destroyed 
from our database. Our research records will be locked in a cabinet in the 
principal investigator’s secure lab in Elborn College, Western University. Listener 
participants will make perceptual ratings from de-identified audio recordings. All 
other data collected will remain accessible only to the investigators of this study. 
Representatives of the University of Western Ontario Health Sciences Research 
Ethics Board may require access to your study-related documents to oversee the 
ethical conduct of this study. Representatives of Lawson Quality Assurance 
Education Program may require access to your study-related documents to ensure 
that proper laws and guidelines are being followed. You do not waive any legal 
rights by signing the consent form.   
 
12. Contacts for Further Information 
If you require any further information regarding this research project or your 
participation in the study, you may contact Dr. Allyson Page at (519) 661-2111 
ext. 88940 and allyson.page@uwo.ca, or Dr. Scott Adams at (519) 661-2111 ext. 
88941 and sadams@uwo.ca . 
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If you have any questions about your rights as a research participant or the 
conduct of this study, you may contact The Office of Human Research Ethics 
(519) 661-3036, email: ethics@uwo.ca.  
 
13. Publication 
If the results of the study are published, your name will not be used and no 
information that discloses your identity will be released or published. If you 
would like to receive a copy of any potential study results, please contact Dr. 
Allyson Page or Dr. Scott Adams. 
 
If you agree to participate in this study, please sign the consent form on the next 
page. 
 
 
Sincerely, 
 
Allyson Page, PhD   Scott Adams, PhD  Cynthia Mancinelli 
Associate Professor  Professor   MClSc/PhD candidate 
 
 
This letter is yours to keep for future reference.  
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Appendix O: Consent Form for Listeners 
Consent Form for Listener Participants 
Project Title:  
Examining the temporal variability of speech intensity, speech intelligibility, and 
communicative participation in individuals with hypophonia and Parkinson’s disease 
 
Principal Investigators: 
Allyson Page, PhD 
Associate Professor 
School of Communication Sciences and Disorders 
Western University 
Tel: 519-661-2111 ext. 88940 
 
Scott Adams, PhD 
Professor 
School of Communication Sciences and Disorders 
Western University 
Tel: 519-661-2111 ext. 88941 
 
Co-Investigators: 
Cynthia Mancinelli 
MClSc/PhD Candidate, Speech and Language Science 
Health and Rehabilitation Sciences 
Western University 
 
Dr. Mandar Jog, MD, FRCPC 
Director 
Movement Disorders Program; Clinical Neurological Sciences 
London Health Sciences Centre, University Campus, and Western University 
 
I have read the Letter of Information and have had the nature of the study explained to 
me, and I agree to participate. All questions have been answered to my satisfaction. 
 
________________________________________________________________________ 
Signature of Research Participant   Printed Name   Date  
 
 
Signature of Person Obtaining Informed Consent Printed Name   Date 
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Appendix P: Visual Analogue Scale for Ratings of Speech Intelligibility 
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